000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|31724|43398|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche Registration GmbH|Epóetín||31724||31724|43398||2|0|S|0|||0
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|7859|12315|lyfalmen|V0457|8760|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||7859||7859|12315||2|0|E|0|||0
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|24130|33793|lyfalmen|V0475|9452|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||24130||24130|33793||2|0|E|0|||0
000193|N05AH0302|Zyprexa Velotab|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|31168|42695|lyfalmen|V0540|20624|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||31168||31168|42695||2|0||0|||0
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|1|FER|0|0|0|100|DKK|4922|8273|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4922||4922|8273||1|H|S|0|||0
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|4703|9093|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||4703||4703|9093||1|0||0|||0
000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|1|FER|0|0|0|100|DKK|13088|19512|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||13088||13088|19512||1|H|S|0|||0
000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|3048|5693|lyfalmen|V0942|5244|1|6|0|6,0000|Icepharma hf|Merck AB|Prógesterón||3048||3048|5693||2|0|G|0|||0
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4142|7199|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4142||4142|7199|30.9.2020|1|0||0|||0
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|G|0|JAS|0|0|0|100|SEK|3115|5785|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3115||3115|5785||1|0|G|0|||0
000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|8437|13111|lyfalmen|V0942|13111|1|15|0|15,0000|Icepharma hf|Merck AB|Prógesterón||8437||8437|13111||2|0|G|0|||0
000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|1|FKA|0|0|0|100|DKK|38171|51552|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||38171||38171|51552||1|H|S|0|||0
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3464|6266|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3464||3464|6266||1|0||0|||0
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|1|0|1|MRP|0|0|0|100|SEK|95498|124059|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||95498||95498|124059||2|0|S|0|||0
000985|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.12.2018||R|1|0|0|0|0|AZD|0|0|0|100|SEK|10572|16049|lyfalmen|V0095|10481|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||10572||10572|16049||1|0|E|0|||0
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|PLS|0|0|0|100|DKK|16295|23926|lyfalmen|V0115|8242|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||16295||16295|23926||1|0|E|0|||0
001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1881|4087|lyfalmen|V0050|2530|1|100|0|15,8333|Vistor hf|Recordati Ireland Limited|Metóprólól||1881||1881|4087||1|0|G|0|||0
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5778|9451|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5778||5778|9451||1|0|G|0|||0
001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2891|5477|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2891||2891|5477||1|0|G|0|||0
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|1|FKA|0|0|0|100|DKK|19749|28680|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||19749||19749|28680||1|0|S|0|||0
001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|G|0|VIF|0|0|1|100|CHF|13744|20415|lyfalmen|V0637|20412|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||13744||13744|20415||1|0|G|0|||0
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|1|FKA|0|0|0|100|DKK|26922|37325|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||26922||26922|37325||1|0|S|0|||0
001870|QP54AA0601|Slice vet.|forbl|0,2|% w/w|2,5|kg|1|þpakki|duft|QP54AA06|01.02.2019||R|0|0|0|0|0|IBV|0|0|0|100|DKK|142240|229291|veteldis|||0|2,5|0||Vistor hf|Intervet International BV|emamektín||142240||142240|229291||1|0||0|||0
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|1|HES|0|0|0|100|DKK|2541|4995|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2541||2541|4995||1|H|S|0|||0
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|4745|8029|lyfalmen|||1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||4745||4745|8029||1|0|G|0|||0
001905|N03AX0901|Lamictal|dreifit.|2|mg|30|stk|1|glas||N03AX09|01.08.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|533|2232|lyfalmen|||1|30|0|0,2000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||533||533|2232||1|0|G|0|||0
001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1820|2646|lyfalmen|V0291|2048|2|60|0|12,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||834||834|2646||1|0|G|0|||0
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|BIG|0|0|1|100|SEK|3526|6351|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3526||3526|6351||2|0|E|0|||0
001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3179|3960|lyfalmen|V0292|3494|2|60|0|24,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||1789||1789|3960||1|0|G|0|||0
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|1690|3824|lyfalmen|V0004|2839|1|28|0|18,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||1690||1690|3824||1|0|E|0|||0
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|3442|6235|lyfalmen|V0005|3012|1|28|0|37,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3442||3442|6235||1|0|E|0|||0
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|1|FKA|0|0|0|100|DKK|22932|32278|lyfsjukr|||1|5760|0||Vistor hf|Fresenius Kabi AB|Blöndur||22932||22932|32278||2|0|S|0|||0
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3030|5668|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3030||3030|5668||1|0|G|0|||0
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|G|0|MSD|0|0|0|100|DKK|12969|19348|lyfalmen|V0492|17561|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||12969||12969|19348||1|0|G|0|||0
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|G|0|ATE|0|0|1|100|IKR|||lyfalmen|V0362|2728|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||2728||1|0|G|0|||0
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|1|0|1|LPT|0|0|0|100|XEU|25963|36112|lyfsjukr|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||25963||25963|36112||1|0|ES|0|||0
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|G|0|MSD|0|0|0|100|DKK|12342|16260|lyfalmen|V0089|3631|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||10725||10725|16260||1|0|G|0|||0
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|8411|13075|lyfalmen|V0515|5198|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||8411||8411|13075||1|0|G|0|||0
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|11677|17570|lyfalmen|V0253|4190|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||11677||11677|17570||1|0|G|0|||0
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|22662|31936|lyfalmen|V0516|7108|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||22662||22662|31936||1|0|G|0|||0
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|SEK|8761|13557|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8761||8761|13557||1|0|G|0|||0
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|SEK|12936|19303|lyfalmen|V0992|16634|1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||12936||12936|19303||1|0|G|0|||0
003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|6242|10089|lyfalmen|V0971|10087|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6242||6242|10089||1|0|G|0|||0
003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|G|0|AZD|0|0|0|100|SEK|7430|11725|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||7430||7430|11725||1|0|G|0|||0
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3178|5872|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3178||3178|5872||1|0|G|0|||0
003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|0|1|SGB|0|0|0|100|XEU|34860|47365|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||34860||34860|47365||1|H|S|0|||0
003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|2099|3050|lyfalmen|||2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1128||1128|3050||1|0|G|0|||0
003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|G|0|ATE|0|0|0|100|XEU|25964|28357|lyfalmen|||2|500|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||19514||19514|28357||1|0|G|0|||0
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1109|2768|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||923||923|2768||1|0|E|0|||0
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2352|3481|lyfalmen|V0322|2858|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||1441||1441|3481||1|0|G|0|||0
004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|1|HES|0|0|0|100|DKK|19412|28217|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||19412||19412|28217||1|H|S|0|||0
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|G|0|HES|0|0|0|100|DKK|8117|12670|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||8117||8117|12670||1|0|G|0|||0
004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4421|7583|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4421||4421|7583||1|0|G|0|||0
004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5942|9676|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5942||5942|9676||1|0|G|0|||0
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|1|PEU|0|0|0|100|DKK|17796|25992|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||17796||17796|25992||1|H|ES|0|||0
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|BOI|0|0|0|100|DKK|7891|15141|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Fenetamathýdrójoðíð í blöndum með öðrum sýklalyfjum||7891||7891|15141||1|0||0|||0
004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2574|5041|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||2574||2574|5041||1|0||0|||0
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2929|2844|lyfalmen|V0494|2844|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||978||978|2844||1|0|G|0|||0
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2914|4406|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||2113||2113|4406|30.11.2020|1|0|G|0|||0
004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3130|5806|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||3130||3130|5806||1|0||0|||0
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4256|4588|lyfalmen|V0320|4251|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||2245||2245|4588||1|0|G|0|||0
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2057|3675|lyfalmen|V0317|3675|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||1582||1582|3675||1|0|G|0|||0
004676|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.03.2018||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1023|3180|0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0||0|||0
004687|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1022|2299|0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0||0|||0
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|G|0|SDH|0|0|0|100|XEU|8446|13123|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8446||8446|13123||1|0|G|0|||0
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|861|2683|lyfalmen|||2|24|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||861||861|2683||1|0||0|||0
004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|1|PLS|0|0|1|100|DKK|4318|7441|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4318||4318|7441||1|0|ES|0|||0
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|ATE|0|0|1|100|DKK|369|2006|lyfalmen|||2|8|0|2,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||369||369|2006||1|0||0|||0
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|947|2801|lyfalmen|||2|14|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||947||947|2801||1|0||0|||0
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1620|3728|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||1620||1620|3728||1|0||0|||0
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2641|5133|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||2641||2641|5133||1|0||0|||0
005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|8992|7800|lyfalmen|V0148|4063|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4579||4579|7800||1|0|G|0|||0
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2617|5100|lyfalmen|||2|20|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díkloxacillín||2617||2617|5100||1|0|E|0|||0
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2682|4464|lyfalmen|V0337|4227|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díkloxacillín||2155||2155|4464||1|0|E|0|||0
005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|18724|27270|lyfalmen|V0356|27268|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18724||18724|27270||1|0|G|0|||0
005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|1|G|0|AZA|0|0|0|100|SEK|52543|68234|lyfalmen|V0451|57792|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||51360||51360|68234||1|0|G|0|||0
005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|G|0|BOI|0|0|0|100|DKK|1835|4024|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1835||1835|4024||1|0|G|0|||0
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|4997|8376|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4997||4997|8376||1|0|G|0|||0
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|5041|8436|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5041||5041|8436||1|0|G|0|||0
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1920|4141|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1920||1920|4141||2|0|G|0|||0
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|6030|9798|lyfalmen|V0020|7004|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||6030||6030|9798||2|0|G|0|||0
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|4405|7561|lyfalmen|V0020|3502|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4405||4405|7561||2|0|G|0|||0
005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4749|8034|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Europe B.V.|Cetrorelix||4749||4749|8034||2|0|G|0|||0
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|5581|9180|lyfalmen|V0324|4245|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5581||5581|9180||1|0|G|0|||0
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8958|13828|lyfalmen|V0325|5338|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8958||8958|13828||1|0|E|0|||0
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|G|0|NED|0|0|0|100|XEU|2815|5372|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2815||2815|5372||2|0|G|0|||0
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|15048|22097|lyfalmen|V0326|6681|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14966||14966|22097||1|0|E|0|||0
005963|J01CR0204|Amoxin comp|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RHA|0|0|1|100|IKR|1834|2532|lyfalmen|V0169|2530|2|14|0|8,1667|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||751||751|2532||2|0|E|0|||0
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5650|9275|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5650||5650|9275||1|0|G|0|||0
006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|1|MSD|0|0|0|100|DKK|102848|134425|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||102848||102848|134425||1|H|ES|0|||0
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5396|8925|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5396||5396|8925||1|0|G|0|||0
006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|1|MSD|0|0|0|100|DKK|78573|102653|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||78573||78573|102653||1|H|ES|0|||0
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|1|0|0|100|DKK|3654|7103|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|Meloxícam||||3654|7103||1|0||0|||0
006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|G|0|LEP|0|0|0|100|DKK|13889|20615|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13889||13889|20615||1|0|G|0|||0
006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|1|GEB|0|1|0|100|XEU|458958|577326|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||458958||458958|577326||1|H|L|0|||0
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|G|0|MSD|0|0|0|100|DKK|13966|20721|lyfalmen|V0099|15805|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||13966||13966|20721||1|0|G|0|||0
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|12081|18126|lyfalmen|V0117|5063|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12081||12081|18126||1|0|E|0|||0
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|17300|25310|lyfalmen|V0118|8199|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||17300||17300|25310||1|0|E|0|||0
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|20570|29291|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20570||20570|29291||1|0|E|0|||0
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|1|0|1|PLS|0|1|0|100|DKK|86197|112296|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||86197||86197|112296||1|0|L|0|||0
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|1|0|1|PLS|0|1|0|100|DKK|220376|280597|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||220376||220376|280597||1|0|L|0|||0
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|G|0|PLS|0|0|0|100|DKK|2343|4723|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2343||2343|4723||1|0|G|0|||0
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|1|BAM|0|0|0|100|SEK|7595|11952|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||7595||7595|11952||2|0|S|0|||0
007449|V03AB3402|Fomepizol EUSA Pharma|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|1|SER|0|0|0|100|XEU|99829|129537|lyfsjukr|||1|100|0||SERB SA|SERB SA|Fómepízól||99829||99829|129537||3|H|S|0|||0
007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|1|ABV|0|0|0|100|DKK|23663|33203|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||23663||23663|33203||1|H|S|0|||0
007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|6208|10043|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||6208||6208|10043||1|0|G|0|||0
007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|0|1|SHG|0|1|0|100|XEU|253744|322098|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||253744|322098||1|H|L|0|||0
007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|5043|8439|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||5043||5043|8439||1|0|G|0|||0
007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|15915|23403|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||15915||15915|23403||1|0|G|0|||0
007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1741|2825|lyfalmen|V0290|2737|2|60|0|6,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||964||964|2825||1|0|G|0|||0
007852|G02BB0101|NuvaRing|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst.|G02BB01|01.11.2002||R|0|0|0|0|0|DSM|0|0|0|100|DKK|4102|6395|lyfalm11|V0983|5636|1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||4102||4102|6395||1|0||0|||0
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|NEL|0|0|0|100|DKK|1412|3441|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1412||1412|3441||1|0||0|||0
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|G|0|MCK|0|0|0|100|SEK|351|1981|lyfalmen|V0502|1067|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||351||351|1981||2|0|G|0|||0
008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|918|2333|lyfalmen|V0226|2255|2|20|0|6,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||607||607|2333||1|0|G|1|30|dagar|0
008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1077|2980|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||1077||1077|2980||1|0|G|0|||0
008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2927|4836|lyfalmen|V0227|4526|2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||2425||2425|4836||1|0|G|1|30|dagar|0
008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4164|5745|lyfalmen|V0228|5352|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||3086||3086|5745||1|0|G|1|30|dagar|0
008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4880|7264|lyfalmen|V0224|6728|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||4189||4189|7264||1|0|G|1|30|dagar|0
008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|0|1|GEB|0|0|0|100|XEU|129766|167904|lyfsjukr|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||129766||129766|167904||1|H|S|0|||0
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|CHP|0|0|0|100|XEU|8120|13996|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |Fenbendazolum||8120||8120|13996||2|0||0|||0
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|CHP|1|0|0|100|XEU|12169|23258|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||12169||12169|23258||2|0||0|||0
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2783||2|0|G|0|||0
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2872|5451|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2872||2872|5451||1|0|G|0|||0
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|89342|116273|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||89342||89342|116273||2|0|S|0|||0
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|109979|143294|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||109979||109979|143294||2|0|S|0|||0
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|7242|11466|lyfalmen|V0145|2105|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||7242|11466||2|0|E|0|||0
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|14360|21263|lyfalmen|V0145|4210|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||14360|21263||2|0|E|0|||0
008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0
009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4383|7531|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4383||4383|7531||2|0|G|0|||0
009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|1|FMC|0|0|0|100|XEU|8034|12556|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8034||8034|12556||2|0|S|0|||0
009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|4944|8303|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4944||4944|8303||2|0|G|0|||0
009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|1|FMC|0|0|0|100|XEU|8034|12556|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8034||8034|12556||2|0|S|0|||0
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|PEU|0|0|1|100|DKK|11267|17006|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Europe MA EEIG|Parekoxíb||11267||11267|17006||1|0||0|||0
009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|1|FMC|0|0|0|100|XEU|7036|11182|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7036||7036|11182||2|0|S|0|||0
009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|1|PEU|0|0|1|100|DKK|22413|31622|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||22413||22413|31622||1|0|ES|0|||0
009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1169|3107|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1169||1169|3107||1|0|G|0|||0
009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1290|3273|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1290||1290|3273||1|0|G|0|||0
009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1489|3547|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1489||1489|3547|31.10.2020|1|0|G|0|||0
009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1868|4069|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1868||1868|4069||1|0|G|0|||0
009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|NOK|6426|10343|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6426||6426|10343||2|0|S|0|||0
009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|XEU|7752|12168|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7752||7752|12168||2|0|S|0|||0
009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|NOK|6426|10343|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6426||6426|10343||2|0|S|0|||0
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|1|0|1|GII|0|0|0|100|DKK|57939|76555|lyfsjukr|||1|30|0|30,0000|Gilead Sciences International Ltd|Gilead Sciences Ireland UC|Tenófóvír dísóproxíl||57939||57939|76555||2|0|S|0|||0
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9626|14747|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9626||9626|14747||1|0||0|||0
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|11001|16640|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||11001||11001|16640||1|0||0|||0
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8713|13490|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8713||8713|13490||1|0||0|||0
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|11001|16640|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||11001||11001|16640||1|0||0|||0
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8833|13656|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8833||8833|13656||1|0||0|||0
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9626|14747|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9626||9626|14747||1|0||0|||0
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002|30.09.2020|R|1|0|0|0|1|ROA|0|0|1|100|DKK|211775|269900|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||211775||211775|269900||2|0|S||||
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|1|0|1|MSD|0|0|0|100|DKK|6085|9873|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||6085||6085|9873||1|H|ES|0|||0
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|G|0|LUN|0|0|0|100|DKK|16367|24025|lyfalmen|V0605|2793|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||16367||16367|24025||1|0|G|0|||0
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|8251|12855|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||8251||8251|12855||1|0|E|0|||0
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|1|FKA|0|0|0|100|DKK|10106|15408|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||10106||10106|15408||1|H|S|0|||0
010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|SAO|0|0|1|100|XEU|1426|3461|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1426||1426|3461||2|0||0|||0
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|1|0|1|JCI|0|1|0|100|SEK|268725|340730|lyfsjukr|||1|56|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||268725||268725|340730||3|0|L|0|||0
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|1|0|1|JCI|0|1|0|100|SEK|269421|341596|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||269421||269421|341596||3|0|L|0|||0
010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|1|0|1|PEU|0|0|0|100|DKK|726304|909830|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||726304||726304|909830||1|0|ES|0|||0
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|0|1|BAM|0|0|0|100|SEK|43150|57850|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||43150||43150|57850||2|H|S|0|||0
010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2840|2815|lyfalmen|V0058|2815|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||957||957|2815||2|0|G|0|||0
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|20740|29506|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||20740||20740|29506||1|0|E|0|||0
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|13973|20730|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||13973||13973|20730||1|0||0|||0
010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|3905|3273|lyfalmen|V0059|3273|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||1290||1290|3273||2|0|G|0|||0
010989|R06AE0707|Cetirizin STADA|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.05.2018||L|1|0|0|G|0|ASR|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cetirizín|||||1677||2|0|G|0|||0
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|31860|43570|lyfalmen|V0683|3060|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||31860||31860|43570||1|0|E|0|||0
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|25742|35832|lyfalmen|V0684|3060|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||25742||25742|35832||1|0|G|0|||0
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3703|6595|lyfalmen|V0825|2811|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3703||3703|6595||1|0|G|0|||0
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3833|6774|lyfalmen|V0826|2870|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3833||3833|6774||1|0|G|0|||0
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|16421|24100|lyfalmen|V0327|8256|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||16421||16421|24100||1|0|E|0|||0
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|MSD|0|0|1|100|DKK|1206|3158|lyfalmen|V0827|2159|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1206||1206|3158||1|0|G|0|||0
011397|J01CA0102|Doktacillin|stl/irs|||1|g|10|hgl||J01CA01|01.03.2020||R|0|0|0|0|1|MEA|0|0|1|100|SEK|15087|22264|lyfsjukr|||1|10|0|1,6666|Icepharma hf|Meda AB|Ampicillín||15087||15087|22264||2|0|0|0|||0
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|G|0|AZD|0|0|0|100|SEK|6158|9974|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6158||6158|9974||1|0|G|0|||0
011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|5548|9134|lyfalmen|V0691|6051|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5548||5548|9134||1|0|E|1|30|dagar|0
011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|7096|8560|lyfalmen|V0624|5813|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5131||5131|8560||1|0|E|1|30|dagar|0
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|CHP|1|0|0|100|XEU|1982|3895|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||1982||1982|3895||2|0||0|||0
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|0|0|1|PLS|0|0|0|100|DKK|3904|6871|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3904||3904|6871||1|H|S|1|30|dagar|0
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|OCO|0|0|0|100|DKK|4592|8882|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||4592||4592|8882||2|0||0|||0
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3745|5297|lyfalmen|V0323|4166|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||2760||2760|5297||1|0|G|0|||0
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|1|MAR|0|0|0|100|DKK|3970|6962|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3970||3970|6962||2|H|S|0|||0
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|1|MAR|0|0|0|100|DKK|2091|4376|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||2091||2091|4376||2|H|S|0|||0
012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|1|0|1|MSD|0|0|0|100|DKK|28982|39930|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||28982||28982|39930||1|0|S|0|||0
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3815|6749|lyfalmen|V0909|3154|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3815||3815|6749||1|0|G|0|||0
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|6968|11089|lyfalmen|V0924|6005|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||6968||6968|11089||2|0|E|0|||0
012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|0|0|0|JAS|0|0|0|100|SEK|9287|10999|lyfalmen|V0622|6677|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6903||6903|10999||1|0|E|1|30|dagar|0
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|GPH|0|0|1|100|DKK|979|2845|lyfalmen|||1|80|0|2,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||979||979|2845||1|0|E|0|||0
012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|JCI|0|0|0|100|SEK|4519|6909|lyfalm11|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4519||4519|6909||1|0||0|||0
012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki|hlaup til notkunar um húð|G03BA03|01.12.2003||R|0|0|0|G|0|LBI|0|0|0|100|DKK|6137|9945|lyfalmen|||1|30|0|30,0000|Vistor hf|Laboratoires Besins International|Testósterón||6137||6137|9945||1|0|G|0|||0
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1974|2723|lyfalmen|V0250|2723|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||890||890|2723||2|0|G|0|||0
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2941|3356|lyfalmen|V0251|3150|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||1350||1350|3356||2|0|G|0|||0
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|6801|9184|lyfalmen|V0959|4870|1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5584||5584|9184||1|0|E|1|30|dagar|0
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|9795|13594|lyfalmen|V0996|7898|1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8788||8788|13594||1|0|E|1|30|dagar|0
013172|J06BB0101|Rhophylac|stl|300|mcg|2|ml|1|áfspr||J06BB01|01.02.2004||R|0|0|0|0|1|CSB|0|0|0|100|SEK|7891|12359|lyfsjukr|||1|2|0||Icepharma hf|CSL Behring GmbH|And-D(rh) immúnóglóbúlín||7891||7891|12359||2|H|S|0|||0
013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3085|5744|lyfalmen|V0042|4460|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxazósín||3085||3085|5744||1|0|G|0|||0
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|1|0|1|AZE|0|1|0|100|SEK|319945|404433|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Gefitiníb||319945||319945|404433||1|0|L|0|||0
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1309|3300|lyfalmen|||1|5|0|1,6700|Icepharma hf|Mundipharma A/S|Oxýcódon||1309||1309|3300||2|0|E|1|30|dagar|0
013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|851|2507|lyfalmen|V0562|2349|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Íbúprófen||733||733|2507||2|0|G|0|||0
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2515|4960|lyfalmen|||1|10|0|3,3300|Icepharma hf|Mundipharma A/S|Oxýcódon||2515||2515|4960||2|0|E|1|30|dagar|0
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|384|2026|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Lídókaín||384||384|2026||2|0||0|||0
013872|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|G|0|AZD|0|0|0|100|SEK|10561|16034|lyfalmen|V0215|10045|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10561||10561|16034||1|0|G|0|||0
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|6332|10213|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6332||6332|10213||1|0|G|0|||0
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2336|4713|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2336||2336|4713||1|0|G|0|||0
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4873|8205|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4873||4873|8205||1|0|G|0|||0
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|1|0|1|NEL|0|1|0|100|DKK|104014|135876|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||104014||104014|135876||1|0|L|0|||0
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|1|0|1|NEL|0|1|0|100|DKK|207078|264058|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||207078||207078|264058||1|0|L|0|||0
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2521|4968|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2521||2521|4968||1|0|G|0|||0
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|1|GRH|0|0|1|100|DKK|6679|10691|lyfsjukr|||1|50|0|13,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||6679||6679|10691||1|0|ES|0|||0
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|G|0|UCB|0|0|0|100|DKK|16704|24489|lyfalmen|V1000|16638|1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||16704||16704|24489||1|0|G|0|||0
014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|53176|70531|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||53176||53176|70531||2|0|E|0|||0
014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1396|3419|lyfalmen|V0479|3099|2|60|0|4,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1396||1396|3419||1|0|E|0|||0
014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1809|3988|lyfalmen|||2|100|0|6,6667|Artasan ehf|Sandoz A/S|Amoxicillín||1809||1809|3988||1|0|E|0|||0
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|G|0|AZD|0|0|0|100|SEK|18477|26930|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18477||18477|26930||1|0|G|0|||0
014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|408|1860|lyfalmen|V0563|1759|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Íbúprófen||263||263|1860||2|0|G|0|||0
014435|QM01AE0303|Dolovet vet.|duft|160|mg/g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|VET|0|0|0|100|XEU|2603|5109|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|Ketóprófen||2603||2603|5109||2|0||0|||0
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|1|0|1|GEI|0|0|0|100|DKK|79117|103341|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Adefovír||||79117|103341||2|0|S|0|||0
014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1108|2351|lyfalmen|V0564|2113|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Íbúprófen||620||620|2351||2|0|G|0|||0
014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|963|2823|lyfalmen|||1|28|0|1,8600|Icepharma hf|Mundipharma A/S|Oxýcódon||963||963|2823||2|0|G|1|30|dagar|0
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|24546|34319|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||24546||24546|34319||1|0|G|0|||0
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|68006|89288|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||68006||68006|89288||1|0|G|0|||0
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|45334|60612|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||45334||45334|60612||1|0|G|0|||0
014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|OEU|0|0|0|100|XEU|743580|931317|lyfalmen|||1|60|0|60,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||743580||743580|931317||3|0|E|0|||0
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2705|4222|lyfalmen|V0673|4030|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1979||1979|4222||1|0|G|0|||0
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|G|0|NAS|0|0|0|100|DKK|7816|12256|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7816||7816|12256||1|0|G|0|||0
015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1121|3041|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1121||1121|3041||1|0|G|0|||0
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1870|2956|lyfalmen|V0234|1831|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||1059||1059|2956||1|0|G|0|||0
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2669|2956|lyfalmen|V0233|2333|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||1059||1059|2956||1|0|G|0|||0
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|G|0|NAS|0|0|0|100|DKK|9093|14014|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||9093||9093|14014||1|0|G|0|||0
015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|1|PAM|0|0|0|100|DKK|306193|387330|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||306193||306193|387330||3|H|S|0|||0
015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|1|PAM|0|0|0|100|DKK|81604|106486|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||||81604|106486||3|H|S|0|||0
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|12393|18556|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12393||12393|18556||1|0|G|0|||0
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|12322|18458|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12322||12322|18458||1|0|G|0|||0
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|10766|16316|lyfalmen|V0829|13781|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10766||10766|16316||1|0|G|0|||0
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|18857|22261|lyfalmen|V0470|22261|1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||15085||15085|22261||1|0|G|0|||0
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|37668|41387|lyfalmen|V1008|41387|1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||30134||30134|41387||1|0|G|0|||0
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4065|7006|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||4065||4065|7006||2|0||0|||0
015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6249|10771|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||6249||6249|10771||2|0||0|||0
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3380|5826|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3380||3380|5826||2|0||0|||0
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3430|5912|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3430||3430|5912||2|0||0|||0
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5998|10338|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5998||5998|10338||2|0||0|||0
015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|100|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2|0||0|||0
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|0|0|0|ETH|0|0|1|100|GBP|1487|3545|lyfalmen|||2|10|0|3,3300|Icepharma hf|Ethypharm|Morfín||1487||1487|3545||2|0|E|1|30|dagar|0
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3298|5684|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3298||3298|5684||2|0||0|||0
015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|60|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2|0||0|||0
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|1670|3797|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1670||1670|3797||1|0|E|0|||0
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2560|5022|lyfalmen|||1|14|0|7,0000|Icepharma hf|Upjohn EESV|Pregabalín||2560||2560|5022||1|0|E|0|||0
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|5436|8980|lyfalmen|V0686|2033|1|56|0|14,0000|Icepharma hf|Upjohn EESV|Pregabalín||5436||5436|8980||1|0|E|0|||0
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|9586|14692|lyfalmen|V0687|2766|1|56|0|28,0000|Icepharma hf|Upjohn EESV|Pregabalín||9586||9586|14692||1|0|E|0|||0
016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|G|0|ATE|0|0|0|100|XEU|5261|8739|lyfalmen|||2|1000|0|1000,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||5261||5261|8739|31.10.2020|1|0|G|0|||0
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|1683|3814|lyfalmen|||1|14|0|3,5000|Icepharma hf|Upjohn EESV|Pregabalín||1683||1683|3814||1|0|E|0|||0
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|12075|18118|lyfalmen|V0689|3460|1|56|0|56,0000|Icepharma hf|Upjohn EESV|Pregabalín||12075||12075|18118||1|0|E|0|||0
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|1|PEU|0|0|1|100|DKK|96507|125336|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||96507||96507|125336||1|0|ES|0|||0
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|0|1|PLS|0|0|0|100|DKK|3365|6130|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3365||3365|6130||1|H|S|0|||0
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2464|4889|lyfalmen|V0685|2190|1|56|0|4,6667|Icepharma hf|Upjohn EESV|Pregabalín||2464||2464|4889||1|0|E|0|||0
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|16999|24895|lyfalmen|V0690|6125|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||16999||16999|24895||1|0|E|0|||0
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||8557||1|0|E|0|||0
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|28071|38778|lyfalmen|V0682|3060|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||28071||28071|38778||1|0|E|0|||0
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|8096|10899|lyfalmen|V0960|6040|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6830||6830|10899||1|0|E|1|30|dagar|0
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|G|0|LVR|0|0|0|100|DKK|3048|5693|lyfalmen|||3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3048||3048|5693|30.11.2020|3|0|G|0|||0
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|G|0|LVR|0|0|0|100|DKK|5797|9477|lyfalmen|||3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5797||5797|9477|30.11.2020|3|0|G|0|||0
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|52977|70279|lyfalmen|V0721|8450|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||52977||52977|70279||1|0||0|||0
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|78049|101990|lyfalmen|V0722|15262|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||78049||78049|101990||1|0||0|||0
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|29017|39974|lyfalmen|V0720|8006|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||29017||29017|39974||1|0||0|||0
016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|1|GEB|0|1|0|100|XEU|66847|87822|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||66847||66847|87822||1|H|L|0|||0
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1615|3721|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1615|3721||1|0|E|0|||0
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|1|0|1|GEI|0|0|0|100|DKK|33060|45088|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín||33060||33060|45088||2|0|S|0|||0
016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|2129|4428|lyfalmen|V0943|3282|1|4|0|2,8000|Icepharma hf|Mundipharma A/S|Búprenorfín||2129||2129|4428||2|0|G|1|30|dagar|0
017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1071|2660|lyfalm11|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1071||1071|2660||1|0|G|0|||0
017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|ATE|0|0|0|100|XEU|6681|10694|lyfalmen|||2|500|0|333,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||6681||6681|10694||1|0||2|225|mg|0
017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|ATE|0|0|0|100|SEK|7335|11594|lyfalmen|||2|500|0|500,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||7335||7335|11594||1|0||2|225|mg|0
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|1|0|1|BNB|0|0|0|100|XEU|93242|121206|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||93242||93242|121206||2|0|S|0|||0
017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|3817|6752|lyfalmen|V0944|3501|1|4|0|5,6000|Icepharma hf|Mundipharma A/S|Búprenorfín||3817||3817|6752||2|0|G|1|30|dagar|0
017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|6800|10857|lyfalmen|V0945|6321|1|4|0|11,2000|Icepharma hf|Mundipharma A/S|Búprenorfín||6800||6800|10857||2|0|G|1|30|dagar|0
017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|1|MSD|0|0|1|100|DKK|7903|12376|lyfsjukr|||1|3|0|1,7273|Vistor hf|M.S.D.|Aprepitant||7903||7903|12376||1|0|S|0|||0
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|G|0|MEA|0|0|1|100|DKK|2799|5350|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2799||2799|5350||2|0|G|0|||0
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|6922|13303|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||6922||6922|13303||1|0||0|||0
017668|J02AC0107|Fluconazol Krka|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1500|2186|lyfalmen|V0556|2186|2|4|0|3,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||500||500|2186||2|0||0|||0
017679|J02AC0107|Fluconazol Krka|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.12.2018||L|1|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól|||||||2|0||0|||0
017701|J02AC0107|Fluconazol Krka|hylki|150|mg|6|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2300|3563|lyfalmen|V0556|3279|2|6|0|4,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1500||1500|3563||2|0||0|||0
017712|J02AC0107|Fluconazol Krka|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1271|2117|lyfalmen|V0551|2007|2|7|0|1,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól||450||450|2117||2|0||0|||0
017745|J02AC0107|Fluconazol Krka|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|3500|2599|lyfalmen|V0552|2555|2|28|0|7,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||800||800|2599||2|0||0|||0
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|PLS|0|0|0|100|DKK|9170|14120|lyfalmen|V0107|2530|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9170||9170|14120||1|0|0|0|||0
018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2599|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||800||800|2599||2|0|G|0|||0
018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2107|3356|lyfalmen|V0947|3356|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1350||1350|3356||2|0|G|0|||0
018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2975|3631|lyfalmen|V0948|3631|2|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1550||1550|3631||2|0|G|0|||0
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|G|0|GPH|0|0|0|100|DKK|900|2360|lyfalmen|V0243|2155|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||626||626|2360||1|0|G|0|||0
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|6828|10896|lyfalmen|V0985|7087|1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6828||6828|10896||1|0|G|0|||0
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|19084|27765|lyfalmen|V0441|12261|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||19084||19084|27765||1|0|G|0|||0
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|G|0|MEC|0|0|1|100|SEK|1174|3114|lyfalmen|V0414|3114|1|100|0|50,0000|Icepharma hf|Merck AB|Prednisólón||1174||1174|3114||2|0|G|0|||0
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|5693|9334|lyfalmen|V0438|3836|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5693||5693|9334||1|0|G|0|||0
018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|4964|8330|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||4964||4964|8330||1|0|E|0|||0
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|14397|21314|lyfalmen|V0440|9648|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||14397||14397|21314||1|0|G|0|||0
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|PLS|0|0|0|100|DKK|33067|45097|lyfalmen|V0111|6315|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||33067||33067|45097||1|0|E|0|||0
018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|0|1|WIL|0|0|0|100|XEU|102968|134575|lyfsjukr|||1|3|0|21,0000|Williams & Halls efh|medac Gesellschaft|BCG bóluefni||102968||102968|134575||2|H|S|0|||0
018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|799|2598|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||799||799|2598||1|0|E|0|||0
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|1|0|1|TGM|0|0|0|100|NOK|80383|104942|lyfsjukr|||1|28|0|28,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||80383||80383|104942||1|0|ES|0|||0
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|KEL|1|0|0|100|NOK|947|1861|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|Lídókaín í blöndum||947||947|1861||2|0||0|||0
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|1|GEH|0|0|0|100|NOK|5723|9375|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||5723||5723|9375||2|H|S|0|||0
019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|184823|226689|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||177032||177032|226689||2|H|L|0|||0
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|17398|25445|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||17398||17398|25445||2|H|S|0|||0
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|20808|29592|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||20808||20808|29592||2|H|S|0|||0
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|18709|27249|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||18709||18709|27249||2|H|S|0|||0
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|25178|35119|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||25178||25178|35119||2|H|S|0|||0
019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|92411|115229|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||88516||88516|115229||2|H|L|0|||0
019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|46205|59251|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||44258||44258|59251||2|H|L|0|||0
019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|23103|31261|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||22128||22128|31261||2|H|L|0|||0
019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|6536|12571|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||6536||6536|12571||1|0||0|||0
019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|502|2020|lyfalmen|V0633|2020|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||379||379|2020||1|0|G|0|||0
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|CAR|0|0|0|100|DKK|33696|64099|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||33696||33696|64099||1|0||0|||0
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|6814|10877|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6814||6814|10877||2|0|E|0|||0
019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|1|RRG|0|1|0|100|DKK|50711|67413|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||50711||50711|67413||2|H|L|0|||0
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|6364|10257|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6364||6364|10257||2|0|E|0|||0
019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|1|RRG|0|1|0|100|DKK|192005|245312|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||192005||192005|245312||2|H|L|0|||0
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|MYL|0|0|1|100|SEK|986|2511|lyfalmen|V0159|2387|2|20|0|6,6667|Icepharma hf|Mylan AB|Amoxicillín||736||736|2511||2|0|E|0|||0
019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|0|1|NED|0|1|0|100|XEU|170244|218247|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||170244||170244|218247||2|H|L|0|||0
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|13307|19814|lyfalmen|V0812|3839|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13307||13307|19814||2|0|E|0|||0
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|13307|19814|lyfalmen|V0813|3839|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13307||13307|19814||2|0|E|0|||0
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12568|18797|lyfalmen|V0814|3839|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12568||12568|18797||2|0|E|0|||0
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12568|18797|lyfalmen|V0815|3839|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12568||12568|18797||2|0|E|0|||0
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12568|18797|lyfalmen|V0816|3968|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12568||12568|18797||2|0|E|0|||0
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|0|1|0|1|VIC|0|0|0|100|DKK|63321|83362|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín og abacavír||63321||63321|83362||1|0|S|0|||0
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1224|2945|lyfalmen|V0160|2945|2|30|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1051||1051|2945||2|0|E|0|||0
019969|N06AB0405|Citalopram PCD|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|G|0|PDA|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|5077|2|100|0|100,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||2600||2600|5077||2|0|G|0|||0
020011|N06AB0405|Citalopram PCD|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|G|0|PDA|0|0|0|100|IKR|4500|4251|lyfalmen|V0320|4251|2|100|0|200,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||2000||2000|4251||2|0|G|0|||0
020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1|0||0|||0
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|32679|44606|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||32679||32679|44606||1|0||0|||0
020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|LVR|0|0|0|100|NOK|2813|5370|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2813||2813|5370|31.10.2020|3|0|E|0|||0
020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|1|0|1|RPR|0|0|0|100|XEU|100336|131301|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|HRA Pharma Rare Diseases|Mitotanum||100336||100336|131301||0|0|S|0|||0
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|ASP|0|0|0|100|XEU|50198|66764|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||50198||50198|66764||1|0|G|0|||0
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|ASP|0|0|0|100|XEU|23260|32693|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||23260||23260|32693||1|0|G|0|||0
020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6779|4814|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||2409||2409|4814||2|0|G|0|||0
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|BOA|0|0|0|100|XEU|2291|3949|vetorma|||0|7,74|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum í blöndum||2291||2291|3949||1|0||0|||0
020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|0|0|UCC|0|0|0|100|DKK|51381|68260|lyfalmen|||1|180|0||Vistor hf|UCB Pharma S.A.|sodium oxybate||||51381|68260||1|0|E|3|||0
020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|VEB|0|0|0|100|XEU|2679|4618|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Pyrantelum||2679||2679|4618||2|0||0|||0
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|LLS|0|0|0|100|DKK|2681|5188|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2681||2681|5188||2|0||0|||0
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|GAN|0|0|0|100|XEU|2094|4380|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2094||2094|4380||2|0||0|||0
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|IKR|633|2369|lyfalmen|V0188|2193|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||633||633|2369||1|0|G|0|||0
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|XEU|1456|2884|lyfalmen|V0189|2668|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||1007||1007|2884||1|0|G|0|||0
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|G|0|MSD|0|0|0|100|DKK|13193|19657|lyfalmen|V0490|16294|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||13193||13193|19657||1|0|G|0|||0
021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1|0||0|||0
021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|URE|0|0|0|100|XEU|36372|49277|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||36372||36372|49277||3|0|G|0|||0
021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|URE|0|0|0|100|XEU|66631|87548|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||66631||66631|87548||3|0|G|0|||0
021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|4128|7180|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4128||4128|7180||1|0|G|0|||0
021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|13780|20465|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13780||13780|20465||1|0|G|0|||0
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|AZD|0|0|0|100|SEK|12809|19128|lyfalmen|V0214|4512|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12809||12809|19128||1|0|E|0|||0
021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|6881|10969|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6881||6881|10969||1|0|G|0|||0
021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|G|0|FER|0|0|0|100|DKK|15136|22331|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15136||15136|22331||1|0|G|0|||0
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|1|FKA|0|0|0|100|DKK|16294|23925|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||16294||16294|23925||1|H|S|0|||0
021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|19334|28109|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||19334||19334|28109||1|0|G|0|||0
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|25080|34995|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||25080||25080|34995||1|0|G|0|||0
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|1|FKA|0|0|0|100|DKK|9369|14393|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||9369||9369|14393||1|H|S|0|||0
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|1|PLS|0|0|1|100|DKK|4484|7670|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4484||4484|7670||1|0|S|0|||0
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|20079|28670|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||20079||20079|28670||1|0|G|0|||0
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|3499|6314|lyfalmen|V0692|2340|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3499||3499|6314||2|0|E|0|||0
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|4916|8264|lyfalmen|V0693|3453|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4916||4916|8264||2|0|E|0|||0
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|12841|19172|lyfalmen|V0694|4135|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||12841||12841|19172||2|0|E|0|||0
021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|1|0|1|SCL|0|0|0|100|DKK|26586|36900|lyfsjukr|||1|100|0||Shire Sweden AB |Shire Pharmaceuticals Ireland Limited|Anagrelidum||26586||26586|36900||1|0|ES|0|||0
022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|1|VIN|0|0|1|100|XEU|2849|5419|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2849||2849|5419||2|0|ES|0|||0
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|1|AXA|0|0|0|100|SEK|109532|142738|lyfsjukr|||1|1200|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||109532||109532|142738||2|H|S|0|||0
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|G|0|SDH|0|0|0|100|XEU|4592|7818|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4592||4592|7818||1|0|G|0|||0
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|1|0|0|LPT|0|0|0|100|XEU|16101|23659|lyfalmen|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||16101||16101|23659||1|0||0|||0
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2340|4033|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||2340||2340|4033||2|0||0|||0
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|3919|3300|lyfalmen|V0056|2307|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1309||1309|3300||1|0|G|0|||0
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|6947|4343|lyfalmen|V0057|2307|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2067||2067|4343||1|0|G|0|||0
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2216|3819|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||2216||2216|3819||2|0||0|||0
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|1435|2473|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|Prazikvantelum í blöndum||1435||1435|2473||2|0||0|||0
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2065|4175|lyfalmen|V0321|4175|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paroxetín||1945||1945|4175||1|0|G|0|||0
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4362||2|0|G|0|||0
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|2339|4717|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2339||2339|4717||1|0|G|0|||0
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|3477|5220|lyfalmen|V0125|3467|2|30|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2704||2704|5220||1|0|G|0|||0
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|1|0|1|GEI|0|0|0|100|DKK|68915|90437|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír dísóproxíl og emtrícítabín||68915||68915|90437||2|0|S|0|||0
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|24728|34550|lyfalmen|||1|90|0|20,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||24728||24728|34550||1|0||0|||0
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|37940|51260|lyfalmen|||1|90|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||37940||37940|51260||1|0||0|||0
023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|3000|3907|lyfalmen|V0125|3467|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||1750||1750|3907||2|0|G|0|||0
023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|LUX|0|0|0|100|DKK|13968|20723|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||13968||13968|20723||1|0|G|0|||0
023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|5231|6935|lyfalmen|V0125|6935|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||3950||3950|6935||2|0|G|0|||0
023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|LUX|0|0|0|100|DKK|16541|24265|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||16541||16541|24265||1|0|G|0|||0
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2411|3140|lyfalmen|V0250|2723|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1193||1193|3140||2|0|G|0|||0
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|3111|3688|lyfalmen|V0251|3150|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1591||1591|3688||2|0|G|0|||0
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|G|0|SGB|0|0|0|100|XEU|17758|25940|lyfalmen|V0029|6134|1|100|0|100,0000|Vistor hf|Sanofi-aventis groupe|Klópídógrel||17758||17758|25940||1|0|G|0|||0
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2115|4409|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2115||2115|4409||2|0|G|0|||0
023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|1|BAM|0|0|0|100|SEK|127473|165052|lyfsjukr|||2|1500|0||Icepharma hf|Baxter Medical AB|Sevóflúran||127473||127473|165052||2|H|S|0|||0
023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|900|2737|lyfalmen|V0066|2737|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2737||2|0|G|0|||0
023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1050|2943|lyfalmen|V0449|2943|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2943||2|0|G|0|||0
023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|750|2530|lyfalmen|V0448|2379|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||750||750|2530||2|0|G|0|||0
023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|6144|9955|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6144||6144|9955||2|0|G|0|||0
023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2327|4030|lyfalmen|V0673|4030|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1840||1840|4030||2|0|G|0|||0
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|1|0|1|UPJ|0|0|0|100|DKK|28349|39129|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Upjohn EESV|Síldenafíl||28349||28349|39129||1|0|ES|0|||0
023993|A02BC0308|Lansoprazol Krka|sþ-hylki|30|mg|98|stk|1|ílát||A02BC03|01.08.2018||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3500|4251|lyfalmen|V0007|4251|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól||2000||2000|4251||2|0|G|0|||0
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|G|0|MSD|0|0|0|100|DKK|2507|4949|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2507||2507|4949||1|0|G|0|||0
024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|OEU|0|0|0|100|XEU|64229|84510|lyfalmen|||1|5|0|5,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||64229||64229|84510||3|0|E|0|||0
024276|N06AB0607|Sertralin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3264|4251|lyfalmen|V0323|4251|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Sertralín||2000||2000|4251||2|0|G|0|||0
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|72367|94803|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||72367||72367|94803||1|0|G|0|||0
024366|N06AB0607|Sertralin Krka|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1926|3012|lyfalmen|V0322|2916|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Sertralín||1100||1100|3012||2|0|G|0|||0
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|12938|19306|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12938||12938|19306||1|0||0|||0
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|12731|19021|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12731||12731|19021||1|0||0|||0
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|10157|15478|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10157||10157|15478||1|0||0|||0
024603|V04CL0001|Soluprick  Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|2525|4973|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||2525||2525|4973||1|0||0|||0
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|5684|9321|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5684||5684|9321|31.10.2020|1|0||0|||0
024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006|30.09.2020|R|0|0|0|0|0|ALK|0|0|0|100|DKK|7596|11953|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7596||7596|11953||1|0||0|||0
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|10310|15689|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10310||10310|15689||1|0||0|||0
024681|V04CL0002|Soluprick  Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|2525|4973|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||2525||2525|4973||1|0||0|||0
024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1820|4003|lyfalmen|||2|100|0|66,6667|Alvogen|ratiopharm GmbH|Metóprólól||1820||1820|4003||2|0|G|0|||0
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|56401|74610|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||56401||56401|74610||1|0|G|0|||0
025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1547|3627|lyfalmen|||2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||1547||1547|3627||2|0|G|0|||0
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|1|0|1|BSP|0|1|0|100|DKK|58665|77473|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||58665||58665|77473||1|0|L|0|||0
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|BOI|1|0|0|100|DKK|9950|19048|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|Meloxícam||9950||9950|19048||1|0||0|||0
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|15600|22970|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||15600||15600|22970||1|0|E|0|||0
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|5448|8997|lyfalmen|V0205|1279|1|1|0|30,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||5448||5448|8997||2|0|E|0|||0
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|14601|21595|lyfalmen|V0205|3838|1|3|0|90,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||14601||14601|21595||2|0|E|0|||0
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|45256|60513|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||45256||45256|60513||1|0|E|0|||0
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|1|MAR|0|0|0|100|DKK|6441|10363|lyfsjukr|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||6441||6441|10363||2|H|S|0|||0
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|72735|95269|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||72735||72735|95269||1|0|G|0|||0
025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|1044|2844|lyfalmen|V0597|2844|2|28|0|3,7300|Alvogen|ratiopharm GmbH|Oxýcódon||978||978|2844||2|0|G|1|30|dagar|0
025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|3497|5677|lyfalmen|V0598|5650|2|98|0|13,0700|Alvogen|ratiopharm GmbH|Oxýcódon||3036||3036|5677||2|0|G|1|30|dagar|0
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|1|0|1|CPV|0|1|0|100|XEU|53579|71040|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Thalidómíde||||53579|71040||2|0|L|0|||0
025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|29612|40727|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||29612||29612|40727||1|0||0|||0
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|4033|6951|vetorma|||0|1|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||4033||4033|6951||1|0||0|||0
025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|1|0|1|IPC|0|0|0|100|XEU|95480|100643|lyfsjukr|||2|28|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||76984||76984|100643||2|0|S|0|||0
025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||2|0||0|||0
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|2271|4463|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2271||2271|4463||1|0||0|||0
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|9622|16584|vetorma|||0|2,5|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||9622||9622|16584||1|0||0|||0
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|56768|75074|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||56768||56768|75074||1|0|G|0|||0
026490|L04AD0204|Dailiport|forðahlk|2|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|17310|25323|lyfalmen|||2|50|0|20,0000|Artasan ehf|Sandoz A/S|Tacrolimus||17310||17310|25323||1|0|G|0|||0
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|1887|4095|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1887|4095||1|0|G|0|||0
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|7449|11751|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||7449|11751||1|0|G|0|||0
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|3727|6628|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3727|6628||1|0|G|0|||0
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|14546|21519|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||14546|21519||1|0|G|0|||0
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|21715|30739|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||21715|30739||1|0|G|0|||0
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|28824|39730|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||28824|39730||1|0|G|0|||0
026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0
026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|DKK|10629|16128|lyfalmen|V0099|16128|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||10629||10629|16128||2|0|G|0|||0
027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7860|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7860||2|0|E|1|30|dagar|0
027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|18451|26894|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||18451||18451|26894||1|0|G|0|||0
027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2043|3563|lyfalmen|V0823|3563|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1500||1500|3563||2|0|G|0|||0
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|MEA|0|0|1|100|DKK|957|2815|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||957||957|2815||2|0||0|||0
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2230|4567|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2230||2230|4567||1|0|G|0|||0
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|13716|11884|lyfalmen|||2|100|0|66,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||7546||7546|11884||1|0|G|0|||0
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|13207|11884|lyfalmen|V0342|11884|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||7546||7546|11884||1|0|G|0|||0
027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|1|BAM|0|0|1|100|SEK|2537|4990|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2537||2537|4990||2|0|S|0|||0
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|G|0|EIG|0|0|0|100|SEK|6522|10475|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai GmbH|Zonisamíð||6522||6522|10475||1|0|G|0|||0
027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|0|G|0|MYL|0|0|0|100|SEK|4287|6363|lyfalmen|V0945|6321|2|4|0|11,2000|Icepharma hf|Mylan AB|Búprenorfín||3535||3535|6363||2|0|G|1|30|dagar|0
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|G|0|TDA|0|0|0|100|DKK|626|2360|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||626||626|2360||1|0|G|0|||0
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|G|0|TDA|0|0|0|100|DKK|721|2490|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||721||721|2490||1|0|G|0|||0
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|21293|30205|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||21293||21293|30205||1|0|E|0|||0
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|1|NED|0|0|0|100|XEU|24483|34240|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||24483|34240||2|H|S|0|||0
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|24148|33816|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||24148||24148|33816||1|0|E|0|||0
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|1|NED|0|0|0|100|XEU|30088|41329|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30088||30088|41329||2|H|S|0|||0
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|1|NED|0|0|0|100|XEU|41467|55721|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||41467|55721||2|H|S|0|||0
028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|BAB|0|0|0|100|DKK|4460|6836|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||4460||4460|6836||2|0||0|||0
028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|18404|26829|lyfalmen|V0387|26829|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||18404||18404|26829||1|0|G|0|||0
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2943||2|0||0|||0
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|17898|26133|lyfalmen|V0386|26133|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||17898||17898|26133||1|0|G|0|||0
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|1|0|1|NEL|0|1|0|100|DKK|51240|68082|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||51240||51240|68082||1|0|L|0|||0
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|SSS|0|0|0|100|XEU|3197|5898|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir  mótefnavakar||3197||3197|5898||1|0||0|||0
028342|J07BL0101|Stamaril|sts|||0,5|ml|1|hgl|+1 áf.spr.með leysi+2 nálar|J07BL01|01.04.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|4387|7536|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Gulusótt, veikluð veira||4387||4387|7536||1|0||0|||0
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|43868|58758|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||43868|58758||1|0||0|||0
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|2551|4164|lyfalmen|V0202|4164|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1937||1937|4164||2|0|G|0|||0
028497|N04BC0505|Oprymea|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|632|2368|lyfalmen|V0266|2368|2|30|0|1,5000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||632||632|2368||2|0|G|0|||0
028519|N04BC0505|Oprymea|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2582|4388|lyfalmen|V0267|4388|2|100|0|10,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||2100||2100|4388||2|0|G|0|||0
028531|N04BC0505|Oprymea|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|14853|21942|lyfalmen|||2|100|0|40,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||14853||14853|21942||2|0|G|0|||0
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|6320|5326|lyfalmen|V0245|4955|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2781||2781|5326||1|0|G|0|||0
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|11906|11927|lyfalmen|V0232|10476|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||7577||7577|11927||1|0|G|0|||0
028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|827|2627|lyfalmen|V0266|2368|2|30|0|1,5000|Alvogen|Alvogen|Pramipexól||820||820|2627||2|0|G|0|||0
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|OCO|1|0|0|100|DKK|8258|15838|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||8258||8258|15838||2|0||0|||0
028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|3098|4596|lyfalmen|V0267|4388|2|100|0|10,0000|Alvogen|Alvogen|Pramipexól||2251||2251|4596||2|0|G|0|||0
029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|G|0|GCA|0|0|1|100|DKK|1255|3090|lyfalmen|V0625|2190|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Flútíkasón||1157||1157|3090||1|0|G|0|||0
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|6453|10380|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||6453||6453|10380||2|0||0|||0
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|17750|25929|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||17750||17750|25929||2|0||0|||0
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1|0|0|0|||0
029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36627|49599|lyfalmen|V0802|49599|1|30|0|10,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36627||36627|49599||2|0|E|1|30|dagar|0
029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36627|49599|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36627||36627|49599||2|0|E|1|30|dagar|0
029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36627|49599|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36627||36627|49599||2|0|E|1|30|dagar|0
029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|12189|18275|lyfalmen|V0801|16508|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||12189||12189|18275||2|0|E|1|30|dagar|0
029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|GOP|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1|0||0|||0
029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36567|49524|lyfalmen|V0801|49524|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36567||36567|49524||2|0|E|1|30|dagar|0
029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|12209|18302|lyfalmen|V0802|16533|1|10|0|3,3300|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||12209||12209|18302||2|0|E|1|30|dagar|0
029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36627|49599|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36627||36627|49599||2|0|E|1|30|dagar|0
029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|36627|49599|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||36627||36627|49599||2|0|E|1|30|dagar|0
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|0|1|EIG|0|1|0|100|SEK|52119|69194|lyfsjukr|||1|2|0||Vistor hf|Eisai GmbH|Eribulin||52119||52119|69194||1|H|L|0|||0
029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|0|1|ATE|0|0|0|100|XEU|11122|16806|lyfsjukr|||2|5|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Vínorelbín||||11122|16806||1|H|S|0|||0
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|GAN|0|0|1|100|XEU|6026|9792|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6026||6026|9792||2|0|E|0|||0
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2778|lyfalmen|V0168|2778|2|20|0|6,6667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||930||930|2778||2|0|E|0|||0
030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|PEU|0|0|0|100|DKK|8527|13234|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||8527||8527|13234||1|0||0|||0
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|17092|29460|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||17092||17092|29460||2|0||0|||0
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|G|0|NED|0|0|0|100|XEU|2848|5418|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2848||2848|5418||2|0|G|0|||0
031140|N06AX2701|Spravato|nefúði|28|mg|28|mg|2|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|0|0|100|SEK|69176|90767|lyfalmen|||1|56|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||69176||69176|90767||1|H||0|||0
031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2619|5103|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2619||2619|5103||2|0|G|0|||0
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5960|9701|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5960||5960|9701||1|0|G|0|||0
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|1|FEL|0|0|0|100|DKK|19925|28923|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19925||19925|28923||1|H|S|0|||0
032257|C01CA1703|Hypotron|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|8875|13713|lyfalmen|V0969|12927|2|50|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||8875||8875|13713||2|0|G|0|||0
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|G|0|OPC|0|0|0|100|DKK|21954|31041|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||21954||21954|31041||1|0|G|0|||0
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|BOA|1|0|0|100|XEU|15176|26157|vetorma|||0|200|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||15176||15176|26157||1|0||0|||0
032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2100|3170|lyfalmen|V0069|2943|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1215||1215|3170||2|0|G|0|||0
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|23179|32590|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||23179||23179|32590||1|0|G|0|||0
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|42320|56800|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||42320|56800||1|0|G|0|||0
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|1274|2196|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||1274||1274|2196||2|0||0|||0
033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|3207|5912|lyfalmen|V1004|4896|1|28|0|3,7400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||3207||3207|5912||2|0|E|1|30|dagar|0
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|9537|18264|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||9537|18264||2|0||0|||0
033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|10999|16637|lyfalmen|V1005|14438|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||10999||10999|16637||2|0|E|1|30|dagar|0
033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|6418|10332|lyfalmen|V1006|8651|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||6418||6418|10332||2|0|E|1|30|dagar|0
033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|21020|29860|lyfalmen|||1|98|0|26,1400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||21020||21020|29860||2|0|E|1|30|dagar|0
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|G|0|HES|0|0|1|100|DKK|1595|3693|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1595||1595|3693||1|0|G|0|||0
033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|RHA|0|0|1|100|XEU|1551|2913|lyfalmen|V0189|2668|2|100|0|50,0000|Alvogen|ratiopharm Oy|Díklófenak||1028||1028|2913||2|0|G|0|||0
033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|RHA|0|0|1|100|XEU|689|2446|lyfalmen|V0188|2193|2|30|0|15,0000|Alvogen|ratiopharm Oy|Díklófenak||689||689|2446||2|0|G|0|||0
033644|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|9247|14225|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||9247||9247|14225||2|0|G|1|30|dagar|0
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|17066|24988|lyfalmen|V0185|23813|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||17066||17066|24988||2|0|G|0|||0
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|1|0|1|JCI|0|0|0|100|SEK|83380|108733|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||83380||83380|108733||1|0|S|0|||0
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2582|5069|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2582|5069||2|0||0|||0
034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|XEU|2194|3148|lyfalmen|V0098|2675|2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||1199||1199|3148||2|0|G|0|||0
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|1|CSB|0|1|0|100|SEK|25125|35052|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||25125||25125|35052||2|H|L|0|||0
034613|N02AB0310|Fentanyl Alvogen|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|3746|6479|lyfalmen|V0220|6479|2|5|0|15,0000|Alvogen|Alvogen|Fentanýl||3619||3619|6479||2|0|G|1|30|dagar|0
034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|G|0|BFP|0|0|0|100|XEU|4329|4709|lyfalmen|V0323|4251|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||2333||2333|4709||1|0|G|0|||0
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|1138|3064|lyfalmen|||1|6|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||1138||1138|3064||1|0|G|0|||0
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|2661|5161|lyfalmen|||1|12|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||2661||2661|5161||1|0|G|0|||0
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|1|LEP|0|0|1|100|DKK|7363|11632|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7363||7363|11632||1|0|S|0|||0
035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|1|FKA|0|0|0|100|DKK|2112|4405|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||2112||2112|4405||1|H|S|0|||0
035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|2600|5077|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||2600|5077||1|0|G|0|||0
035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|16236|23845|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16236||16236|23845||1|0|G|0|||0
035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|1144|2544|lyfalmen|V0050|2530|2|100|0|15,8333|Alvogen|ratiopharm GmbH|Metóprólól||760||760|2544||2|0|G|0|||0
035495|N02AJ0602|Parkodin forte|filmhtfl|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|666|2415|lyfalmen|||2|20|0|6,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||666||666|2415||1|0|E|3|||0
035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|1389|2884|lyfalmen|V0048|2884|2|100|0|31,6667|Alvogen|ratiopharm GmbH|Metóprólól||1007||1007|2884||2|0|G|0|||0
035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2334|3012|lyfalmen|V0049|2943|2|100|0|63,3333|Alvogen|ratiopharm GmbH|Metóprólól||1100||1100|3012||2|0|G|0|||0
035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4390|5571|lyfalmen|V0054|4939|2|100|0|126,6667|Alvogen|ratiopharm GmbH|Metóprólól||2959||2959|5571||2|0|G|0|||0
035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|3084|3499|lyfalmen|V0233|3499|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1454||1454|3499||1|0|G|0|||0
035802|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.12.2018||R|1|0|0|0|0|AZD|0|0|0|100|SEK|12782|19091|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||12782||12782|19091||1|0|E|0|||0
035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|GEB|0|0|0|100|XEU|25418|35422|lyfalmen|V0680|16638|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||25418||25418|35422||1|0||0|||0
036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|8649|13402|lyfalmen|V0806|9749|1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||8649|13402||2|0|G|0|||0
036339|N02BE5107|Paradorm|filmhtfl|525|mg|10|stk|1|þpakki|500+25 mg|N02BE51|01.09.2020||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6666|Acare ehf|Acare ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||2|0|0|0|||0
036353|R06AX2708|Dasergin|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|G|0|KAN|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||2979||2|0|G|0|||0
036431|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.09.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1561|3646|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer Aps|Metýlprednisólón||||1561|3646||1|0|G|0|||0
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|773|2562|lyfalmen|||1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||773||773|2562||2|0|E|0|||0
036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|G|0|NEL|0|0|0|100|DKK|17585|25702|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17585||17585|25702||1|0|G|0|||0
036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|BIV|0|0|0|100|DKK|1490|2568|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1490||1490|2568||1|0||0|||0
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1|0||0|||0
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2683|5191|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2683||2683|5191||2|0|E|0|||0
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|1019|2900|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||1019||1019|2900||2|0|E|0|||0
036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|G|0|VAL|0|0|1|100|IKR|342|1969|lyfalmen|V0006|1312|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||342||342|1969||2|0|G|0|||0
037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|7002|7957|lyfalmen|V0532|7379|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4693||4693|7957||1|0|G|0|||0
037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|13094|11171|lyfalmen|||1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||7028||7028|11171||1|0|G|0|||0
037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|18101|20967|lyfalmen|||1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||14145||14145|20967||1|0|G|0|||0
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2584|5055|lyfalmen|V0434|4950|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2584||2584|5055||2|0|G|0|||0
037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3533|4939|lyfalmen|V0054|4939|2|100|0|133,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||2500||2500|4939||2|0|G|0|||0
037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||2833||2|0|G|0|||0
037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||5027||2|0|G|0|||0
038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3635|4486|lyfalmen|V0321|4175|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||2171||2171|4486||1|0|G|0|||0
038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1779|2887|lyfalmen|V0110|2701|2|100|0|133,3333|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||1009||1009|2887||1|0|G|0|||0
039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|14962|22092|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||14962|22092||2|0|G|0|||0
039145|L01XC0303|Trazimera|st/irþ|420|mg|420|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|1|PEU|0|1|0|100|DKK|236903|301152|lyfsjukr|||1|420|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||236903||236903|301152||1|H|L|0|||0
039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|1|0|1|PSS|0|0|0|100|SEK|29827|40999|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||29827||29827|40999||2|0|S|0|||0
039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|12888|18041|lyfalmen|||2|50|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||12019||12019|18041||1|0|G|0|||0
039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|1687|3820|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1687||1687|3820||2|0|G|0|||0
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5962|9704|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5962||5962|9704||1|0||0|||0
039441|A09AA0217|Creon 10.000 (Lyfjaver)|sþ-hylki|||100|stk|1|tfílát||A09AA02|01.12.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|3889|6851|lyfalmen|V0706|6851|3|100|0|16,6700|Lyfjaver ehf|Lyfjaver ehf|Hvatablöndur (lípasi, próteasi o.s.frv.)||3889||3889|6851||3|0|G|0|||0
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|1|0|0|SGB|0|0|0|100|XEU|19563|28424|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||19563||19563|28424||1|0|E|0|||0
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4622|7030|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||4019||4019|7030||2|0|G|0|||0
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1145|3074|lyfalmen|||2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||1145||1145|3074||2|0|G|0|||0
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1147|2876|lyfalmen|V0542|2280|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||1001||1001|2876||2|0|G|0|||0
039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|PLS|0|0|1|100|DKK|764|2549|lyfalmen|V0821|2186|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||764||764|2549||1|0|E|0|||0
039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1608|3711|lyfalmen|V0822|2874|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1608||1608|3711||1|0|E|0|||0
039829|L04AX0402|Lenalidomid Alvogen|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|1|ALO|0|1|0|100|XEU|782503|979726|lyfsjukr|||2|21|0|52,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||782503||782503|979726||2|0|L|0|||0
039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2185|2701|lyfalmen|V0110|2647|2|98|0|130,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||874||874|2701||1|0|G|0|||0
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|G|0|ATE|0|0|1|100|XEU|6902|4498|lyfalmen|V0182|4438|2|42|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír||2180||2180|4498||1|0|G|0|||0
040092|N02AX0213|Tramadol Krka|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2200|4526|lyfalmen|V0227|4526|2|100|0|33,3300|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2200||2200|4526||2|0|G|1|30|dagar|0
040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2949|5557|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2949||2949|5557||2|0|G|0|||0
040771|N06AX2701|Spravato|nefúði|28|mg|28|mg|3|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|0|0|100|SEK|103764|135565|lyfalmen|||1|84|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||103764||103764|135565||1|H||0|||0
040823|A06AD6503|Movicol Junior Neutral|mixtduft|6,9|g|30|pokar|1|pakki|lausn|A06AD65|01.11.2018||L|0|0|0|0|0|NOG|0|0|0|100|IKR|||lyfalmen|||0|30|0||Vistor hf|Norgine BV|Makrógól 3350|||||3874||1|0|E|0|||0
040977|J01DD0402|Ceftriaxona Normon|sts|1000|mg|100|stk|1|hgl|+ 100 lykjur með leysi.|J01DD04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|242624|308268|lyfsjukr|||2|100|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||242624||242624|308268||2|0|ES|0|||0
041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|8665|13424|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8665||8665|13424||2|0|E|0|||0
041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|8665|13424|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8665||8665|13424||2|0|E|0|||0
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|IBV|0|0|0|100|DKK|4210|7256|vetbolu|||0|100|0||Vistor hf|Intervet International BV|Clostridíum bóluefni||4210||4210|7256||1|0||0|||0
041816|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|5274|3060|lyfalmen|V0682|3060|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1135||1135|3060||2|0|G|0|||0
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1411|3440|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||1411||1411|3440||2|0|G|0|||0
041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|7000|11133|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7000||7000|11133||2|0|G|0|||0
041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|7161|11354|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7161||7161|11354||2|0|G|0|||0
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1|0||0|||0
042157|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1278|3257|lyfalmen|V0449|2943|2|100|0|200,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||1278||1278|3257||1|0|G|0|||0
042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|IKR|6000|9619|lyfalmen|||2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5900||5900|9619||2|0|E|0|||0
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|2497|4935|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2497||2497|4935||1|0|S|0|||0
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3690|6577|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3690||3690|6577||1|0|S|0|||0
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|2228|4565|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2228||2228|4565||1|0|S|0|||0
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|1|FKA|0|0|1|100|DKK|2151|4459|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2151||2151|4459||1|0|S|0|||0
042500|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|1 innöndunartæk+3 rörlykjur|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|13803|20239|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||13616||13616|20239||1|0|G|0|||0
042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2373|4764|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||2373||2373|4764||1|0||0|||0
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|2093|4379|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2093||2093|4379||1|0|S|0|||0
042628|N06AX2108|Aritavi|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.07.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|7173|5695|lyfalmen|V0811|5695|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||3049||3049|5695||1|0|E|0|||0
042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|XEU|1462|3510|lyfalmen|V0560|3510|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1462||1462|3510||2|0||0|||0
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|PLS|0|0|1|100|DKK|547|2251|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||547||547|2251||1|0||2|60|töflur|0
043965|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|5557|6000|lyfalmen|V0624|5813|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3271||3271|6000||1|0|E|1|30|dagar|0
044065|H02AB0804|Kenacort-T|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2019||R|0|0|0|0|0|BBB|0|0|1|100|DKK|760|2544|lyfalmen|||0|1|0|5,3330|Vistor hf|Bristol-Myers Squibb AB|Tríamcínólón||760||760|2544||1|0||0|||0
044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|G|0|LVR|0|0|1|100|CHF|13742|20412|lyfalmen|V0637|20412|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||13742||13742|20412||3|0|G|0|||0
044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|0|1|ZAA|0|0|0|100|DKK|14510|21469|lyfsjukr|||1|8|0|1,0000|Azanta Danmark A/S|Azanta Danmark A/S|Misóprostól||14510||14510|21469||2|H|S|0|||0
044532|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8866|13701|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||8866||8866|13701||2|0||0|||0
044560|J05AB0105|Zovirax|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|5425|8965|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||5425||5425|8965||1|0|G|0|||0
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|1|0|1|NEL|0|1|0|100|DKK|355839|449075|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||355839||355839|449075||1|0|L|0|||0
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|1|0|1|NEL|0|1|0|100|DKK|498304|626262|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||498304||498304|626262||1|0|L|0|||0
044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|G|0|BAM|0|0|0|100|SEK|5533|9114|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5533||5533|9114||2|0|G|0|||0
045332|V03AN0502|Airapy|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|7647|12023|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||7647||7647|12023||1|0|G|0|||0
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1408|2478|lyfalmen|V0109|2376|2|98|0|65,3400|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||712||712|2478||1|0|G|0|||0
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1164|2404|lyfalmen|V0108|2229|2|98|0|32,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||658||658|2404||1|0|G|0|||0
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|1|VIN|0|0|1|100|DKK|1822|4006|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1822|4006||2|0|ES|0|||0
045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|G|0|ATE|0|0|0|100|SEK|4045|7065|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||4045||4045|7065||1|0|G|0|||0
046155|L01AD0105|Carmustine Obvius|sts|100|mg|1|hgl|1|pakki|1 lykja m. 3 ml leysi|L01AD01|01.03.2019||R|0|0|0|0|1|OBV|0|0|0|100|NOK|180077|230477|lyfsjukr|||2|1|0||Oresund Pharma ApS|Obvius Investment B.V.|Carmustine ||180077||180077|230477||2|H|S|0|||0
046188|M01AH0108|Celecoxib Medical|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|2075|4354|lyfalmen|V0429|4354|2|100|0|50,0000|LYFIS ehf|Medical ehf|Celekoxíb||2075||2075|4354||2|0|G|0|||0
046214|J02AC0107|Fluconazol Krka|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|14206|10582|lyfalmen|V0419|10582|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||6600||6600|10582||2|0||0|||0
046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|1473|3525|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1473|3525||1|0|G|0|||0
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1032|2918|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1032||1032|2918||1|0|G|0|||0
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|539|2159|lyfalmen|V0021|2048|2|90|0|45,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||480||480|2159||1|0|G|0|||0
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|831|2494|lyfalmen|V0022|2373|2|90|0|90,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||724||724|2494||1|0|G|0|||0
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1064|2772|lyfalmen|V0023|2635|2|90|0|135,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||926||926|2772||1|0|G|0|||0
046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|G|0|TSA|0|0|1|100|IKR|1563|2737|lyfalmen|V0625|2737|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||900||900|2737||2|0|G|0|||0
046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|G|0|POF|0|0|0|100|IKR|6568|3838|lyfalmen|V0205|3838|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1700||1700|3838||2|0|G|0|||0
047108|QA14AB0101|Myodine vet|stl|25|mg/ml|10|ml|1|hgl|lausn|QA14AB01|01.04.2019||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3385|6593|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Nandrolone||3385||3385|6593||2|0|0|0|||0
047154|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|3271|4851|lyfalmen|V1010|3681|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||2436||2436|4851||2|0|G|0|||0
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|G|0|MYL|0|0|0|100|SEK|905|2744|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||905||905|2744|31.10.2020|2|0|G|0|||0
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19925|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19925||5|H|S|0|||0
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|63421|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|63421||5|H|S|0|||0
047709|J05AB1403|Valganciclovir Medical Valley|filmhtfl|450|mg|60|stk|1|glas||J05AB14|01.06.2020||R|1|0|0|0|1|VAL|0|0|1|100|XEU|40838|54926|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Valgancíklóvír||40838||40838|54926||2|0|S|0|||0
047840|C02CA0408|Doxazosin Krka|töflur|4|mg|120|stk|1|þpakki|með br.losunarhraða|C02CA04|01.10.2020||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3622|5352|lyfalmen|V0042|5352|2|120|0|120,0000|Krka Sverige AB|Krka d.d. Novo mesto|Doxazósín||2800||2800|5352||2|0|G|0|||0
048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|1|AXA|0|0|0|100|SEK|4613|7847|lyfsjukr|||1|250|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||4613||4613|7847||2|H|S|0|||0
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|1|FKA|0|0|1|100|DKK|8356|12999|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||8356||8356|12999||1|0|S|0|||0
048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|1|AXA|0|0|0|100|SEK|7483|11798|lyfsjukr|||1|100|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||7483||7483|11798||2|H|S|0|||0
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1996|4245|lyfalmen|V0324|4245|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1996||1996|4245||1|0|G|0|||0
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1174|3114|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1174||1174|3114||1|0|E|0|||0
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2790|5338|lyfalmen|V0325|5338|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||2790||2790|5338||1|0|G|0|||0
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3766|6681|lyfalmen|V0326|6681|2|100|0|150,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||3766||3766|6681||1|0|G|0|||0
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5846|8256|lyfalmen|V0327|8256|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||4910||4910|8256||1|0|G|0|||0
048196|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5754|8125|lyfalmen|||2|120|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4815||4815|8125||2|0|G|0|||0
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|G|0|MEA|0|0|0|100|DKK|2209|3532|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||1478||1478|3532||2|0|G|2|100|töflur|0
048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|MBV|0|0|0|100|DKK|1862|3635|lyfalm11|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1862||1862|3635||1|0||0|||0
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|0|1|GEB|0|1|0|100|XEU|893280|1117501|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||893280||893280|1117501||1|H|L|0|||0
048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|GCA|0|0|1|100|DKK|426|2084|lyfalmen|V0230|2084|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||426||426|2084||1|0|E|0|||0
048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|0|1|GAA|0|0|0|100|SEK|4043|7063|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||4043||4043|7063||2|H|S|0|||0
048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|1|TMA|0|1|0|100|DKK|39409|53118|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||39409||39409|53118||3|0|L|0|||0
048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4758|4269|lyfalmen|V0148|4063|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||2013||2013|4269||2|0|G|0|||0
049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|7464|11771|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||7464||7464|11771||1|0|G|0|||0
049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|G|0|PLS|0|0|0|100|DKK|5504|9074|lyfalmen|V0376|5367|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||5504|9074||1|0|G|0|||0
049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|1|RRD|0|0|0|100|DKK|301385|381350|lyfsjukr|||1|1|0|16,6700|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||301385||301385|381350||1|0|ES|0|||0
049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|949|2804|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||949||949|2804||1|0|G|0|||0
049536|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|G|0|AZD|0|0|0|100|SEK|8235|12833|lyfalmen|V0080|6599|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8235||8235|12833||1|0|G|0|||0
049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|5515|9089|lyfalmen|||1|7|0|1,7500|Eisai AB|Eisai GmbH|Perampanel||5515||5515|9089||1|0|G|0|||0
049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|G|0|GOV|0|0|0|100|XEU|2525|2376|lyfalmen|V0109|2376|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||638||638|2376||2|0|G|0|||0
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1107|3022|lyfalmen|||2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1107||1107|3022||1|0|G|0|||0
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1890|4099|lyfalmen|||2|100|0|400,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1890||1890|4099||1|0|G|0|||0
049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||1938||1|0|E|0|||0
049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|0|0|WPA|0|0|0|100|DKK|78197|102177|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma (International) B.V|Cannabinoids||78197||78197|102177||1|0|E|1|30|dagar|0
049906|N02CC0106|Sumatriptan Apofri|filmhtfl|50|mg|2|stk|1|þpakki||N02CC01|01.06.2020||L|1|0|0|0|0|APO|0|0|0|100|IKR|||lyflausa|||0|2|0||LYFIS ehf|Apofri AB|Súmatriptan|||||||2|0||0|||0
049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|1|0|1|MBV|0|1|0|100|DKK|1166225|1456969|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme B.V.|Elbasvir og grazoprevir||1166225||1166225|1456969||1|0|L|0|||0
050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|6728|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6728||2|0|E|0|||0
050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4278||1|0|G|0|||0
050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|7779|12205|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||7779||7779|12205||2|0|G|0|||0
050323|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9201|14162|lyfalmen|V0925|14162|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||||9201|14162||2|0|E|0|||0
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|1|NEL|0|1|0|100|DKK|68711|90179|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||68711|90179||1|0|L|0|||0
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0
050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2750|5283|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||2750||2750|5283||2|0|G|0|||0
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|11773|17702|lyfalmen|V0688|12655|1|56|0|42,0000|Icepharma hf|Upjohn EESV|Pregabalín||11773||11773|17702||1|0|E|0|||0
050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|G|0|PLS|0|0|0|100|DKK|5714|5862|lyfalmen|V0042|4460|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3171||3171|5862|||0|G|0|||0
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|0|ATE|0|0|1|100|IKR|4615|6816|lyfalmen|V0002|6816|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||3864||3864|6816||1|0|0|0|||0
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|4360|2324|lyfalmen|V0006|2186|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||600||600|2324||1|0|G|0|||0
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|6304|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||1000||1000|2874||1|0|G|0|||0
051109|V03AN0502|Airapy|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1129|2819|lyfalmen|V0363|2819|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||960||960|2819||2|0|G|0|||0
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|3474|5255|lyfalmen|V0365|5255|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2730||2730|5255||2|0|G|0|||0
051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|1|UCB|0|0|0|100|DKK|17833|26043|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||17833||17833|26043||1|H|S|0|||0
052210|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5559|4157|lyfalmen|V0144|4157|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1932||1932|4157||2|0|E|0|||0
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|191|1761|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||191||191|1761||2|0||2|120|töflur|0
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|740|2384|lyfalmen|V0305|1296|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||644||644|2384||2|0||2|120|töflur|0
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|286|1892|lyfalmen|V0439|1892|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||286||286|1892||2|0|0|2|60|töflur|0
052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|659|2405|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||659||659|2405||2|0||2|60|töflur|0
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|911|2591|lyfalmen|V0305|2591|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||794||794|2591||2|0||2|120|töflur|0
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|1|0|1|BMS|0|1|0|100|DKK|602282|755581|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||602282||602282|755581||1|0|L|0|||0
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|G|0|AGC|0|0|0|100|XEU|3506|6324|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Tímólól í blöndum||3506||3506|6324||1|0|G|0|||0
052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.04.2018||R|0|0|0|G|0|TIC|0|0|0|100|XEU|8444|13120|lyfalmen|||1|9|0|180,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||8444||8444|13120||1|0|G|0|||0
052467|N06AX1615|Venlafaxine Alvogen|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2018||R|1|0|0|G|0|POF|0|0|0|100|IKR|7035|2874|lyfalmen|V0335|2601|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|31882|43598|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||31882||31882|43598||1|0|S|0|||0
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|25920|36057|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||25920||25920|36057||1|0|S|0|||0
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|26648|36978|lyfsjukr|||1|7680|0||Vistor hf|Fresenius Kabi AB|Blöndur||26648||26648|36978||2|0|S|0|||0
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|1|FKA|0|0|0|100|DKK|23365|32826|lyfsjukr|||1|7200|0||Vistor hf|Fresenius Kabi AB|Blöndur||23365||23365|32826||2|0|S|0|||0
052677|N02AB0310|Fentanyl Alvogen|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.09.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|1865|4065|lyfalmen|V0222|4065|2|5|0|3,6000|Alvogen|Alvogen|Fentanýl||1865||1865|4065||2|0|G|1|30|dagar|0
052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|G|0|KRK|0|0|0|100|IKR|4448|3934|lyfalmen|V0682|3060|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
052790|N06BA0904|Atomoxetine Sandoz|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|SHS|0|0|0|100|DKK|11965|5619|lyfalmen|V0815|3839|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Atomoxetín||2994||2994|5619||1|0|0|0|||0
052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|NAS|0|0|0|100|DKK|15575|22935|lyfalmen|||1|6|0|24,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||15575||15575|22935||1|0|E|0|||0
053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|43572|58383|lyfalmen|V1007|45050|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||43572||43572|58383||2|0|E|1|30|dagar|0
053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|6286|10150|lyfalmen|V1003|8926|1|98|0|6,5400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||6286||6286|10150||2|0|E|1|30|dagar|0
053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|1843|4024|lyfalmen|V1002|3377|1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||1835||1835|4024||2|0|E|1|30|dagar|0
053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|6489|8242|lyfalmen|V0115|8242|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||4900||4900|8242||2|0|E|0|||0
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|1|G|0|SDH|0|0|0|100|XEU|27541|38107|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||27541||27541|38107||1|0|G|0|||0
053846|M05BA0602|Bonviva|stl|3|mg|3|ml|1|áfspr||M05BA06|01.11.2019||R|0|1|0|0|0|ATP|0|0|0|100|DKK|14725|21765|lyfalmen|V0957|16820|1|3|0|0,5000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||14725||14725|21765||2|0|E|0|||0
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|0|0|0|ETH|0|0|0|100|GBP|11150|16845|lyfalmen|||2|10|0|50,0000|Icepharma hf|Ethypharm|Hýdrómorphón||11150||11150|16845||2|0||1|30|dagar|0
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|OPC|0|0|0|100|DKK|1554|3637|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||1554||1554|3637||1|0|E|0|||0
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|2085|4368|lyfalmen|||1|15|0|10,0000|Alvogen|Karo Pharma AB|Pívmecillínam||2085||2085|4368||2|0|E|0|||0
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|2939|5543|lyfalmen|||1|20|0|13,3300|Alvogen|Karo Pharma AB|Pívmecillínam||2939||2939|5543||2|0|E|0|||0
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|UCN|0|0|1|100|SEK|1185|3129|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1185||1185|3129||1|0||0|||0
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|UCN|0|0|1|100|SEK|1274|3251|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1274||1274|3251||1|0||0|||0
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1589|3685|lyfalmen|V0061|3685|2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||1589||1589|3685||1|0|E|0|||0
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|0|0|0|CES|1|0|0|100|DKK|5864|11296|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||5864||5864|11296||2|0||1|30|dagar|0
055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|11631|17507|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||11631||11631|17507||2|0|G|0|||0
055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|7216|5984|lyfalmen|V0187|5984|2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||3259||3259|5984||2|0|G|0|||0
055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|HES|0|0|1|100|DKK|2150|4457|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||2150|4457||1|0||0|||0
055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|PLS|0|0|0|100|DKK|9699|14848|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9699||9699|14848||1|0|G|1|30|dagar|0
055372|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2861|lyfalmen|V0334|2861|2|110|0|82,5000|Acare ehf|Medical Valley Invest AB|Venlafaxín||990||990|2861||2|0|G|0|||0
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|1971|3787|lyfalmen|V0467|2772|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1663||1663|3787||1|0|E|0|||0
055873|N05AX1304|Paliperidon Krka|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|10082|15375|lyfalmen|V0965|15375|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10082||10082|15375||2|0|G|0|||0
055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|3279|6011|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3279||3279|6011||1|0|G|0|||0
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2745|3079|lyfalmen|V0112|2806|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1149||1149|3079||1|0|G|0|||0
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4174|3362|lyfalmen|V0113|2806|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1354||1354|3362||1|0|G|0|||0
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6063|3362|lyfalmen|V0114|2806|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1354||1354|3362||1|0|G|0|||0
056196|L01XC0501|Mylotarg|st/irþ|5|mg|1|hgl|1|pakki|lausn|L01XC05|01.06.2019||R|0|0|0|0|1|PEU|0|0|0|100|DKK|1143250|1428394|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Gemtuzumab ozogamicin||1143250||1143250|1428394||2|H|0|0|||0
056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|24911|34781|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||24911||24911|34781||2|0|E|0|||0
056339|C09BA0203|Enalapril-Hydrochlorthiazid Krka|töflur|32,5|mg|110|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2943|lyfalmen|V0098|2943|2|110|0|110,0000|LYFIS ehf|Krka Sverige AB|Enalapríl og þvagræsilyf||1050||1050|2943||2|0|G|0|||0
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|CES|1|0|0|100|XEU|28374|48905|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28374||28374|48905||2|0||0|||0
056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|3544|6376|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||3544||3544|6376||1|0|G|0|||0
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|MEA|0|0|1|100|DKK|2090|3915|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1756||1756|3915||2|0|E|0|||0
056858|L04AD0204|Dailiport|forðahlk|5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|49730|66172|lyfalmen|||2|50|0|50,0000|Artasan ehf|Sandoz A/S|Tacrolimus||49730||49730|66172||1|0|G|0|||0
056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|0|1|BNB|0|1|0|100|XEU|226229|287877|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Netherlands B.V.|Natalizumab||226229||226229|287877||2|H|L|0|||0
057304|V03AN0502|Airapy|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|3573|6416|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3573||3573|6416||2|0|S|0|||0
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|1|HES|0|0|0|100|DKK|3729|6631|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3729||3729|6631||1|0|S|0|||0
057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2859|2874|lyfalmen|V0334|2601|2|100|0|75,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0
057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3700|2874|lyfalmen|V0335|2601|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|1|HES|0|0|0|100|DKK|2598|5074|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2598||2598|5074||1|0|S|0|||0
057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|11013|2870|lyfalmen|V0607|2737|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||997||997|2870||2|0|G|0|||0
057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|1|LLS|0|1|0|100|DKK|97369|126426|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||97369|126426||2|0|L|0|||0
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|21217|30109|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||21217|30109||1|0||0|||0
058199|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5120|8468|lyfalmen|V0585|8468|2|100|0|26,6666|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||5064||5064|8468||1|0|G|1|30|dagar|0
058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|1|RRD|0|0|0|100|DKK|385099|485467|lyfsjukr|||1|1|0|33,3300|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||385099||385099|485467||1|0|ES|0|||0
058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|170471|293824|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||170471|293824||2|0||0|||0
058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|258962|446347|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||258962|446347||2|0||0|||0
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2252|4598|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||2252||2252|4598||2|0|E|0|||0
058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|38893|52465|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||38893||38893|52465||1|0|E|0|||0
058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|5253|8728|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5253||5253|8728||2|0|S|0|||0
058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1258|3229|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1258||1258|3229||1|0|G|0|||0
058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1812|3992|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1812||1812|3992||1|0|G|0|||0
059012|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki|stakskammtaþynna|A06AH03|01.10.2018||R|1|0|0|0|0|KWA|0|0|0|100|XEU|12698|18975|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||12698||12698|18975||2|0|0|0|||0
059059|N06DA0405|Galantamin STADA|forðahlk|16|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|14895|21999|lyfalmen|||2|84|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||14895||14895|21999||2|0|G|0|||0
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|G|0|ATE|0|0|1|100|IKR|2374|2737|lyfalmen|V0006|1224|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||900||900|2737||1|0|G|0|||0
059211|L01XC2801|Imfinzi|irþ|50|mg/ml|10|ml|1|hgl|500 mg/10 ml|L01XC28|01.06.2019||R|0|0|0|0|1|AZE|0|1|0|100|SEK|474709|596916|lyfsjukr|||1|10|0||Vistor hf|AstraZeneca AB|Durvalumab||||474709|596916||1|H|L|0|||0
059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|1|HBP|0|0|0|100|DKK|11895|17870|lyfsjukr|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||11895||11895|17870||3|H||0|||0
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|1|G|0|ASP|0|0|0|100|XEU|98989|128475|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||98989||98989|128475||1|0|G|0|||0
059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|0|1|PEU|0|0|0|100|DKK|62067|81776|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Europe MA EEIG|Anidulafungin||62067||62067|81776||1|H|ES|0|||0
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|G|0|BPC|0|0|0|100|SEK|26137|36332|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||26137||26137|36332||1|0|G|0|||0
059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|G|0|BAB|0|0|0|100|DKK|4858|8184|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4858|8184||2|0|G|0|||0
059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|9400|14436|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||9400||9400|14436||1|0|E|0|||0
059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|47000|62719|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||47000||47000|62719||1|0|E|0|||0
059976|J01DD0402|Ceftriaxona Normon|irs|2000|mg|1|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|3413|6196|lyfsjukr|||2|1|0|1,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||3413||3413|6196||2|0|ES|0|||0
060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|2144|4449|lyfalmen|V0219|4372|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||2144||2144|4449||2|0|G|1|30|dagar|0
060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|3746|6479|lyfalmen|V0220|6479|2|5|0|15,0000|Alvogen|ratiopharm GmbH|Fentanýl||3619||3619|6479||2|0|G|1|30|dagar|0
060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5537|8874|lyfalmen|V0221|8873|2|5|0|22,5000|Alvogen|ratiopharm GmbH|Fentanýl||5359||5359|8874||2|0|G|1|30|dagar|0
060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5929|9492|lyfalmen|V0223|8797|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||5808||5808|9492||2|0|G|1|30|dagar|0
060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|22907|32246|lyfalmen|V0713|32246|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||22907||22907|32246||1|0|G|0|||0
060930|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|100|stk|1|þpakki||J01AA02|01.07.2018||R|1|0|0|0|0|EQL|0|0|1|100|IKR|5000|8380|lyfalmen|||2|100|0|100,0000|LYFIS ehf|EQL Pharma AB|Doxýcýklín||5000||5000|8380||2|0|E|0|||0
061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|1|0|1|SGB|0|1|0|100|XEU|107546|140268|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||107546||107546|140268||1|0|L|0|||0
061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1994|2806|lyfalmen|V0112|2806|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|G|0|MBV|0|0|0|100|DKK|5360|8875|lyfalmen|V0133|7522|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||5360||5360|8875||1|0|G|0|||0
061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|1|HES|0|0|0|100|DKK|4033|7049|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||4033||4033|7049||1|H|S|0|||0
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|1|MLD|0|0|0|100|DKK|14828|21907|lyfsjukr|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||14828||14828|21907||1|0|ES|0|||0
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|1|MLD|0|0|0|100|DKK|18127|26448|lyfsjukr|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||18127||18127|26448||1|0|ES|0|||0
062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|15000|18015|lyfalmen|V0924|18015|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||12000||12000|18015||2|0|E|0|||0
062544|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.11.2019||R|1|0|0|G|0|PIX|0|0|1|100|DKK|6015|9777|lyfalmen|||1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||6015||6015|9777||2|0|G|0|||0
062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|1|0|1|GSE|0|1|0|100|XEU|2161570|2694899|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir||||2161570|2694899||1|0|L|0|||0
062662|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|úðaílá|HFA 134a|R03AC12|01.09.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|3974|6968|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3974||3974|6968||1|0|G|0|||0
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|PLS|0|0|0|100|DKK|968|2830|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||968||968|2830|30.11.2020|1|0||2|60|mg|0
062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|BAN|0|0|0|100|DKK|18929|32626|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Phoximum||18929||18929|32626||2|0||0|||0
062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|1|ALO|0|0|0|100|XEU|81930|72386|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||54643||54643|72386||2|0|S|0|||0
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|GBI|0|0|0|100|DKK|12399|16521|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||10915||10915|16521||1|0||0|||0
062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|GBI|0|0|0|100|DKK|125095|162094|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||125095||125095|162094||1|0||0|||0
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995|31.10.2020|R|1|0|0|G|0|PIX|0|0|1|100|DKK|6006|9765|lyfalmen|||1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||6006||6006|9765||1|0|G|0|||0
063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1923|3050|lyfalmen|V0276|3050|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1128||1128|3050||1|0|G|0|||0
063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5935|6891|lyfalmen|V0277|6891|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||3918||3918|6891||1|0|G|0|||0
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||3580||2|0|E|0|||0
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|2285|3779|lyfalmen|V0123|3779|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín||1657||1657|3779||1|0|E|0|||0
063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|1|0|1|RRG|0|1|0|100|DKK|151437|194856|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||151437||151437|194856||2|0|L|0|||0
063940|N05CD0806|Buccolam|munnh.l|2,5|mg|0,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|SSE|0|0|1|100|DKK|13798|20489|lyfalmen|||2|2|0|0,6667|Shire Services BVBA|Shire Services BVBA|Mídazólam||13798||13798|20489||1|0|E|2|450|mg|0
063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1015|2895|lyfalmen|V0310|2863|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1015||1015|2895||1|0||2|60|mg|0
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|1|FEC|0|0|0|100|XEU|984937|1231497|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||984937|1231497||2|H|S|0|||0
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|1|FEC|0|0|0|100|XEU|390530|492221|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||390530|492221||2|H|S|0|||0
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|1|FEC|0|0|0|100|XEU|3376132|4205474|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||3376132|4205474||2|H|S|0|||0
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|1|FEC|0|0|0|100|XEU|1749558|2182472|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||1749558|2182472||2|H|S|0|||0
064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2151|4459|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||2151||2151|4459||2|0|G|0|||0
064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|6860|6134|lyfalmen|V0029|6134|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3368||3368|6134||2|0|G|0|||0
064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1244|2445|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Oxytetracyclinum||1244||1244|2445||1|0||0|||0
064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|7099|12236|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||7099|12236||1|0||0|||0
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|1|OCT|0|0|0|100|DKK|34138|46451|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||34138||34138|46451||1|H|S|0|||0
064809|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.03.2020||R|1|0|0|G|0|ATE|0|0|0|100|IKR|4118|3904|lyfalmen|V0679|3904|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1748||1748|3904||1|0|G|0|||0
064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|G|0|ASS|0|0|1|100|DKK|873|2700|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||873||873|2700||1|0|G|0|||0
064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|G|0|ASS|0|0|1|100|DKK|1173|3112|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||1173||1173|3112||1|0|G|0|||0
065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5238|10108|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketóprófen||5238||5238|10108||2|0||0|||0
065200|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|584|2302|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||584||584|2302||2|0|ES|0|||0
065276|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.12.2018||R|1|0|0|G|0|AZD|0|0|0|100|SEK|7319|11572|lyfalmen|V0081|6812|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7319||7319|11572||1|0|G|0|||0
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|G|0|FEL|0|0|0|100|DKK|16513|24226|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||16513||16513|24226||1|0|G|0|||0
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|1|GEH|0|0|0|100|NOK|10072|15361|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||10072||10072|15361||2|H|S|0|||0
065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5183|7140|lyfalmen|V0830|6864|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4099||4099|7140||2|0|G|0|||0
065583|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|112|stk|1|þpakki||C10AX09|01.07.2019||R|0|0|0|0|0|VAL|0|0|0|100|DKK|9684|7422|lyfalmen|V0954|7422|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||4304||4304|7422||2|0|0|0|||0
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|1|G|0|LVR|0|0|0|100|SEK|52502|68234|lyfalmen|V0451|57792|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||51360||51360|68234||3|0|G|0|||0
065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065751|J01CR0204|Amoxin comp|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RTH|0|0|1|100|DKK|2142|4446|lyfalmen|||2|70|0|3,7333|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||2142||2142|4446||2|0|E|0|||0
065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|ílát|10+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|2976|5594|lyfalmen|||2|200|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||2976||2976|5594||1|0|E|1|||0
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|1|GEH|0|0|0|100|NOK|3182|5878|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Iohexol||3182||3182|5878||2|H|S|0|||0
065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|1661|3784|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||1661||1661|3784||1|0|G|0|||0
065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|3038|5679|lyfalmen|||2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||3038||3038|5679||1|0|G|0|||0
065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|5222|8244|lyfalmen|||2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||4901||4901|8244||1|0|G|0|||0
066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|URE|0|0|0|100|XEU|12705|18985|lyfalmen|||1|20|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||12705||12705|18985||3|0|E|0|||0
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|DOR|1|0|0|100|DKK|4722|9129|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Meloxícam||4722||4722|9129||2|0||0|||0
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|GOG|0|0|1|100|DKK|921|2766|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||921||921|2766||2|0||0|||0
066497|N05AH0415|Quetiapin Krka|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|7500|8930|lyfalmen|V0272|8917|2|100|0|75,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||5400||5400|8930||2|0|G|0|||0
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0
066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|0|1|ATE|0|0|0|100|XEU|13315|19825|lyfsjukr|||2|50|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paklítaxel||||13315|19825||1|H|S|0|||0
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|8609|13347|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||8609||8609|13347||1|0|S|0|||0
067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|1|0|1|GSU|0|0|0|100|DKK|114231|148583|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland UC|Emtricitabine, tenofovir alafenamide og rilpivirine||||114231|148583||2|0|S|0|||0
067394|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.05.2019||R|1|0|0|0|0|LVR|0|0|1|100|DKK|12021|17051|lyfalmen|V0012|5765|3|100|0|133,3300|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||11300||11300|17051||3|0|0|0|||0
067829|QA04AD9002|Prevomax|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|8886|17029|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|maropitant||||8886|17029||2|0||0|||0
067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|2512|4955|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2512|4955||2|0|S|0|||0
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|1|G|0|MEA|0|0|0|100|DKK|4850|8173|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||4850||4850|8173||2|0|G|0|||0
068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||3123||2|0|G|0|||0
068555|J05AB1106|Valablis|filmhtfl|500|mg|40|stk|1|þpakki||J05AB11|01.06.2017||R|1|0|0|G|0|POF|0|0|1|100|GBP|7003|4227|lyfalmen|V0182|4227|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1983||1983|4227||2|0|G|0|||0
068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|1|0|G|0|GRP|0|0|0|100|XEU|8967|13840|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||8967||8967|13840||1|0|G|0|||0
068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0
068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3246|5966|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3246||3246|5966||2|0|G|0|||0
068860|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2|0||0|||0
068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|1|RAU|0|0|0|100|XEU|2846|5415|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2846||2846|5415||2|H|S|0|||0
068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|1|RAU|0|0|0|100|XEU|3628|6491|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||3628||3628|6491||2|H|S|0|||0
068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3622||2|0||0|||0
068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3805||2|0||0|||0
068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3576||2|0||0|||0
068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3755||2|0||0|||0
069030|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.08.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|16578|24316|lyfalmen|V0651|24316|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||16578||16578|24316||3|0|G|0|||0
069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|13721|20384|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13721||13721|20384||1|0|G|0|||0
069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|39707|53495|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||39707||39707|53495||1|0|G|0|||0
069177|C10AA0704|Rosuvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|9540|10169|lyfalmen|V0195|10169|2|100|0|400,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0
069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|407445|513259|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||407445||407445|513259||1|0|L|0|||0
069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
069536|L04AA0607|Mycofenolsýra Accord|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|16078|23628|lyfalmen|V0470|22261|2|120|0|10,8000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||16078||16078|23628||1|0|G|0|||0
069596|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|G|0|KRK|0|0|1|100|IKR|||lyfalmen|||2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||3284||2|0|G|0|||0
069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|1|0|1|GEI|0|0|0|100|DKK|70331|92228|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír alafenamíð||||70331|92228||2|0|S|0|||0
070203|N05CF0107|Imomed|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2020||R|1|0|0|0|0|DIC|0|0|0|100|IKR|450|2117|lyfalmen|V0312|2117|2|30|0|30,0000|LYFIS ehf|Medical ehf|Zópíklón||450||450|2117||2|0||2|30|töflur|0
070512|L01XE3501|Tagrisso|filmhtfl|40|mg|30|stk|1|stsk.þ||L01XE35|01.07.2020||R|0|0|1|0|1|AZE|0|1|0|100|SEK|952819|1191551|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||952819||952819|1191551||1|0|L|0|||0
070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|22642|31911|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||22642||22642|31911||2|0|L|0|||0
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|G|0|JAS|0|0|0|100|SEK|10286|15656|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10286||10286|15656||1|0|G|0|||0
070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|CZV|1|0|0|100|XEU|7349|12667|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||7349||7349|12667||1|0||0|||0
071450|J01FA1008|Azitromicina Normon|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.03.2019||R|1|0|0|0|0|WEH|0|0|1|100|IKR|1100|2640|lyfalmen|V0174|2599|2|3|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Azitrómýcín||830||830|2640||2|0||0|||0
071784|A10BD2401|Steglujan|filmhtfl|105|mg|98|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|38456|51693|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||38282||38282|51693||1|0|G|0|||0
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|1|0|1|GEB|0|0|0|100|XEU|79822|104232|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||79822|104232||1|0|S|0|||0
072103|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7909|12384|lyfalmen|V0609|12384|2|56|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||7909||7909|12384||1|0|E|0|||0
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|ORF|1|0|0|100|DKK|7378|14168|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|Detomidinum||7378||7378|14168||1|0||0|||0
072374|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|300|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|5764|9431|lyfalmen|V1029|9431|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||5764||5764|9431||3|0|E|0|||0
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|G|0|PSA|0|0|0|100|XEU|6860|6187|lyfalmen|V0029|6134|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3407||3407|6187||2|0|G|0|||0
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184956|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184956||5|H|S|0|||0
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184956|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184956||5|H|S|0|||0
072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|6000|9756|lyfalmen|||2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||6000||6000|9756||2|0|G|0|||0
072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3188|5886|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3188||3188|5886||2|0|G|0|||0
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|0|0|1|PBV|0|0|0|100|SEK|552|2258|lyfsjukr|||1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Súfentaníl||552||552|2258||1|0|S|1|30|dagar|0
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|1|0|1|JCI|0|0|0|100|SEK|58165|76841|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||58165||58165|76841||1|0|S|0|||0
073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9313|6948|lyfalmen|V0286|5627|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||3960||3960|6948||1|0|G|0|||0
073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|G|0|SHS|0|0|0|100|DKK|487|2168|lyfalmen|V0500|2082|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||487||487|2168||1|0|G|0|||0
073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|1|0|1|JCI|0|1|0|100|SEK|365276|460812|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Macitentan||||365276|460812||1|0|L|0|||0
073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|1|0|1|PEU|0|1|0|100|DKK|542354|681048|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotiníb||542354||542354|681048||1|0|L|0|||0
073495|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|38 mg/8 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2997|5166|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2997||2997|5166||1|0||0|||0
073520|N02AE0101|Bupremyl|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|0|G|0|MYL|0|0|0|100|SEK|2294|3604|lyfalmen|V0944|3501|2|4|0|5,6000|Icepharma hf|Mylan AB|Búprenorfín||1530||1530|3604||2|0|G|1|30|dagar|0
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3283|6017|lyfalmen|V1010|3681|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||3283||3283|6017||1|0|G|0|||0
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|17066|23813|lyfalmen|V0185|23813|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Letrózól||16213||16213|23813||1|0|G|0|||0
073728|L01CB0105|Etópósíð Accord|irþ|20|mg/ml|25|ml|1|hgl||L01CB01|01.06.2020||R|0|0|0|0|1|AEE|0|0|0|100|XEU|9717|14872|lyfsjukr|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Etoposíð||9717||9717|14872||1|H|S|0|||0
073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|7967|lyfalmen|V0924|6005|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4700||4700|7967||2|0|E|0|||0
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1007|2884|lyfalmen|V0305|2591|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||1007||1007|2884||1|0||2|120|töflur|0
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|PLS|0|0|1|100|DKK|542|2244|lyfalmen|V0439|1892|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||542||542|2244||1|0||2|60|töflur|0
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1472|3524|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1472||1472|3524||1|0||2|60|töflur|0
073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1342|3345|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1342||1342|3345||2|0|G|0|||0
073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|3687|6355|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||3687||3687|6355||2|0||0|||0
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|969|2832|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||969||969|2832||2|0|G|0|||0
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|NEL|0|0|0|100|DKK|3129|5805|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3129||3129|5805||1|0|E|0|||0
074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|22061|31176|lyfalmen|||1|28|0|28,0000|Eisai AB|Eisai GmbH|Perampanel||22061||22061|31176||1|0|G|0|||0
074364|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|40|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|EQL|0|0|1|100|IKR|917|2760|lyfalmen|||2|40|0|20,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||917||917|2760||2|0|E|0|||0
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1123|3044|lyfalmen|||2|25|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1123||1123|3044|30.11.2020|1|0||2|50|töflur|0
074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2|0||0|||0
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|ATE|0|0|0|100|DKK|961|2821|lyfalmen|||2|50|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||961||961|2821||1|0||2|50|töflur|0
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|ATE|0|0|0|100|DKK|1437|3476|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1437||1437|3476||1|0||2|50|töflur|0
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|717|2485|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||717||717|2485||2|0|G|0|||0
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|G|0|AEP|0|0|0|100|DKK|404|2054|lyfalmen|V1025|2054|1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||404||404|2054||2|0|G|0|||0
074927|C02AC0201|Intuniv|forðatfl|2|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|11279|17022|lyfalmen|||1|28|0|18,6666|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||11279||11279|17022||1|0|E|0|||0
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|G|0|AEP|0|0|0|100|DKK|2343|4723|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||2343||2343|4723||2|0|G|0|||0
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|5516|9090|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5516||5516|9090||1|0|G|0|||0
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|16168|23752|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||16168||16168|23752||1|0|G|0|||0
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|5814|9500|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5814||5814|9500||1|0|G|0|||0
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1202|3152|lyfalmen|V0363|2819|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1202||1202|3152||1|0|G|0|||0
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|17020|24924|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||17020||17020|24924||1|0|G|0|||0
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|NBV|0|0|0|100|DKK|||lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun|||||5072||1|0|E|0|||0
075451|G04CB0106|Finasteride Alvogen|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|G|0|POF|0|0|0|100|IKR|5987|2984|lyfalmen|V0445|2984|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1080||1080|2984||2|0|G|0|||0
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011|30.11.2020|R|0|0|0|0|0|DEC|0|0|0|100|DKK|1273|2502|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1273||1273|2502||1|0||0|||0
075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|13413|11430|lyfalmen|V0440|9648|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||7216||7216|11430||2|0|G|0|||0
075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|XEU|6043|9816|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6043||6043|9816||2|0|S|0|||0
075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|XEU|6043|9816|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6043||6043|9816||2|0|S|0|||0
075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|1|FMC|0|0|0|100|XEU|6360|10252|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6360||6360|10252||2|0|S|0|||0
075921|N02AA0507|OxyContin Depot|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|4307|7426|lyfalmen|V0598|5650|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxýcódon||4307||4307|7426||2|0|G|1|30|dagar|0
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|5177|8624|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||5177||5177|8624||1|0|G|0|||0
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|G|0|MBV|0|0|0|100|DKK|17996|26268|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||||17996|26268||1|0|G|0|||0
076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|15988|23504|lyfalmen|||1|98|0|24,5000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||15988||15988|23504||1|0|G|0|||0
076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16142|23716|lyfalmen|V0982|23714|1|98|0|49,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||16142||16142|23716||1|0|G|0|||0
076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1605|2461|lyfalmen|V0143|1198|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2461||2|0|E|0|||0
076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2971|3571|lyfalmen|V0143|2396|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3571||2|0|E|0|||0
076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3742|3604|lyfalmen|V0143|3594|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1530||1530|3604||2|0|E|0|||0
076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1667|2613|lyfalmen|V0144|1386|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2613||2|0|E|0|||0
076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3208|3897|lyfalmen|V0144|2771|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3897||2|0|E|0|||0
076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|7023|4182|lyfalmen|V0144|4157|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1950||1950|4182||2|0|E|0|||0
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1944|2048|lyfalmen|V0291|2048|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||400||400|2048||2|0|G|0|||0
076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|dropaí||S01GX08|01.06.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen|||||3591||1|0|G|0|||0
076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2737|lyfalmen|V0290|2737|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2737||2|0|G|0|||0
076657|N05AH0416|Quetiapin Medical Valley|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|6400|5008|lyfalmen|V0273|5008|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||2550||2550|5008||2|0|0|0|||0
076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|253768|322128|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||253768||253768|322128||1|0|L|0|||0
076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|147113|189479|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||147113||147113|189479||1|0|L|0|||0
076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|73556|96307|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||73556||73556|96307||1|0|L|0|||0
076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|42295|56768|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||42295||42295|56768||1|0|L|0|||0
076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3038|5679|lyfalmen|V0598|5650|2|98|0|13,0700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||3038||3038|5679||1|0|G|1|30|dagar|0
076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|87568|114030|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||87568||87568|114030||2|0|L|0|||0
076995|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|IKR|4503|2668|lyfalmen|V0145|2105|2|4|0|8,0000|Alvogen|ratiopharm GmbH|Tadalafíl||850||850|2668||2|0|E|0|||0
077085|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|105|stk|1|glas||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|7330|11587|lyfalmen|||2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||7330||7330|11587||2|0|E|0|||0
077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|0|1|SPP|0|0|0|100|XEU|55997|74099|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||55997||55997|74099||2|H|S|0|||0
077555|N07BC0102|Buvidal|stl|8|mg|0,16|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|14546|21519|lyfsjukr|||1|0,16|0|1,0000|Vistor hf|Camurus AB|Búprenorfín||14546||14546|21519||1|H|L|1|30|dagar|0
077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2625|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2625||2|0|E|1|30|dagar|0
077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2701|lyfalmen|V0671|2701|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||874||874|2701||2|0|E|1|30|dagar|0
077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4697|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4697||2|0|E|1|30|dagar|0
077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|6040|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0
077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8380|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8380||2|0|E|1|30|dagar|0
077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10169|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0
077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12674|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12674||2|0|E|1|30|dagar|0
077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|G|0|TVA|0|0|0|100|IKR|5017|5352|lyfalmen|V0275|4788|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||2800||2800|5352||2|0|G|0|||0
078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|10631|16130|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||10631||10631|16130||1|0|G|0|||0
078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|41376|78669|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||41376||41376|78669||2|0||0|||0
078674|N06BA1201|Elvanse Adult|hylki|50|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|14220|21070|lyfalmen|||1|30|0|50,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||14220||14220|21070||1|0|E|1|30|dagar|0
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|G|0|MSD|0|0|0|100|DKK|8869|6887|lyfalmen|V0069|2884|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3915||3915|6887||1|0|G|0|||0
079195|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5559|4157|lyfalmen|V0144|4157|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1932||1932|4157||2|0|E|0|||0
079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2071|3975|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3975||2|0|G|0|||0
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4227|7316|lyfalmen|V0315|7316|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||4227||4227|7316||1|0|G|0|||0
079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|G|0|TSA|0|0|0|100|XEU|11247|14091|lyfalmen|V0184|14091|2|100|0|100,0000|Alvogen|Teva Sweden AB|Anastrózól||9149||9149|14091||2|0|G|0|||0
079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1|0||0|||0
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|527|2223|lyfalmen|||2|10|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||527||527|2223||1|0|E|0|||0
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|855|2537|lyfalmen|V0418|2537|2|20|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||755||755|2537||1|0|E|0|||0
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|867|2551|lyfalmen|V0177|2551|2|10|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||765||765|2551||1|0|E|0|||0
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1511|3395|lyfalmen|V0411|3395|2|20|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||1378||1378|3395||1|0|E|0|||0
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Cloprostenolum||4985||4985|9628||2|0||0|||0
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|ANI|1|0|0|100|XEU|4196|8131|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4196|8131||2|0||2|||0
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
080431|H02AB0207|Dexamethasone Krka|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|3000|3287|lyfalmen|V0422|3287|2|20|0|53,3300|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||1300||1300|3287||2|0|G|0|||0
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|VEO|0|0|0|100|DKK|13674|23569|vetorma|||0|24|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||13674||13674|23569||2|0||0|||0
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|G|0|BFP|0|0|0|100|XEU|7279|7460|lyfalmen|||2|30|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Letrózól||4332||4332|7460||1|0|G|0|||0
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|G|0|LBK|0|0|0|100|DKK|2395|4794|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2395||2395|4794||1|0|G|0|||0
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|5766|9434|lyfalmen|V1029|9431|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||5766||5766|9434||1|0|E|0|||0
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2734|5261|lyfalmen|V1028|5260|1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2734||2734|5261||1|0|E|0|||0
080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|35436|48093|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||35436||35436|48093||1|0|G|0|||0
080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|0|1|AMR|0|0|0|100|XEU|3284|6018|lyfsjukr|||1|1|0|1,0000|Alvogen|Amring|Mifepriston||3284||3284|6018||2|H|S|0|||0
081038|QI01AN0101|Evalon|innúðal|||1000|skammtar|1|hgl|+50ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|22950|39557|vetorma|||0|1000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||22950||22950|39557||2|0|0|0|||0
081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4018|lyfalmen|V0815|3839|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1831||1831|4018||2|0|E|0|||0
081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|1|0|1|PEU|0|1|0|100|DKK|677942|849681|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotiníb||677942||677942|849681||1|0|L|0|||0
081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0
081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081626|N06AX2108|Aritavi|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2053|2507|lyfalmen|V0692|2507|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||733||733|2507||1|0|E|0|||0
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Bauluventill.|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|4705|7974|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4705||4705|7974||1|0|G|0|||0
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Kranaventill|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081681|N06DA0304|Nimvastid|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|6070|9853|lyfalmen|||2|28|0|4,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||6070||6070|9853||2|0|G|0|||0
081821|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|lykjur|innr.lyf, fleyti|N01AX10|01.11.2019||R|0|0|0|0|1|FKA|0|0|0|100|DKK|1630|3741|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1630||1630|3741||1|H|S|0|||0
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|5218|8680|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||5218||5218|8680||1|0|G|0|||0
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|7060|11215|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7060||7060|11215||1|0|G|0|||0
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|29022|39981|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||29022||29022|39981||2|H|S|0|||0
082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|14339|24715|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||14339||14339|24715||1|0||0|||0
082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|60209|103776|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||60209||60209|103776||1|0||0|||0
082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|546|2249|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||546||546|2249||1|0|G|0|||0
082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|3167|5857|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3167||3167|5857||1|0|G|0|||0
082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2851|5422|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2851||2851|5422||1|0|G|0|||0
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4043|7063|lyfalmen|V0080|6734|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||4043||4043|7063||1|0|G|0|||0
083019|L01XE0302|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.04.2018||R|1|1|1|0|1|ALO|0|1|0|100|XEU|289629|327963|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||258460||258460|327963||2|0|L|0|||0
083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|G|0|MYL|0|0|0|100|DKK|3890|6852|lyfalmen|V0706|6851|1|100|0|16,6700|Icepharma hf|Mylan AB|Hvatablöndur (lípasi, próteasi o.s.frv.)||3890||3890|6852||2|0|G|0|||0
083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|3598|6450|lyfalmen|V0701|5558|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3598||3598|6450||1|0|G|0|||0
083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5379|3714|lyfalmen|V0686|3631|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||1610||1610|3714||1|0|E|0|||0
083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|6445|12398|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||6445||6445|12398||2|0||0|||0
083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|GCA|0|0|1|100|DKK|930|2676|lyfalmen|V0231|2676|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||856||856|2676||1|0|E|0|||0
083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|5372|5813|lyfalmen|V0624|5813|2|30|0|36,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3135||3135|5813||1|0|E|1|30|dagar|0
084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|176878|226498|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||176878||176878|226498||1|0||0|||0
084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2430|4843|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||2430||2430|4843||2|0||2|60|mg|0
084252|C03EA0115|Amiloride/HCT Alvogen|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|1345|3349|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||1345||1345|3349||2|0|G|0|||0
084454|G04CA5203|Dutasteride/Tamsulosin Teva|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.05.2020||R|0|0|0|G|0|TVI|0|0|0|100|XEU|3089|4851|lyfalmen|V1010|3681|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Dútasteríð og tamsúlósínhýdroklóríð||2436||2436|4851||1|0|G|0|||0
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|1|0|1|PEU|0|1|0|100|DKK|64490|84841|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||64490||64490|84841||1|0|L|0|||0
084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|6210|10045|lyfalmen|V0215|10045|2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||6210||6210|10045||2|0|G|0|||0
084866|N02AJ0602|Parkodin forte|filmhtfl|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1317|3311|lyfalmen|||2|40|0|13,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1317||1317|3311||1|0|E|3|||0
084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|1|0|1|MSD|0|0|0|100|DKK|39535|53277|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||39535||39535|53277||1|0|S|0|||0
085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|0|G|0|PLS|0|0|0|100|DKK|13263|19753|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||13263||13263|19753||1|0|G|1|30|dagar|0
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|1|G|0|GAN|0|0|0|100|XEU|38104|51468|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||38104||38104|51468||2|0|G|0|||0
085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,3|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|SAO|0|0|1|100|XEU|2717|5238|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Levófloxacín||2717||2717|5238||2|0||0|||0
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|G|0|GPH|0|0|1|100|DKK|855|2675|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||855||855|2675||1|0|G|0|||0
085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl||B01AB04|01.05.2018||R|0|0|0|0|1|PLS|0|0|0|100|DKK|12826|19152|lyfsjukr|||1|4|0|40,0000|Icepharma hf|Pfizer Aps|Dalteparín||12826||12826|19152||1|H|S|0|||0
085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|4533|7737|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4533||4533|7737||2|0|S|0|||0
085515|G04CB0105|Finasterid STADA|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4051|3563|lyfalmen|V0445|3045|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||1500||1500|3563||2|0|G|0|||0
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ 5x1ml lykja m.leysi|G03GA02|01.03.2001||R|0|0|1|G|0|FEL|0|0|0|100|DKK|21532|30507|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||21532||21532|30507||1|0|G|0|||0
085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|18113|25092|lyfalmen|V0652|24858|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||17142||17142|25092||1|0|G|0|||0
085584|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|75|pokar|lausn|B05BB01|01.01.2019||R|0|0|0|0|1|BAM|0|0|1|100|SEK|9274|14263|lyfsjukr|||1|3750|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9274||9274|14263||2|0|S|0|||0
085627|G03AA0708|Melleva|filmhtfl|||63|stk|1|þpakki|150mcg/30mcg|G03AA07|01.04.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|957|1927|lyfalm11|V0545|1927|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Levónorgestrel og ethinylestradíól||476||476|1927||2|0||0|||0
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|1|0|1|NED|0|0|0|100|XEU|80187|104694|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||80187||80187|104694||2|0|ES|0|||0
085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|1|G|0|ATE|0|0|0|100|SEK|22500|31732|lyfalmen|V0579|31732|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rílúzól||22500||22500|31732||1|0|G|0|||0
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|AEB|0|0|0|100|DKK|32352|44192|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||32352||32352|44192||1|0|E|0|||0
085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|0|1|ATE|0|0|0|100|XEU|8866|13701|lyfsjukr|||2|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Karbóplatín||8866||8866|13701||1|H|S|0|||0
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|2798|5349|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||2798||2798|5349||1|0|G|0|||0
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|6801|10859|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||6801||6801|10859||1|0|G|0|||0
085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|SNP|0|0|1|100|XEU|397|2044|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||397||397|2044||1|0||2|45|töflur|0
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|2011|4266|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||2011||2011|4266||1|0|G|0|||0
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|3278|6010|lyfalmen|V0365|5255|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3278||3278|6010||1|0|G|0|||0
086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|43254|57981|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||43254||43254|57981||2|0|E|0|||0
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|1|GPH|0|0|1|100|DKK|8075|12612|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||8075||8075|12612||1|0|ES|0|||0
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|1|GPH|0|0|1|100|DKK|8764|13561|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||8764||8764|13561||1|0|ES|0|||0
086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|11300|17051|lyfalmen|V0012|5765|1|100|0|133,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||11300||11300|17051||1|0|E|0|||0
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|29678|40810|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||29678|40810||1|0|G|0|||0
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|51875|68885|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||51875|68885||1|0|G|0|||0
086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|0|1|BSP|0|1|0|100|DKK|53550|71004|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||53550||53550|71004||1|H|L|0|||0
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|17532|22942|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||17532|22942||2|0|E|0|||0
086649|L01XX5001|Ninlaro|hylki|3|mg|1|stk|3|þpakki|Hver hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|1|0|1|TPA|0|0|0|100|DKK|873742|1093202|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||873742||873742|1093202||1|0|S|0|||0
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|1|ROA|0|0|1|100|DKK|46969|62680|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||46969||46969|62680||2|0|S|0|||0
087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1|0||0|||0
087094|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|30|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|EQL|0|0|1|100|IKR|680|2434|lyfalmen|V0931|2434|2|30|0|15,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||680||680|2434||2|0|E|0|||0
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1|0||0|||0
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|SNP|0|0|1|100|XEU|368|2004|lyfalmen|V0060|1940|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||368||368|2004||1|0||2|30|töflur|0
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|249|1841|lyfalmen|V0312|706|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||249||249|1841||1|0||2|30|töflur|0
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|656|2401|lyfalmen|V0312|2117|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||656||656|2401||1|0||2|30|töflur|0
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|1845|4037|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1845||1845|4037||1|0||2|30|töflur|0
087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|16283|23910|lyfalmen|||2|250|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||16283||16283|23910||1|0|G|0|||0
087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|16283|23910|lyfalmen|||2|250|0|333,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||16283||16283|23910||1|0|G|0|||0
087572|G04BD0801|Vesicare|mixtúra|1|mg/ml|150|ml|1|glas||G04BD08|01.08.2019||R|0|0|0|G|0|ASP|0|0|0|100|XEU|5954|9693|lyfalmen|||1|150|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5954||5954|9693||1|0|G|0|||0
087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1690|3824|lyfalmen|V0952|3418|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1690||1690|3824||1|0|G|0|||0
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|CHP|0|0|0|100|XEU|36048|62132|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||36048||36048|62132||2|0||0|||0
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1|0||0|||0
087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|5139|9920|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||5139||5139|9920||1|0||0|||0
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|CES|1|0|0|100|SEK|25067|43205|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||25067||25067|43205||2|0||0|||0
088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|3255|5351|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||3255||3255|5351||2|0||0|||0
088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|G|0|RGP|0|0|1|100|DKK|1110|3026|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Flútíkasón fúróat||1110||1110|3026||1|0|G|0|||0
088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3358|6120|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3358||3358|6120||2|0|G|0|||0
088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|G|0|KRK|0|0|0|100|IKR|7196|3934|lyfalmen|V0684|3060|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|8538|13250|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||8538||8538|13250||1|0||0|||0
088677|N07BC0102|Buvidal|stl|24|mg|0,48|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|14546|21519|lyfsjukr|||1|0,48|0|3,0000|Vistor hf|Camurus AB|Búprenorfín||14546||14546|21519||1|H|L|1|30|dagar|0
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|4923|8274|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4923||4923|8274||1|0|G|0|||0
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|G|0|LEP|0|0|0|100|DKK|8507|13207|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8507||8507|13207||1|0|G|0|||0
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|13953|20703|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13953||13953|20703||1|0|G|0|||0
088817|A10BD2301|Segluromet|filmhtfl|1002,5|mg|56|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|6378|10277|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||6378||6378|10277||1|0|G|0|||0
088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|1|0|1|NAS|0|0|0|100|DKK|456760|574593|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||456760||456760|574593||1|H|S|0|||0
088961|N02AA0507|OxyContin Depot|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|22897|32234|lyfalmen|V0588|26325|1|98|0|104,5300|Icepharma hf|Mundipharma A/S|Oxýcódon||22897||22897|32234||2|0|G|1|30|dagar|0
088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|PLS|0|0|0|100|DKK|1536|3233|lyfalm11|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||||1536|3233||1|0||0|||0
089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|MPS|0|0|0|100|DKK|24312|34023|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||24312||24312|34023||1|0|0|0|||0
089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|1|0|1|NEL|0|1|0|100|DKK|142456|183687|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||142456||142456|183687||1|0|L|0|||0
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|NDR|0|0|1|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6222||1|0||0|||0
089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|1|PLS|0|1|0|100|DKK|20286|28931|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20286||20286|28931||1|0|L|0|||0
089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|1|PLS|0|1|0|100|DKK|44124|59082|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||44124||44124|59082||1|0|L|0|||0
089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|1419|3150|lyfalmen|V0048|2884|2|100|0|33,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1200||1200|3150||2|0|G|0|||0
089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|24704|34519|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24704||24704|34519||1|0|G|0|||0
089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|98815|128255|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||98815||98815|128255||1|0|G|0|||0
090153|N05AH0414|Quetiapin Hexal|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|G|0|SSA|0|0|0|100|DKK|16644|19229|lyfalmen|V0261|11408|2|100|0|100,0000|Artasan ehf|Hexal A/S|Quetíapín||12882||12882|19229||1|0|G|0|||0
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|2570|5035|lyfalmen|||1|20|0|5,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||2570||2570|5035||2|0|E|0|||0
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|5141|8574|lyfalmen|||1|40|0|10,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||5141||5141|8574||2|0|E|0|||0
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|STA|0|0|1|100|DKK|778|2569|lyfalmen|||1|100|0|2,5000|Icepharma hf|STADA Nordic ApS.|Cefalexín||778||778|2569||2|0|E|0|||0
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|1|STA|0|0|1|100|DKK|4594|7821|lyfsjukr|||1|10|0|3,3333|Icepharma hf|STADA Nordic ApS.|Cefazólín||4594||4594|7821||2|0|ES|0|||0
090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1968|4207|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1968||1968|4207||1|0|G|0|||0
090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|842|2657|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai GmbH|Rúfínamíð||842||842|2657||1|0|G|0|||0
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|0|1|AAS|0|0|0|100|XEU|14120|20933|lyfsjukr|||1|60|0||Alcon Danmark A/S|Alcon Nordic A/S|Flúorescein||14120||14120|20933||1|H|S|0|||0
091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1084|2990|lyfalmen|V0333|2990|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1084||1084|2990||2|0|E|0|||0
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|1|PLS|0|0|0|100|DKK|2715|5235|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2715||2715|5235||1|H|S|0|||0
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|1|PLS|0|0|0|100|DKK|4697|7963|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4697||4697|7963||1|H|S|0|||0
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|1|PLS|0|0|0|100|DKK|13786|20473|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||13786||13786|20473||1|H|S|0|||0
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.03.2011||R|1|1|0|0|0|HES|0|0|0|100|DKK|3687|6363|lyfalmen|V0958|6179|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3535||3535|6363||1|0|E|1|30|dagar|0
091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|6471|10405|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6471||6471|10405||1|0|G|0|||0
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|sk-ílá|lausn|S01BA01|01.05.2011||R|0|0|0|G|0|TAE|0|0|1|100|SEK|3809|6741|lyfalmen|||1|30|0||Alvogen|Trimb Healthcare AB|Dexametasón||3809||3809|6741||2|0|G|0|||0
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1076|2048|lyfalmen|V0021|2048|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||400||400|2048||1|0|G|0|||0
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1860|2373|lyfalmen|V0022|2373|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||636||636|2373||1|0|G|0|||0
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1208|3161|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||1208||1208|3161||1|0|G|0|||0
092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9507|18207|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||9507||9507|18207||2|0||0|||0
092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2|0||0|||0
092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|KRK|0|0|1|100|IKR|||lyfalmen|V0004|2839|2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2839||2|0|E|0|||0
092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2060|4251|lyfalmen|V0011|2778|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0
092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3453|4939|lyfalmen|V0011|4861|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2500||2500|4939||2|0|G|0|||0
092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1510|3012|lyfalmen|V0005|3012|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1100||1100|3012||2|0|E|0|||0
092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2400|4251|lyfalmen|V0012|3228|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0
092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|4794|5765|lyfalmen|V0012|5650|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||3100||3100|5765||2|0|G|0|||0
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2355|4739|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2355||2355|4739||1|0|G|0|||0
092694|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|án rotvarnar|H02AB04|01.01.2019||R|0|0|0|G|0|PLS|0|0|1|100|DKK|508|2197|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer Aps|Metýlprednisólón||508||508|2197||1|0|G|0|||0
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|G|0|WEH|0|0|0|100|IKR|1863|4026|lyfalmen|V0203|4026|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1837||1837|4026||2|0|G|0|||0
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1188|3133|lyfalmen|||1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxýcódon||1188||1188|3133||2|0|E|1|30|dagar|0
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2371|4761|lyfalmen|||1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||2371||2371|4761||2|0|E|1|30|dagar|0
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|4611|7845|lyfalmen|||1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||4611||4611|7845||2|0|E|1|30|dagar|0
093072|L01XE1101|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01XE11|01.01.2017||R|1|0|1|0|1|NEL|0|1|0|100|DKK|350199|442061|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||350199||350199|442061||1|0|L|0|||0
093083|L01XE1101|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01XE11|01.01.2017||R|1|0|1|0|1|NEL|0|1|0|100|DKK|467153|587519|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||467153||467153|587519||1|0|L|0|||0
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5104|8523|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||5104||5104|8523||1|0|G|0|||0
093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|5656|9283|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5656||5656|9283||1|0|G|0|||0
093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|1|0|1|ERZ|0|0|0|100|XEU|25536|33227|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||23682||23682|33227||2|0|ES|0|||0
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|G|0|HES|0|0|0|100|DKK|2002|4253|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||2002||2002|4253||1|0|G|0|||0
093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|5680|9316|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5680||5680|9316||2|0|G|0|||0
093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|4206|7287|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4206||4206|7287||2|0|G|0|||0
093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2532|4983|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||2532||2532|4983||2|0||0|||0
093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|G|0|ABC|0|0|0|100|SEK|34969|47502|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||34969||34969|47502||2|0|G|0|||0
093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|22860|32187|lyfalmen|||1|98|0|104,5300|Icepharma hf|Mundipharma A/S|Oxýcódon||22860||22860|32187||2|0|G|1|30|dagar|0
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|0|1|0|1|JCI|0|1|0|100|SEK|430806|542313|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||430806||430806|542313||1|0|L|0|||0
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|0|1|0|1|JCI|0|1|0|100|SEK|430806|542313|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||430806||430806|542313||1|0|L|0|||0
094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|G|0|AAC|0|0|0|100|DKK|5279|8764|lyfalmen|||1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||5279||5279|8764||2|0|G|0|||0
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|1846|3628|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|Meloxícam||1846||1846|3628||1|0||0|||0
094146|L04AA2901|Xeljanz|forðatfl|11|mg|28|stk|1|þpakki||L04AA29|01.06.2020||R|0|1|1|0|1|PEU|0|1|0|100|DKK|125847|163030|lyfsjukr|||1|28|0|30,8000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||125847||125847|163030||1|0|L|0|||0
094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1897|4109|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||1897||1897|4109||2|0|G|0|||0
094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|G|0|BFP|0|0|0|100|IKR|1955|4189|lyfalmen|V0324|4160|2|98|0|49,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||1955||1955|4189||1|0|0|0|||0
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|1|0|1|VIC|0|0|0|100|DKK|78714|102831|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín, lamívúdín og abacavír||78714||78714|102831||1|0|S|0|||0
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|HAL|0|0|1|100|DKK|47249|63034|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||47249|63034||1|0|E|0|||0
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6690|11531|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6690||6690|11531||2|0||0|||0
094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1|0||0|||0
095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|0|1|TAG|0|0|0|100|DKK|44752|59876|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||44752||44752|59876||1|H|S|0|||0
095314|N04BA0211|Duodopa|hlaup|||100|ml|7|askja||N04BA02|01.10.2018||R|0|1|0|0|1|AIS|0|1|0|100|DKK|105129|137262|lyfsjukr|||1|700|0||Vistor hf|AbbVie A/S|Levódópa og dópadekarboxýl­asa­hemill||105129||105129|137262||1|0|L|0|||0
095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|G|0|ATE|0|0|0|100|DKK|9060|13968|lyfalmen|||1|50|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dísúlfíram||9060||9060|13968||1|0|G|0|||0
095621|L04AX0306|Metojectpen|stl|20|mg|0,4|ml|6|áfpen||L04AX03|01.11.2019||R|0|0|0|G|0|WIL|0|0|0|100|XEU|15911|23398|lyfalmen|||1|2,4|0|48,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||15911||15911|23398||2|0|G|0|||0
095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|16231|23838|lyfalmen|V0963|14969|1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16231||16231|23838||1|0|E|0|||0
095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|16474|24173|lyfalmen|V0964|16808|1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16474||16474|24173||1|0|E|0|||0
095682|N06BA0408|Methylphenidate Teva|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|5438|4877|lyfalmen|V0959|4870|2|30|0|20,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||2455||2455|4877||1|0|E|1|30|dagar|0
095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|19179|27896|lyfalmen|V0965|15375|1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||19179||19179|27896||1|0|G|0|||0
095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|1|GOV|0|0|0|100|XEU|1999|4249|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1999|4249||2|H|ES|0|||0
095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|1|GOV|0|0|0|100|XEU|3476|6282|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||3476|6282||2|H|ES|0|||0
095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|5558|lyfalmen|V0701|5558|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||2950||2950|5558||2|0|G|0|||0
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|4999|8516|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||4399||4399|8516||2|0|0|0|||0
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|6895|11886|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||6175||6175|11886||2|0|0|0|||0
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|11467|20376|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||10650||10650|20376||2|0|0|0|||0
096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|1|RRG|0|1|0|100|DKK|758875|950339|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||758875||758875|950339||2|H|L|0|||0
096223|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|830|2599|lyfalmen|V0685|2190|2|56|0|4,6667|Acare ehf|Medical Valley Invest AB|Pregabalín||800||800|2599||2|0|E|0|||0
096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|G|0|NEL|0|0|0|100|DKK|9791|14974|lyfalmen|V0347|14971|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||9791||9791|14974||1|0|G|0|||0
096473|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|EQL|0|0|1|100|IKR|470|2048|lyfalmen|V0930|2048|2|20|0|10,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||400||400|2048||2|0|E|0|||0
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|1|CPV|0|1|0|100|XEU|723795|906710|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||723795||723795|906710||2|0|L|0|||0
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|1|CPV|0|1|0|100|XEU|664356|832784|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||664356||664356|832784||2|0|L|0|||0
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|1|CPV|0|1|0|100|XEU|699309|876256|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||699309||699309|876256||2|0|L|0|||0
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|1|CPV|0|1|0|100|XEU|769216|963201|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||769216||769216|963201||2|0|L|0|||0
096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|G|0|NEL|0|0|0|100|DKK|9165|14113|lyfalmen|V0349|13427|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||9165||9165|14113||1|0|G|0|||0
096703|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.02.2019||R|0|0|0|0|1|ATE|0|0|0|100|GBP|9947|15189|lyfsjukr|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Epírúbicín||||9947|15189||1|H|S|0|||0
096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012|30.09.2020|R|0|0|1|G|0|SNP|0|0|0|100|XEU|12331|18470|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||12331||12331|18470||1|0|G||||
097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|ELC|0|0|0|100|DKK|75904|130828|vetorma|||1|1000|0||Elanco Denmark ApS|Elanco GmbH|Óvirkar bakteríur í bóluefnum||75904||75904|130828||2|0||0|||0
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|VMD|1|0|0|100|XEU|8359|16029|vetalmen|||0|10|0||Icepharma hf|V.M.D. n.v.|Bútorfanóltartrat||||8359|16029||2|0||2|||0
097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|PLS|0|0|0|100|DKK|11479|17298|lyfalmen|V0334|2549|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11479||11479|17298||1|0|E|0|||0
097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|PLS|0|0|0|100|DKK|21356|30285|lyfalmen|V0335|2549|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||21356|30285||1|0|E|0|||0
097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|36104|48938|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||36104||36104|48938||1|0|E|0|||0
097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|6399|12311|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||6399||6399|12311||2|0||0|||0
097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|1|0|0|0|DSM|0|0|0|100|DKK|18296|23883|lyfalm11|||1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||18296||18296|23883||1|0||0|||0
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2669|2635|lyfalmen|V0023|2635|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||826||826|2635||1|0|G|0|||0
097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|1|VIN|0|0|1|100|DKK|3130|5806|lyfsjukr|||2|2000|0|5,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||3130|5806||2|0|ES|0|||0
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1658|3780|lyfalmen|||2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1658||1658|3780||1|0|E|0|||0
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|G|0|ATE|0|0|0|100|IKR|2976|3563|lyfalmen|V0678|3563|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1500||1500|3563|||0|G|0|||0
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|G|0|BIG|0|0|1|100|SEK|609|2336|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||609||609|2336||2|0|G|0|||0
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|G|0|BIG|0|0|1|100|SEK|609|2336|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||609||609|2336||2|0|G|0|||0
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2|0||0|||0
098363|L04AA4201|Mayzent|filmhtfl|0,25|mg|120|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|1|NEP|0|0|0|100|DKK|264389|335337|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Limited|Siponimod||264389||264389|335337||1|0|0|0|||0
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|999|2565|lyfalmen|V0243|2565|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||775||775|2565||2|0|G|0|||0
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|1733|3055|lyfalmen|V0244|2838|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1131||1131|3055||2|0|G|0|||0
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|4617|5056|lyfalmen|V0245|5056|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||2585||2585|5056||2|0|G|0|||0
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|8043|10690|lyfalmen|V0232|10690|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||6678||6678|10690||2|0|G|0|||0
098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|2790|5114|lyfalmen|V0381|5114|2|10|0|2,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2627||2627|5114||1|0|G|0|||0
099100|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2991|2530|lyfalmen|V0107|2530|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||750||750|2530||2|0||0|||0
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|1|AZA|0|0|0|100|SEK|88205|114835|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca AB|Fulvestrant||88205||88205|114835||1|0|S|0|||0
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2525|2503|lyfalmen|V0284|2365|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||730||730|2503||2|0|G|0|||0
099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|G|0|SSA|0|0|0|100|DKK|11430|13884|lyfalmen|V0272|8917|2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||8999||8999|13884||1|0|G|0|||0
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4718|4430|lyfalmen|V0285|3287|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2130||2130|4430||2|0|G|0|||0
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|8444|7605|lyfalmen|V0286|5627|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4437||4437|7605||2|0|G|0|||0
099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|3019|4527|lyfalmen|V0685|3910|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||2201||2201|4527||1|0|E|0|||0
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1722|2313|lyfalmen|V0247|2313|2|60|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||592||592|2313||1|0|G|0|||0
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2851|3996|lyfalmen|V0248|3996|2|60|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||1815||1815|3996||1|0|G|0|||0
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5936|4567|lyfalmen|V0249|4567|2|60|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||2230||2230|4567||1|0|G|0|||0
099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|1|0|1|PEU|0|1|0|100|DKK|174535|223584|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||174535||174535|223584||1|0|L|0|||0
099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|1|0|1|PEU|0|1|0|100|DKK|348293|439690|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||348293||348293|439690||1|0|L|0|||0
099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|1|0|1|PEU|0|1|0|100|DKK|696561|872838|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitíníb||696561||696561|872838||1|0|L|0|||0
099959|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|storn f. innr.þykkni lausn|L01BA04|01.04.2018||R|0|0|0|0|1|CLU|0|1|0|100|XEU|153281|197150|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||153281||153281|197150||1|H|L|0|||0
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|NED|0|0|0|100|XEU|11986|17995|lyfalmen|V0925|14162|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||11986|17995||2|0|E|0|||0
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2322|3585|lyfalmen|V0823|3563|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1516||1516|3585||1|0|G|0|||0
100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|322|1759|lyfalmen|V0563|1759|2|30|0|15,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||190||190|1759||2|0|G|0|||0
100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1000|2874|lyfalmen|V0685|2190|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1000||1000|2874||2|0|E|0|||0
100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2186|lyfalmen|V0821|2186|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||500||500|2186||2|0|E|0|||0
100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2874|lyfalmen|V0822|2874|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2874||2|0|E|0|||0
100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|ATE|0|0|1|100|XEU|3561|6399|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lymecycline||3561||3561|6399||1|0|E|0|||0
101021|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3469|5765|lyfalmen|V0598|5765|2|100|0|13,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||3100||3100|5765||1|0|G|1|30|dagar|0
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|PLS|0|0|0|100|DKK|10343|14307|lyfalmen|V0254|12632|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9306||9306|14307||1|0|G|0|||0
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|PLS|0|0|0|100|DKK|14764|21819|lyfalmen|V0256|18952|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||14764||14764|21819||1|0|G|0|||0
101148|QI10AB0301|Alpha Ject  5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|PHA|0|0|0|100|NOK|59375|88038|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||54614||54614|88038||1|0||0|||0
101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5189||5189|10015||2|0||0|||0
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1981|4225|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||1981|4225||1|0||0|||0
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3417|6201|lyfalmen|||2|96|0|96,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||3417|6201||1|0|G|0|||0
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|12860|24568|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|Meloxícam||12860||12860|24568||1|0||0|||0
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|6374|10271|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6374||6374|10271||2|0|E|0|||0
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|18909|27524|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||18909||18909|27524||2|0|E|0|||0
102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1108|3023|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1108||1108|3023||1|0|G|0|||0
102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1672|3799|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1672||1672|3799||1|0|G|0|||0
102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|1|BAM|0|0|0|100|SEK|5970|9715|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5970||5970|9715||2|H|S|0|||0
102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|432|2093|lyfalmen|V0230|2084|2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||432||432|2093||1|0|E|0|||0
102249|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|2|glas|2 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|400|0|13,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|G|0|WEH|0|0|0|100|XEU|8676|3228|lyfalmen|V0684|3060|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1257||1257|3228||2|0|G|0|||0
102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|G|0|TOG|0|0|0|100|SEK|3322|6070|lyfalmen|V0041|3931|1|98|0|147,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||3322||3322|6070||1|0|G|0|||0
102952|G04BD0805|Solifenacin Alvogen|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|16485|14838|lyfalmen|V0441|12261|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||9692||9692|14838||2|0|G|0|||0
103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|WEH|0|0|1|100|IKR|321|1940|lyfalmen|V0060|1940|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1940||2|0||2|30|töflur|0
103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2725|5249|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2725||2725|5249||2|0|G|0|||0
103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|1|0|0|PMA|0|0|0|100|DKK|7725|10030|lyfalmen|V0657|8655|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||6199||6199|10030||1|0|E|2|||0
103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|1|0|1|TBB|0|0|0|100|NOK|96163|124901|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Teva B.V.|Lipegfilgrastim||96163||96163|124901||1|0|S|0|||0
103444|L04AB0404|IDACIO|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.08.2020||R|0|1|1|0|1|FKA|0|0|0|100|DKK|37391|50566|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||37391||37391|50566||1|0|0|0|||0
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2030|3161|lyfalmen|V0088|3108|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3161||2|0|G|0|||0
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2590|3747|lyfalmen|V0089|3631|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3747||2|0|G|0|||0
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1845|3934|lyfalmen|V0069|2884|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3934||2|0|G|0|||0
103678|N06AX1615|Venlafaxine Alvogen|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|G|0|POF|0|0|0|100|IKR|5678|2874|lyfalmen|V0334|2601|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0
103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|0|G|0|RTH|0|0|0|100|XEU|1865|4065|lyfalmen|V0222|4065|2|5|0|3,6000|Alvogen|ratiopharm GmbH|Fentanýl||1865||1865|4065||2|0|G|1|30|dagar|0
103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|306619|387859|lyfsjukr|||1|40|0||Icepharma hf|Baxter Medical AB|Blöndur||306619||306619|387859||2|H|S|0|||0
103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|1|0|1|PEU|0|1|0|100|DKK|109419|142598|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||109419||109419|142598||1|0|L|0|||0
103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|DEC|0|0|0|100|DKK|4110|7968|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||4110||4110|7968||1|0||0|||0
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2466||1|0|E|0|||0
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|1|GEH|0|0|0|100|NOK|8606|13343|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8606||8606|13343||2|H|S|0|||0
104401|N06AB0607|Sertralin Krka|filmhtfl|50|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3689|6575|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Sertralín||3689||3689|6575||2|0|G|0|||0
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|G|0|FEL|0|0|0|100|DKK|2931|5532|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2931||2931|5532||1|0|G|0|||0
104482|L01CA0403|Vinorelbine Alvogen|hylki|30|mg|1|stk|1|þpakki|mjúkt|L01CA04|01.10.2019||R|0|0|1|G|0|ALE|0|0|0|100|SEK|12319|16634|lyfalmen|V0992|16634|2|1|0||Alvogen|Alvogen Pharma Trading Europe EOOD|Vínorelbín||10997||10997|16634||2|0|G|0|||0
104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|G|0|FEL|0|0|0|100|DKK|6510|10458|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6510||6510|10458||1|0|G|0|||0
104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|10982|16614|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||10982||10982|16614||1|0|E|0|||0
104688|N05AH0415|Quetiapin Krka|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|4500|4801|lyfalmen|V0275|4788|2|100|0|12,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||2400||2400|4801||2|0|G|0|||0
104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|G|0|FER|0|0|0|100|DKK|7411|11698|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7411||7411|11698||1|0|G|0|||0
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|G|0|FER|0|0|0|100|DKK|3870|6825|lyfalmen|V0017|6019|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3870||3870|6825||1|0|G|0|||0
104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|6184|10010|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6184||6184|10010||1|0|G|0|||0
104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|4704|7973|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4704||4704|7973||2|0|G|0|||0
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|106522|138995|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||106522|138995||1|0|S|0|||0
105331|N02AE0105|Buprenorphine Alvogen|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|IKR|1916|3501|lyfalmen|V0944|3501|2|4|0|5,6000|Alvogen|Alvogen|Búprenorfín||1455||1455|3501||2|0|G|1|30|dagar|0
105363|C03DA0403|Eplerenon  Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BFP|0|0|0|100|XEU|3462|3313|lyfalmen|V0107|2530|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||1319||1319|3313||1|0|E|0|||0
105669|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|2156|4465|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2156||2156|4465||2|0|G|1|30|dagar|0
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3085|5744|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||3085||3085|5744||2|0||0|||0
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3700|6591|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||3700||3700|6591||2|0||0|||0
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|2030|4292|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||2030||2030|4292||2|0||0|||0
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|3309|4292|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||2030||2030|4292||2|0||0|||0
106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|1|0|1|NEL|0|1|0|100|DKK|472603|594297|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||472603||472603|594297||1|0|L|0|||0
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|1|GPH|0|0|0|100|DKK|18192|26537|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||18192||18192|26537||1|H|S|0|||0
106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|3746|2661|lyfalmen|V0107|2530|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||845||845|2661||2|0|E|0|||0
107002|R07AA0201|Curosurf|innönddr|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|1|CHI|0|0|0|100|XEU|129825|167977|lyfsjukr|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||129825||129825|167977||1|H|S|0|||0
107194|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|75 mg/15 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|3348|5771|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3348||3348|5771||1|0||0|||0
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1623|3732|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1623||1623|3732|31.10.2020|1|0|G|0|||0
107464|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|4815|5648|lyfalmen|V0438|3836|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||3015||3015|5648||2|0|G|0|||0
107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|1|PBV|0|0|0|100|XEU|20744|28362|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||19518||19518|28362||2|H|S|0|||0
107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|13287|4018|lyfalmen|V0814|3839|2|28|0|8,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1831||1831|4018||1|0|E|0|||0
107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|G|0|KRK|0|0|0|100|IKR|5625|3934|lyfalmen|V0683|3060|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
107785|L01XE4201|Kisqali|filmhtfl|200|mg|42|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|1|0|1|NEL|0|1|0|100|DKK|309824|391846|lyfsjukr|||1|42|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||309824||309824|391846||1|0|L|0|||0
107918|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|V0960|6040|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0
107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2|0||1|30|dagar|0
108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2|0||1|30|dagar|0
108413|C10AX1401|Praluent|stl|75|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|75807|99154|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||75807||75807|99154||1|0|E|0|||0
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|9589|14696|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9589||9589|14696||1|0|G|0|||0
108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|1|0|0|OEU|0|0|0|100|XEU|87088|113423|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||87088||87088|113423||3|0|E|0|||0
109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ALO|0|0|1|100|IKR|776|2159|lyfalmen|V0827|2159|2|7|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||480||480|2159||2|0|G|0|||0
109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|1748|3755|lyfalmen|V0584|3750|2|28|0|7,4700|Alvogen|ratiopharm GmbH|Oxýcódon||1640||1640|3755||2|0|G|1|30|dagar|0
109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|5954|8326|lyfalmen|V0585|8299|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||4961||4961|8326||2|0|G|1|30|dagar|0
109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|4296|7411|lyfalmen|V0586|7411|2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||4296||4296|7411||2|0|G|1|30|dagar|0
109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|10876|14863|lyfalmen|V0587|14165|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||9710||9710|14863||2|0|G|1|30|dagar|0
109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|20999|26325|lyfalmen|V0588|26325|2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||18038||18038|26325||2|0|G|1|30|dagar|0
110001|N03AX1602|Lyrica (Lyfjaver)|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|9706|14857|lyfalmen|V0686|3631|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||9706||9706|14857||3|0|E|0|||0
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0
110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|1921|4142|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1921||1921|4142||1|0|G|0|||0
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2461|lyfalmen|V0291|2048|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||700||700|2461||2|0|G|0|||0
110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2608|3494|lyfalmen|V0292|3494|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1450||1450|3494||2|0|G|0|||0
110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4870|8201|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4870||4870|8201||2|0|G|0|||0
110341|A10BJ0601|Ozempic|stl|0,25|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|20312|28964|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||20312||20312|28964||1|0||0|||0
110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5000|8380|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8380||2|0|G|0|||0
110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|MBV|0|0|0|100|DKK|1591|3301|lyfalm11|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1591||1591|3301||1|0||0|||0
110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|G|0|COR|0|0|0|100|DKK|5752|9415|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||5752||5752|9415||1|0|G|0|||0
110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|1|0|1|MBV|0|0|0|100|DKK|95289|123795|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Raltegravír||95289||95289|123795||1|0|S|0|||0
110958|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|1|CLU|0|1|0|100|XEU|9028|13924|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||9028||9028|13924||1|0|L|0|||0
111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|GED|0|0|0|100|XEU|15059|18592|lyfalm11|||2|1|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||14001||14001|18592||1|0|E|0|||0
111479|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|G|0|POF|0|0|0|100|XEU|4977|5184|lyfalmen|V0373|4995|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2678||2678|5184||2|0|G|0|||0
111775|G03AA1209|Asubtela|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.11.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|2750|4729|lyfalm11|V0993|4729|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Dróspírenón og ethinylestradíól||2750||2750|4729||2|0||0|||0
111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|GCA|0|0|1|100|DKK|725|2496|lyfalmen|||1|100|0|33,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||725||725|2496||1|0|E|0|||0
112073|V03AB3301|Cyanokit|irs|5|g|1|hgl|1|pakki|lausn|V03AB33|01.05.2019||R|0|0|0|0|1|SEB|0|0|0|100|XEU|140560|181329|lyfsjukr|||2|1|0||Swedish Orphan Biovitrum A/S|SERB S.A.|Hydroxocobalamin||140560||140560|181329||3|H|0|0|||0
112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|203723|259886|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||203723||203723|259886||1|0|L|0|||0
112345|J01FF0104|Clindamycin EQL Pharma|hylki|150|mg|32|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|1500|3563|lyfalmen|||2|32|0|4,0000|LYFIS ehf|EQL Pharma AB|Klindamýcín||1500||1500|3563||2|0|E|0|||0
112704|N05AH0415|Quetiapin Krka|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|1800|2599|lyfalmen|V0284|2365|2|100|0|6,2500|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||800||800|2599||2|0|G|0|||0
112713|N05AH0415|Quetiapin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3800|3287|lyfalmen|V0285|3287|2|100|0|25,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||1300||1300|3287||2|0|G|0|||0
112732|N05AH0415|Quetiapin Krka|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|5000|5627|lyfalmen|V0286|5627|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||3000||3000|5627||2|0|G|0|||0
112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3737|lyfalmen|||2|100|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3737||2|0|E|0|||0
113088|M05BA0802|Aclasta|irl|5|mg|100|ml|1|glas|lausn|M05BA08|01.04.2019||R|0|1|1|0|0|NEL|0|0|0|100|DKK|56032|74143|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||56032||56032|74143||1|0|E|0|||0
113179|S01LA0601|Beovu|stl|120|mg/ml|0,165|ml|1|áfspr|lausn|S01LA06|01.06.2020||R|0|1|0|0|1|NEP|0|0|0|100|DKK|123089|159599|lyfsjukr|||1|0,165|0||Vistor hf|Novartis Europharm Limited|Brolucizumab||123089||123089|159599||1|H|0|0|||0
113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|V0655|4918|2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||5077||2|0|E|0|||0
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7137|11321|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||7137||7137|11321||1|0|G|0|||0
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|6256|10109|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6256||6256|10109||1|0|G|0|||0
113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|1|SPP|0|0|0|100|XEU|2394|4793|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||2394||2394|4793||2|H|S|0|||0
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|3694|6582|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3694||3694|6582||1|0|G|0|||0
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|5138|8570|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5138||5138|8570||1|0|G|0|||0
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|1|0|1|NEL|0|1|0|100|DKK|527601|662699|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||527601||527601|662699||1|0|L|0|||0
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|627|2361|lyfalmen|V0930|2048|1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||627||627|2361||2|0|E|0|||0
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|911|2752|lyfalmen|V0931|2434|1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||911||911|2752||2|0|E|0|||0
114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5000|3590|lyfalmen|V0145|2105|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||1520||1520|3590||2|0|E|0|||0
114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1|0||0|||0
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|1|WIL|0|1|0|100|XEU|36513|49455|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||36513|49455||2|0|L|0|||0
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3929|6906|lyfalmen|V0824|2876|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3929||3929|6906||1|0|G|0|||0
114461|G04BE0809|Tadalafil ratiopharm|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|IKR|16097|6315|lyfalmen|V0145|6315|2|12|0|24,0000|Alvogen|ratiopharm GmbH|Tadalafíl||3500||3500|6315||2|0|E|0|||0
114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|G|0|AEP|0|0|0|100|DKK|11097|16772|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||11097||11097|16772||2|0|G|0|||0
114605|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|9202|12977|lyfalmen|V0973|12977|2|100|0|60,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||8340||8340|12977||2|0|G|0|||0
114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|G|0|MED|0|0|0|100|IKR|14000|18015|lyfalmen|V0420|16638|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||12000||12000|18015||2|0|G|0|||0
114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|6267|10802|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||6267||6267|10802||2|0||0|||0
114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2173|3982|lyfalmen|V0278|3982|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1805||1805|3982||2|0|G|0|||0
114950|L01BC0702|Azacitidine Accord|sts|25|mg/ml|100|mg|1|hgl||L01BC07|01.05.2020||R|0|0|0|0|1|CLU|0|1|0|100|XEU|53915|71465|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Azasitidín||53915||53915|71465||1|H|L|0|||0
114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2928|3911|lyfalmen|V0279|3911|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1753||1753|3911||2|0|G|0|||0
114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|8713|7324|lyfalmen|V0280|7324|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4233||4233|7324||2|0|G|0|||0
114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|12041|7324|lyfalmen|V0282|7324|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4233||4233|7324||2|0|G|0|||0
114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|0|KNM|0|0|0|100|IKR|5276|8760|lyfalmen|V0457|8760|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8760||2|0|G|0|||0
115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12539|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12539||2|0|G|0|||0
115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9452|lyfalmen|V0475|9452|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9452||2|0|G|0|||0
115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20624|lyfalmen|V0540|20624|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20624||2|0|G|0|||0
115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|1|0|1|NAS|0|0|0|100|DKK|91352|118816|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||91352||91352|118816||1|H|S|0|||0
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|1|RAU|0|0|1|100|XEU|8057|12588|lyfsjukr|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||8057||8057|12588||2|0|S|0|||0
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1188|3057|lyfalmen|V0158|2858|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1133||1133|3057||2|0|E|0|||0
115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|1741|3287|lyfalmen|V0276|3050|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1300||1300|3287||2|0|G|0|||0
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|11768|17695|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11768||11768|17695||1|0|G|0|||0
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|10132|15444|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10132||10132|15444||1|0|G|0|||0
115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|47047|62779|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||47047||47047|62779||1|0|G|0|||0
115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|STE|0|0|0|100|DKK|3756|6668|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||3756||3756|6668||1|0|0|0|||0
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|1|GPH|0|0|1|100|DKK|3629|6493|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3629||3629|6493||1|0|ES|0|||0
116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|1|GPH|0|0|1|100|DKK|1898|4110|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1898||1898|4110||1|0|ES|0|||0
116551|M01AE0102|Ibufen|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
116573|M01AE0102|Ibufen|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
116584|M01AE0102|Ibufen|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|882|2578|lyfalmen|V0562|2349|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||785||785|2578||1|0|G|0|||0
116595|M01AE0102|Ibufen|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|449|2033|lyfalmen|V0563|1759|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||389||389|2033||1|0|G|0|||0
116606|M01AE0102|Ibufen|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|938|2766|lyfalmen|V0564|2113|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||921||921|2766||1|0|G|0|||0
116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|15375|22660|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||15375||15375|22660||1|0|G|0|||0
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4619|7222|lyfalmen|V0081|6951|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||4159||4159|7222||1|0|G|0|||0
116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|5993|9747|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5993||5993|9747||1|0|G|0|||0
116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|6525|10479|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||6525||6525|10479||1|0|G|0|||0
116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|16746|24547|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||16746||16746|24547||1|0|G|0|||0
116907|N02AE0104|Buprenorphine ratiopharm|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|0|G|0|RTH|0|0|0|100|IKR|1916|3501|lyfalmen|V0944|3501|2|4|0|5,6000|Alvogen|ratiopharm GmbH|Búprenorfín||1455||1455|3501||2|0|G|1|30|dagar|0
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|KEL|1|0|0|100|XEU|10101|19334|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||10101||10101|19334||2|0||0|||0
117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1618|3725|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1618||1618|3725||1|0|G|0|||0
117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|ASZ|0|0|0|100|SEK|12022|17255|lyfalmen|V0275|4788|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||11448||11448|17255||1|0|E|0|||0
117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|22146|28874|lyfalmen|V0273|5008|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||20241||20241|28874||1|0|G|0|||0
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1529|3602|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||1529||1529|3602||2|0|G|0|||0
117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|31785|43475|lyfalmen|V0272|8917|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||31785||31785|43475||1|0|G|0|||0
117676|L01DB0107|Caelyx pegylated liposomal|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|0|1|JCI|0|1|0|100|SEK|58701|77519|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||58701||58701|77519||1|H|L|0|||0
117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|NOK|5357|10334|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5357||5357|10334||2|0||0|||0
117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|XEU|14653|27970|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||14653||14653|27970||2|0||0|||0
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1889|4098|lyfalmen|V0278|3982|2|28|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1889||1889|4098||1|0|G|0|||0
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2842|4189|lyfalmen|V0279|3911|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1955||1955|4189||1|0|G|0|||0
118046|N07BC0102|Buvidal|stl|96|mg|0,27|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|62206|81952|lyfsjukr|||1|0,27|0|12,0000|Vistor hf|Camurus AB|Búprenorfín||62206||62206|81952||1|H|L|1|30|dagar|0
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8527|8198|lyfalmen|V0282|7324|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||4868||4868|8198||1|0|G|0|||0
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1808|3986|lyfalmen|V0283|3986|2|28|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1808||1808|3986||1|0|G|0|||0
118153|L02BB0401|Xtandi|filmhtfl|40|mg|112|stk|1|þpakki||L02BB04|01.10.2019||R|1|0|0|0|1|APE|0|1|0|100|XEU|448482|564297|lyfsjukr|||1|112|0|28,0000|Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||448482||448482|564297||1|0|L|0|||0
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14590|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14590||5|H|S|0|||0
118421|C02AC0201|Intuniv|forðatfl|3|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|12415|18586|lyfalmen|||1|28|0|28,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||12415||12415|18586||1|0|E|0|||0
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8713|8877|lyfalmen|V0280|7324|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||5361||5361|8877||1|0|G|0|||0
118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|5565|10728|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5565||5565|10728||2|0||0|||0
118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|G|0|FER|0|0|0|100|DKK|21618|30616|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||21618||21618|30616||1|0|G|0|||0
118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|1|BAM|0|0|0|100|SEK|1305|3294|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1305||1305|3294||2|H|S|0|||0
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|G|0|AEP|0|0|0|100|DKK|505|2193|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||505||505|2193||2|0|G|0|||0
119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|1488|3546|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1488||1488|3546||2|0|G|0|||0
119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2326|2993|lyfalmen|V0824|2876|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1086||1086|2993||2|0|G|0|||0
119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|GAN|0|0|0|100|XEU|3211|5918|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||3211||3211|5918||2|0|E|0|||0
119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5500|9068|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5500||5500|9068||2|0|E|0|||0
119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1297|3283|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1297||1297|3283||2|0||2|60|mg|0
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|1|RGP|0|1|0|100|DKK|349711|441454|lyfsjukr|||1|30|0|20,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||349711||349711|441454||1|0|L|0|||0
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|1|RGP|0|1|0|100|DKK|324668|410307|lyfsjukr|||1|30|0|40,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||324668||324668|410307||1|0|L|0|||0
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|G|0|CLA|0|0|0|100|XEU|1871|4073|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Cýklópentólat||1871||1871|4073||1|0|G|0|||0
120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|0|1|NED|0|1|0|100|XEU|40371|54335|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||40371||40371|54335||2|H|L|0|||0
120278|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|1|HSS|0|1|0|100|DKK|57055|75437|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||57055||57055|75437||1|H|L|0|||0
120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|7679|8586|lyfalmen|V0118|8366|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||5150||5150|8586||2|0|E|0|||0
121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|1|RRG|0|1|0|100|DKK|436669|549605|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||436669||436669|549605||2|H|L|0|||0
121133|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7410|8366|lyfalmen|V0118|8366|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||4990||4990|8366||2|0|E|0|||0
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|skpokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|GRH|0|0|1|100|DKK|4051|7074|lyfalmen|||1|28|0|9,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||4051||4051|7074||1|0|E|0|||0
121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3340|6095|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3340||3340|6095||2|0|G|0|||0
122133|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018|31.10.2020|R|1|0|0|0|0|MBP|0|0|0|100|IKR|3416|6200|lyfalmen|||2|4|0|8,0000|BGP Products ApS|Mylan S.A.S|Tadalafíl||3416||3416|6200||2|0|E|0|||0
122231|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.12.2020||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2190|4512|lyfalmen|V0214|4512|2|98|0|49,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2190||2190|4512||2|0|E|0|||0
122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2|0||0|||0
122326|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|2500|2861|lyfalmen|V0010|2193|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||990||990|2861||2|0|G|0|||0
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9556|16471|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9556||9556|16471||1|0||0|||0
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|34020|58637|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||34020||34020|58637||2|0||0|||0
123487|L01BC0603|Ecansya|filmhtfl|500|mg|120|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|1|KAN|0|0|0|100|IKR|18000|26273|lyfsjukr|||2|120|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||18000||18000|26273||2|0|S|0|||0
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|683|2438|lyfalmen|||2|100|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||683||683|2438||1|0|G|0|||0
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|1|G|0|SMA|0|0|0|100|XEU|33692|45887|lyfalmen|V0579|31732|1|56|0|28,0000|Vistor hf|Sanofi Mature IP|Rílúzól||33692||33692|45887||1|0|G|0|||0
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|CHP|0|0|0|100|XEU|1882|3699|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||1882|3699||2|0||0|||0
124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|URE|0|0|0|100|XEU|37803|51087|lyfalmen|||1|60|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||37803||37803|51087||3|0|E|0|||0
124347|R03AC0206|Ventoline|innönddu|200|mcg/sk|60|skammtar|1|stk||R03AC02|01.03.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|754|2536|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||754||754|2536||1|0|G|0|||0
124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|8564|13285|lyfalmen|V0995|5613|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||8564||8564|13285||1|0|G|0|||0
124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|G|0|GAB|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||4529||1|0|G|0|||0
125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|DKK|12313|18446|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||12313||12313|18446||2|0|G|0|||0
125376|B03BA0105|Optovite B12|stl|1000|mcg|2|ml|5|lykjur||B03BA01|01.05.2020||R|0|0|0|G|0|LNA|0|0|1|100|XEU|6363|7728|lyfalmen|||2|10|0|250,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Cyanocobalamin||4526||4526|7728||2|0|G|0|||0
125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|5524|3356|lyfalmen|V0285|3287|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1350||1350|3356||2|0|G|0|||0
125613|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|1|FEC|0|0|0|100|XEU|1749558|2182472|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||1749558||1749558|2182472||2|H|S|0|||0
126390|A10BK0101|Forxiga|filmhtfl|5|mg|28|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|7128|11309|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||7128||7128|11309||1|0|G|0|||0
126496|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2411|2702|lyfalmen|V0057|2307|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||875||875|2702||1|0|G|0|||0
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|1|CSB|0|1|0|100|SEK|50248|66827|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||50248||50248|66827||2|H|L|0|||0
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|1|CSB|0|1|0|100|SEK|100491|131494|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||100491||100491|131494||2|H|L|0|||0
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|1|CSB|0|1|0|100|SEK|201019|256523|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||201019||201019|256523||2|H|L|0|||0
126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|0|1|FIN|0|1|0|100|DKK|132023|170711|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||132023||132023|170711||2|H|L|0|||0
126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|33302|45394|lyfalmen|V0976|45394|1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||33302|45394||2|0|G|0|||0
126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|G|0|NEL|0|0|1|100|DKK|3655|6529|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||3655|6529||1|0|G|0|||0
126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|7798|12231|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||7798||7798|12231||2|0|G|0|||0
127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|XEU|3447|4960|lyfalmen|V0011|4960|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||2515||2515|4960||1|0|G|0|||0
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||2|0||0|||0
128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|NED|0|0|0|100|XEU|6497|10440|lyfalmen|V0279|3911|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||6497||6497|10440||2|0|E|0|||0
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|G|0|KPA|0|0|0|100|DKK|1402|3428|lyfalmen|||1|100|0|50,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||1402||1402|3428||2|0|G|0|||0
128750|L04AA2901|Xeljanz|filmhtfl|10|mg|56|stk|1|þpakki||L04AA29|01.01.2019||R|0|1|1|0|1|PEU|0|1|0|100|DKK|251694|319548|lyfsjukr|||1|56|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||251694||251694|319548||1|0|L|0|||0
129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|G|0|NED|0|0|0|100|XEU|24968|34853|lyfalmen|V0282|7324|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||24968||24968|34853||2|0|G|0|||0
129152|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|1 innöndunartæki og 1 rörlykja|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|4632|7873|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4632||4632|7873||1|0|G|0|||0
129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|19504|16842|lyfalmen|V0680|16638|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||11148||11148|16842||2|0||0|||0
129289|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|V0997|10169|2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0
129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||3601||2|0||0|||0
129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|G|0|BOI|0|0|0|100|DKK|3883|6842|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3883||3883|6842||1|0|G|0|||0
129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4018|lyfalmen|V0812|3839|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1831||1831|4018||2|0|E|0|||0
129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15164|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15164||2|0|E|1|30|dagar|0
130001|N06AB0608|Sertralin WH|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|3423|4251|lyfalmen|V0323|4251|2|100|0|200,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||2000||2000|4251||2|0|G|0|||0
130242|L04AA4001|Mavenclad|töflur|10|mg|1|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|1|MRP|0|1|0|100|SEK|335730|424065|lyfsjukr|||1|1|0|29,4118|Icepharma hf|Merck Europe B.V.|Cladribine||335730||335730|424065||2|0|L|0|||0
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|DKK|5735|5260|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2733||2733|5260||2|0||0|||0
130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|0|1|PFM|0|0|0|100|SEK|331389|418666|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||331389||331389|418666||1|H|S|0|||0
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|21313|40606|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||21313||21313|40606||1|0||0|||0
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1618|3725|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1618||1618|3725||2|0||0|||0
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|10636|16137|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||10636|16137||1|0||0|||0
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|PHA|0|0|0|100|NOK|42269|68138|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||42269|68138||1|0||0|||0
131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|RPG|1|0|0|100|XEU|7307|14033|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||7307||7307|14033||2|0||0|||0
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|MYL|0|0|0|100|SEK|5060|6397|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||3559||3559|6397||2|0||0|||0
131383|N03AA0207|Fenemal Meda|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|G|0|MEA|0|0|0|100|DKK|1723|3869|lyfalmen|||2|100|0|15,0000|Icepharma hf|Meda AB|Phenobarbital||1723||1723|3869||2|0|G|2|||0
131417|N03AA0207|Fenemal Meda|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|G|0|MEA|0|0|0|100|DKK|1951|4183|lyfalmen|||2|100|0|50,0000|Icepharma hf|Meda AB|Phenobarbital||1951||1951|4183||2|0|G|2|||0
131620|C08CA0107|Amlodipine Vitabalans|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|2050|2461|lyfalmen|V0057|2307|2|100|0|200,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0
132106|H05BX0107|Cinacalcet STADA|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|15128|8380|lyfalmen|V0720|8006|2|28|0|14,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||5000||5000|8380||2|0||0|||0
132322|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|VAL|0|0|1|100|XEU|1240|2292|lyfalmen|V0003|2238|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||577||577|2292||2|0||0|||0
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|5076|6597|lyfalmen|V0581|6302|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3705||3705|6597|||0|G|0|||0
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|3156|5159|lyfalmen|V0580|5159|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||2660||2660|5159|||0|G|0|||0
132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|0|1|TPA|0|1|0|100|DKK|431304|542933|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||431304||431304|542933||1|H|L|0|||0
132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|G|0|AGC|0|0|0|100|XEU|9596|14706|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||9596||9596|14706||1|0|G|0|||0
132633|D11AH0501|Dupixent|stl|300|mg|2|áf.spr|1|pakki|með nálarhlíf|D11AH05|01.08.2019||R|0|0|1|0|1|SGB|0|1|0|100|XEU|194531|248453|lyfsjukr|||1|2|0|28,0374|Vistor hf|Sanofi-aventis groupe|Dupilumab||194531||194531|248453||1|0|L|0|||0
132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2364|3631|lyfalmen|V0089|3631|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1550||1550|3631||2|0|G|0|||0
132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|0|0|0|JAS|0|0|0|100|SEK|5182|8630|lyfalmen|V0681|8001|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5182||5182|8630||1|0|E|1|30|dagar|0
132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|6814|13098|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||||6814|13098||2|0||0|||0
132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|4886|4226|lyfalmen|V0335|2601|2|100|0|150,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1982||1982|4226||1|0|G|0|||0
132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|467|2141|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Proxýmetakaín||467||467|2141||1|0||0|||0
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1|0||0|||0
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|1|SLP|0|0|0|100|SEK|24059|33703|lyfsjukr|||1|0,5|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||24059||24059|33703||1|H|S|0|||0
133101|M01AH0108|Celecoxib Medical|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|1323|3319|lyfalmen|V0037|3319|2|20|0|20,0000|LYFIS ehf|Medical ehf|Celekoxíb||1323||1323|3319||2|0|G|0|||0
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|1|SLP|0|0|0|100|SEK|31989|43733|lyfsjukr|||1|1|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||31989||31989|43733||1|H|S|0|||0
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|0|1|SLP|0|0|0|100|SEK|43499|58291|lyfsjukr|||1|2|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||||43499|58291||1|H|S|0|||0
133227|R03AK0605|Salmex|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GLZ|0|0|0|100|DKK|5524|7491|lyfalmen|V0981|7491|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||4354||4354|7491||2|0|G|0|||0
133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|0|1|GAA|0|0|0|100|SEK|4422|7584|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||4422||4422|7584||2|H|S|0|||0
133856|N06BA0904|Atomoxetine Sandoz|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|SHS|0|0|0|100|DKK|11704|5528|lyfalmen|||2|28|0|8,7500|Artasan ehf|Sandoz A/S|Atomoxetín||2928||2928|5528|30.9.2020|1|0|E|0|||0
133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|BFP|0|0|0|100|XEU|1432|3469|lyfalmen|V0333|3204|2|30|0|11,2500|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1432||1432|3469||1|0|E|0|||0
134067|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2019||R|0|0|1|G|0|AZA|0|0|0|100|SEK|52543|68234|lyfalmen|V0451|57792|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||51360||51360|68234||1|0|G|0|||0
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3082|5740|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3082||3082|5740||2|0|G|0|||0
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7832|12278|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7832||7832|12278||2|0|G|0|||0
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|1|0|1|BRS|0|0|0|100|DKK|61945|81622|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||61945||61945|81622||1|0|S|0|||0
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|1|0|1|GAD|0|0|0|100|DKK|113139|147224|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland UC|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||113139||113139|147224||2|0|S|0|||0
135062|C09CA0306|Valsartan Krka|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3912|3838|lyfalmen|V0678|3563|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan||1700||1700|3838||2|0|G|0|||0
135084|C09CA0306|Valsartan Krka|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5538|4251|lyfalmen|V0679|3904|2|98|0|196,0000|LYFIS ehf|Krka Sverige AB|Valsartan||2000||2000|4251||2|0|G|0|||0
135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|10512|15967|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10512||10512|15967||1|0|G|0|||0
135253|A10BB0906|Gliclazíð Krka|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3500|5008|lyfalmen|V0020|3502|2|90|0|45,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||2550||2550|5008||2|0|G|0|||0
135264|A10BB0906|Gliclazíð Krka|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4800|7004|lyfalmen|V0020|7004|2|180|0|90,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||4000||4000|7004||2|0|G|0|||0
135384|R03BA0501|Flixotide|innönddu|500|mcg/sk|60|skammtar|1|sk-ílá|Fjölskammtaílát|R03BA05|01.09.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4646|7893|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4646||4646|7893||1|0|G|0|||0
135434|R03BA0501|Flixotide|innönddu|100|mcg/sk|60|skammtar|1|pakki|fjölskammtaílát|R03BA05|01.07.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1319|3313|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1319||1319|3313||1|0|G|0|||0
135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|G|0|VAL|0|0|0|100|DKK|2439|3154|lyfalmen|V0909|3154|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||1203||1203|3154||2|0|G|0|||0
135533|R03AC1201|Serevent|innönddu|50|mcg/sk|60|skammtar|1|innö.t||R03AC12|01.10.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|3016|5649|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3016||3016|5649||1|0|G|0|||0
136121|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|2 hgl m 5 ml leysi + 2 millist|B06AC01|01.03.2019||R|0|1|1|0|1|SSE|0|1|0|100|DKK|215056|273981|lyfsjukr|||1|2|0|0,7143|Shire Services BVBA|Shire Services BVBA|C1 hemill||215056||215056|273981||1|0|L|0|||0
136180|M05BA0306|Pamidronatdinatrium Pfizer|irþ|3|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|1|PLS|0|0|0|100|DKK|6478|10414|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||6478||6478|10414||1|H|S|0|||0
136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|1|G|0|PEU|0|0|0|100|DKK|38715|52240|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||38715||38715|52240||1|0|G|0|||0
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|MEA|0|0|0|100|DKK|9351|11927|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||7577||7577|11927||2|0||0|||0
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|1|0|1|PEU|0|1|0|100|DKK|64490|84841|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||64490||64490|84841||1|0|L|0|||0
136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|3023|5659|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||3023||3023|5659||1|0||0|||0
136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|804|2605|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||804||804|2605||2|0||2|60|mg|0
136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól|||||||1|0||0|||0
137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|16195|14574|lyfalmen|V0261|11408|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||9500||9500|14574||2|0|G|0|||0
137665|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|30|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|1795|3618|lyfalmen|V1002|3618|2|30|0|2,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||1540||1540|3618||2|0|E|1|30|dagar|0
137690|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|682|2437|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck AB|Levótýroxínnatríum||682||682|2437||2|0|G|0|||0
137721|L04AA4001|Mavenclad|töflur|10|mg|6|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|1|MRP|0|1|0|100|SEK|2014383|2511840|lyfsjukr|||1|6|0|176,4706|Icepharma hf|Merck Europe B.V.|Cladribine||2014383||2014383|2511840||2|0|L|0|||0
137883|N05AH0415|Quetiapin Krka|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6500|7004|lyfalmen|V0273|5008|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||4000||4000|7004||2|0|G|0|||0
138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4824|5613|lyfalmen|V0689|3460|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2990||2990|5613||2|0|E|0|||0
138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2877|5458|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2877||2877|5458||2|0|G|0|||0
138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|1|0|1|GSE|0|0|0|100|DKK|2555080|3184315|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|sofosbuvir,velpatasvir,voxilaprevir||||2555080|3184315||2|0|ES|0|||0
138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2500|2806|lyfalmen|V0114|2806|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||950||950|2806||2|0|G|0|||0
138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|17696|25855|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||17696||17696|25855||1|0||0|||0
138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3752|6662|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3752||3752|6662||2|0|G|0|||0
138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|5312|6051|lyfalmen|V0691|6051|2|30|0|18,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3308||3308|6051||1|0|E|1|30|dagar|0
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|G|0|ATE|0|0|0|100|XEU|2866|4995|lyfalmen|V0373|4995|2|15|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tímólól í blöndum||2541||2541|4995||1|0|G|0|||0
139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|1|0|1|AEB|0|1|0|100|XEU|112727|146712|lyfsjukr|||1|56|0|28,0000|Vistor hf|Amgen Europe B.V.|Apremilast||112727||112727|146712||1|0|L|0|||0
139959|N06DA0304|Nimvastid|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0
140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|568|2280|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||568||568|2280||1|0|G|0|||0
140132|C08CA0107|Amlodipine Vitabalans|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|1267|2461|lyfalmen|V0056|2307|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0
140191|R06AX2708|Dasergin|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|0|0|KAN|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||||2|0||0|||0
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|1075|2978|lyfalmen|V0266|2368|1|30|0|1,5000|Vistor hf|Boehringer Ingelheim International |Pramipexól||1075||1075|2978||1|0|G|0|||0
140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015|30.09.2020|R|1|0|0|G|0|ATE|0|0|0|100|XEU|15991|21307|lyfalmen|||2|98|0|104,5300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||14392||14392|21307||1|0|G|0|||0
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|1|LBK|0|0|0|100|DKK|9952|15196|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9952||9952|15196||1|0|S|0|||0
140563|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|1|dropaí||A07DA02|01.06.2018||R|0|0|0|0|0|ARO|0|0|0|100|DKK|7370|11642|lyfalmen|||2|10|0|1,0000|Pharmanovia A/S|Pharmanovia A/S|opium||7370||7370|11642||2|0|E|1|30|dagar|0
140611|N06BA0408|Methylphenidate Teva|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|3401|6179|lyfalmen|V0958|6179|2|30|0|10,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3401||3401|6179||1|0|E|1|30|dagar|0
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|SRR|0|0|0|100|NOK|74539|141586|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||74539||74539|141586||1|0||0|||0
140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|1|0|1|JAS|0|0|0|100|SEK|68214|89551|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||68214||68214|89551||1|0|S|0|||0
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1250|3218|lyfalmen|V0413|2962|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1250||1250|3218||1|0|G|0|||0
141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|G|0|NEL|0|0|1|100|DKK|3276|6007|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||3276||3276|6007||1|0|G|0|||0
141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1|0||0|||0
141238|N05CH0104|Melatonin Vitabalans|töflur|3|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|4000|3700|lyfalmen|||2|50|0|75,0000|LYFIS ehf|LYFIS ehf|Melatonin||1600||1600|3700||2|0|0|0|||0
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|1|FKA|0|0|1|100|DKK|3720|6618|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3720||3720|6618||1|0|S|0|||0
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|15389|22679|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||15389|22679||2|0|G|0|||0
141783|R02AX0101|Strefen|munnhúði|16,2|mg/ml|15|ml|1|glas||R02AX01|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
141847|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|100|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|37548|45969|lyfalmen|V1007|45969|2|100|0|53,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||33757||33757|45969||2|0|E|1|30|dagar|0
141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3794||1|0||0|||0
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|6520|10472|lyfalmen|V0267|4388|1|100|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||6520||6520|10472||1|0|G|0|||0
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1745|3900|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1745||1745|3900||2|0|G|0|||0
142123|R07AX0101|INOmax|lyfjagas|800|ppm|2|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|1|LIN|0|0|0|100|XEU|23941|33554|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||23941|33554||5|H|S|0|||0
142177|QP54AA5401|BROADLINE|bl.lausn|||0,3|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2783|4797|vetorma|||0|0,9|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2783||2783|4797||1|0||0|||0
142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|4384|4982|lyfalmen|V0384|3887|2|10|0|5,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2531||2531|4982||1|0|G|0|||0
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|G|0|SNP|0|0|0|100|XEU|958|2817|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||958||958|2817||1|0|G|0|||0
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|MEA|0|0|1|100|DKK|3443|6237|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Metenamín||3443||3443|6237||2|0|E|0|||0
142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|1|PEU|0|0|0|100|DKK|469006|589823|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||469006||469006|589823||1|0|ES|0|||0
142606|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1078|2982|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||1078||1078|2982||2|0|G|1|30|dagar|0
142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2599|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||800||800|2599||2|0|G|0|||0
142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2043|2943|lyfalmen|V0049|2943|2|100|0|66,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1050||1050|2943||2|0|G|0|||0
143139|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16820||1|0||0|||0
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|1|PLS|0|0|0|100|DKK|2331|4706|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2331||2331|4706||1|H|S|0|||0
143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|9053|5071|lyfalmen|V0687|4939|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||2596||2596|5071||1|0|E|0|||0
143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5023|8412|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5023||5023|8412||1|0||0|||0
143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|602|2327|lyfalmen|V0542|2327|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atenólól||602||602|2327||1|0|G|0|||0
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|1129|3052|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Trópíkamíð||1129||1129|3052||1|0||0|||0
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1405|3432|lyfalmen|V0173|2676|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1405||1405|3432||1|0|E|0|||0
143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|5197|8651|lyfalmen|V0387|7665|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5197||5197|8651||1|0|G|0|||0
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|G|0|MBV|0|0|0|100|DKK|5092|8507|lyfalmen|V0386|7467|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||5092||5092|8507||1|0|G|0|||0
143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|G|0|ATE|0|0|0|100|DKK|3016|5649|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Litíum||3016||3016|5649||1|0|G|0|||0
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1774|3940|lyfalmen|V0174|2599|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1774||1774|3940||1|0|E|0|||0
144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|4212|7295|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4212||4212|7295||1|0|G|0|||0
144490|N07XX0801|Vyndaqel|hylki|61|mg|30|stk|1|stsk.þ||N07XX08|01.10.2020||R|0|1|1|0|1|PEU|0|0|0|100|DKK|1505668|1879141|lyfsjukr|||1|30|0|91,5000|Icepharma hf|Pfizer Europe MA EEIG|Tafamidis||1505668||1505668|1879141||1|0|0|0|||0
144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9945|14863|lyfalmen|V0587|14165|2|98|0|52,2700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||9710||9710|14863||1|0|G|1|30|dagar|0
144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|tfílát||N05BA02|01.04.2020||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1494|3554|lyfalmen|||2|24|0|8,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1494||1494|3554||1|0||2|50|töflur|0
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|0|0|0|1|JAN|0|1|0|100|DKK|83481|108860|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||83481||83481|108860||1|H|L|0|||0
145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4912|8259|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4912|8259||1|0|G|0|||0
145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|4857|9385|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4857||4857|9385||1|0||0|||0
145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|6566|12628|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||6566||6566|12628||1|0||0|||0
145479|L04AX0402|Lenalidomid Alvogen|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|1|ALO|0|1|0|100|XEU|711389|891280|lyfsjukr|||2|21|0|31,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||711389||711389|891280||2|0|L|0|||0
145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|526|2222|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||526||526|2222||1|0|G|0|||0
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2|0||0|||0
145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|7986|15322|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||7986||7986|15322||1|0||0|||0
145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|9560|18308|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||9560||9560|18308||1|0||0|||0
145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|1|BAM|0|0|1|100|SEK|7336|11595|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7336||7336|11595||2|0|S|0|||0
145691|L03AA1302|Pelgraz|stl|6|mg/spr|0,6|ml|1|spr|áföst nál með nálavörn|L03AA13|01.03.2019||R|0|0|1|0|1|CLU|0|0|0|100|XEU|118234|153561|lyfsjukr|||2|0,6|0|20,0000|Artasan ehf|Accord Healthcare S.L.U.|Pegfilgrastím||118234||118234|153561||1|0|S|0|||0
145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|G|0|VIF|0|0|1|100|CHF|5761|9427|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||5761||5761|9427||1|0|G|0|||0
145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|G|0|VIF|0|0|1|100|CHF|27492|38045|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||27492||27492|38045||1|0|G|0|||0
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|1|RGP|0|1|0|100|DKK|26419|36688|lyfsjukr|||1|1|0|4,8000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||26419||26419|36688||1|H|L|0|||0
146102|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.07.2019|31.10.2020|R|1|0|0|G|0|MYL|0|0|0|100|DKK|6011|6157|lyfalmen|||2|30|0|60,0000|Icepharma hf|Mylan AB|Sólífenacín||3385||3385|6157||2|0|G|0|||0
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|DAN|0|0|0|100|XEU|18357|26764|lyfalmen|V0817|3968|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18357||18357|26764||2|0|E|0|||0
146494|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|15306|12261|lyfalmen|V0441|12261|2|90|0|180,0000|Icepharma hf|Mylan AB|Sólífenacín||7820||7820|12261||2|0|G|0|||0
146529|B06AC0201|Firazyr|stl|30|mg|3|ml|1|áfspr|+ ein nál|B06AC02|01.05.2020||R|0|0|1|0|1|HPI|0|0|0|100|DKK|265713|336984|lyfsjukr|||1|3|0|1,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Icatibant ||265713||265713|336984||1|0|ES|0|||0
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|1072|2973|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1072||1072|2973||1|0||0|||0
146751|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4018|lyfalmen|V0815|3839|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1831||1831|4018||2|0|E|0|||0
146812|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.08.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9396|14431|lyfalmen|V0608|14431|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||9396||9396|14431||1|0|G|0|||0
147481|N06AB0608|Sertralin WH|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1825|2916|lyfalmen|V0322|2916|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||1030||1030|2916||2|0|G|0|||0
147578|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3370||1|0||0|||0
147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BFP|0|0|1|100|XEU|1811|3991|lyfalmen|||2|30|0|3,7500|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1811||1811|3991||1|0|E|0|||0
147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|6431|5311|lyfalmen|V0687|4939|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2770||2770|5311||2|0|E|0|||0
147902|L01XE2901|Lenvima|hylki|10|mg|30|stk|1|þpakki||L01XE29|01.12.2018||R|0|0|1|0|1|SIE|0|0|0|100|SEK|251826|319712|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||251826||251826|319712||1|0|S|0|||0
147931|D11AX1802|Solaraze 3%|hlaup|3|% w/w|100|g|1|túpa||D11AX18|01.01.2020||R|0|0|0|0|0|ALM|0|0|0|100|XEU|16851|24692|lyfalmen|V1009|24692|1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||16851||16851|24692||1|0|E|0|||0
148087|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|164590|211215|lyfsjukr|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||||164590|211215||2|0|ES|0|||0
148170|J05AE1003|Darunavir Medical Valley|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|1|VAL|0|0|0|100|XEU|52805|70061|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Darunavír||52805||52805|70061||2|0|S|0|||0
148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|1|0|0|ROA|0|0|0|100|DKK|102923|134519|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||102923||102923|134519||2|0||0|||0
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1243|2906|lyfalmen|V0577|2906|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||1023||1023|2906||1|0|E|0|||0
148266|QI01AN0101|Evalon|innúðal|||5000|skammtar|1|hgl|+250ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|104840|180702|vetorma|||0|5000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||104840||104840|180702||2|0|0|0|||0
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1849|4043|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1849||1849|4043||1|0|E|0|||0
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|6356|9824|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||6049||6049|9824||1|0|E|0|||0
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|63683|83820|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||63683||63683|83820||1|0|E|0|||0
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|63683|83820|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||63683||63683|83820||1|0|E|0|||0
148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|SEK|581|2182|lyfalmen|V0601|2182|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||497||497|2182||1|0|G|0|||0
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|G|0|LFS|0|0|0|100|DKK|1023|2906|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1023||1023|2906||1|0|G|0|||0
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81814||5|H|S|0|||0
148780|J01DH0205|Meropenem WH|sts/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|1|WEH|0|0|1|100|XEU|14660|16728|lyfsjukr|||2|10|0|1,6667|Williams & Halls efh|Williams & Halls ehf|Meropenem||11065||11065|16728||2|0|S|0|||0
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|BAN|1|0|0|100|DKK|3742|7270|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|Xylazinum||3742||3742|7270||2|0||0|||0
149203|R03AC0206|Ventoline|innúðal|0,1|mg/sk|200|skammtar|1|úðaílá|dreifa|R03AC02|01.04.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|484|2164|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||484||484|2164||1|0|G|0|||0
149240|A02BX1301|Gaviscon|mixtúra|||400|ml|1|glas||A02BX13|01.06.2019||L|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4121||1|0||0|||0
149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|1|JCI|0|1|0|100|SEK|289027|365980|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||289027||289027|365980||1|H|L|0|||0
149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|1|FKA|0|0|1|100|DKK|2531|4982|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2531||2531|4982||1|0|S|0|||0
149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|1|WEH|0|0|0|100|XEU|15793|23235|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||15793||15793|23235||2|H|ES|0|||0
150005|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9914|15144|lyfalmen|V0611|15144|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||9914||9914|15144||1|0|G|0|||0
150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen|||||7927||1|0|G|0|||0
150281|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4613|6866|lyfalmen|V0253|4190|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3900||3900|6866||2|0|G|0|||0
150448|L01XX4501|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XX45|01.10.2016||R|0|0|0|0|1|AEB|0|1|0|100|DKK|174199|223166|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomibum||174199||174199|223166||1|H|L|0|||0
150498|B01AC2202|Prasugrel Krka|filmhtfl|5|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|V0805|10445|2|30|0|15,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445||2|0|G|0|||0
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|43121|57813|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||43121|57813||1|0|S|0|||0
151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4300|2737|lyfalmen|V0607|2737|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||900||900|2737||2|0|G|0|||0
151060|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|47270|59607|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||44539||44539|59607||2|0|ES|0|||0
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|G|0|LBK|0|0|0|100|DKK|6237|10083|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6237||6237|10083||1|0|G|0|||0
151207|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|1|glas|1 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|200|0|6,6667|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|G|0|SNP|0|0|0|100|XEU|1582|3675|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1582||1582|3675||1|0|G|0|||0
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|G|0|LUN|0|0|0|100|DKK|31529|43151|lyfalmen|V0607|2737|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||31529||31529|43151||1|0|G|0|||0
151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|TPA|0|0|0|100|DKK|437|2099|lyfalmen|V0633|2020|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||437||437|2099||1|0|G|0|||0
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4447|7619|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Europe B.V.|Chóríógónadótrópín alfa||||4447|7619||2|0|G|0|||0
151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|5413|3060|lyfalmen|V0682|3060|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1135||1135|3060||2|0|G|0|||0
151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|LTH|0|0|1|100|SEK|1165|3101|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||1165||1165|3101||1|0||0|||0
151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1195|2349|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1195|2349||2|0||0|||0
151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1973|2874|lyfalmen|V0234|1831|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1000||1000|2874||1|0|G|0|||0
151905|L03AX1302|Remurel|stl|40|mg/ml|12|áf.spr|1|pakki||L03AX13|01.07.2018||R|0|0|1|0|1|IPC|0|0|0|100|XEU|120747|115937|lyfsjukr|||2|12|0|24,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||89076||89076|115937||2|0|S|0|||0
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|1|HES|0|0|0|100|DKK|1823|4007|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1823||1823|4007||1|H|S|0|||0
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0
152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2884|5467|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2884||2884|5467||1|0|G|0|||0
152410|N05AH0416|Quetiapin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|7800|8917|lyfalmen|V0272|8917|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||5390||5390|8917||2|0|0|0|||0
152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|AZD|0|0|0|100|SEK|4629|7869|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4629||4629|7869||1|0|G|0|||0
152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|ASZ|0|0|0|100|SEK|8464|13148|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||8464||8464|13148||1|0|G|0|||0
152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|G|0|BFP|0|0|1|100|XEU|6873|9628|lyfalmen|||2|90|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||5907||5907|9628|30.11.2020|1|0|G|0|||0
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1595|3693|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1595||1595|3693||2|0||0|||0
153179|R03AK0605|Salmex|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GLZ|0|0|0|100|DKK|3711|5532|lyfalmen|V0436|5532|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||2931||2931|5532||2|0|G|0|||0
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|32476|44349|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||32476|44349||1|0|S|0|||0
153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||5423||1|0|G|0|||0
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|1|GSE|0|0|0|100|DKK|185188|236833|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Sciences Ireland|Amfóterícín||185188||185188|236833||2|H|ES|0|||0
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|743|2521|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||743||743|2521||1|0|G|0|||0
153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|40529|54535|lyfalmen|V0452|54535|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Exemestan||40529||40529|54535||1|0|G|0|||0
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|3812|6745|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3812||3812|6745||1|0|E|0|||0
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1238|3202|lyfalmen|||2|24|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1238||1238|3202||1|0||2|25|töflur|0
154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|IKR|726|2131|lyfalmen|V0908|2048|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||460||460|2131||2|0|G|0|||0
154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ALE|0|0|0|100|SEK|22792|21072|lyfalmen|V0183|21072|2|1|0|27,9070|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||14221||14221|21072||2|0|G|0|||0
154116|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|6978|5627|lyfalmen|V0995|5613|2|7,5|0|75,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||3000||3000|5627||2|0|G|0|||0
154147|R03AL0801|Trelegy Ellipta|innönddu|||30|skammtar|1|innö.t|92 mcg/55 mcg/22 mcg|R03AL08|01.06.2019||R|0|0|0|G|0|GSD|0|0|0|100|DKK|9089|14008|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Trading Services Ltd.|Vilanterol, umeclidinium bromide, fluticasone furoate||9089||9089|14008||1|0|G|0|||0
154377|G03CA0325|Estrofem 1 mg|filmhtfl|1|mg|84|stk|1|skífup||G03CA03|01.05.2020||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2353|4737|lyfalmen|||1|84|0|42,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2353||2353|4737||1|0|G|0|||0
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||13636||1|0|G|0|||0
154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|22061|31176|lyfalmen|||1|28|0|42,0000|Eisai AB|Eisai GmbH|Perampanel||22061||22061|31176||1|0|G|0|||0
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|18387|26806|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||18387||18387|26806||1|0|S|0|||0
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|21009|29846|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||21009||21009|29846||1|0|S|0|||0
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|26282|36515|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||26282||26282|36515||1|0|S|0|||0
154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|1|FKA|0|0|0|100|DKK|23978|33601|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||23978||23978|33601||1|0|S|0|||0
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|24043|33683|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||24043||24043|33683||1|0|S|0|||0
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|29140|40130|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||29140||29140|40130||1|0|S|0|||0
154697|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|4848|3836|lyfalmen|V0438|3836|2|30|0|30,0000|Icepharma hf|Mylan AB|Sólífenacín||1699||1699|3836||2|0|G|0|||0
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|15676|23074|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||15676||15676|23074||1|0|S|0|||0
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3139|5818|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3139||3139|5818||1|0|G|0|||0
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|23166|32574|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||23166||23166|32574||1|0|S|0|||0
154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3616|2877|lyfalmen|V0334|2549|2|98|0|73,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||1002||1002|2877||1|0|G|0|||0
154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6338|2877|lyfalmen|V0335|2549|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||1002||1002|2877||1|0|G|0|||0
155121|L04AA4001|Mavenclad|töflur|10|mg|4|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|1|MRP|0|1|0|100|SEK|1342922|1676730|lyfsjukr|||1|4|0|117,6471|Icepharma hf|Merck Europe B.V.|Cladribine||1342922||1342922|1676730||2|0|L|0|||0
155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1722|2313|lyfalmen|V0247|2313|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||592||592|2313||2|0|G|0|||0
155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3218|3996|lyfalmen|V0248|3996|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1815||1815|3996||2|0|G|0|||0
155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|6083|4567|lyfalmen|V0249|4567|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||2230||2230|4567||2|0|G|0|||0
155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|18267|26641|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18267||18267|26641||1|0||0|||0
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1602|3703|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1602||1602|3703||1|0|G|0|||0
155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|5947|7401|lyfalmen|V0253|4190|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4289||4289|7401||1|0|G|0|||0
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|690|2448|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||690||690|2448||1|0|G|0|||0
155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1457|3136|lyfalm11|V0590|3095|2|84|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Desógestrel||1457||1457|3136||1|0||0|||0
155485|L01XX4601|Lynparza|filmhtfl|150|mg|56|stk|1|þpakki||L01XX46|01.03.2020||R|0|0|1|0|1|AZA|0|1|0|100|SEK|392860|495119|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||392860||392860|495119||1|0|L|0|||0
155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|RHG|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0
155579|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|39465|53189|lyfalmen|||1|50|0|8,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||39465||39465|53189||1|0|E|0|||0
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|6148|9960|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6148||6148|9960||1|0|E|0|||0
156066|J05AR0603|Efavirenz/Emtricitabine/Tenofovir Krka|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.06.2020||R|0|0|1|0|1|KAN|0|0|0|100|IKR|59860|78985|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||59860||59860|78985||2|0|S|0|||0
156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|21129|29998|lyfalmen|V0383|21492|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||21129||21129|29998||1|0|G|0|||0
156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|4589|2737|lyfalmen|V0552|2737|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||900||900|2737||2|0|E|0|||0
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|5369|8888|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5369||5369|8888||2|0|G|0|||0
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|6232|10076|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6232||6232|10076||2|0|G|0|||0
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|MEA|0|0|1|100|DKK|406|2057|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||406||406|2057||2|0|0|0|||0
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|JAS|0|0|0|100|SEK|664|2412|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||664||664|2412||1|0||0|||0
156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|0|0|0|RPG|1|0|0|100|DKK|8262|13643|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||7101||7101|13643||2|0|0|1|30|dagar|0
157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13451|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13451||2|0|E|1|30|dagar|0
157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||2|0||0|||0
157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2|0||2|||0
157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|64658|85053|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||64658||64658|85053||2|H|S|0|||0
157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|1|SAR|0|0|0|100|DKK|40715|49620|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||36643||36643|49620||1|0|S|0|||0
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|G|0|HES|0|0|0|100|DKK|1516|3585|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1516||1516|3585||1|0|G|0|||0
157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|ALM|0|0|0|100|DKK|6668|10676|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6668||6668|10676||1|0||0|||0
158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|1|SNP|0|0|0|100|XEU|1056|2951|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1056||1056|2951||1|H|S|0|||0
158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|ASA|0|0|0|100|SEK|20601|29330|lyfalmen|V0910|7540|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||20601|29330||1|0||0|||0
158608|J02AX0501|Mycamine|irþstofn|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|1|APG|0|0|0|100|XEU|46980|62694|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||46980|62694||1|H|ES|0|||0
158619|J02AX0501|Mycamine|irþstofn|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|1|APG|0|0|0|100|XEU|72054|94407|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||72054||72054|94407||1|H|ES|0|||0
158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|GPA|0|0|0|100|XEU|4150|3759|lyfalmen|V0143|3594|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1643||1643|3759||1|0|E|0|||0
158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|1|LLS|0|1|0|100|DKK|261816|332137|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||261816||261816|332137||2|0|L|0|||0
158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|15015|4340|lyfalmen|V0817|3968|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2065||2065|4340||2|0|E|0|||0
158860|J01FA0904|Clarithromycin Krka|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|1724|3871|lyfalmen|V0967|2668|2|14|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1724||1724|3871||2|0||0|||0
159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|2088|4372|lyfalmen|V0219|4372|2|5|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||2088||2088|4372||1|0|G|1|30|dagar|0
159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3711|6606|lyfalmen|V0220|6479|2|5|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||3711||3711|6606||1|0|G|1|30|dagar|0
159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|5358|8873|lyfalmen|V0221|8873|2|5|0|22,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||5358||5358|8873||1|0|G|1|30|dagar|0
159138|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1023|3180|0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0||0|||0
159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|5303|8797|lyfalmen|V0223|8797|2|5|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||5303||5303|8797||1|0|G|1|30|dagar|0
159387|N06BA0905|Atomoxetin STADA|hylki|25|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4800|4113|lyfalmen|V0814|4113|2|30|0|9,3750|LYFIS ehf|LYFIS ehf|Atomoxetín||1900||1900|4113||2|0|E|0|||0
159405|A10BD2401|Steglujan|filmhtfl|115|mg|28|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|11059|16487|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||10890||10890|16487||1|0|G|0|||0
159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|0|1|IPC|0|1|0|100|SEK|134675|158730|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||122390||122390|158730||2|H|L|0|||0
159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0
159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|1|ESS|0|0|0|100|DKK|45873|61294|lyfsjukr|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||45873||45873|61294||2|H|S|0|||0
159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|713|2479|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||713||713|2479||2|0|G|0|||0
159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|1750|3907|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1750||1750|3907||2|0|G|0|||0
159751|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|523|2115|lyfsjukr|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||448||448|2115||2|0|ES|0|||0
159762|N06DA0304|Nimvastid|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|74,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0
159765|N05AX1212|Abilify Maintena (Lyfjaver)|sts|400|mg|1|hgl|1|pakki||N05AX12|01.05.2019||R|0|0|0|0|0|LVR|0|0|0|100|DKK|45318|60592|lyfalmen|V0980|60592|3|1|0|30,0800|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||45318||45318|60592||3|0|E|0|||0
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|1|GRP|0|0|0|100|DKK|141576|182592|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||141576||141576|182592||1|H|S|0|||0
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|NIL|1|0|0|100|XEU|4341|8406|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Flunixinum||4341||4341|8406||2|0||0|||0
160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|1|SUG|0|1|0|100|XEU|64718|85129|lyfsjukr|||2|4|0|14,2900|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||64718||64718|85129||2|0|L|0|||0
160195|C09CA0307|Valsartan Jubilant|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|2000|3838|lyfalmen|V0678|3563|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan||1700||1700|3838||2|0|G|0|||0
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|G|0|ATE|0|0|1|100|XEU|5914|3129|lyfalmen|V0010|2193|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1185||1185|3129||1|0|E|0|||0
160487|N06BA0409|Methylphenidate STADA|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|5600|7898|lyfalmen|V0996|7898|2|30|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||4650||4650|7898||2|0|E|1|30|dagar|0
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|G|0|SNP|0|0|0|100|XEU|847|2664|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||847||847|2664||1|0|G|0|||0
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|1|PLS|0|0|0|100|DKK|952|2808|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||952||952|2808||1|H|S|0|||0
161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1520|3590|lyfalmen|V0169|2530|1|14|0|8,1667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1520||1520|3590||1|0|E|0|||0
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2623|5108|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2623||2623|5108||1|0|G|0|||0
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|627|2361|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||627||627|2361||1|0|G|0|||0
161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1747|2534|lyfalmen|V0143|1198|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||753||753|2534||1|0|E|0|||0
161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|7692|lyfalmen|V0145|4210|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4500||4500|7692||2|0|E|0|||0
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|G|0|PLS|0|0|0|100|DKK|59227|78184|lyfalmen|V0452|54535|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||59227||59227|78184||1|0|G|0|||0
161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|1|VIN|0|0|1|100|DKK|6724|10753|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||6724|10753||2|0|ES|0|||0
161596|R03BA0501|Flixotide|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.08.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2776|5319|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2776||2776|5319||1|0|G|0|||0
161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|G|0|AGC|0|0|0|100|XEU|29025|39984|lyfalmen|||1|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||29025||29025|39984||1|0|G|0|||0
162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|RRD|0|0|0|100|DKK|564126|708126|lyfalmen|||1|60|0|30,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||564126||564126|708126||1|0|E|0|||0
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2011|4266|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||2011||2011|4266||1|0|G|0|||0
162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|13997|7761|lyfalmen|V0145|6315|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4550||4550|7761||2|0|E|0|||0
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|LEV|1|0|0|100|XEU|5845|11260|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|Detomidinum||5845||5845|11260||2|0||0|||0
162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2559|4011|lyfalmen|V0041|4011|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1826||1826|4011||2|0|G|0|||0
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BFP|0|0|0|100|XEU|511|2115|lyfalmen|V0500|2082|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||448||448|2115||1|0|G|0|||0
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BFP|0|0|0|100|XEU|739|2515|lyfalmen|||2|100|0|42,5000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||739||739|2515||1|0|G|0|||0
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BFP|0|0|0|100|XEU|462|2134|lyfalmen|V0502|2134|2|60|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||462||462|2134||1|0|G|0|||0
162872|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.10.2019||R|0|0|1|0|1|CLU|0|1|0|100|XEU|26827|37204|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||26827||26827|37204||1|0|L|0|||0
162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1234|3196|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1234||1234|3196||1|0|G|0|||0
163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|9996|15256|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai GmbH|Rúfínamíð||9996||9996|15256||1|0|G|0|||0
163082|N02BA5103|Triplo|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2018||L|0|0|0|0|0|OEC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|Orifarm Generics A/S|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1|0||0|||0
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|0|0|0|HES|0|0|0|100|DKK|1268|3243|lyfalmen|V0671|2701|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1268||1268|3243||1|0|E|1|30|dagar|0
163164|QH01CA9002|Busol|stl|0,004|mg/ml|10|ml|5|hgl|lausn|QH01CA90|01.11.2018||R|0|0|0|0|0|TPW|1|0|0|100|IKR|14280|27263|vetalmen|||0|50|0||Dýraheilsa ehf|T.P. Whelehan Son & Co. Ltd.|Buserelin||14280||14280|27263||2|0||0|||0
163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|4231|7321|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||4231||4231|7321||2|0|G|0|||0
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|1173|3112|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1173||1173|3112||1|0||0|||0
163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3339|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0
163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|6529|10484|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6529||6529|10484||1|0||0|||0
163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|11302|17054|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11302||11302|17054||2|H|S|0|||0
163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2511|4954|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2511||2511|4954||1|0|G|0|||0
163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|1|0|1|FIN|0|1|0|100|DKK|448852|564757|lyfsjukr|||1|112|0||Icepharma hf|Bayer AG|Sorafeníb||448852||448852|564757||2|0|L|0|||0
163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1829|4015|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1829||1829|4015||1|0|G|0|||0
163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RHG|0|0|1|100|XEU|630|2365|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm GmbH|Íbúprófen||630||630|2365||2|0|G|0|||0
163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1888|4097|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm GmbH|Íbúprófen||1888||1888|4097||2|0|G|0|||0
163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2159|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||500||500|2186||2|0|G|0|||0
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3817|6752|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3817||3817|6752||1|0|S|0|||0
164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|1|0|1|NRO|0|0|0|100|DKK|40849|54939|lyfsjukr|||1|100|0||Pharmanovia A/S|Nova Laboratories Ireland Limited|Merkaptópúrín||40849||40849|54939||2|0|S|0|||0
164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9939|19027|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||9939||9939|19027||1|0||0|||0
164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|398587|502242|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||398587||398587|502242||1|0|L|0|||0
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1044|2935|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1044||1044|2935||2|0|G|0|||0
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1282|3262|lyfalmen|V0314|3262|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1282||1282|3262||2|0|G|0|||0
164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|5476|9035|lyfalmen|||1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5476||5476|9035||2|0|G|0|||0
164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||2|0||0|||0
165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1|0||0|||0
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|ATE|0|0|0|100|GBP|4141|7198|lyfalmen|||2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||4141||4141|7198||1|0||2|50|töflur|0
165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|22061|31176|lyfalmen|V0667|31176|1|28|0|35,0000|Eisai AB|Eisai GmbH|Perampanel||22061||22061|31176||1|0|G|0|||0
165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|LAS|1|0|0|100|XEU|7151|13737|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||7151||7151|13737||2|0||0|||0
165507|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2018||R|0|0|0|0|1|ATE|0|0|0|100|XEU|8866|13701|lyfsjukr|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Írinótekan||8866||8866|13701||1|H|S|0|||0
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|1|MEC|0|1|0|100|SEK|171777|220154|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||171777||171777|220154||2|0|L|0|||0
165689|N06AB0406|Citalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.09.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|5077|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||2600||2600|5077||2|0|G|0|||0
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|GOP|0|0|1|100|DKK|||lyflausa|||0|10|0|5,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín||||||||0|0|0|||0
165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|203723|259886|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||203723||203723|259886||1|0|L|0|||0
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|4329|7456|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4329||4329|7456||1|0|S|0|||0
165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|RPG|1|0|0|100|XEU|6187|11908|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|butylscopolamine and analgesics||||6187|11908||2|0||0|||0
166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8916|6040|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3300||3300|6040||2|0|E|0|||0
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1582|3675|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1582||1582|3675||1|0|G|0|||0
166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|1|G|0|PLS|0|0|0|100|DKK|14903|22010|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14903||14903|22010||1|0|G|0|||0
166204|J07BB0205|Influvac|stl|||0,5|ml|10|áfspr||J07BB02|01.11.2017||R|0|0|0|0|0|MDK|0|0|0|100|DKK|9012|13902|lyfalmen|||1|5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir  mótefnavakar||||9012|13902||2|0||0|||0
166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2665|2806|lyfalmen|V0113|2806|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|1|0|1|ABD|0|1|0|100|DKK|127095|164582|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||127095||127095|164582||1|0|L|0|||0
167366|C01CA1702|Midodrin Evolan|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|G|0|EVO|0|0|0|100|IKR|8346|11312|lyfalmen|V0968|10556|2|50|0|4,1666|LYFIS ehf|Evolan Pharma AB|midodrine||7130||7130|11312||2|0|G|0|||0
167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|44635|59728|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||44635||44635|59728||2|0|L|0|||0
167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2548|3081|lyfalmen|V0826|3075|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3081||2|0|G|0|||0
167887|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|1220|2668|lyfalmen|V0189|2668|2|100|0|50,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||850||850|2668||2|0|G|0|||0
167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1855|3088|lyfalmen|V0005|3012|2|28|0|37,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||1155||1155|3088||1|0|E|0|||0
168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|1|0|1|GEI|0|0|0|100|DKK|143967|185566|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||143967||143967|185566||2|0|S|0|||0
168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|16638|lyfalmen|V0420|16638|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||11000||11000|16638||2|0|G|0|||0
168119|B06AC0102|Berinert|sts/irs|500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|1|CSB|0|1|0|100|SEK|105637|137894|lyfsjukr|||1|1|0|0,3571|Icepharma hf|CSL Behring GmbH|C1 hemill||105637||105637|137894||2|0|L|0|||0
168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5208|5737|lyfalmen|V0007|4251|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lansóprazól||3080||3080|5737||1|0|E|0|||0
168388|L04AC1301|Taltz|stl|80|mg|1|ml|1|áfpen||L04AC13|01.06.2020||R|0|0|1|0|1|NED|0|1|0|100|XEU|155597|200030|lyfsjukr|||1|1|0|27,5862|Icepharma hf|Eli Lilly Nederland B.V.|Ixekizumab||155597||155597|200030||2|0|L|0|||0
168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2591|5064|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2591||2591|5064||2|0|G|0|||0
168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3085|5744|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3085||3085|5744||2|0|G|0|||0
168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|3450|6247|lyfalmen|||1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||3450||3450|6247||1|0|G|0|||0
168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|6290|10155|lyfalmen|||1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||6290||6290|10155||1|0|G|0|||0
169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8106|12655|lyfalmen|V0688|12655|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||8106||8106|12655||2|0|E|0|||0
169293|L01XX2702|Arsenic Trioxide Accord|irþ|1|mg/ml|10|ml|10|hgl||L01XX27|01.05.2020||R|0|0|0|0|1|CLU|0|0|0|100|XEU|548580|688791|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Arsenic trioxide||548580||548580|688791||1|H|0|0|||0
169402|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|2815|2461|lyfalmen|V0994|2448|2|2,5|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||700||700|2461||2|0|G|0|||0
169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1682|3395|lyfalmen|V0411|3395|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1378||1378|3395||2|0|E|0|||0
169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1112|2551|lyfalmen|V0177|2551|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||765||765|2551||2|0|E|0|||0
169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1098|2538|lyfalmen|V0418|2537|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||756||756|2538||2|0|E|0|||0
169872|QG03XA9101|Improvac|stl|||100|ml|1|glas||QG03XA91|01.04.2019||R|0|0|0|0|0|ZBE|0|0|0|100|IKR|6255|12037|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||6255||6255|12037||2|0|0|0|||0
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3425|6212|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||3425||3425|6212||2|0||0|||0
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|4219|7305|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||4219||4219|7305||2|0||0|||0
169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|CLE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Clear Eyes Pharma Ltd.|Nafazólín|||||||2|0||0|||0
170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|1|RRG|0|1|0|100|DKK|21819|30870|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||21819||21819|30870||2|H|L|0|||0
170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|1|RRG|0|1|0|100|DKK|54260|71902|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||54260||54260|71902||2|H|L|0|||0
170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5464|9019|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5464||5464|9019||1|0||0|||0
170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|1|RRG|0|1|0|100|DKK|108665|141660|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||108665||108665|141660||2|H|L|0|||0
170237|L04AA2701|Gilenya|hylki|0,25|mg|28|stk|1|þpakki||L04AA27|01.07.2019||R|0|1|1|0|1|NEL|0|1|0|100|DKK|274948|348470|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||274948||274948|348470||1|0|L|0|||0
170309|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.07.2018||R|1|0|0|G|0|BFP|0|0|0|100|XEU|981|2274|lyfalmen|V0108|2274|2|100|0|33,3400|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||564||564|2274||1|0|G|0|||0
170335|N02AX0213|Tramadol Krka|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|550|2255|lyfalmen|V0226|2255|2|20|0|6,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||550||550|2255||2|0|G|1|30|dagar|0
170486|C10AX1401|Praluent|stl|75|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|198550|253452|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||198550||198550|253452||1|0|E|0|||0
170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|G|0|HSS|0|0|0|100|DKK|11790|17726|lyfalmen|||1|100|0|50,0000|Artasan ehf|Sandoz GmbH|Rífampicín||11790||11790|17726|30.9.2020|1|0|G|0|||0
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2513|4957|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||2513||2513|4957||2|0||0|||0
170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|1|SAR|0|0|0|100|DKK|32157|39879|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||28942||28942|39879||1|0|S|0|||0
170758|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|978|2844|lyfalmen|||1|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||978||978|2844||1|0|G|0|||0
170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|Meloxícam||1158||1158|2276||2|0||0|||0
170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|0|1|CPV|0|1|0|100|XEU|54222|71854|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe B.V.|Azasitidín||54222||54222|71854||2|H|L|0|||0
171292|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|12809|13886|lyfalmen|V0441|13623|2|100|0|200,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||9000||9000|13886||2|0|G|0|||0
171340|R01AX0302|Lomuspray|nefúði|21|mcg/sk|15|ml|1|úðaílá|180 sk, lausn|R01AX03|01.04.2020||L|0|0|0|G|0|SNP|0|0|1|100|XEU|||lyfalmen|||1|15|0|15,7500|Vistor hf|Sanofi-aventis Norge AS|Ípratrópínbrómíð|||||3084||1|0|G|0|||0
171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012|30.11.2020|R|0|0|0|0|0|DEC|0|0|0|100|DKK|2819|5519|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|Prednisolonum og sýkingalyf||2819||2819|5519||1|0||0|||0
171486|L04AB0202|Remsima|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|0|0|0|1|HUN|0|1|0|100|DKK|49106|65383|lyfsjukr|||2|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||49106||49106|65383||1|H|L|0|||0
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3471|6275|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||||3471|6275||2|0||0|||0
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3938|6918|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||3938||3938|6918||2|0||0|||0
171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|G|0|MYL|0|0|0|100|DKK|1311|3302|lyfalmen|||1|30|0|20,0000|Icepharma hf|Mylan AB|Mebeverín||1311||1311|3302||2|0|G|0|||0
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|3099|5763|lyfalmen|V0247|2313|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3099||3099|5763||1|0|G|0|||0
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|5372|8892|lyfalmen|V0248|3996|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||5372||5372|8892||1|0|G|0|||0
172269|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|200|stk|1|þpakki||N03AX14|01.12.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|5000|8380|lyfalmen|V0253|8380|2|200|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||5000||5000|8380||2|0|G|0|||0
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|9938|15177|lyfalmen|V0249|4567|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||9938||9938|15177||1|0|G|0|||0
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|18010|26287|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||18010||18010|26287||1|0|G|0|||0
172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|16833|24667|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||16833||16833|24667||1|0||0|||0
172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|G|0|RDT|0|0|0|100|DKK|9517|14597|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||9517||9517|14597||1|0|G|0|||0
172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2815|2471|lyfalmen|V0284|2365|2|100|0|6,2500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||707||707|2471||1|0|G|0|||0
173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7887|8460|lyfalmen|V0118|8199|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||5058||5058|8460||1|0|E|0|||0
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||4201||1|0|E|0|||0
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|1|RAG|0|0|0|100|DKK|12949|19321|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||12949||12949|19321||1|0|S|0|||0
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|1|ATE|0|0|1|100|DKK|3810|4968|lyfsjukr|||2|20|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2521||2521|4968||1|0|S|2|20|lykjur|0
174063|C03EA0115|Amiloride/HCT Alvogen|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|2015|4271|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||2015||2015|4271||2|0|G|0|||0
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|MEA|0|0|1|100|DKK|600|2324|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||600||600|2324||2|0|E|0|||0
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|1485|3542|lyfalmen|||1|5|0|25,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1485||1485|3542||1|0|G|0|||0
174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5489|lyfalmen|||2|30|0|4,5000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5489||2|0|G|0|||0
174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|10922|16531|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||10922||10922|16531||1|0|G|0|||0
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|3884|6844|lyfalmen|V0368|4810|1|15|0|75,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3884||3884|6844||1|0|G|0|||0
174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|1|ALO|0|0|0|100|XEU|55456|50218|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||37116||37116|50218||2|0|S|0|||0
174825|N02CX0001|Glitinum|hylki|100|mg|30|stk|1|þpakki||N02CX|01.12.2018||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|30|0||Florealis ehf|Florealis ehf|Tanacetum parthenium|||||||2|0||0|||0
174903|N06BA1201|Elvanse Adult|hylki|70|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|17010|24910|lyfalmen|||1|30|0|70,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||17010||17010|24910||1|0|E|1|30|dagar|0
175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|24567|34346|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||24567|34346||3|0|L|0|||0
175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|7420|9496|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||5811||5811|9496||1|0|G|0|||0
175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|0|0|0|100|XEU|5528|10658|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||5528||5528|10658||2|0||0|||0
175351|L01XC0203|Truxima|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|1|CTH|0|1|0|100|DKK|191799|245055|lyfsjukr|||2|50|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||191799||191799|245055||1|H|L|0|||0
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|G|0|GPH|0|0|1|100|DKK|2303|2708|lyfalmen|||1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||879||879|2708||1|0|G|0|||0
175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|NED|0|0|0|100|XEU|4828|8143|lyfalmen|V0278|3982|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4828||4828|8143||2|0|E|0|||0
176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|G|0|KPA|0|0|1|100|DKK|1426|3461|lyfalmen|||1|100|0||Alvogen|Karo Pharma AB|Hýdrókortisón||1426||1426|3461||2|0|G|0|||0
176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2746|5016|lyfalmen|V0429|4354|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2556||2556|5016||2|0|G|0|||0
176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|RNE|0|0|1|100|DKK|2849|5419|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||2849||2849|5419||1|0|0|0|||0
176773|R02AA0308|Strepsils Ingefær|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3105|5772|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||3105||3105|5772||2|0|G|0|||0
176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6827|11767|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6827||6827|11767||2|0||0|||0
176955|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas|+spaði|D01AE16|01.12.2017||R|0|0|0|0|0|GAN|0|0|1|100|XEU|2485|4918|lyfalmen|V0655|4918|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||||2485|4918||2|0|E|0|||0
177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|0|1|AEB|0|0|0|100|DKK|445869|561047|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||445869||445869|561047||1|H|S|0|||0
177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|8078|12616|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||8078||8078|12616||2|0|S|0|||0
177199|L01XE3301|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|1|0|1|PEU|0|1|0|100|DKK|366091|461826|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||366091||366091|461826||1|0|L|0|||0
177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1051|2945|lyfalmen|V0231|2676|2|300|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||||1051|2945||1|0|0|0|||0
177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|DOR|1|0|0|100|XEU|4745|9173|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4745||4745|9173||2|0||0|||0
177723|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3838|3594|lyfalmen|V0143|3594|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1523||1523|3594||2|0|E|0|||0
177754|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|150|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|2733|5260|lyfalmen|V1028|5260|3|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||2733||2733|5260||3|0|E|0|||0
177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|375392|473394|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration GmbH|Pírfenidon||||375392|473394||2|0|E|0|||0
177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|G|0|ATE|0|0|0|100|XEU|9704|12849|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kolkisín||8247||8247|12849||1|0|G|0|||0
178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|35189|47781|lyfalmen|V0975|47021|1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||35189||35189|47781||2|0|G|0|||0
178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|1|0|1|NEL|0|1|0|100|DKK|855147|1070075|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||855147||855147|1070075||1|0|L|0|||0
178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|98270|127565|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||98270|127565||3|0|L|0|||0
178752|L04AD0204|Dailiport|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|10494|15942|lyfalmen|||2|50|0|10,0000|Artasan ehf|Sandoz A/S|Tacrolimus||10494||10494|15942||1|0|G|0|||0
178991|N05AH0416|Quetiapin Medical Valley|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|3000|4788|lyfalmen|V0275|4788|2|100|0|12,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||2390||2390|4788||2|0|0|0|||0
179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|1|SDG|0|1|0|100|DKK|143067|166654|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||128761||128761|166654||1|0|L|0|||0
179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9452|14508|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||9452|14508||2|0|G|0|||0
179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|18520|26989|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18520||18520|26989||1|0||0|||0
179733|N02AA0507|OxyContin Depot|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|1435|3473|lyfalmen|V0597|2844|1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||1435||1435|3473||2|0|G|1|30|dagar|0
179790|N06BA0903|Atomoxetin Medical Valley|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2020||R|1|1|0|0|0|VAL|0|0|0|100|XEU|8203|12789|lyfalmen|V0818|12789|2|28|0|35,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||8203||8203|12789||2|0|E|0|||0
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|1|WIL|0|1|0|100|XEU|120966|156959|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||120966||120966|156959||2|0|L|0|||0
180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|G|0|MED|0|0|0|100|IKR|2191|4514|lyfalmen|V0148|4514|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||2191||2191|4514||2|0|G|0|||0
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|G|0|PLS|0|0|1|100|DKK|737|2512|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||737||737|2512||1|0|G|0|||0
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|0|1|PLS|0|0|0|100|DKK|10128|15438|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||10128||10128|15438||1|H|S|0|||0
181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1|0||0|||0
181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|6339|10223|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||6339||6339|10223||1|0||0|||0
182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||6914||2|0|G|0|||0
182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|2031|2186|lyfalmen|V0556|2186|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||500||500|2186||2|0|E|0|||0
182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|10029|15302|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||10029||10029|15302||1|0|G|0|||0
182416|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|glas|47,5 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|1444|3485|lyfalmen|V0048|2884|2|100|0|33,3333|Artasan ehf|Hexal A/S|Metóprólól||1444||1444|3485||1|0|G|0|||0
182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|15562|22917|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||15562||15562|22917||2|H|S|0|||0
182561|L01XE0303|Erlotinib WH|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.06.2020||R|0|1|1|0|1|WEH|0|1|0|100|XEU|329815|327963|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlótiníb||258460||258460|327963||2|0|L|0|||0
182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|8577|4340|lyfalmen|V0817|3968|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||2065||2065|4340||1|0|E|0|||0
182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|17083|32580|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||17083||17083|32580||1|0||0|||0
182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|0|0|0|RPG|1|0|0|100|XEU|21385|40742|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||21385|40742||2|0||1|30|dagar|0
183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|0|1|PIP|0|0|1|100|DKK|184154|235547|lyfsjukr|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||184154||184154|235547||1|0|ES|0|||0
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|IBV|1|0|0|100|DKK|5585|10766|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5585||5585|10766||1|0||0|||0
183366|L04AD0204|Dailiport|forðahlk|0,5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|6283|10146|lyfalmen|||2|50|0|5,0000|Artasan ehf|Sandoz A/S|Tacrolimus||6283||6283|10146||1|0|G|0|||0
183455|C10AX0903|Ezetimib Krka|töflur|10|mg|30|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3187|5885|lyfalmen|V0612|5885|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||3187||3187|5885||2|0|E|0|||0
183485|L01XE4201|Kisqali|filmhtfl|200|mg|21|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|1|0|1|NEL|0|1|0|100|DKK|156578|201250|lyfsjukr|||1|21|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||156578||156578|201250||1|0|L|0|||0
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5996|9751|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5996|9751||1|0|G|0|||0
183794|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|30430|41761|lyfalmen|V0652|41761|3|168|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban 	||30430||30430|41761||3|0|G|0|||0
183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|7213|12432|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||7213||7213|12432||2|0||0|||0
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|G|0|MDK|0|0|0|100|DKK|1231|3192|lyfalmen|||1|100|0|100,0000|Icepharma hf|Mylan Denmark ApS|Flúdrókortisón||1231||1231|3192||2|0|G|0|||0
183924|N06BA0905|Atomoxetin STADA|hylki|40|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|4113|lyfalmen|V0815|4113|2|30|0|15,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||1900||1900|4113||2|0|E|0|||0
184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|0|0|0|1|JCI|0|1|0|100|SEK|365947|461647|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||365947||365947|461647||1|H|L|0|||0
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|3285|6019|lyfalmen|V0017|6019|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3285||3285|6019||2|0|G|0|||0
184247|V08CA0901|Gadovist|stl|1|mmol/ml|10|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|1|BAB|0|0|0|100|DKK|45588|60933|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadóbútról||||45588|60933||2|H|S|0|||0
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|G|0|HES|0|0|0|100|DKK|48602|64745|lyfalmen|V0185|23813|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||48602||48602|64745||1|0|G|0|||0
184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|PHM|0|0|0|100|XEU|13253|25314|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||13253||13253|25314||2|0||0|||0
184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|0|KRK|0|0|0|100|IKR|3362|6125|lyfalmen|V0690|6125|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||3362||3362|6125||2|0|E|0|||0
185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2|0||0|||0
185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|ASR|0|0|0|100|IKR|985|2554|lyfalm11|V0545|1927|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||985||985|2554||2|0||0|||0
185822|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.10.2020||R|1|0|0|0|0|LVR|0|0|1|100|DKK|10091|6648|lyfalmen|V0011|4960|3|100|0|66,6667|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||3742||3742|6648||3|0|E|0|||0
185859|C02AC0201|Intuniv|forðatfl|4|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|13944|20690|lyfalmen|||1|28|0|37,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||13944||13944|20690||1|0|E|0|||0
186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|294809|373171|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||294809|373171||3|0|L|0|||0
186236|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|V0960|6040|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0
186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|ATE|0|0|1|100|XEU|18440|11587|lyfalmen|V0419|11338|2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||7330||7330|11587||1|0|E|0|||0
186615|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|16839|20418|lyfalmen|||2|360|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||13746||13746|20418||2|0|G|0|||0
186638|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.10.2019||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1|0||0|||0
186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1033|2847|lyfalmen|V0597|2844|2|28|0|3,7300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||980||980|2847||1|0|G|1|30|dagar|0
186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|10028|3081|lyfalmen|V0607|2793|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||1150||1150|3081||2|0|G|0|||0
186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|6454|10381|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6454||6454|10381||1|0||0|||0
187067|L04AB0205|Flixabi|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|1|0|0|1|SUG|0|1|0|100|XEU|43651|58483|lyfsjukr|||2|1|0|26,6700|Icepharma hf|Samsung Bioepis NL B.V.|Infliximab||43651||43651|58483||2|H|L|0|||0
187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2459|4882|lyfalmen|V0462|4882|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4882||2|0|G|0|||0
187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|6046|10421|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||6046||6046|10421||2|0||0|||0
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|G|0|MEA|0|0|1|100|DKK|4022|7034|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||4022||4022|7034||2|0|G|0|||0
187612|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|944|2797|lyfalmen|V0066|2737|2|100|0|100,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||944||944|2797||1|0|G|0|||0
188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3304||2|0|G|0|||0
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|1|PEU|0|0|0|100|DKK|73303|95987|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Europe MA EEIG|Tigecýklín||73303||73303|95987||1|H|ES|0|||0
188405|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|G|0|POF|0|0|0|100|XEU|2211|3981|lyfalmen|V0621|3574|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||1804||1804|3981||2|0|G|0|||0
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|G|0|DEA|0|0|0|100|XEU|5599|9204|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5599||5599|9204||1|0|G|0|||0
188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|5763|9430|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||5763||5763|9430||1|0|G|0|||0
188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1400|3012|lyfalmen|V0458|2979|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||1100||1100|3012||2|0|G|0|||0
188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|2931|3631|lyfalmen|V0422|3287|2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||1550||1550|3631||2|0|G|0|||0
189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|1|PSA|0|0|0|100|DKK|9999|14487|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||9437||9437|14487||2|H|S|0|||0
189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|1|0|1|JCI|0|0|0|100|SEK|42998|57657|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||42998||42998|57657||1|0|S|0|||0
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|1|HES|0|0|0|100|DKK|7054|11207|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||7054||7054|11207||1|H|S|0|||0
189312|N02CD0101|Aimovig|stl|140|mg|1|ml|1|áfpen||N02CD01|01.12.2019||R|0|0|1|0|0|NEL|0|0|0|100|DKK|79984|104437|lyfalmen|||1|1|0|56,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||79984||79984|104437||1|0|E|0|||0
189430|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|5582|9181|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||5582||5582|9181||2|0|G|1|30|dagar|0
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2783|5328|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2783||2783|5328||1|0|G|0|||0
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1064|2962|lyfalmen|V0413|2962|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1064||1064|2962||1|0|G|0|||0
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|515|2207|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||515||515|2207||1|0|G|0|||0
190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1769|3933|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1769||1769|3933||2|0|G|0|||0
190696|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1038|2737|lyfalmen|V0685|2737|2|70|0|5,8333|Acare ehf|Medical Valley Invest AB|Pregabalín||900||900|2737||2|0|E|0|||0
190889|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016|30.09.2020|R|0|1|1|G|0|CLP|0|0|0|100|XEU|23613|33139|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||23613||23613|33139||1|0|G||||
191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4260||1|0|G|0|||0
191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3674|6555|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3674||3674|6555||1|0|S|0|||0
191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5621|5291|lyfalmen|V0117|5063|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||2756||2756|5291||1|0|E|0|||0
191242|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|þpakki||C07AA07|01.08.2020||R|1|0|0|G|0|MYL|0|0|0|100|SEK|912|2753|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||912||912|2753||2|0|G|0|||0
191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3769|6686|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3769||3769|6686||1|0|S|0|||0
191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2149|3108|lyfalmen|V0088|3108|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1170||1170|3108||2|0|G|0|||0
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3990|6990|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3990||3990|6990||1|0|S|0|||0
191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
191724|S01ED5119|Cosopt sine|augndr|25|mg/ml|10|ml|1|glas|20mg/ml+5mg/ml|S01ED51|01.05.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3716|6613|lyfalmen|||1|10|0|50,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3716||3716|6613||2|0|G|0|||0
191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.12.2018||R|1|0|0|0|0|ATE|0|0|0|100|XEU|19357|6179|lyfalmen|V0689|6179|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||3401||3401|6179||1|0||0|||0
192030|QD06AA0203|Cyclospray|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|ERO|0|0|0|100|XEU|1184|2327|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||1184||1184|2327||1|0||0|||0
192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír|||||||2|0||0|||0
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|0|ATE|0|0|0|100|XEU|5440|8560|lyfalmen|||2|96|0|48,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||5131||5131|8560||1|0|G|0|||0
192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|3159|4370|lyfalmen|V0429|4354|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||2087||2087|4370||1|0|G|0|||0
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|G|0|KPA|0|0|0|100|DKK|2430|4843|lyfalmen|||1|100|0|100,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||2430||2430|4843||2|0|G|0|||0
192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|6800|10857|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6800||6800|10857||2|0|S|0|||0
192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|0|1|TIC|0|1|0|100|XEU|154113|198185|lyfsjukr|||2|1|0||Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Dexametasón||154113||154113|198185||1|H|L|0|||0
193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2818|2873|lyfalmen|V0233|2333|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||999||999|2873||1|0|G|0|||0
193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|G|0|MCS|0|0|0|100|SEK|883|2713|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||883||883|2713||1|0|G|0|||0
193285|N06DX0109|Marbodin|filmhtfl|10|mg|98|stk|1|stsk.þ||N06DX01|01.11.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4000|2737|lyfalmen|V0605|2737|2|98|0|49,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||900||900|2737||2|0|G|0|||0
193411|H05BX0104|Cinacalcet Mylan|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.11.2016|31.10.2020|R|1|0|0|0|0|ASD|0|0|0|100|IKR|21696|7689|lyfalmen|||2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||4498||4498|7689||2|0||0|||0
193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|G|0|EIG|0|0|0|100|SEK|22061|31176|lyfalmen|V0667|31176|1|28|0|35,0000|Vistor hf|Eisai GmbH|Perampanel||22061||22061|31176||1|0|G|0|||0
193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|20,0000|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2760||1|0|E|0|||0
193975|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfspr||R03DX10|01.12.2018||R|0|0|1|0|1|ZEN|0|1|0|100|SEK|364255|459542|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||364255||364255|459542||1|0|L|0|||0
194245|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3838|3594|lyfalmen|V0143|3594|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1523||1523|3594||2|0|E|0|||0
194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|2595|2353|lyfalmen|V0556|2186|2|4|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||621||621|2353||1|0|E|0|||0
194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5663|10914|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||5663||5663|10914||2|0||0|||0
194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5841|5765|lyfalmen|V0012|5765|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||3100||3100|5765||1|0|G|0|||0
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|3018|5652|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||3018||3018|5652||2|0|G|0|||0
195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
195449|A02BC0403|Rabeprazol Krka|sh-tfl|10|mg|14|stk|1|þpakki||A02BC04|01.01.2019||L|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0||LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0||0|||0
195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|BAM|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13320||2|0||0|||0
195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|G|0|MED|0|0|0|100|IKR|23000|28570|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28570||2|0|G|0|||0
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|1|MEC|0|1|0|100|SEK|57259|75695|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||57259||57259|75695||2|0|L|0|||0
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|1|0|1|JAN|0|1|0|100|DKK|157502|202400|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||157502||157502|202400||1|0|L|0|||0
195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|850|2668|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||850||850|2668||1|0|G|0|||0
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|JAS|0|0|1|100|SEK|692|2450|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||692||692|2450||1|0|E|0|||0
195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|G|0|WEH|0|0|0|100|IKR|3842|3893|lyfalmen|V0205|3838|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1740||1740|3893||2|0|G|0|||0
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|3369|5529|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2929||2929|5529||2|0|G|0|||0
196218|N02AA0508|Oxycodone Alvogen|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1748|3755|lyfalmen|V0584|3750|2|28|0|7,4700|Alvogen|Alvogen ehf|Oxýcódon||1640||1640|3755||2|0|G|1|30|dagar|0
196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2615|5097|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||2615||2615|5097||2|0|G|0|||0
196518|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.04.2019||R|0|0|0|0|1|NEL|0|0|0|100|DKK|58011|76646|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Ltd|Tópótecan||58011||58011|76646||1|H|0|0|||0
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||2141||1|0|E|0|||0
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|G|0|AEP|0|0|0|100|DKK|6396|10301|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||6396||6396|10301||2|0|G|0|||0
196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|G|0|OEL|0|0|1|100|DKK|639|2377|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||639||639|2377||1|0|G|0|||0
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|21668|30679|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||21668|30679||1|0|S|0|||0
197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|842|2657|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||842||842|2657||2|0|G|0|||0
197320|L04AB0204|Inflectra|st/irþ|100|mg|100|mg|1|hgl||L04AB02|01.06.2020||R|0|0|0|0|1|PEU|0|1|0|100|DKK|43883|58777|lyfsjukr|||2|100|0|26,6700|Icepharma hf|Pfizer Europe MA EEIG|Infliximab||43883||43883|58777||1|H|L|0|||0
197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2964|5578|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||2964||2964|5578||2|0||0|||0
197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|265156|336291|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||265156||265156|336291||1|0|E|0|||0
198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
198361|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|2872|3563|lyfalmen|V0116|3293|2|14|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1500||1500|3563||2|0||0|||0
198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3429|2943|lyfalmen|V0069|2943|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||1050||1050|2943||2|0|G|0|||0
198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|4163|7228|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4163||4163|7228||1|0|G|0|||0
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978|30.11.2020|R|0|0|0|G|0|PLS|0|0|0|100|DKK|37064|50152|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||37064||37064|50152||1|0|G|0|||0
199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|8649|13402|lyfalmen|V0805|9749|1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||8649|13402||2|0|G|0|||0
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|PLS|0|0|1|100|DKK|651|2394|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||651||651|2394||1|0||2|30|töflur|0
199637|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|V1022|2299|0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0||0|||0
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|77622|101450|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||77622|101450||1|0|S|0|||0
199903|A10BK0401|Steglatro|filmhtfl|15|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|6144|9955|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Ertugliflozin||6144||6144|9955||1|0|G|0|||0
199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|1|BMS|0|1|0|100|DKK|2345132|2923199|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2345132||2345132|2923199||1|H|L|0|||0
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|40391|76800|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||40391||40391|76800||1|0||0|||0
370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1952|4185|lyfalmen|||2|20|0|7,5000|Alvogen|ratiopharm GmbH|Amoxicillín||1952||1952|4185||2|0|E|0|||0
370901|L01XE0302|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.07.2017||R|1|1|1|0|1|ALO|0|1|0|100|XEU|264159|310979|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||244804||244804|310979||2|0|L|0|||0
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||10756||1|0|E|0|||0
371826|L01XE3601|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01XE36|01.06.2017||R|0|0|1|0|1|RRG|0|1|0|100|DKK|800277|1001832|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration GmbH|Alectinib hydrochloride||800277||800277|1001832||2|0|L|0|||0
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|3836|6778|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3836||3836|6778||1|0|G|0|||0
372074|L01XX3502|Anagrelide AOP|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.05.2020||R|0|0|1|0|1|AOP|0|0|0|100|XEU|33554|45713|lyfsjukr|||1|100|0||AOP Orphan Pharmaceuticals AG|AOP Orphan Pharmaceuticals AG|Anagrelidum||||33554|45713||2|0|0|0|||0
372121|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.11.2018||R|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0||0|||0
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|3375|6143|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||3375||3375|6143||2|0|G|0|||0
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|1|WIL|0|1|0|100|XEU|7352|11617|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||7352||7352|11617||2|H|L|0|||0
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
372531|N06BA0408|Methylphenidate Teva|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|8609|7911|lyfalmen|V0996|7898|2|30|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||4659||4659|7911||1|0|E|1|30|dagar|0
372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2986||2|0|G|0|||0
373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3105|5772|lyfalmen|V0934|5772|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||3105||3105|5772||2|0||0|||0
373205|V04CX0005|Hexvix|duft|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.05.2018||R|0|0|0|0|1|CUR|0|0|0|100|XEU|85564|111495|lyfsjukr|||1|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||85564|111495||3|H|S|0|||0
373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2770|5311|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5311||2|0|G|0|||0
373239|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5632|8125|lyfalmen|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4815||4815|8125||2|0|G|0|||0
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|13076|19496|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||13076||13076|19496||1|0|G|0|||0
373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|0|1|BNB|0|0|0|100|XEU|88445|115139|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||88445||88445|115139||2|0|S|0|||0
373324|R03AK0601|Seretide|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3934|6913|lyfalmen|V0436|5532|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3934||3934|6913||1|0|G|0|||0
373340|R03AK0601|Seretide|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4804|8110|lyfalmen|V0437|6458|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4804||4804|8110||1|0|G|0|||0
373365|R03AK0601|Seretide|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|6086|9875|lyfalmen|V0981|7491|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||6086||6086|9875||1|0|G|0|||0
373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|MBV|0|0|0|100|DKK|4367|7509|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||4367||4367|7509||1|0||0|||0
373887|A05AA0401|Ocaliva|töflur|5|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|1|ILT|0|0|0|100|XEU|430549|541994|lyfsjukr|||1|30|0|15,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||430549||430549|541994||2|0|S|0|||0
374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|1|EUS|0|0|0|100|XEU|8730|13514|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||8730||8730|13514||3|H|ES|0|||0
374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|1|0|1|GEB|0|0|0|100|XEU|373558|460545|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||365061||365061|460545||1|0|S|0|||0
374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|1|0|1|NEL|0|1|0|100|DKK|245621|311995|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||245621||245621|311995||1|0|L|0|||0
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|G|0|MCK|0|0|0|100|SEK|503|2190|lyfalmen|V0500|2082|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||503||503|2190||2|0|G|0|||0
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|5667|9298|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5667||5667|9298||1|0|S|0|||0
374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|3946|6929|lyfalmen|V0926|3940|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3946||3946|6929||1|0|G|0|||0
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|G|0|GPH|0|0|1|100|DKK|11157|16854|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||11157||11157|16854||1|0|G|0|||0
374450|L01XE3301|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|1|0|1|PEU|0|1|0|100|DKK|366091|461826|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||366091||366091|461826||1|0|L|0|||0
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|1 hgl og1 áf spr+ 2 aðsk nálar|J07CA06|01.04.2020||R|0|0|0|0|0|SSS|0|0|0|100|XEU|5573|9169|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5573||5573|9169||1|0||0|||0
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|8404|13065|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8404||8404|13065||1|0|G|0|||0
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|11136|16826|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11136||11136|16826||1|0|G|0|||0
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|13218|19691|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||13218||13218|19691||1|0|G|0|||0
374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|6719|10746|lyfalmen|V0383|10746|2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||6719||6719|10746||1|0|G|0|||0
374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|3774|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||1920||1920|3774||2|0|0|0|||0
375005|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|1|FEC|0|0|0|100|XEU|3376132|4205472|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||3376130||3376130|4205472||2|H|S|0|||0
375153|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3448|5352|lyfalmen|V0580|5159|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||2800||2800|5352||2|0|G|0|||0
375275|J02AC0304|Voriconazole Accord|filmhtfl|50|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|1|ACC|0|0|1|100|XEU|11742|17660|lyfsjukr|||2|30|0|3,7500|Artasan ehf|Accord Healthcare Limited|Voricónazól||||11742|17660||1|0|ES|0|||0
375304|N06DX0109|Marbodin|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4000|2737|lyfalmen|||2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||900||900|2737|31.10.2020|2|0|G|0|||0
375508|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|1|glas||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2662|5162|lyfalmen|||1|3|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2662||2662|5162|31.10.2020|2|0|G|0|||0
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|33208|45275|lyfalmen|V0459|43854|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||33208||33208|45275||1|0|G|0|||0
376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|6000|9756|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||6000||6000|9756||1|0|G|0|||0
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|17465|25537|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||17465||17465|25537||1|0|G|0|||0
376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|91448|118937|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||91448||91448|118937||1|0|G|0|||0
377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|BRO|1|0|0|100|XEU|13110|22596|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||13110||13110|22596||2|0||0|||0
377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|221682|282222|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||221682||221682|282222||1|0|E|0|||0
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|G|0|GPH|0|0|1|100|DKK|9446|8266|lyfalmen|V0182|4438|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4917||4917|8266||1|0|G|0|||0
377504|G04CB0203|Dutasteride ratiopharm|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.06.2018||R|1|0|0|G|0|TVA|0|0|0|100|DKK|2369|3154|lyfalmen|V0909|3154|2|30|0|30,0000|Alvogen|Teva B.V.|Dútasteríð||1203||1203|3154||2|0|G|0|||0
377577|G03DA0408|Cyclogest|sk-stíll|400|mg|15|stk|1|pakki||G03DA04|01.05.2020||R|0|0|1|G|0|GRI|0|0|0|100|SEK|5303|8797|lyfalmen|||1|15|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Prógesterón||5303||5303|8797||3|0|G|0|||0
377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|1|SDG|0|1|0|100|DKK|28614|35846|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||25753||25753|35846||1|0|L|0|||0
378432|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|1|0|1|GSE|0|0|0|100|DKK|586863|736404|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||586863||586863|736404||2|0|S|0|||0
378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1407|3435|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1407||1407|3435||1|0|G|0|||0
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|ALM|0|0|0|100|XEU|16851|24692|lyfalmen|V1009|24692|1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||16851||16851|24692||1|0|E|0|||0
378801|A10BH0102|Januvia (Lyfjaver)|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.06.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|16141|23714|lyfalmen|V0982|23714|3|98|0|49,0000|Lyfjaver ehf|Lyfjaver ehf|Sítagliptín||16141||16141|23714||3|0|G|0|||0
378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|G|0|MSD|0|0|0|100|DKK|1816|3997|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1816||1816|3997||1|0|G|0|||0
379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1432|3469|lyfalmen|V0677|2753|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1432||1432|3469||1|0|G|0|||0
379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5289|7004|lyfalmen|V0830|7004|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4000||4000|7004||2|0|G|0|||0
379351|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9413|14454|lyfalmen|V0587|14454|2|100|0|53,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||9413||9413|14454||1|0|G|1|30|dagar|0
379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|196539|250951|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||196539|250951||3|0|L|0|||0
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|1|0|1|PEU|0|1|0|100|DKK|128022|165735|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||128022||128022|165735||1|0|L|0|||0
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|1|HES|0|0|0|100|DKK|120514|112484|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||86346||86346|112484||1|0|S|0|||0
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|1|HES|0|0|0|100|DKK|131912|123401|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||94977||94977|123401||1|0|S|0|||0
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|1|HES|0|0|0|100|DKK|168299|157220|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||121176||121176|157220||1|0|S|0|||0
379796|N04BC0408|Ropinirole Alvogen|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|G|0|POF|0|0|0|100|XEU|6007|7379|lyfalmen|V0532|7379|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||4273||4273|7379||2|0|G|0|||0
379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2380|4774|lyfalmen|||2|12,5|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2380||2380|4774||1|0||2|50|túpur|0
379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|3155|5840|lyfalmen|||2|12,5|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||3155||3155|5840||1|0||2|25|túpur|0
379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2400|3313|lyfalmen|V0322|2916|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||1319||1319|3313||1|0|G|0|||0
380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2|0||2|||0
380308|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2075|3563|lyfalmen|V0687|2766|2|56|0|28,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0
380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|30376|41693|lyfalmen|V0653|41692|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||30376|41693||1|0|G|0|||0
380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|619|2350|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||619||619|2350||1|0|G|0|||0
380658|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|9136|11042|lyfalmen|V1010|11042|2|90|0|90,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||6934||6934|11042||2|0|G|0|||0
380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|10426|10169|lyfalmen|V0195|10169|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0
380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|594|2316|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||594||594|2316||1|0|G|0|||0
381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|3266|5629|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3266||3266|5629||2|0||0|||0
381510|A10BK0101|Forxiga|filmhtfl|5|mg|98|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|23557|33068|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||23557||23557|33068||1|0|G|0|||0
381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|325327|411127|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||325327||325327|411127||1|0||0|||0
382318|S01XA2103|Cystadrops|augndr|3,8|mg/ml|5|ml|1|glas||S01XA21|01.01.2019||R|0|0|1|0|0|OHA|0|0|0|100|XEU|199590|254745|lyfalmen|||1|5|0||Orphan Europe Nordic AB|Orphan Europe SARL|mercaptamine ||199590||199590|254745||3|0||0|||0
382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
382474|V03AN0502|Airapy|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|147404|189841|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||147404|189841||3|0|L|0|||0
382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|5196|8650|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||5196||5196|8650||1|0|G|0|||0
383037|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfspr||N02CD03|01.11.2019||R|0|0|1|0|0|TGH|0|0|0|100|XEU|77178|100888|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||77178||77178|100888||1|0|E|0|||0
383105|J06BA0104|Cutaquig|stl|165|mg/ml|6|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|1|OCT|0|1|0|100|DKK|12571|18801|lyfsjukr|||1|6|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||12571||12571|18801||1|0|L|0|||0
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1325|2249|vetorma|||0|2|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||1305||1305|2249||2|0||0|||0
383238|N02AA0508|Oxycodone Alvogen|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|5954|8326|lyfalmen|V0585|8299|2|98|0|26,1300|Alvogen|Alvogen ehf|Oxýcódon||4961||4961|8326||2|0|G|1|30|dagar|0
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|120|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0
383672|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.02.2019||R|1|0|0|G|0|NAA|0|0|0|100|DKK|1763|3925|lyfalmen|V0314|3262|1|100|0|25,0000|Artasan ehf|Novartis Healthcare A/S|Klómípramín||1763||1763|3925||1|0|G|0|||0
383719|L01BA0402|Pemetrexed W&H|irþ|25|mg/hgl|20|ml|1|hgl||L01BA04|01.05.2020||R|0|0|0|0|1|WEH|0|1|0|100|XEU|170552|218630|lyfsjukr|||2|20|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||170552||170552|218630||2|H|L|0|||0
384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|G|0|RTH|0|0|1|100|IKR|3250|2117|lyfalmen|V0006|1224|2|56|0|56,0000|Alvogen|ratiopharm GmbH|Ómeprazól||450||450|2117||2|0|G|0|||0
384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|7378|11653|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||7378||7378|11653||1|0|G|0|||0
384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|15|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín|||||||1|0||0|||0
384837|N07BC0102|Buvidal|stl|32|mg|0,64|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|14546|21519|lyfsjukr|||1|0,64|0|4,0000|Vistor hf|Camurus AB|Búprenorfín||14546||14546|21519||1|H|L|1|30|dagar|0
384858|L01XE0105|Imatinib ratiopharm|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.01.2019||R|1|0|1|0|1|RTH|0|1|0|100|XEU|174392|114242|lyfsjukr|||2|30|0||Alvogen|ratiopharm GmbH|Imatiníb||87736||87736|114242||2|0|L|0|||0
385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|7816|12256|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||7816||7816|12256||1|0||0|||0
386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|1|RRD|0|0|0|100|DKK|385099|485467|lyfsjukr|||1|1|0|50,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||385099||385099|485467||1|0|ES|0|||0
386950|L04AB0404|IDACIO|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.08.2020||R|0|1|1|0|1|FKA|0|0|0|100|DKK|37391|50566|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||37391||37391|50566||1|0|0|0|||0
386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|13329|6701|lyfalmen|V0111|6315|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||3780||3780|6701||2|0|E|0|||0
387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|8014|12528|lyfalmen|||1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||8014||8014|12528||1|0|G|0|||0
387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|0|1|WEH|0|1|0|100|XEU|153282|197151|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||153282||153282|197151||2|H|L|0|||0
387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|956|2814|lyfalmen|||2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||956||956|2814||2|0||2|60|mg|0
387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5937|11434|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5937||5937|11434||2|0||0|||0
387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|1|DIC|0|0|0|100|IKR|6709|10732|lyfsjukr|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10732||2|H|S|0|||0
388032|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|30|stk|1|þpakki||A02BC05|01.09.2019||L|1|0|0|0|0|JUB|0|0|0|100|IKR|||lyflausa|||2|30|0||Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól|||||||2|0||0|||0
388180|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.2020||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|0|1|PEU|0|0|0|100|DKK|136250|175968|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Temsirolímus||136250||136250|175968||1|H|S|0|||0
388256|N01BB2001|Emla|krem|50|mg/g|5|g|5|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2700|5214|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2700||2700|5214||2|0||0|||0
388264|N01BB2001|Emla|krem|50|mg/g|30|g|1|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3921|6895|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||3921||3921|6895||2|0||0|||0
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2|0||0|||0
388280|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.04.1994|30.11.2020|R|0|0|0|0|0|MAR|0|0|1|100|DKK|5767|9436|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur||5767||5767|9436||2|0||0|||0
388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|69572|91268|lyfalmen|V0722|15262|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||69572||69572|91268||2|0||0|||0
388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|9411|14451|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||9411||9411|14451||2|0|G|0|||0
389095|A04AA0108|Cinveron|stl|2|mg/ml|4|ml|5|lykjur|lausn|A04AA01|01.07.2018||R|0|0|0|0|1|WEH|0|0|0|100|XEU|7050|11202|lyfsjukr|||2|20|0|2,5000|Williams & Halls efh|Williams & Halls ehf|Ondansetrón||7050||7050|11202||2|H|S|0|||0
389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|1|LLS|0|1|0|100|DKK|338675|427728|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||338675|427728||2|0|L|0|||0
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|820|2627|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||820||820|2627||1|0|G|0|||0
389404|N06DA0405|Galantamin STADA|forðahlk|24|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|11830|17781|lyfalmen|||2|84|0|126,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||11830||11830|17781||2|0|G|0|||0
389424|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7500|11821|lyfalmen|||2|100|0|300,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||7500||7500|11821|30.11.2020|2|0|0|0|||0
389453|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|14|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|EQL|0|0|1|100|IKR|450|2117|lyfalmen|||2|14|0|5,6000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||450||450|2117||2|0|E|0|||0
389603|R06AX2709|Desloratadine Alvogen|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.11.2020||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|44285|59285|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||44285|59285||2|0|G|0|||0
389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|16420|24098|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||16420||16420|24098||1|0|G|0|||0
390439|R01AD0905|Mometason Apofri|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.10.2018||L|0|0|0|G|0|APO|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|LYFIS ehf|Apofri AB|Mómetasón|||||2753||2|0|G|0|||0
390541|R03DX0801|Cinqaero|irþ|10|mg/ml|10|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|1|TVB|0|1|0|100|NOK|69619|91328|lyfsjukr|||1|10|0|14,0845|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||69619||69619|91328||1|H|L|0|||0
390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|1|COR|0|0|0|100|DKK|81020|105748|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||81020||81020|105748||1|H|S|0|||0
390835|A04AA0101|Zofran|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.07.2019||R|1|0|0|G|0|NAA|0|0|1|100|DKK|3539|6369|lyfalmen|V0381|5114|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3539||3539|6369||1|0|G|0|||0
390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18190|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18190||2|0|E|1|30|dagar|0
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|6092|9883|lyfalmen|V0429|4354|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6092||6092|9883||1|0|G|0|||0
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|2858|5432|lyfalmen|V0037|3319|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2858||2858|5432||1|0|G|0|||0
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|10453|15885|lyfalmen|V0196|6431|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||10453||10453|15885||1|0|G|0|||0
391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|1|0|1|NEL|0|1|0|100|DKK|284911|360861|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||284911||284911|360861||1|0|L|0|||0
392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1007|1966|lyfalm11|V0545|1927|2|63|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||507||507|1966||1|0||0|||0
392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|1|0|1|ASR|0|0|0|100|IKR|45000|31099|lyfsjukr|||2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||22000||22000|31099||2|0|ES|0|||0
392196|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.07.2019||R|0|0|0|G|0|BAB|0|0|0|100|DKK|1054|2949|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||1054||1054|2949||2|0|G|0|||0
392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|1|0|0|SAO|0|0|0|100|XEU|13693|20345|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||13693||13693|20345||2|0|E|0|||0
392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9709|11105|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||6980||6980|11105||1|0|G|0|||0
392438|L04AX0701|Tecfidera|hylki|120|mg|14|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|1|BNB|0|1|0|100|XEU|24945|34824|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||24945||24945|34824||2|0|L|0|||0
393248|C10AA0107|Simvastatin LYFIS|filmhtfl|20|mg|100|stk|1|glas||C10AA01|01.12.2016|31.10.2020|R|1|0|0|G|0|LYF|0|0|0|100|IKR|2250|2874|lyfalmen|||2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Simvastatín||1000||1000|2874||2|0|G|0|||0
393642|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3474||1|0||0|||0
393939|S01EE0404|Travoprost Alvogen|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|DKK|2360|4165|lyfalmen|V0669|4165|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1938||1938|4165||2|0|G|0|||0
394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|XEU|2151|3779|lyfalmen|V0123|3779|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1657||1657|3779||2|0|E|0|||0
394364|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|54366|72036|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||54366||54366|72036||2|0|ES|0|||0
394768|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|5398|8112|lyfalmen|V0681|8001|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4805||4805|8112||1|0|E|1|30|dagar|0
395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|87991|114565|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||87991||87991|114565||1|0||0|||0
395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|NAS|0|0|0|100|DKK|36984|50051|lyfalmen|||1|15|0|60,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||36984||36984|50051||1|0||0|||0
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|1|RAG|0|0|0|100|DKK|148627|191362|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||148627||148627|191362||1|0|S|0|||0
395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|6613|10600|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||6613||6613|10600||1|0||0|||0
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|18723|27268|lyfalmen|V0356|27268|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||18723||18723|27268||3|0|G|0|||0
396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|5119|8544|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||5119||5119|8544||1|0|G|0|||0
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||5595||1|0|G|0|||0
396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|RPG|1|0|0|100|DKK|22023|41953|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||22023||22023|41953||2|0||0|||0
396463|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|dreifa,dreifa|J07CA06|01.04.2019||R|0|0|0|0|0|SSS|0|0|0|100|XEU|55732|73763|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||55732||55732|73763||1|0|0|0|||0
396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2300|2048|lyfalmen|V0006|1224|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|2048||2|0|G|0|||0
396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|5817|11207|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5817||5817|11207||1|0||0|||0
396873|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|50|stk|1|þpakki||J01CF01|01.07.2019||R|0|0|0|0|0|BFP|0|0|1|100|XEU|3462|6263|lyfalmen|||2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||3462||3462|6263||1|0|0|0|||0
397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4186|3838|lyfalmen|V0686|3631|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0
397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|G|0|SHS|0|0|0|100|DKK|2385|2934|lyfalmen|V0250|2723|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||1043||1043|2934||1|0|G|0|||0
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|0|1|MRP|0|1|0|100|SEK|33899|46149|lyfsjukr|||1|20|0||Icepharma hf|Merck Europe B.V.|Cetúxímab||33899||33899|46149||2|H|L|0|||0
397659|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|10|lykjur|innr.lyf, fleyti|N01AX10|01.05.2020||R|0|0|0|0|1|FKA|0|0|0|100|DKK|3562|6401|lyfsjukr|||2|200|0||Vistor hf|Fresenius Kabi AB|Própófól||3562||3562|6401||1|H|S|0|||0
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5828||1|0|E|0|||0
397933|L04AA0607|Mycofenolsýra Accord|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|32521|44406|lyfalmen|V1008|41387|2|120|0|21,6000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||32521||32521|44406||1|0|G|0|||0
398181|N05CD0804|Midazolam Accord|stl/irl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|1|AEE|0|0|0|100|XEU|1519|3589|lyfsjukr|||2|50|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1519||1519|3589||1|H|S|2|450|mg|0
398565|N06AA0907|Amitriptylin Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|687|2444|lyfalmen|||2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||687||687|2444||2|0|G|0|||0
398659|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.08.2019||R|0|0|0|0|1|ATE|0|0|0|100|XEU|22897|32234|lyfsjukr|||2|2|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúdarabín||22897||22897|32234||1|H|S|0|||0
399034|C09CA0307|Valsartan Jubilant|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|3500|4113|lyfalmen|||2|98|0|196,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan||1900||1900|4113|30.11.2020|2|0|G|0|||0
399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|1|0|1|GSD|0|1|0|100|DKK|182045|232924|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||182045||182045|232924||1|0|L|0|||0
399210|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.07.2019||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|0|1|OCT|0|0|0|100|DKK|83064|108333|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||83064||83064|108333||1|H|S|0|||0
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|0|100|DKK|517|2210|lyfalmen|||1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||517||517|2210||1|0|G|1|30|dagar|0
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|G|0|GPH|0|0|0|100|DKK|2793|3179|lyfalmen|V0244|3179|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1221||1221|3179||1|0|G|0|||0
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/sprautu|B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|9330|14340|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9330||9330|14340||1|0|G|0|||0
399825|L01XE3301|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|1|0|1|PEU|0|1|0|100|DKK|366091|461826|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||366091||366091|461826||1|0|L|0|||0
399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ALO|0|0|1|100|IKR|2326|2902|lyfalmen|V0824|2876|2|28|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1020||1020|2902||2|0|G|0|||0
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1271|3247|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1271||1271|3247||1|0|G|0|||0
400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981|30.11.2020|L|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis Group PTC ehf|Blöndur||||||||0|0|0|||0
400134|J05AR2201|Symtuza|filmhtfl|||30|stk|1|glas|800+150+200+10 mg|J05AR22|01.03.2018||R|0|0|1|0|1|JCI|0|0|0|100|SEK|130015|168213|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||130015||130015|168213||1|0|S|0|||0
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|PLS|0|0|0|100|DKK|2691|5202|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2691||2691|5202||1|0|E|0|||0
400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|G|0|VIF|0|0|1|100|CHF|62729|82613|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||62729||62729|82613||1|0|G|0|||0
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|514|2205|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||514||514|2205||1|0||2|50|töflur|0
400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|568|2280|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||568||568|2280||1|0|G|0|||0
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1631|3743|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||1631||1631|3743||1|0||2|100|töflur|0
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|455|2124|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||455||455|2124||1|0||2|100|töflur|0
400508|N02AE0104|Buprenorphine ratiopharm|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|0|G|0|RTH|0|0|0|100|DKK|1296|3282|lyfalmen|V0943|3282|2|4|0|2,8000|Alvogen|ratiopharm GmbH|Búprenorfín||1296||1296|3282||2|0|G|1|30|dagar|0
400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|5575|9171|lyfalmen|V0612|5493|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||5575||5575|9171||1|0|E|0|||0
400574|L04AX0701|Tecfidera|hylki|240|mg|56|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|1|BNB|0|1|0|100|XEU|159255|204580|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||159255||159255|204580||2|0|L|0|||0
401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2412|4591|lyfalmen|V0037|3319|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2247||2247|4591||2|0|G|0|||0
401139|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.04.2020||R|1|1|0|0|1|PEU|0|0|1|100|DKK|22413|31622|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||22413||22413|31622||1|0|ES|0|||0
401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|856|2676|lyfalmen|V0173|2676|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||856||856|2676||2|0|E|0|||0
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|9532|14618|lyfalmen|V0459|14618|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||9532||9532|14618||1|0|G|0|||0
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|853|2672|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||853||853|2672||1|0|G|0|||0
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1251|3220|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1251||1251|3220||1|0|G|0|||0
402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|0|WEH|0|0|0|100|IKR|1032|2918|lyfalmen|||2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1032||1032|2918||2|0|G|0|||0
402141|J05AE1003|Darunavir Medical Valley|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|1|VAL|0|0|0|100|XEU|36932|49985|lyfsjukr|||2|30|0|20,0000|Acare ehf|Medical Valley Invest AB|Darunavír||36932||36932|49985||2|0|S|0|||0
402203|D07AC1302|Ovixan|húðlausn|1|mg/g|100|ml|1|glas||D07AC13|01.08.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|1395|3418|lyfalmen|V0952|3418|2|100|0||Vistor hf|Galenica AB|Mómetasón||1395||1395|3418||1|0|G|0|||0
402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|1|0|1|SPD|0|0|0|100|DKK|797292|998119|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||797292||797292|998119||1|0|ES|0|||0
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|BID|0|0|0|100|DKK|2055|4039|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Penicillín í blöndum með öðrum sýklalyfjum||2055||2055|4039||1|0||0|||0
402801|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfspr||L04AC16|01.01.2019||R|0|0|1|0|1|JCI|0|1|0|100|SEK|366417|462231|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||366417||366417|462231||1|0|L|0|||0
402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|8873|13427|lyfalmen|V0349|13427|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||8667||8667|13427||3|0|G|0|||0
402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|5351|3096|lyfalmen|V0552|2737|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||1161||1161|3096||1|0|E|0|||0
403163|N02AA0508|Oxycodone Alvogen|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1044|2844|lyfalmen|V0597|2844|2|28|0|3,7300|Alvogen|Alvogen ehf|Oxýcódon||978||978|2844||2|0|G|1|30|dagar|0
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|IBV|1|0|0|100|DKK|6767|13009|vetalmen|||0|20|0||Vistor hf|Intervet International BV|Cloprostenolum||6767||6767|13009||1|0||0|||0
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|dropaí||S01GX01|01.09.2018||R|0|0|0|G|0|SNP|0|0|0|100|XEU|1094|3004|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||||1094|3004||1|0|G|0|||0
403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|G|0|AEP|0|0|0|100|DKK|19172|27886|lyfalmen|||1|6|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||19172||19172|27886||2|0|G|0|||0
404136|J01XD0102|Flagyl|irl|5|mg/ml|100|ml|40|pokar||J01XD01|01.04.2020||R|0|0|0|0|1|SNP|0|0|1|100|XEU|22421|31632|lyfsjukr|||1|4000|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||22421||22421|31632||1|0|ES|0|||0
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2826||2|0|G|0|||0
404491|B01AD0201|Actilyse|sts/irs|20|mg|1|hgl|1|pakki||B01AD02|01.12.2019||R|0|0|0|0|1|BOI|0|0|0|100|DKK|40827|54912|lyfsjukr|||1|1|0|0,2000|Vistor hf|Boehringer Ingelheim|Alteplasi||40827||40827|54912||1|H|0|0|||0
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.03.2020||R|0|0|0|0|1|BOI|0|0|0|100|DKK|68273|89625|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||68273||68273|89625||1|H|S|0|||0
404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|G|0|MEV|0|0|0|100|DKK|1062|2960|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1062||1062|2960||1|0|G|0|||0
404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|DKK|3271|5638|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3271||3271|5638||2|0||0|||0
405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2673||1|0||0|||0
405200|A05AA0401|Ocaliva|töflur|10|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|1|ILT|0|0|0|100|XEU|430549|541994|lyfsjukr|||1|30|0|30,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||430549||430549|541994||2|0|S|0|||0
405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|G|0|KRK|0|0|1|100|IKR|2436|4851|lyfalmen|V0467|4851|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||2436||2436|4851||2|0|G|0|||0
405491|V08CA0901|Gadovist|stl|1|mmol/ml|7,5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|1|BAB|0|0|0|100|DKK|34191|46518|lyfsjukr|||1|37,5|0||Icepharma hf|Bayer AB|Gadóbútról||||34191|46518||2|H|S|0|||0
405677|J01DD0401|Rocephalin|irs|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|1|ROA|0|0|1|100|DKK|3774|6692|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche A.S.|Ceftríaxón||3774||3774|6692||2|0|ES|0|||0
405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|18979|27621|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18979||18979|27621||1|0||0|||0
405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|462|2134|lyfalmen|V0502|2134|2|60|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||462||462|2134||1|0|G|0|||0
406106|C10AX1401|Praluent|stl|150|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|198550|253452|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||198550||198550|253452||1|0|E|0|||0
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|19003|27654|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19003||19003|27654||1|0|E|0|||0
406356|L01XX4601|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XX46|01.07.2016||R|0|0|1|0|1|AZA|0|1|0|100|SEK|775170|970606|lyfsjukr|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||775170||775170|970606||1|0|L|0|||0
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|57332|75787|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||57332||57332|75787||1|0|E|0|||0
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|66745|87693|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||66745||66745|87693||1|0|E|0|||0
407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cyanocobalamin|||||4770||1|0|G|0|||0
407101|N02AA0507|OxyContin Depot|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|8267|12877|lyfalmen|V0585|8299|1|98|0|26,1300|Icepharma hf|Mundipharma A/S|Oxýcódon||8267||8267|12877||2|0|G|1|30|dagar|0
407393|L04AA3701|OLUMIANT|filmhtfl|2|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|1|NED|0|1|0|100|XEU|129504|167578|lyfsjukr|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||129504||129504|167578||2|0|L|0|||0
407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|19110|36426|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Penetamathýdrójoðíð||||19110|36426||2|0||0|||0
407586|N06BA0905|Atomoxetin STADA|hylki|80|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|7000|4251|lyfalmen|V0817|4251|2|30|0|30,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||2000||2000|4251||2|0|E|0|||0
407933|QP54AA5401|BROADLINE|bl.lausn|||0,9|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2936|5060|vetorma|||0|2,7|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2936||2936|5060||1|0||0|||0
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|380|2021|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||380||380|2021||1|0||2|150|töflur|0
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|683|2438|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||683||683|2438||1|0||2|150|töflur|0
408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|32356|44197|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||32356||32356|44197||1|0|G|0|||0
408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|17597|25718|lyfalmen|V0974|21586|1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||17597||17597|25718||2|0|G|0|||0
408166|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|15074|19666|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||13200||13200|19666||1|0|G|0|||0
408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|2020|2863|lyfalmen|V0310|2863|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||992||992|2863||2|0||2|60|mg|0
408561|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0
408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|GAN|0|0|0|100|XEU|4777|8073|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4777||4777|8073||2|0||0|||0
408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4018|lyfalmen|V0813|3839|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1831||1831|4018||2|0|E|0|||0
408927|N03AX1408|Levetiracetam STADA|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2688|5198|lyfalmen|V0515|5198|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||2688||2688|5198||2|0|G|0|||0
409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|3392|5846|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3392||3392|5846||2|0||0|||0
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|PLS|0|0|1|100|DKK|3982|6979|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3982||3982|6979||1|0|E|0|||0
409115|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.04.2020||R|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0||0|||0
409210|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|30|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|11586|17445|lyfalmen|||2|30|0|16,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||11586||11586|17445||2|0|E|1|30|dagar|0
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|8763|13559|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||8763||8763|13559||1|0|E|0|||0
409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016|30.11.2020|R|0|0|0|0|0|NEL|0|0|0|100|DKK|65529|86155|lyfalmen|||1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||65529||65529|86155||1|0|E|0|||0
409594|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|105|stk|1|glas||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|1330|3329|lyfalmen|V0414|3270|2|105|0|52,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||1330||1330|3329||2|0|G|0|||0
409673|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|2|mg|28|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|2932|5534|lyfalmen|||3|28|0|9,3333|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||2932||2932|5534||3|0|G|0|||0
409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|1|0|G|0|GRP|0|0|0|100|XEU|16384|24049|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||16384||16384|24049||1|0|G|0|||0
409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|61771|81402|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||61771||61771|81402||1|0|E|0|||0
409748|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.12.2019||R|1|0|0|G|0|TOG|0|0|0|100|SEK|2149|4456|lyfalmen|||1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||2149||2149|4456|31.10.2020|1|0|G|0|||0
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|7105|11277|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7105||7105|11277||1|0|E|0|||0
409850|J07BA0104|TicoVac Junior|stl|1,2|mcg/sk|0,25|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3553|6388|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3553||3553|6388||1|0||0|||0
409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|16580|24319|lyfalmen|V0651|24316|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16580||16580|24319||1|0|G|0|||0
409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|4013|7021|lyfalmen|V0196|6431|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||4013||4013|7021||2|0|G|0|||0
410223|L01XE2701|IMBRUVICA|filmhtfl|280|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|1|0|1|JCI|0|1|0|100|SEK|510152|640997|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||510152||510152|640997||1|0|L|0|||0
410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|3831|6041|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||3301||3301|6041||1|0|G|0|||0
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|G|0|MYL|0|0|1|100|SEK|725|2496|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||725||725|2496||2|0|G|0|||0
411034|N06AA0907|Amitriptylin Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|912|2753|lyfalmen|||2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||912||912|2753||2|0|G|0|||0
411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|G|0|MEV|0|0|0|100|DKK|2143|4448|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||2143||2143|4448||1|0|G|0|||0
411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|RTH|0|0|1|100|XEU|451|2084|lyfalmen|V0230|2084|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||426||426|2084||2|0|E|0|||0
411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015|30.11.2020|R|0|0|0|0|0|ASD|0|0|0|100|SEK|1629|2698|lyfalmen|||2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||872||872|2698||2|0|E|0|||0
411409|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|12074|18117|lyfalmen|V0689|3460|3|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||12074||12074|18117||3|0|E|0|||0
411466|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.07.2017||R|1|0|0|G|0|WEH|0|0|0|100|IKR|8924|13781|lyfalmen|V0829|13781|2|100|0|22,2200|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13781||2|0|G|0|||0
411723|N06BA0703|Aspendos|töflur|100|mg|90|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|12650|16638|lyfalmen|||2|90|0|30,0000|LYFIS ehf|Medochemie Limited|Modafinil||11000||11000|16638||2|0|E|2|||0
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|1|0|1|VIC|0|0|0|100|DKK|24608|34398|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín||24608||24608|34398||1|0|S|0|||0
411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól|||||2292||1|0|E|0|||0
411913|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2695|2448|lyfalmen|V0994|2448|2|2,5|0|25,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||690||690|2448||2|0|G|0|||0
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|1|SNP|0|0|0|100|XEU|3189|5887|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3189||3189|5887||1|H|S|0|||0
412395|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|CES|1|0|0|100|DKK|4589|8877|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4589||4589|8877||2|0||0|||0
412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5097|9841|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||5097||5097|9841||2|0||0|||0
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|1|0|1|BNB|0|0|0|100|XEU|93242|121206|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||93242||93242|121206||2|0|S|0|||0
412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|G|0|TEE|0|0|0|100|NOK|47732|63645|lyfalmen|V0711|12509|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||47732||47732|63645||1|0|G|0|||0
412566|N03AX1213|Gabapentin Teva|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.08.2019||R|1|0|0|G|0|TVA|0|0|0|100|DKK|8089|12632|lyfalmen|V0254|12632|2|100|0|33,3300|Alvogen|Teva B.V.|Gabapentín||8089||8089|12632||2|0|G|0|||0
412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|49091|65364|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||49091||49091|65364||1|0|E|0|||0
412662|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5864|7004|lyfalmen|V0581|6302|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4000||4000|7004||2|0|G|0|||0
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|3483|6292|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3483||3483|6292||2|0|G|0|||0
413053|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|4472|7653|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||4472||4472|7653||2|0|G|1|30|dagar|0
413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|1|OVE|0|0|1|100|DKK|34819|47313|lyfsjukr|||1|50|0||Pharmanovia A/S|Provepharm S.A.S.|Metýltíónín||34819||34819|47313||2|H|S|0|||0
413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0
414424|N06AA0907|Amitriptylin Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1298|3284|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1298||1298|3284||2|0|G|0|||0
414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|1|0|1|TGM|0|0|0|100|NOK|92835|120691|lyfsjukr|||1|12|0|24,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||92835||92835|120691||1|0|ES|0|||0
414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|0|1|WIL|0|0|0|100|XEU|43065|57742|lyfsjukr|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||43065||43065|57742||2|H|S|0|||0
414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1351|3357|lyfalmen|||1|90|0|54,0000|Icepharma hf|Les Laboratoires Servier|Indapamíð||1351||1351|3357||2|0|G|0|||0
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|G|0|HES|0|0|0|100|DKK|1275|3253|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1275||1275|3253||1|0|G|0|||0
414921|L04AA4201|Mayzent|filmhtfl|2|mg|28|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|1|NEP|0|0|0|100|DKK|246762|313414|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Limited|Siponimod||246762||246762|313414||1|0|0|0|||0
414991|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.12.2020||R|1|0|0|G|0|BFP|0|0|0|100|IKR|3122|4030|lyfalmen|V0203|4026|2|12|0|84,0000|Vistor hf|Bluefish Pharmaceuticals AB|Alendrónsýra||1840||1840|4030||1|0|G|0|||0
415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|203723|259886|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||203723||203723|259886||1|0|L|0|||0
415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|165454|212290|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||165454||165454|212290||1|0|G|0|||0
415724|G04CA5202|Dutaprostam|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.10.2019||R|0|0|0|G|0|ALO|0|0|0|100|DKK|3283|4855|lyfalmen|V1010|3681|2|30|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Dútasteríð og tamsúlósínhýdroklóríð||2439||2439|4855||2|0|G|0|||0
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|G|0|PSA|0|0|0|100|XEU|5947|8504|lyfalmen|V0253|4190|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||5090||5090|8504||2|0|G|0|||0
416330|A10BD2401|Steglujan|filmhtfl|115|mg|98|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|38456|51693|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||38282||38282|51693||1|0|G|0|||0
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|G|0|MSD|0|0|0|100|DKK|9564|10409|lyfalmen|V0088|3108|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||6474||6474|10409||1|0|G|0|||0
416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|G|0|GOG|0|0|1|100|XEU|2987|5609|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2987||2987|5609||2|0|G|0|||0
417633|A10BJ0601|Ozempic|stl|0,5|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|20312|28964|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||20312||20312|28964||1|0||0|||0
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|0|1|0|1|VIC|0|0|0|100|DKK|40278|54217|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Abacavír||40278||40278|54217||1|0|S|0|||0
417880|B02BD0401|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD04|01.07.2012||R|0|0|1|0|1|PEU|0|1|0|100|DKK|102740|134291|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||102740||102740|134291||1|0|L|0|||0
417898|C01CA1703|Hypotron|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|17695|25853|lyfalmen|V0969|25853|2|100|0|16,6666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||17695||17695|25853||2|0|G|0|||0
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|29338|40380|lyfalmen|V0460|40380|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||29338|40380||1|0|G|0|||0
418642|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.02.2019||R|0|1|1|0|1|BIO|0|0|0|100|DKK|30741|41597|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||30300||30300|41597||3|0|S|0|||0
418667|L01XC0203|Truxima|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|1|CTH|0|1|0|100|DKK|76719|100308|lyfsjukr|||2|20|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||76719||76719|100308||1|H|L|0|||0
418714|C10BA0202|Ezetimib/Simvastatin Krka|töflur|50|mg|100|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|18000|26273|lyfalmen|V0615|26273|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||18000||18000|26273||2|0||0|||0
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|LEP|0|0|0|100|DKK|2585|5056|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2585||2585|5056||1|0|G|0|||0
419294|J01DD0403|Rocephalin IV|sts|1|g|1|stk|1|hgl|+ leysir, lausn|J01DD04|01.09.2018||R|0|0|0|0|1|ROA|0|0|1|100|DKK|2828|5390|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche A.S.|Ceftríaxón||||2828|5390||2|0|S|0|||0
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|LEP|0|0|0|100|DKK|9408|14447|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||9408||9408|14447||1|0|G|0|||0
419311|N03AX1408|Levetiracetam STADA|mixtúra|100|mg/ml|300|ml|1|glas|+ 10 ml munngj.spr.|N03AX14|01.12.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|11000|16638|lyfalmen|V1000|16638|2|300|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||11000||11000|16638||2|0|G|0|||0
419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5426|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5426||2|0|E|1|30|dagar|0
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|1|0|0|ORP|0|0|0|100|XEU|41234|55426|lyfalmen|||1|100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mercaptamín||41234||41234|55426||3|0|E|0|||0
419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|1|0|0|ORP|0|0|0|100|XEU|14176|21010|lyfalmen|||1|100|0|2,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mercaptamín||14176||14176|21010||3|0|E|0|||0
419952|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AD01|01.10.2018||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1888|4097|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||1888||1888|4097||1|0|G|0|||0
419969|S01AD0302|Xorox|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.03.2020||R|0|0|0|G|0|AGE|0|0|1|100|XEU|2327|4701|lyfalmen|||1|4,5|0||Agepha Pharma s.r.o.|Agepha Pharma s.r.o.|Acíklóvír||2327||2327|4701||2|0|G|0|||0
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|12466|18656|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12466||12466|18656||1|0|G|0|||0
420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|1|0|1|GEI|0|0|0|100|DKK|145898|187968|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||145898||145898|187968||2|0|S|0|||0
420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|G|0|RTH|0|0|1|100|IKR|4816|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||500||500|2186||2|0|G|0|||0
420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2.500 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|3870|6825|lyfalmen|||1|2|0|10,0000|Icepharma hf|Pfizer Aps|Dalteparín||3870||3870|6825||1|0|G|0|||0
420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5.000 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|5516|9090|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer Aps|Dalteparín||5516||5516|9090||1|0|G|0|||0
420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|RTH|0|0|1|100|DKK|1605|3099|lyfalmen|V0479|3099|2|60|0|6,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1163||1163|3099||2|0|E|0|||0
420639|L01XE2701|IMBRUVICA|filmhtfl|140|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|1|0|1|JCI|0|1|0|100|SEK|254715|323305|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||254715||254715|323305||1|0|L|0|||0
420696|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|60|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0
421120|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2280|4636|lyfalmen|V0214|4604|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1332|3331|lyfalmen|||1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1332||1332|3331||1|0|G|0|||0
421434|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|98|stk|1|þpakki||C10AA05|01.07.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2000|2779|lyfalmen|V0114|2750|2|98|0|196,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
421673|M04AA0303|Febuxostat Medical Valley|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.10.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|9539|14627|lyfalmen|V1011|14627|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|febuxostat||9539||9539|14627||2|0|E|0|||0
421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|34986|66546|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||34986||34986|66546||1|0||0|||0
421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|XEU|1831|3470|lyfalmen|V0458|2979|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1433||1433|3470||2|0|G|0|||0
422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|626|2360|lyfalmen|V0596|2360|2|28|0|1,8600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||626||626|2360||1|0|G|1|30|dagar|0
422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|2911|5505|lyfalmen|V0049|2884|1|98|0|62,0667|Vistor hf|Recordati Ireland Limited|Metóprólól||2911||2911|5505||1|0|G|0|||0
422323|L01DB1101|Pixuvri|st/irþ|29|mg|1|hgl|1|pakki||L01DB11|01.02.2020||R|0|0|0|0|1|LLS|0|0|0|100|DKK|101487|132733|lyfsjukr|||1|1|0||Icepharma hf|Les Laboratoires Servier|Pixantron||101487||101487|132733||2|H|0|0|||0
422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|7417|11707|lyfalmen|V0054|4840|1|98|0|124,1333|Vistor hf|Recordati Ireland Limited|Metóprólól||7417||7417|11707||1|0|G|0|||0
422340|C02AC0201|Intuniv|forðatfl|1|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|10306|15683|lyfalmen|||1|28|0|9,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||10306||10306|15683||1|0|E|0|||0
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|0|1|CSB|0|0|0|100|SEK|76994|100656|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||76994||76994|100656||2|H|S|0|||0
422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|1|SAB|0|1|0|100|DKK|49135|65420|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||49135|65420||3|0|L|0|||0
422591|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.10.2020||R|1|0|0|0|0|ASA|0|0|0|100|SEK|20570|29291|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|Astra Zeneca A/S|Rósuvastatín||20570||20570|29291||1|0|E|0|||0
422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|3059|5708|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||3059||3059|5708||3|0|G|0|||0
422860|N03AF0401|Zebinix|töflur|200|mg|60|stk|1|þpakki||N03AF04|01.12.2018||R|1|0|0|G|0|BPC|0|0|0|100|SEK|11621|17493|lyfalmen|||1|60|0|15,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||11621||11621|17493||1|0|G|0|||0
422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9878|15094|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||9878||9878|15094||2|0|G|0|||0
423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|BAB|0|0|0|100|DKK|3172|5249|lyfalm11|V0993|4729|1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3172|5249||2|0||0|||0
423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|1|LEM|0|0|1|100|XEU|20190|28810|lyfsjukr|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||20190||20190|28810||2|0|ES|0|||0
423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|6059|9838|lyfalmen|V0373|4995|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||6059||6059|9838||2|0|G|0|||0
424199|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|73922|96770|lyfalmen|||1|50|0|33,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||73922||73922|96770||1|0|E|0|||0
424477|N06BA1201|Elvanse Adult|hylki|30|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|12095|18145|lyfalmen|||1|30|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||12095||12095|18145||1|0|E|1|30|dagar|0
424761|A07AA0204|Nystatin Orifarm|mixtúra|100000|ae/ml|100|ml|1|glas|dreifa|A07AA02|01.03.2020||R|0|0|0|0|0|IRO|0|0|1|100|XEU|5834|9528|lyfalmen|||2|100|0||Artasan ehf|Orifarm Generics A/S|Nýstatín||5834||5834|9528||1|0|0|0|||0
424829|N06AX2108|Aritavi|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|10646|4219|lyfalmen|V0694|4219|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||1977||1977|4219||1|0|G|0|||0
424973|R03BB0404|Braltus|innönddu|10|mcg|30|stk|3|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|G|0|TVA|0|0|0|100|DKK|13820|18827|lyfalmen|||2|90|0|90,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||12590||12590|18827||2|0|G|0|||0
425016|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|1|G|0|AZA|0|0|0|100|SEK|23332|27154|lyfalmen|V0183|21072|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||18640||18640|27154||1|0|G|0|||0
425282|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|1|0|1|ACC|0|1|0|100|XEU|20280|28924|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||20280||20280|28924||1|0|L|0|||0
425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|G|0|TTT|0|0|0|100|DKK|14862|21954|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||14862||14862|21954||2|0|G|0|||0
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|1045|2616|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||812||812|2616||2|0|E|0|||0
427030|J05AR0602|Padviram|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.03.2018||R|1|0|1|0|1|SHS|0|0|0|100|DKK|113139|133152|lyfsjukr|||2|30|0|30,0000|Artasan ehf|Sandoz A/S|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||101824||101824|133152||1|0|S|0|||0
427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2|0||0|||0
427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|8788|13594|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||8788||8788|13594||1|0||0|||0
427289|B01AC0603|Hjartamagnýl|sþ-tfl|75|mg|100|stk|1|þpakki||B01AC06|01.04.2019||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1|0|0|0|||0
427556|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|30|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|3314|5246|lyfalmen|V1004|5246|2|30|0|4,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||2723||2723|5246||2|0|E|1|30|dagar|0
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3268||1|0|E|0|||0
428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2508||1|0|G|0|||0
429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|3504|6321|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3504||3504|6321||2|0|S|0|||0
429358|R03BB0404|Braltus|innönddu|10|mcg|30|stk|1|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|G|0|TVA|0|0|0|100|DKK|4611|7429|lyfalmen|||2|30|0|30,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||4309||4309|7429||2|0|G|0|||0
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|1|0|1|MLD|0|0|0|100|DKK|84455|110092|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||84455||84455|110092||1|0|ES|0|||0
429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7148|4018|lyfalmen|V0812|3839|2|28|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1831||1831|4018||1|0|E|0|||0
429759|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|3|glös||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7994|12501|lyfalmen|||1|9|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7994||7994|12501||2|0|G|0|||0
429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|tfílát|30+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|4745|8029|lyfalmen|||2|200|0|66,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||4745||4745|8029||1|0|E|1|||0
429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|10108|15411|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||10108||10108|15411||3|0|G|0|||0
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|IBV|0|0|0|100|DKK|5906|11375|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Sulfadiazinum og trimethoprimum||5906||5906|11375||1|0||0|||0
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|19179|14125|lyfalmen|V0184|13809|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||9174||9174|14125||2|0|G|0|||0
430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5488|7875|lyfalmen|V0831|7403|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4633||4633|7875||2|0|G|0|||0
430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|G|0|TTT|0|0|0|100|DKK|6025|9791|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||6025||6025|9791||2|0|G|0|||0
430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
431017|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|hgl|+ein spr og tvær nálar|B06AC05|01.09.2020||R|0|0|1|0|1|HPI|0|0|0|100|DKK|2031676|2533347|lyfsjukr|||1|2|0||Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||2031676||2031676|2533347||1|0|0|0|||0
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1178|3119|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1178||1178|3119||1|0||0|||0
431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|1461|3509|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1461||1461|3509||1|0|G|0|||0
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3795|6721|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3795||3795|6721||1|0|G|0|||0
431922|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|7042|5613|lyfalmen|V0995|5613|2|7,5|0|75,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||2990||2990|5613||2|0|G|0|||0
431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17596|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17596||2|0|E|1|30|dagar|0
431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|0|1|TPA|0|1|0|100|DKK|326314|412354|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||326314||326314|412354||1|H|L|0|||0
431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|2144|4449|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2144||2144|4449||1|0|G|0|||0
432220|QM01AC0603|Rheumocam|stl|20|mg/ml|100|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.06.2018||R|0|0|0|0|0|CHP|1|0|0|100|IKR|6850|13166|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||6850|13166||2|0||0|||0
432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|3245|3700|lyfalmen|V0693|3700|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1600||1600|3700||2|0|E|0|||0
432723|A10BJ0602|Rybelsus|töflur|7|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|22998|32361|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||22998||22998|32361||1|0||0|||0
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|BRO|0|0|0|100|XEU|2995|4518|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||2299||2299|4518||2|0|0|0|||0
433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||2176||1|0|E|0|||0
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|G|0|COR|0|0|0|100|DKK|11521|17355|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11521||11521|17355||1|0|G|0|||0
433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2595|5070|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2595||2595|5070||1|0|G|1|30|dagar|0
433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|5702|9346|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5702||5702|9346||1|0|G|1|30|dagar|0
433345|QI08AA0101|Eravac|stl|||0,5|ml|10|hgl|fleyti|QI08AA01|01.05.2020||R|0|0|0|0|0|LHS|0|0|0|100|IKR|14085|24277|vetbolu|||0|5|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Rabbit haemorrhagic disease virus||14085||14085|24277||2|0||0|||0
433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|1|0|1|MLD|0|0|0|100|DKK|425987|536320|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||425987||425987|536320||1|0|ES|0|||0
434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|1|BAB|0|0|0|100|DKK|163476|209830|lyfsjukr|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||163476||163476|209830||2|H|S|0|||0
434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|NOK|69511|106381|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||65993||65993|106381||1|0||0|||0
434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||15098||15098|28814||2|0||0|||0
434366|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|áfpen|+ 3 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|15298|22554|lyfalmen|||1|0,36|0|1,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||15298||15298|22554||1|0|G|0|||0
434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|8336|12972|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai GmbH|Zonisamíð||8336||8336|12972||1|0|G|0|||0
434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3272|3838|lyfalmen|V0010|3838|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0
434601|N07BC0102|Buvidal|stl|128|mg|0,36|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|62206|81952|lyfsjukr|||1|0,36|0|16,0000|Vistor hf|Camurus AB|Búprenorfín||62206||62206|81952||1|H|L|1|30|dagar|0
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|MCS|0|0|1|100|SEK|811|2614|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||811||811|2614||1|0|E|0|||0
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|DKK|7194|11400|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||7194||7194|11400||2|0|G|0|||0
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|DKK|7178|11378|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||7178||7178|11378||2|0|G|0|||0
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|XEU|10618|16113|lyfalmen|V0315|7316|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10618||10618|16113||2|0|E|0|||0
434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|1|0|1|AMC|0|1|0|100|XEU|2591598|3229734|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeutics Europe Limited|Migalastat||2591598||2591598|3229734||1|0|L|0|||0
435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|1|SDG|0|1|0|100|DKK|14307|21190|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||14307||14307|21190||1|0|L|0|||0
435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3847||1|0|G|0|||0
435666|G04BE0810|Tadalafil Alvogen|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2020||R|1|0|0|0|0|GOV|0|0|0|100|IKR|4503|2668|lyfalmen|V0145|2105|2|4|0|8,0000|Alvogen|Alvogen ehf|Tadalafíl||850||850|2668||2|0|E|0|||0
435882|N05CD0806|Buccolam|munnh.l|5|mg|1|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|SSE|0|0|1|100|DKK|13798|20489|lyfalmen|||2|4|0|1,3333|Shire Services BVBA|Shire Services BVBA|Mídazólam||13798||13798|20489||1|0|E|2|450|mg|0
436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|1|AST|0|1|0|100|DKK|225201|286598|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||225201||225201|286598||2|H|L|0|||0
436044|N02AJ0601|Parkodin|filmhtfl|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.07.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|312|1927|lyfalmen|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||312||312|1927||1|0|E|3|||0
436308|J05AR2001|Biktarvy|filmhtfl|275|mg|30|stk|1|glas|50+200+25 mg|J05AR20|01.10.2018||R|0|0|1|0|1|GSE|0|0|0|100|DKK|142132|183284|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Emtricitabine, Tenofovir alafenamide og Bictegravir||142132||142132|183284||2|0|S|0|||0
436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|1|0|1|FEL|0|0|0|100|DKK|67949|89215|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||67949||67949|89215||1|0|ES|0|||0
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1134|3059|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1134||1134|3059||1|0||0|||0
436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|1|CFS|0|0|0|100|XEU|76019|99422|lyfsjukr|||1|60|0|0,7500|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||76019||76019|99422||3|0|ES|0|||0
436669|J02AC0106|Fungyn|hylki|150|mg|2|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|POF|0|0|1|100|XEU|562|2113|lyfalmen|V0555|2113|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||447||447|2113||2|0|E|0|||0
436810|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk|Stök áfyllingarpakkning|R03AC19|01.08.2019||R|0|0|0|G|0|BII|0|0|1|100|DKK|4412|7571|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||4412||4412|7571||1|0|G|0|||0
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|G|0|JAS|0|0|0|100|SEK|746|2525|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||746||746|2525||1|0|G|0|||0
437007|N06BA0905|Atomoxetin STADA|hylki|18|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4200|4113|lyfalmen|V0813|4113|2|30|0|6,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1900||1900|4113||2|0|E|0|||0
437221|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|8515|10464|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6514||6514|10464||1|0|G|0|||0
437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|0|1|FIN|0|1|0|100|DKK|663995|832335|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||663995||663995|832335||2|H|L|0|||0
437581|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|11675|17567|lyfalmen|V0253|4190|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||11675||11675|17567||3|0|G|0|||0
437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|22658|31931|lyfalmen|V0712|31931|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||22658||22658|31931||1|0|G|0|||0
437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|G|0|DEA|0|0|0|100|XEU|1223|3181|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1223||1223|3181||1|0|G|0|||0
437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|1|AST|0|1|0|100|DKK|59370|78365|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||59370||59370|78365||2|H|L|0|||0
438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|DEH|1|0|0|100|XEU|24548|46743|vetalmen|||0|1|0||Vistor hf|Dechra Regulatory B.V.|Clodronic acid||24548||24548|46743||1|0|0|0|||0
438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|1|FKA|0|0|1|100|DKK|2151|4459|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2151||2151|4459||1|0|S|0|||0
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|G|0|HES|0|0|1|100|DKK|2273|4626|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2273||2273|4626||1|0|G|0|||0
438571|A07EC0204|Asacol|töflur|1600|mg|60|stk|1|þpakki|með breyttan.losunarhraða|A07EC02|01.02.2019||R|1|0|0|G|0|TIL|0|0|0|100|DKK|11009|16651|lyfalmen|||1|60|0|64,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||11009||11009|16651|||0|G|0|||0
438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|1768|3931|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1768||1768|3931||1|0|G|0|||0
438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|6296|2870|lyfalmen|V0605|2737|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||997||997|2870||2|0|G|0|||0
438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|1|0|1|RRG|0|1|0|100|DKK|250013|317457|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration GmbH|Vemurafeníb||250013||250013|317457||2|0|L|0|||0
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|167990|215444|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||167990||167990|215444||1|0|S|0|||0
438974|D01AE1501|Lamisil|krem|1|%|15|g|1|túpa||D01AE15|01.10.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0
439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
439419|B06AC0102|Berinert|sts/irs|2000|ae|1|hgl|1|pakki||B06AC01|01.07.2020||R|0|0|1|0|1|CSB|0|1|0|100|SEK|493995|620903|lyfsjukr|||1|1|0|1,4286|Icepharma hf|CSL Behring GmbH|C1 hemill||493995||493995|620903||2|0|L|0|||0
439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|G|0|RDT|0|0|0|100|DKK|5338|8845|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||5338||5338|8845||1|0|G|0|||0
439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|22109|31237|lyfalmen|V0615|25748|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||22109||22109|31237||1|0||0|||0
439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|16879|12789|lyfalmen|V0818|12789|2|28|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||8203||8203|12789||1|0|E|0|||0
439822|R03DC0306|Montelukast ratiopharm|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|11840|17794|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||11840||11840|17794||2|0|G|0|||0
440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|186600|238589|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||186600||186600|238589||1|0|G|0|||0
440431|N02AX0213|Tramadol Krka|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|4500|6728|lyfalmen|V0224|6728|2|100|0|66,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||3800||3800|6728||2|0|G|1|30|dagar|0
440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3115|5785|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5785||2|0|G|0|||0
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|1|ATE|0|0|1|100|DKK|1456|3502|lyfsjukr|||2|10|0|1,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||1456||1456|3502||1|0|ES|0|||0
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|1|ATE|0|0|1|100|DKK|2297|4660|lyfsjukr|||2|10|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||2297||2297|4660||1|0|ES|0|||0
441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|JAS|0|0|1|100|SEK|1170|3108|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1170||1170|3108||1|0|E|0|||0
441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|TPA|0|0|0|100|DKK|1185|3129|lyfalmen|V0046|2505|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1185||1185|3129||1|0|G|0|||0
441451|N02CC0101|Imigran|nefúði|20|mg/sk|0,1|ml|6|úðaílá||N02CC01|01.04.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|6416|10329|lyfalmen|||1|0,6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||6416||6416|10329||1|0|G|0|||0
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|1|0|1|GEI|0|0|0|100|DKK|111521|145212|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín, rilpívírin og tenófóvír||111521||111521|145212||2|0|S|0|||0
442258|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|2.000 PFU bóluefni|J07BK01|01.01.2020||R|0|0|0|0|0|GPH|0|0|0|100|DKK|6144|9955|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||6144||6144|9955||1|0|0|0|||0
442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2754|5289|lyfalmen|V0283|3986|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2754||2754|5289||2|0|G|0|||0
442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|1|TMA|0|1|0|100|DKK|77316|101063|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||77316||77316|101063||3|0|L|0|||0
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|11536|17376|lyfalmen|V0460|13460|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11536|17376||1|0|G|0|||0
443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1750|3907|lyfalmen|V0560|3510|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1750||1750|3907||2|0||0|||0
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|G|0|NAS|0|0|1|100|DKK|3469|6273|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3469||3469|6273||1|0|G|0|||0
443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|G|0|NAS|0|0|1|100|DKK|27532|38096|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||27532||27532|38096||1|0|G|0|||0
443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|25412|35415|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||25412||25412|35415||1|0|G|1|30|dagar|0
443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|1|EUS|0|0|0|100|XEU|26192|36401|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||26192||26192|36401||3|H|ES|0|||0
443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|TSA|0|0|1|100|IKR|2475|3700|lyfalmen|V0116|3293|2|14|0|14,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||1600||1600|3700||2|0|E|0|||0
444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2801|5353|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2801||2801|5353||2|0|G|0|||0
444260|L04AC0801|Ilaris|stl|150|mg/ml|1|ml|1|hgl|lausn|L04AC08|01.04.2018||R|0|1|1|0|1|NEP|0|0|0|100|DKK|1743658|2175134|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Limited|Canakinumab||1743658||1743658|2175134||1|0|S|0|||0
444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BFP|0|0|1|100|XEU|2227|4227|lyfalmen|V0337|4227|2|30|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1983||1983|4227||1|0|E|0|||0
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|DKK|3230|5944|lyfalmen|V0061|3685|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3230||3230|5944||2|0|E|0|||0
444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|22418|31628|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||22418||22418|31628||2|H|S|0|||0
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|2323|4695|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2323||2323|4695||2|0|G|0|||0
444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|3537|6366|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||3537||3537|6366||2|0|G|0|||0
444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|G|0|IRO|0|0|0|100|XEU|5450|8999|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||5450||5450|8999||1|0|G|0|||0
444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|174260|223242|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||174260||174260|223242||2|0|L|0|||0
445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|G|0|BOE|0|0|0|100|DKK|20100|28696|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||20100||20100|28696||1|0|G|0|||0
445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|5077|8486|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||5077||5077|8486||1|0|G|0|||0
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|G|0|LEO|0|0|1|100|DKK|2066|4342|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||2066||2066|4342||1|0|G|0|||0
445169|L01XX1907|Irinotecan Accord|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.06.2020||R|0|0|0|0|1|AEE|0|0|0|100|XEU|44180|59152|lyfsjukr|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Írinótekan||44180||44180|59152||1|H|S|0|||0
445240|N05CH0104|Melatonin Vitabalans|töflur|5|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|7000|5902|lyfalmen|||2|50|0|125,0000|LYFIS ehf|LYFIS ehf|Melatonin||3200||3200|5902||2|0|0|0|||0
445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|7428|3060|lyfalmen|V0684|3060|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1135||1135|3060||2|0|G|0|||0
445580|H05BX0105|Cinacalcet Accord|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2018|31.10.2020|R|1|0|0|0|0|AEE|0|0|0|100|XEU|54403|17168|lyfalmen|||2|28|0|42,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||11385||11385|17168||1|0||0|||0
445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|6138|9946|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6138||6138|9946||1|0|G|0|||0
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|1|G|0|EIG|0|0|0|100|SEK|17194|25164|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai GmbH|Rúfínamíð||17194||17194|25164||1|0|G|0|||0
446639|C10BA0202|Ezetimib/Simvastatin Krka|töflur|30|mg|100|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|17377|22144|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||15000||15000|22144|30.11.2020|2|0||0|||0
447013|L04AB0402|Imraldi|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.03.2019||R|0|1|1|0|1|SUG|0|1|0|100|XEU|63024|82986|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||63024||63024|82986||2|0|L|0|||0
447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|G|0|KNM|0|0|0|100|IKR|7968|5214|lyfalmen|V0694|4219|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||2700||2700|5214||2|0|G|0|||0
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|11969|17972|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||11969||11969|17972||1|0|G|0|||0
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|6700|10720|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6700||6700|10720||1|0|G|0|||0
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|8422|13090|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||8422||8422|13090||1|0|G|0|||0
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|8715|13493|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8715||8715|13493||1|0|G|0|||0
447357|A10AE0407|Toujeo [DoubleStar]|stl|300|ein/ml|3|ml|3|áfpen|áfylltir lyfjapennar|A10AE04|01.09.2019||R|0|1|0|G|0|SDH|0|0|0|100|XEU|12276|18395|lyfalmen|||1|9|0|67,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||12276||12276|18395||1|0|G|0|||0
447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2999|3673|lyfalmen|V0948|3631|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||1580||1580|3673||2|0|G|0|||0
447608|J06BA0104|Cutaquig|stl|165|mg/ml|12|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|1|OCT|0|1|0|100|DKK|25142|35073|lyfsjukr|||1|12|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||25142||25142|35073||1|0|L|0|||0
447939|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|84|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|28000|38688|lyfalmen|||2|84|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||28000||28000|38688||2|0|E|0|||0
448122|A02BA0208|Asýran|filmhtfl|300|mg|90|stk|1|þpakki||A02BA02|01.07.2019|30.09.2020|R|1|0|0|G|0|TEE|0|0|1|100|XEU|1799|3974|lyfalmen|||2|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín||1799||1799|3974||1|0|G||||
448253|A10AB0505|Fiasp|stl|100|ein/ml|10|ml|1|hgl||A10AB05|01.02.2019||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3096|5759|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3096||3096|5759||1|0|G|0|||0
448379|G03AD0103|Levonorgestrel Apofri|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.12.2019||L|0|0|0|0|0|APO|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|LYFIS ehf|Apofri AB|Levonorgestrel|||||||2|0||0|||0
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|G|0|HES|0|0|1|100|DKK|2152|4460|lyfalmen|V0202|4164|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||2152||2152|4460||1|0|G|0|||0
448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|KRK|0|0|0|100|IKR|4087|4636|lyfalmen|V0214|4604|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0
448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016|30.11.2020|R|0|0|0|0|0|NEL|0|0|0|100|DKK|65529|86155|lyfalmen|||1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||65529||65529|86155||1|0|E|0|||0
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|1|RAU|0|0|0|100|XEU|1184|3128|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1184||1184|3128||2|H|S|0|||0
449480|B02BC3002|TISSEEL|vefjalím|||4|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|1|BAM|0|0|0|100|SEK|35718|48450|lyfsjukr|||1|4|0||Icepharma hf|Baxter Medical AB|Blöndur||35718||35718|48450||2|H|S|0|||0
449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2271|3474|lyfalmen|V0686|2033|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1436||1436|3474||2|0|E|0|||0
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1978|3220|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1251||1251|3220||2|0|G|0|||0
449697|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfpen||R03DX10|01.05.2020||R|0|0|1|0|1|ZEN|0|1|0|100|SEK|364255|459542|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||364255||364255|459542||1|0|L|0|||0
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|1|ATE|0|0|1|100|DKK|5446|8994|lyfsjukr|||2|10|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||5446||5446|8994||1|0|ES|0|||0
449842|L01XX2401|Oncaspar|stl/irs|750|ein/ml|5|ml|1|hgl||L01XX24|01.04.2019||R|0|0|0|0|1|LLS|0|0|0|100|DKK|259361|329084|lyfsjukr|||1|5|0||Icepharma hf|Les Laboratoires Servier|Pegaspargase||||259361|329084||2|H|S|0|||0
449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|3576|6420|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||3576||3576|6420||2|0|G|0|||0
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|0|0|0|LEV|1|0|0|100|XEU|5016|9687|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||5016||5016|9687||2|0||1|30|dagar|0
450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1272|3249|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1272||1272|3249||2|0|G|0|||0
450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|0|1|MBV|0|0|0|100|DKK|130982|169416|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||130982||130982|169416||1|H|S|0|||0
450216|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4018|lyfalmen|V0814|3839|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||1831||1831|4018||2|0|E|0|||0
450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|1|BOE|0|0|0|100|DKK|381803|481367|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||381803||381803|481367||1|H|S|0|||0
450537|N05CD0806|Buccolam|munnh.l|10|mg|2|ml|4|spr|munngjaf.spr|N05CD08|01.11.2019||R|0|0|0|0|0|SSE|0|0|1|100|DKK|13798|20489|lyfalmen|||2|8|0|2,6667|Shire Services BVBA|Shire Services BVBA|Mídazólam||13798||13798|20489||1|0|E|2|450|mg|0
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|SNP|0|0|0|100|XEU|2596|4165|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1938||1938|4165||1|0||2|30|töflur|0
450846|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|4000|ml|1|glas|HDPE plastílát|QN01AX94|01.03.2019||R|0|0|0|0|0|SAS|0|0|0|100|NOK|252876|407636|veteldis|||0|4000|0||Vistor hf|Scan Aqua AS|Isoeugenol||252876||252876|407636||1|0||0|||0
450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|XEU|9072|15636|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||9072||9072|15636||2|0||0|||0
450993|R07AX0101|INOmax|lyfjagas|800|ppm|10|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|1|LIN|0|0|0|100|XEU|22091|31214|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||22091|31214||5|H|S|0|||0
451135|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|3521|6344|lyfalmen|||3|84|0|7,0000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||3521||3521|6344||3|0|G|0|||0
451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|OTS|0|0|0|100|DKK|45319|60593|lyfalmen|V0980|60592|1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||45319||45319|60593||1|0|E|0|||0
451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|G|0|ATE|0|0|1|100|XEU|697|2457|lyfalmen|||2|25|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prednisólón||697||697|2457||1|0|G|0|||0
451428|B06AC0102|Berinert|sts/irs|1500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|1|CSB|0|1|0|100|SEK|323347|408664|lyfsjukr|||1|1|0|1,0714|Icepharma hf|CSL Behring GmbH|C1 hemill||323347||323347|408664||2|0|L|0|||0
451655|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.09.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0
451670|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2594|3563|lyfalmen|V0687|3457|2|70|0|35,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0
451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|G|0|ATE|0|0|0|100|XEU|10776|16330|lyfalmen|V0608|14431|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||10776||10776|16330||1|0|G|0|||0
451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|DKK|41351|55574|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||41351||41351|55574||2|0|G|0|||0
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|120|0||Alvogen|Trimb Healthcare AB|Ketókónazól|||||||2|0||0|||0
452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1|0||0|||0
452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|8391|13047|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||8391||8391|13047||2|0|G|0|||0
452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5813||2|0||0|||0
452499|A10BJ0602|Rybelsus|töflur|3|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|22998|32361|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||22998||22998|32361||1|0||0|||0
452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|1|0|1|RRG|0|1|0|100|DKK|860452|1076673|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration GmbH|Cobimetinib||||860452|1076673||2|0|L|0|||0
452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3500|2874|lyfalmen|V0010|2193|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2874||2|0|G|0|||0
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|MEA|0|0|1|100|DKK|9005|13892|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||9005||9005|13892||2|0|E|0|||0
452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|1|SPP|0|0|0|100|XEU|8518|13222|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||8518||8518|13222||2|H|S|0|||0
452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|1433|3470|lyfalmen|||1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||1433||1433|3470||2|0|G|1|30|dagar|0
452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|4301|7418|lyfalmen|||1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxýcódon||4301||4301|7418||2|0|G|1|30|dagar|0
452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|2738|5267|lyfalmen|||1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||2738||2738|5267||2|0|G|1|30|dagar|0
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|BOA|0|0|0|100|XEU|1524|2627|vetorma|||0|6,4|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||1524||1524|2627||1|0||0|||0
453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|8254|12859|lyfalmen|||1|98|0|26,1300|Icepharma hf|Mundipharma A/S|Oxýcódon||8254||8254|12859||2|0|G|1|30|dagar|0
453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|108770|141791|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||108770|141791||2|0|E|0|||0
453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003|31.10.2020|R|1|0|0|G|0|MUP|0|0|0|100|DKK|15395|22688|lyfalmen|||1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxýcódon||15395||15395|22688||2|0|G|1|30|dagar|0
453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|6315|lyfalmen|||2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||3500||3500|6315||2|0|G|0|||0
454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|Bel|1|0|0|100|DKK|5490|10586|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||5490||5490|10586||2|0||0|||0
454650|D05AX5204|Enstilar|húðfroða|||60|g|1|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|9139|14077|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9139||9139|14077||1|0|G|0|||0
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|36831|45876|lyfalmen|V0342|11646|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||33683||33683|45876||1|0|G|0|||0
454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0||0|||0
454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|1|0|0|BIM|0|0|0|100|SEK|414273|521751|lyfalmen|||1|120|0||Icepharma hf|BioMarin International Limited|Saprópterín||414273||414273|521751||2|0||0|||0
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|BID|0|0|0|100|DKK|1187|2333|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín (BAN)||1187||1187|2333||1|0||0|||0
454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|1100|2599|lyfalmen|V0174|2599|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||800||800|2599||2|0|E|0|||0
455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|1|FKA|0|0|1|100|DKK|5013|8398|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5013||5013|8398||1|0|S|0|||0
455223|J05AR0303|Emtricitabine/Tenofovir disoproxil Krka|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.08.2017||R|0|1|1|0|1|KNM|0|1|0|100|IKR|50000|66514|lyfsjukr|||2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Tenófóvír dísóproxíl og emtrícítabín||||50000|66514||2|0|L|0|||0
455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|8044|12570|lyfalmen|V0713|10749|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||8044||8044|12570||1|0|G|0|||0
455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|1|CPV|0|1|0|100|XEU|1146623|1432589|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1146623||1146623|1432589||2|0|L|0|||0
455398|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|30375|41692|lyfalmen|V0653|41692|3|168|0|42,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban 	||30375||30375|41692||3|0|G|0|||0
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|842|2657|lyfalmen|||2|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||842||842|2657||1|0|E|0|||0
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|ATE|0|0|1|100|XEU|950|2806|lyfalmen|||2|15|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||950||950|2806||1|0|E|0|||0
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1778|3945|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||1778||1778|3945||1|0|E|0|||0
456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|4752|8039|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||4752||4752|8039||2|0|G|0|||0
456795|L01XE3501|Tagrisso|filmhtfl|80|mg|30|stk|1|stsk.þ||L01XE35|01.06.2019||R|0|0|1|0|1|ZEN|0|1|0|100|SEK|967071|1209277|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||967071||967071|1209277||1|0|L|0|||0
456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|4926|7004|lyfalmen|V0277|6891|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||4000||4000|7004||2|0|G|0|||0
457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7148|4340|lyfalmen|V0816|3968|2|28|0|21,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||2065||2065|4340||1|0|E|0|||0
457185|H05BX0107|Cinacalcet STADA|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|28190|11821|lyfalmen|V0721|8450|2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||7500||7500|11821||2|0||0|||0
457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ALE|0|0|0|100|SEK|53095|57792|lyfalmen|V0451|57792|2|1|0|83,7200|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||43104||43104|57792||2|0|G|0|||0
457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.04.2019||R|1|0|0|G|0|BFP|0|0|0|100|XEU|3771|6688|lyfalmen|V0326|6547|2|98|0|147,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||3771||3771|6688||1|0|0|0|||0
457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|XEU|1634|3747|lyfalmen|V0561|3747|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1634||1634|3747||2|0||0|||0
457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|PEU|0|0|0|100|DKK|6623|10614|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||6623||6623|10614||1|0||0|||0
457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3103|5769|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3103||3103|5769||2|0|G|0|||0
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|2812|2238|lyfalmen|V0003|2238|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||538||538|2238||1|0|E|0|||0
457755|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|4541|7748|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4541||4541|7748||1|0|G|0|||0
457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|LHS|0|0|0|100|XEU|11533|19878|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11533||11533|19878||2|0||0|||0
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|CHE|0|0|1|100|DKK|1183|3126|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1183||1183|3126||1|0|E|2|150|hylki|0
458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|1|0|1|FIN|0|1|0|100|DKK|408187|514182|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||408187||408187|514182||2|0|L|0|||0
458266|L04AB0402|Imraldi|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.03.2019||R|0|1|1|0|1|SUG|0|1|0|100|XEU|63024|82986|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||63024||63024|82986||2|0|L|0|||0
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|KPA|0|0|1|100|DKK|1363|3374|lyfalmen|V0577|2906|1|20|0|6,6667|Alvogen|Karo Pharma AB|Pívmecillínam||1363||1363|3374||2|0|E|0|||0
458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|1|TMA|0|1|0|100|DKK|118283|153622|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||118283||118283|153622||3|0|L|0|||0
458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|10443|15135|lyfalmen|V0653|14890|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||9908||9908|15135||1|0|G|0|||0
458838|M09AX0701|Spinraza|stl|12|mg|5|ml|1|hgl|lausn|M09AX07|01.11.2018||R|0|0|0|0|1|BNB|0|1|0|100|XEU|12430926|15467083|lyfsjukr|||1|5|0|120,0000|Icepharma hf|Biogen Netherlands B.V.|Nusinersen||12430910||12430910|15467083||2|H|L|0|||0
459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|1|0|1|NEL|0|1|0|100|DKK|906664|1134147|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||906664||906664|1134147||1|0|L|0|||0
459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|0|1|BNB|0|0|0|100|XEU|88445|115139|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||88445||88445|115139||2|0|S|0|||0
459324|V08CA0901|Gadovist|stl|1|mmol/ml|5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|1|BAB|0|0|0|100|DKK|22794|32103|lyfsjukr|||1|25|0||Icepharma hf|Bayer AB|Gadóbútról||||22794|32103||2|H|S|0|||0
459342|N05AX1304|Paliperidon Krka|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|11123|16808|lyfalmen|V0964|16808|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||11123||11123|16808||2|0|G|0|||0
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|1|PLS|0|0|1|100|DKK|886|2717|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||886||886|2717||1|0|ES|0|||0
459405|L01XE2701|IMBRUVICA|filmhtfl|560|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|1|0|1|JCI|0|1|0|100|SEK|1029353|1286738|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||1029353||1029353|1286738||1|0|L|0|||0
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|1|PLS|0|0|1|100|DKK|1623|3732|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1623||1623|3732||1|0|ES|0|||0
459423|N07BC0102|Buvidal|stl|16|mg|0,32|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|14546|21519|lyfsjukr|||1|0,32|0|2,0000|Vistor hf|Camurus AB|Búprenorfín||14546||14546|21519||1|H|L|1|30|dagar|0
459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|21940|41795|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|Cefovecinum||21940||21940|41795||2|0||0|||0
459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|2514|2365|lyfalmen|V0284|2365|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||630||630|2365||2|0|G|0|||0
459838|N05AH0416|Quetiapin Medical Valley|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|10500|11408|lyfalmen|V0261|11408|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||7200||7200|11408||2|0|0|0|||0
459845|A10BD2301|Segluromet|filmhtfl|1007,5|mg|56|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|6378|10277|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||6378||6378|10277||1|0|G|0|||0
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|G|0|MEA|0|0|1|100|DKK|2119|4415|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||2119||2119|4415||2|0|G|0|||0
459926|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.04.2019||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír|||||||1|0|0|0|||0
460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|0|1|AEE|0|1|0|100|XEU|147202|189589|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare B.V.|Bendamústín||147202||147202|189589||1|H|L|0|||0
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|G|0|HSS|0|0|0|100|DKK|9790|14973|lyfalmen|||1|100|0|25,0000|Artasan ehf|Sandoz GmbH|Rífampicín||9790||9790|14973||1|0|G|0|||0
460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|0|1|RRG|0|1|0|100|DKK|261896|332237|lyfsjukr|||1|5|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||261896||261896|332237||2|H|L|0|||0
460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|7789|4383|lyfalmen|V0144|4157|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2096||2096|4383||1|0|E|0|||0
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|5318|9550|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||4944||4944|9550||2|0|0|0|||0
460889|N02AE0105|Buprenorphine Alvogen|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|DKK|1296|3282|lyfalmen|V0943|3282|2|4|0|2,8000|Alvogen|Alvogen|Búprenorfín||1296||1296|3282||2|0|G|1|30|dagar|0
461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5080|8326|lyfalmen|V0585|8299|2|98|0|26,1300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||4961||4961|8326||1|0|G|1|30|dagar|0
461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|1|0|1|NEL|0|1|0|100|DKK|472603|594297|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||472603||472603|594297||1|0|L|0|||0
461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1916||2|0|E|0|||0
461405|N02AA0508|Oxycodone Alvogen|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|4296|7411|lyfalmen|V0586|7411|2|28|0|14,9300|Alvogen|Alvogen ehf|Oxýcódon||4296||4296|7411||2|0|G|1|30|dagar|0
461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|1|CPV|0|1|0|100|XEU|1182080|1476688|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1182080||1182080|1476688||2|0|L|0|||0
461563|V03AB1506|Nyxoid|nefúði|1,8|mg|0,1|ml|2|stsk.í||V03AB15|01.03.2020||R|0|1|0|0|0|MIP|0|0|1|100|DKK|6719|10746|lyfalmen|||1|0,2|0||Icepharma hf|Mundipharma Corporation (Ireland) Ltd|Naloxón||6719||6719|10746||2|0|E|0|||0
461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|0|1|MBV|0|0|0|100|DKK|327455|413774|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||327455||327455|413774||1|H|S|0|||0
461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|19634|28522|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||19634||19634|28522||1|0|G|0|||0
462130|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4340|lyfalmen|V0816|3968|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2065||2065|4340||2|0|E|0|||0
462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|0|1|IND|0|0|0|100|DKK|4234|7326|lyfsjukr|||1|28|0|7,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||4234||4234|7326||1|0|ES|1|30|dagar|0
462849|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4245|7341|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4245||4245|7341||2|0|G|0|||0
463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|5821|2874|lyfalmen|V0605|2793|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||1000||1000|2874||2|0|G|0|||0
463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.04.2020||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2830|5393|lyfalmen|V0325|5231|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||2830||2830|5393||1|0|0|0|||0
463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|1|0|1|JCI|0|0|0|100|SEK|53922|71474|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||53922|71474||1|0|S|0|||0
463744|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|tfílát||G02CB03|01.07.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|4806|8113|lyfalmen|||1|8|0|8,0000|Icepharma hf|Pfizer Aps|Kabególín||||4806|8113||1|0|G|0|||0
463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.11.2020||R|0|0|0|G|0|MBV|0|0|1|100|DKK|2052|4322|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2052||2052|4322||1|0|G|0|||0
463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2|0||0|||0
463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
464078|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|150 mg/30 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|3627|6251|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3627||3627|6251||1|0||0|||0
464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
464170|N02BA5104|Treo Citrus|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2019||L|0|0|0|0|0|MEA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2130|3425|lyfalmen|V0947|3356|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||1400||1400|3425||2|0|G|0|||0
464327|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|10|hgl||B01AB01|01.07.2019||R|0|0|0|0|1|LEP|0|0|0|100|DKK|8097|12643|lyfsjukr|||1|50|0|25,0000|Vistor hf|LEO Pharma A/S|Heparín||8097||8097|12643||1|H|S|0|||0
464335|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2016||R|1|0|0|G|0|ATE|0|0|0|100|XEU|17401|25449|lyfalmen|V0718|25449|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||17401||17401|25449||1|0|G|0|||0
464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|1|G|0|WIL|0|0|0|100|XEU|6861|10941|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||6861||6861|10941||2|0|G|0|||0
464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|TSA|0|0|1|100|IKR|1713|2668|lyfalmen|V0967|2668|2|14|0|7,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||850||850|2668||2|0|E|0|||0
464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016||L|0|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|V0677|2753|2|140|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mómetasón|||||3156||1|0|G|0|||0
464827|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|505|2193|lyfalmen|V0188|2193|2|30|0|15,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||505||505|2193||2|0|G|0|||0
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|G|0|ATE|0|0|0|100|DKK|2811|5367|lyfalmen|V0376|5367|2|7,5|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Latanóprost||2811||2811|5367||1|0|G|0|||0
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1478|2905|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Penicillín í blöndum með öðrum sýklalyfjum||1478||1478|2905||1|0||0|||0
465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|G|0|MDK|0|0|0|100|DKK|2117|4412|lyfalmen|||1|98|0|49,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||2117||2117|4412||2|0|G|0|||0
465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3438|6230|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3438||3438|6230||2|0|G|0|||0
465472|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.04.2019|30.09.2020|R|0|1|0|0|1|GRP|0|0|0|100|XEU|11378|5768|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||3102||3102|5768||1|H|0||||
465772|L01XC0302|Kanjinti|st/irþ|150|mg|1|hgl|1|pakki||L01XC03|01.12.2018||R|0|0|0|0|1|AEB|0|1|0|100|DKK|81206|105983|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||81206||81206|105983||1|H|L|0|||0
466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013|30.09.2020|R|1|0|0|G|0|RTH|0|0|0|100|IKR|2763|3012|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Flúoxetín||1100||1100|3012||2|0|G||||
466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|647|2388|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||647||647|2388||1|0|G|1|30|dagar|0
466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2016|4273|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2016||2016|4273||1|0|G|1|30|dagar|0
466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|1336|2987|lyfalm11|V0545|1927|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1336|2987||2|0||0|||0
466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1529|3602|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1529||1529|3602||1|0|G|1|30|dagar|0
466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|PLS|0|0|0|100|DKK|5297|8789|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5297||5297|8789||1|0|G|1|30|dagar|0
466276|J01XD0103|Metronidazol Normon|irl|5|mg/ml|100|ml|50|pokar||J01XD01|01.09.2019||R|0|0|0|0|1|LNA|0|0|1|100|XEU|31316|37861|lyfsjukr|||2|5000|0|16,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Metrónídazól||27346||27346|37861||2|0|0|0|||0
466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|1|RRG|0|1|0|100|DKK|273339|346468|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||273339||273339|346468||2|H|L|0|||0
466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|19549|28405|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai GmbH|Zonisamíð||19549||19549|28405||1|0|G|0|||0
466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2842|5410|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2842||2842|5410||1|0|G|1|30|dagar|0
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|7355|11621|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||7355||7355|11621||1|0|G|0|||0
466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1|0||0|||0
466667|L01AA0501|LEDAGA|hlaup|160|mcg/g|60|g|1|túpa||L01AA05|01.03.2020||R|0|1|0|0|1|HEL|0|0|0|100|XEU|391156|493000|lyfsjukr|||1|60|0||Recordati AB|Helsinn Birex Pharmaceuticals Ltd.|Chlormethine||391156||391156|493000||3|0|0|0|||0
466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|PLS|0|0|0|100|DKK|4676|7934|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4676||4676|7934||1|0|G|1|30|dagar|0
466723|V03AN0502|Airapy|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|21964|31054|lyfalmen|V0728|28872|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||21964||21964|31054||1|0|E|0|||0
466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|WEH|0|0|1|100|IKR|361|1831|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||242||242|1831||2|0|E|0|||0
467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7294|6677|lyfalmen|V0622|6677|2|30|0|54,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3763||3763|6677||1|0|E|1|30|dagar|0
467437|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|250|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6201|10688|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||6201||6201|10688||2|0||0|||0
467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|6401|10308|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6401||6401|10308||2|0|S|0|||0
467473|H02AB0912|Alkindi|kyrnhylk|2|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|31818|43517|lyfalmen|||1|50|0|3,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||31818||31818|43517||2|0|G|0|||0
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|12496|18697|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||12496||12496|18697||1|0|G|0|||0
467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|6425|10341|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||6425||6425|10341||2|0||0|||0
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|23452|32936|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||23452||23452|32936||1|0|G|0|||0
467756|A10BJ0301|Lyxumia|stl|20|mcg/sk|3|ml|2|áfpen||A10BJ03|01.10.2013||R|0|0|0|0|0|SGB|0|0|0|100|XEU|11957|17956|lyfalmen|||1|6|0|28,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||11957||11957|17956||1|0|E|0|||0
467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|1|PIP|0|0|1|100|DKK|83421|108784|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftarólin||83421||83421|108784||1|0|ES|0|||0
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|1|JAS|0|0|0|100|SEK|426|2084|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||426||426|2084||1|0|S|0|||0
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|6310|7399|lyfalmen|V0317|3675|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4287||4287|7399||1|0|G|0|||0
468103|H05BX0104|Cinacalcet Mylan|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.11.2016|30.09.2020|R|1|0|0|0|0|ASD|0|0|0|100|SEK|14474|8756|lyfalmen|||2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||5273||5273|8756||2|0|||||
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|7773|7371|lyfalmen|V0318|5077|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4267||4267|7371||1|0|G|0|||0
468374|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|1022|2905|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1022||1022|2905||1|0|G|0|||0
468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|2429|4187|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2429||2429|4187||2|0||0|||0
468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|3568|5426|lyfalmen|V0467|4950|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||2854||2854|5426||1|0|G|0|||0
469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7706|12104|lyfalmen|V0712|10644|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7706||7706|12104||1|0|G|0|||0
469152|N06BA0408|Methylphenidate Teva|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|6660|6050|lyfalmen|V0960|6040|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3307||3307|6050||1|0|E|1|30|dagar|0
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|PLS|0|0|0|100|DKK|3364|6128|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3364||3364|6128||1|0|E|0|||0
469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|AEP|0|0|0|100|DKK|3651|5839|lyfalm11|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||3651||3651|5839||2|0||0|||0
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|7188|11391|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7188||7188|11391||1|0|S|0|||0
469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|2598|3323|lyfalmen|V0037|3319|2|20|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||1326||1326|3323||1|0|G|0|||0
469899|C01CA1703|Hypotron|töflur|2,5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|14250|21112|lyfalmen|V0968|21112|2|100|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||14250||14250|21112||2|0|G|0|||0
469912|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|þpakki||C01AA05|01.08.2020||R|1|0|0|G|0|AEP|0|0|0|100|DKK|404|2054|lyfalmen|V1025|2054|1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||404||404|2054||2|0|G|0|||0
469990|L04AB0403|Amgevita|stl|40|mg/penna|0,8|ml|2|áfpen|SureClick penni|L04AB04|01.06.2020||R|0|1|1|0|1|AEB|0|1|0|100|DKK|64714|85124|lyfsjukr|||1|1,6|0|27,5860|Vistor hf|Amgen Europe B.V.|Adalimumab||64714||64714|85124||1|0|L|0|||0
470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|1|0|1|IPC|0|0|0|100|DKK|50810|61165|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||45771||45771|61165||2|0|S|0|||0
470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4272|7378|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4272||4272|7378||1|0|G|0|||0
470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|G|0|AEP|0|0|0|100|DKK|6417|10330|lyfalmen|||1|5|0|10,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||6417||6417|10330||2|0|G|0|||0
470817|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|65893|86615|lyfalmen|V0728|86615|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||65893||65893|86615||1|0|E|0|||0
471066|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|527|2223|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck AB|Levótýroxínnatríum||527||527|2223||2|0|G|0|||0
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|COR|1|0|0|100|DKK|6113|11768|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||6113||6113|11768||1|0||0|||0
471970|N05CH0105|Slenyto|forðatfl|5|mg|30|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|17751|13489|lyfalmen|||2|30|0|75,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||8712||8712|13489||2|0|0|0|||0
472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1794|3967|lyfalmen|V0048|2826|1|98|0|31,0333|Vistor hf|Recordati Ireland Limited|Metóprólól||1794||1794|3967||1|0|G|0|||0
472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3967|6958|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3967||3967|6958||1|0||0|||0
472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|0|1|TEA|0|0|0|100|SEK|8889|13733|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||8889||8889|13733||1|H|S|0|||0
472610|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|98|stk|1|þpakki||N06AX21|01.12.2018||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5470|5611|lyfalmen|V0811|5581|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2988||2988|5611||2|0|G|0|||0
472741|N03AX1402|Keppra (Lyfjaver)|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|22661|31935|lyfalmen|V0516|7108|3|100|0|66,6700|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||22661||22661|31935||3|0|G|0|||0
472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.12.2019||R|1|0|0|G|0|MBV|0|0|1|100|DKK|3316|6062|lyfalmen|V0458|2979|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||3316||3316|6062||1|0|G|0|||0
472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2721|5243|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2721||2721|5243||1|0|G|0|||0
473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|G|0|ATR|0|0|1|100|DKK|1499|3561|lyfalmen|||1|5|0|5,0000|Atnahs Pharma Nordics A/S|Atnahs Pharma Netherlands B.V.|Ketórólak||1499||1499|3561||2|0|G|0|||0
473879|B01AF0101|Xarelto|filmhtfl|2,5|mg|196|stk|1|þpakki||B01AF01|01.05.2020||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30862|42308|lyfalmen|V0974|42308|1|196|0|24,5000|Icepharma hf|Bayer AG|Rivaoxaban||30862||30862|42308||2|0|G|0|||0
473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|1|SUG|0|1|0|100|XEU|91556|119074|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||91556||91556|119074||2|0|L|0|||0
473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4761|8051|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||4761||4761|8051||1|0|G|0|||0
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000|30.11.2020|L|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2|0||0|||0
474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|PHM|0|0|0|100|DKK|31439|59817|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||31439||31439|59817||2|0||0|||0
475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2904|5495|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2904||2904|5495||2|0|E|0|||0
475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||2|0||2|||0
475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0
476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||5695||5695|10975||2|0||0|||0
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|64195|84467|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||64195|84467||1|0|S|0|||0
476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|4622|7860|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4622|7860||2|0|S|0|||0
477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|16366|24024|lyfalmen|V0954|6494|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||16366||16366|24024||1|0|E|0|||0
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|4711|7982|lyfalmen|V0934|5772|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4711||4711|7982||1|0||0|||0
477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|1|0|1|AEB|0|1|0|100|XEU|61191|80668|lyfsjukr|||1|27|0||Vistor hf|Amgen Europe B.V.|Apremilast||61191||61191|80668||1|0|L|0|||0
477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|1|SUG|0|1|0|100|XEU|91556|119074|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||91556||91556|119074||2|0|L|0|||0
477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|10359|9481|lyfalmen|V0272|8917|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||5800||5800|9481||2|0|G|0|||0
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||2|0||0|||0
477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||1|0||0|||0
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|553|2116|lyfalmen|V0500|2082|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||449||449|2116||1|0|G|0|||0
478163|D05AX5204|Enstilar|húðfroða|||60|g|2|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|18278|26656|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||18278||18278|26656||1|0|G|0|||0
478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|1|0|0|100|XEU|7844|15052|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||7844||7844|15052||2|0||0|||0
478386|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.10.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3897|5636|lyfalm11|V0983|5636|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3486||3486|5636||2|0||0|||0
478808|R03DX0901|Nucala|stl|100|mg|1|pennar|1|pakki||R03DX09|01.07.2020||R|0|0|1|0|1|GSD|0|1|0|100|DKK|182045|232924|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||182045||182045|232924||1|0|L|0|||0
478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ALO|0|0|1|100|IKR|2221|3012|lyfalmen|V0825|2811|2|28|0|28,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0
479127|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|0|MVX|0|0|0|100|IKR|4900|8105|lyfalmen|V0115|8077|2|98|0|392,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||4800||4800|8105||2|0|E|0|||0
479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|1|0|1|PEU|0|1|0|100|DKK|126544|163897|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||126544||126544|163897||1|0|L|0|||0
479954|L01XC1701|OPDIVO|irþ|10|mg/ml|24|ml|1|hgl||L01XC17|01.10.2019||R|0|1|0|0|1|BMS|0|1|0|100|DKK|427406|538085|lyfsjukr|||1|24|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||427406||427406|538085||1|H|L|0|||0
479991|L01XX5001|Ninlaro|hylki|4|mg|1|stk|3|þpakki|Hvert hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|1|0|1|TPA|0|0|0|100|DKK|873742|1093202|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||873742||873742|1093202||1|0|S|0|||0
480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|OCO|0|0|0|100|DKK|3408|6636|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||3408||3408|6636||2|0||0|||0
480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4558|6599|lyfalmen|V0080|6599|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3706||3706|6599||2|0|G|0|||0
480750|B01AF0101|Xarelto|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.12.2018||R|1|1|0|G|0|FIN|0|0|0|100|DKK|33845|46081|lyfalmen|V0975|46081|1|98|0|49,0000|Icepharma hf|Bayer AG|Rivaoxaban||33845||33845|46081||2|0|G|0|||0
481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|GPH|0|0|0|100|DKK|13558|20159|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||13558||13558|20159||1|0||0|||0
481208|D07AC1302|Ovixan|krem|1|mg/g|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|737|2512|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||737||737|2512||1|0|G|0|||0
481345|N06DA0304|Nimvastid|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|25104|35025|lyfalmen|||2|112|0|37,3300|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||25104||25104|35025||2|0|G|0|||0
481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6194|8001|lyfalmen|V0681|8001|2|30|0|27,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||4725||4725|8001||1|0|E|1|30|dagar|0
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|1|100|DKK|269|1868|lyfalmen|V0055|1867|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||269||269|1868||1|0|G|1|30|dagar|0
482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|G|0|BAB|0|0|0|100|DKK|16257|23874|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||16257||16257|23874||2|0|G|0|||0
482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||2|0||0|||0
483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|0|1|AEB|0|1|0|100|DKK|61775|81407|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||61775||61775|81407||1|H|L|0|||0
483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|32846|44817|lyfalmen|V0977|44486|1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||32846|44817||2|0|G|0|||0
483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|1|SPP|0|0|0|100|XEU|6816|10879|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|albumin||6816||6816|10879||2|H|S|0|||0
483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|48492|64606|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||48492||48492|64606||2|H|S|0|||0
483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|G|0|DAN|0|0|0|100|XEU|5273|8756|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5273||5273|8756||2|0|G|0|||0
483556|S01EA0502|Brimonidin Bluefish|augndr|2|mg/ml|5|ml|3|glös|lausn|S01EA05|01.04.2018||R|0|0|0|G|0|BFP|0|0|0|100|XEU|2406|4810|lyfalmen|V0368|4810|2|15|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Brímónidín||2406||2406|4810||1|0|G|0|||0
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|G|0|SHS|0|0|1|100|DKK|7024|11166|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||7024||7024|11166||1|0|G|0|||0
483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2486|4920|lyfalmen|||2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4920||2|0|G|0|||0
483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|G|0|MEV|0|0|0|100|DKK|1198|3147|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1198||1198|3147||1|0|G|0|||0
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|0|G|0|ATE|0|0|1|100|XEU|301|1867|lyfalmen|V0055|1867|2|20|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||268||268|1867||1|0|G|1|30|dagar|0
484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|364293|459590|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||364293||364293|459590||1|0|E|0|||0
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|1|0|1|AEB|0|0|0|100|DKK|130592|168931|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||130592||130592|168931||1|0|S|0|||0
484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|10728|16264|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||10728||10728|16264||2|0|G|0|||0
484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|48901|65124|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||48901||48901|65124||1|0|G|0|||0
484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|9102|14026|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||9102||9102|14026||1|0|G|0|||0
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|G|0|ANS|0|0|1|100|XEU|1462|3510|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1462||1462|3510||2|0|G|0|||0
485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|G|0|ATN|0|0|0|100|DKK|8995|13879|lyfalmen|||1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8995||8995|13879||2|0|G|0|||0
485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|407445|513259|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||407445||407445|513259||1|0|L|0|||0
485462|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|30|mg|30|stk|1|þpakki|20+10 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|6528|9269|lyfalmen|V1006|9269|2|30|0|8,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5646||5646|9269||2|0|E|1|30|dagar|0
485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|15083|22258|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||15083||15083|22258||1|0|G|0|||0
485553|L04AX0402|Lenalidomid Alvogen|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|1|ALO|0|1|0|100|XEU|675828|847052|lyfsjukr|||2|21|0|21,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||675828||675828|847052||2|0|L|0|||0
485592|QL04AD0101|Sporimune vet.|mixtúra|50|mg/ml|25|ml|1|glas||QL04AD01|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|6894|13250|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ciclosporin||6894||6894|13250||2|0||0|||0
485593|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|21|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|4800|4939|lyfalmen|V0116|4939|2|21|0|21,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||2500||2500|4939||2|0||0|||0
485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|1|0|1|VIC|0|0|0|100|DKK|75750|99082|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravír||75750||75750|99082||1|0|S|0|||0
485799|A10BK0401|Steglatro|filmhtfl|5|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|6144|9955|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Ertugliflozin||6144||6144|9955||1|0|G|0|||0
485911|L04AX0402|Lenalidomid Alvogen|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|1|ALO|0|1|0|100|XEU|736295|922256|lyfsjukr|||2|21|0|10,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||736295||736295|922256||2|0|L|0|||0
486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|15|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0||0|||0
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|G|0|HES|0|0|1|100|DKK|365|2000|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||365||365|2000||1|0|G|0|||0
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|G|0|HES|0|0|1|100|DKK|573|2287|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||573||573|2287||1|0|G|0|||0
487105|L01XE2801|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01XE28|01.05.2017||R|1|0|1|0|1|NEL|0|1|0|100|DKK|865063|1082407|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||865063||865063|1082407||1|0|L|0|||0
487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|1922|4143|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||1922||1922|4143||1|0|G|0|||0
487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|1|0|1|PEU|0|1|0|100|DKK|26522|36819|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||26522||26522|36819||1|0|L|0|||0
487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|IKR|2489|4924|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||2489||2489|4924||2|0|G|0|||0
487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9484|18164|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||9484||9484|18164||1|0||0|||0
488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|1|0|1|NEL|0|1|0|100|DKK|239498|304380|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||239498||239498|304380||1|0|L|0|||0
488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|2924|5523|lyfalmen|||1|50|0|14,2857|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||2924||2924|5523||1|0|G|0|||0
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|8112|12663|lyfalmen|||1|50|0|35,7143|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||8112||8112|12663||1|0|G|0|||0
488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
489128|A10BD2301|Segluromet|filmhtfl|1007,5|mg|196|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|22134|31269|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||22134||22134|31269||1|0|G|0|||0
489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|6599|10581|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6599||6599|10581||3|0|G|0|||0
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|85569|111501|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||85569|111501||1|0|S|0|||0
489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0
489349|N03AX0901|Lamictal|dreifit.|5|mg|60|stk|1|glas||N03AX09|01.10.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1687|3820|lyfalmen|||1|60|0|1,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1687||1687|3820||1|0|G|0|||0
489662|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 33 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|21503|30471|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og  lixisenatide||21503||21503|30471||1|0|E|0|||0
490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|G|0|IRO|0|0|0|100|XEU|4377|7522|lyfalmen|V0133|7522|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4377||4377|7522||1|0|G|0|||0
490525|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.2020||R|0|0|0|G|0|RDT|0|0|0|100|DKK|2530|4980|lyfalmen|||1|25|0|0,1667|Vistor hf|Recordati Ireland Limited|Metóprólól||2530||2530|4980||1|0|G|0|||0
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|PLS|0|0|0|100|DKK|11195|11488|lyfalmen|V0112|2806|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7258||7258|11488||1|0|E|0|||0
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|PLS|0|0|0|100|DKK|13666|15404|lyfalmen|V0113|2806|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10103||10103|15404||1|0|E|0|||0
490823|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|21319|27582|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||18951||18951|27582||1|0|G|0|||0
490827|J01CF0503|Flucloxacillin WH|sts/irs|1000|mg|10|hgl|1|pakki||J01CF05|01.08.2020||R|0|0|0|0|1|WEH|0|0|1|100|XEU|15927|23420|lyfsjukr|||2|10|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Flúkloxacillín||15927||15927|23420||2|0|0|0|||0
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|PLS|0|0|0|100|DKK|16047|19048|lyfalmen|V0114|2806|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12751||12751|19048||1|0|E|0|||0
491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|22061|31176|lyfalmen|V0665|31176|1|28|0|21,0000|Eisai AB|Eisai GmbH|Perampanel||22061||22061|31176||1|0|G|0|||0
491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|1|0|1|GSE|0|0|0|100|DKK|1478827|1845758|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvír og Velpatasvír||1478827||1478827|1845758||2|0|S|0|||0
491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|1|JCI|0|1|0|100|SEK|382334|482028|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||382334||382334|482028||1|0|L|0|||0
491257|A10BK0401|Steglatro|filmhtfl|5|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|21476|30436|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Ertugliflozin||21476||21476|30436||1|0|G|0|||0
491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|1|0|1|PEU|0|1|0|100|DKK|128022|165735|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||128022||128022|165735||1|0|L|0|||0
491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|0|1|AEB|0|0|0|100|DKK|47099|62844|lyfsjukr|||1|1,7|0|363,6364|Vistor hf|Amgen Europe B.V.|Denosúmab||47099||47099|62844||1|H|S|0|||0
491660|N05CD0806|Buccolam|munnh.l|7,5|mg|1,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|SSE|0|0|1|100|DKK|13798|20489|lyfalmen|||2|6|0|2,0000|Shire Services BVBA|Shire Services BVBA|Mídazólam||13798||13798|20489||1|0|E|2|450|mg|0
491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|ASD|0|0|0|100|SEK|2416|3710|lyfalmen|V0693|3453|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||1607||1607|3710||2|0|E|0|||0
491758|H01CB0203|Octreoanne|sts|10|mg|10|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|1|TVI|0|0|0|100|NOK|108703|118115|lyfsjukr|||2|10|0|14,2900|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||90798||90798|118115||1|0|S|0|||0
492114|J07BB0205|Influvac|stl|||0,5|ml|1|áfspr|með nál|J07BB02|01.08.2017||R|0|0|0|0|0|MDK|0|0|0|100|DKK|901|2738|lyfalmen|||1|0,5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir  mótefnavakar||901||901|2738||2|0||0|||0
492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|1|0|1|PEU|0|1|0|100|DKK|569447|714744|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||569447||569447|714744||1|0|L|0|||0
492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2860|5434|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2860||2860|5434||2|0|G|0|||0
492507|S01BA0201|Softacort|augndr|3,35|mg/ml|0,4|ml|30|sk-ílá|lausn í staksk.íláti|S01BA02|01.05.2018||R|0|0|0|G|0|TEA|0|0|1|100|SEK|1647|3765|lyfalmen|||1|12|0||Vistor hf|Laboratories THEA|Hydrocortisone||1647||1647|3765||1|0|G|0|||0
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1|0||0|||0
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|AZD|0|0|1|100|SEK|6895|10988|lyfalmen|V0002|6816|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||6895||6895|10988||1|0|E|0|||0
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1|0||0|||0
492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|18040|26328|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||18040||18040|26328||1|0||0|||0
492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2|0||0|||0
493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
493143|QN02AE0102|Bupredine vet|stl|0,3|mg/ml|10|ml|1|hgl||QN02AE01|01.06.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3725|7238|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Buprenorphinhýdróklóríð||||3725|7238||2|0||1|30|dagar|0
493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7148|4018|lyfalmen|V0813|3839|2|28|0|6,3000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1831||1831|4018||1|0|E|0|||0
493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|24724|34545|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24724||24724|34545||1|0|G|0|||0
493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|116519|151428|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||116519||116519|151428||1|0|G|0|||0
493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|1|JCI|0|1|0|100|SEK|72386|94827|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||72386||72386|94827||1|H|L|0|||0
493782|L04AD0204|Dailiport|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|31008|42493|lyfalmen|||2|50|0|30,0000|Artasan ehf|Sandoz A/S|Tacrolimus||31008||31008|42493||1|0|G|0|||0
493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3273|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0
493896|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0113|2750|2|98|0|98,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1206|3158|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1206||1206|3158||1|0|G|0|||0
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|G|0|HES|0|0|0|100|DKK|3562|6401|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||3562||3562|6401||1|0|G|0|||0
494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|1|RRG|0|1|0|100|DKK|81232|106016|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||81232||81232|106016||2|H|L|0|||0
494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|1|RRG|0|1|0|100|DKK|203200|259235|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||203200||203200|259235||2|H|L|0|||0
494474|J02AC0106|Fungyn|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.10.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|1250|2007|lyfalmen|V0551|2007|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||370||370|2007||2|0|E|0|||0
494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|MBP|0|0|0|100|IKR|7287|7162|lyfalmen|V0145|4210|2|8|0|16,0000|BGP Products ApS|Mylan S.A.S|Tadalafíl||4115||4115|7162||2|0|E|0|||0
494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2140|4443|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2140||2140|4443||1|0||0|||0
494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0||0|||0
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2335|4712|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2335||2335|4712||1|0|G|0|||0
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3394|6169|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3394||3394|6169||1|0|G|0|||0
494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|OCO|0|0|0|100|IKR|3363|6551|vetalmen|||0|100|0||Icepharma hf|Orion Corporation (I)|Magnesíum súlfat||3363||3363|6551||2|0||0|||0
494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006|30.11.2020|R|1|0|0|G|0|BII|0|0|0|100|DKK|3513|6333|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||3513||3513|6333||1|0|G|0|||0
494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|1|CFS|0|0|0|100|XEU|950239|1188342|lyfsjukr|||1|250|0|9,3700|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||950239||950239|1188342||3|0|ES|0|||0
495203|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|1|FEC|0|0|0|100|XEU|449110|565078|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||449110||449110|565078||2|H|S|0|||0
495256|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|3000|3838|lyfalmen|V0010|3838|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|G|0|NAA|0|0|1|100|DKK|22718|8464|lyfalmen|V0384|5830|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||5061||5061|8464||1|0|G|0|||0
495637|J02AC0304|Voriconazole Accord|filmhtfl|200|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|0|1|ACC|0|0|1|100|XEU|77897|101798|lyfsjukr|||2|30|0|15,0000|Artasan ehf|Accord Healthcare Limited|Voricónazól||77897||77897|101798||1|0|ES|0|||0
495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|5652|9277|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||5652||5652|9277||1|0||0|||0
496076|N06BA0408|Methylphenidate Teva|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|10132|10187|lyfalmen|V0997|10169|2|30|0|60,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||6313||6313|10187||1|0|E|1|30|dagar|0
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4732|9148|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4732||4732|9148||2|0||0|||0
496614|B03BB0108|Folsyra Evolan|töflur|5|mg|105|stk|1|þpakki||B03BB01|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|2100|4388|lyfalmen|||2|105|0|1312,5000|LYFIS ehf|Evolan Pharma AB|Fólínsýra||2100||2100|4388||2|0|G|0|||0
496912|N02AA0507|OxyContin Depot|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|965|2826|lyfalmen|V0596|2360|1|28|0|1,8600|Icepharma hf|Mundipharma A/S|Oxýcódon||965||965|2826||2|0|G|1|30|dagar|0
496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klemastín|||||5732||1|0||0|||0
496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|485|2165|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||485||485|2165||1|0|G|1|30|dagar|0
496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|875|2702|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||875||875|2702||1|0|G|1|30|dagar|0
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|1|APE|0|0|1|100|XEU|233876|297387|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||233876||233876|297387||1|0|S|0|||0
497083|H02AB0912|Alkindi|kyrnhylk|1|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|15909|23395|lyfalmen|||1|50|0|1,6667|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||15909||15909|23395||2|0|G|0|||0
497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|3337|6091|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3337||3337|6091||1|0|G|1|30|dagar|0
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990|30.09.2020|R|1|0|0|G|0|GPA|0|0|0|100|XEU|617|2347|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||617||617|2347||1|0|G||||
497730|H03BB0212|Thiamazole Uni-Pharma|töflur|5|mg|100|stk|1|þpakki||H03BB02|01.12.2018||R|0|0|0|G|0|UNI|0|0|0|100|XEU|4392|7543|lyfalmen|||2|100|0|50,0000|Artasan ehf|Uni-Pharma Kleon Tsetis|thiamazole||4392||4392|7543||1|0|G|0|||0
497905|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|glas|23,75 mg metoprololsuccinat|C07AB02|01.01.2020||R|1|0|0|G|0|SSA|0|0|0|100|DKK|921|2766|lyfalmen|V0050|2530|2|100|0|16,6667|Artasan ehf|Hexal A/S|Metóprólól||921||921|2766||1|0|G|0|||0
497995|S01EC0304|Dorzolamide Alvogen|augndr|20|mg/ml|5|ml|1|ílát||S01EC03|01.01.2019||R|0|0|0|G|0|POF|0|0|0|100|XEU|2025|4285|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||2025||2025|4285||2|0|G|0|||0
498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2300|4664|lyfalmen|V0472|4664|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4664||2|0|G|0|||0
498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6846|3060|lyfalmen|V0683|3060|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1135||1135|3060||2|0|G|0|||0
498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|SAS|0|0|0|100|NOK|67328|108533|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||67328||67328|108533||1|0||0|||0
498656|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2019||R|1|0|0|G|0|BFP|0|0|0|100|XEU|7461|5492|lyfalmen|V0234|5492|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2902||2902|5492||1|0|G|0|||0
498877|N06BA0905|Atomoxetin STADA|hylki|10|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4000|4113|lyfalmen|V0812|4113|2|30|0|3,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1900||1900|4113||2|0|E|0|||0
498978|G03AC0904|Desirett|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.03.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|1596|3095|lyfalm11|V0590|3095|2|84|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Desógestrel||1424||1424|3095||2|0||0|||0
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|PLS|0|0|0|100|DKK|25678|35751|lyfalmen|V0718|25449|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||25678||25678|35751||1|0|G|0|||0
499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|22061|31176|lyfalmen|V0664|31176|1|28|0|14,0000|Eisai AB|Eisai GmbH|Perampanel||22061||22061|31176||1|0|G|0|||0
499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9452|14508|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||9452|14508||2|0|G|0|||0
499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|6485|10424|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||6485||6485|10424||2|0|G|0|||0
499865|J01FA0905|Clarithromycin Alvogen|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.10.2020||R|1|0|0|0|0|POF|0|0|1|100|IKR|2475|3425|lyfalmen|V0116|3293|2|14|0|14,0000|Alvogen|Alvogen|Klaritrómýcín||1400||1400|3425||2|0|E|0|||0
499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|10634|16135|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||10634||10634|16135||1|0||0|||0
500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|900|2530|lyfalmen|V0050|2530|2|100|0|16,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||750||750|2530||2|0|G|0|||0
500476|L01XE3901|Rydapt|hylki|25|mg|112|stk|1|þpakki|4 x 28|L01XE39|01.04.2018||R|0|0|1|0|1|NEL|0|1|0|100|DKK|2129129|2654552|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||2129129||2129129|2654552||1|0|L|0|||0
500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|1|0|1|GSE|0|0|0|100|DKK|66846|87820|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||66846||66846|87820||2|0|S|0|||0
501204|R03DX0801|Cinqaero|irþ|10|mg/ml|2,5|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|1|TVB|0|1|0|100|NOK|17484|25563|lyfsjukr|||1|2,5|0|3,5211|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||17484||17484|25563||1|H|L|0|||0
501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|6119|9920|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||6119||6119|9920||1|0|G|0|||0
501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2015||R|1|1|0|0|0|HES|0|0|0|100|DKK|15076|15680|lyfalmen|V0997|10169|1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||10304||10304|15680||1|0|E|1|30|dagar|0
501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|29183|40184|lyfalmen|V0974|36264|1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||29183||29183|40184||2|0|G|0|||0
501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
501950|R03DC0306|Montelukast ratiopharm|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.11.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|10750|16294|lyfalmen|V0490|16294|2|98|0|98,0000|Alvogen|Teva Sweden AB|Montelúkast||10750||10750|16294||2|0|G|0|||0
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2508|4950|lyfalmen|V0434|4950|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2508||2508|4950||2|0|G|0|||0
502157|L01XC2801|Imfinzi|irþ|50|mg/ml|2,4|ml|1|hgl|120 mg/2,4 ml|L01XC28|01.06.2019||R|0|0|0|0|1|AZE|0|1|0|100|SEK|114497|148913|lyfsjukr|||1|2,4|0||Vistor hf|AstraZeneca AB|Durvalumab||||114497|148913||1|H|L|0|||0
502341|QP52AF0203|Nematel Vet.|pasta|439|mg/g|30,33|g|1|spr||QP52AF02|01.12.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|1414|2437|vetorma|||0|30,33|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Pyrantelum||||1414|2437||2|0||0|||0
502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3838|4058|lyfalmen|V0143|3594|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1860||1860|4058||2|0|E|0|||0
502423|H05BX0106|Cinacalcet ratiopharm|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.04.2019||R|1|0|0|0|0|RTH|0|0|0|100|XEU|63950|20046|lyfalmen|||2|28|0|42,0000|Alvogen|ratiopharm GmbH|Cinacalcet||13476||13476|20046|31.10.2020|2|0|0|0|||0
502486|S01LA0501|Eylea|stl|40|mg/ml|1|áf.spr|1|pakki||S01LA05|01.08.2020||R|0|1|0|0|1|FIN|0|1|0|100|DKK|125518|162620|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||125518||125518|162620||2|H|L|0|||0
502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|1774|3940|lyfalmen|V0926|3940|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||1774||1774|3940||2|0|G|0|||0
502761|QP51AA0101|Metrobactin vet|töflur|250|mg|100|stk|1|þpakki||QP51AA01|01.04.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3335|5748|vetorma|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metronidazolum||3335||3335|5748||2|0||0|||0
502790|A10BD2401|Steglujan|filmhtfl|105|mg|28|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|11059|16487|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||10890||10890|16487||1|0|G|0|||0
502843|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfpen|m. áfastri nál og nálarhlíf|L04AC16|01.03.2019||R|0|0|1|0|1|JCI|0|1|0|100|SEK|366417|462231|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||366417||366417|462231||1|0|L|0|||0
502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|6076|9861|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||6076||6076|9861||1|0|G|0|||0
503078|N02BE0115|Paracet|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.04.2019||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0|0|0|||0
503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|G|0|EIG|0|0|0|100|SEK|22061|31176|lyfalmen|V0665|31176|1|28|0|21,0000|Vistor hf|Eisai GmbH|Perampanel||22061||22061|31176||1|0|G|0|||0
503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|G|0|ZEN|0|0|0|100|SEK|5206|8663|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||5206||5206|8663||1|0|G|0|||0
504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|1|SPP|0|0|0|100|XEU|4443|7613|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|albumin||4443||4443|7613||2|H|S|0|||0
504026|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.10.2019||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1582|2994|lyfalmen|V0494|2844|2|90|0|180,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||1087||1087|2994||1|0|G|0|||0
504120|R03AL0302|Anoro Ellipta|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|6753|10793|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og umeclidinium bromide||6753||6753|10793||1|0|G|0|||0
504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|1|0|1|UPJ|0|0|0|100|DKK|39230|52892|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Upjohn EESV|Síldenafíl||39230||39230|52892||1|0|ES|0|||0
504231|N02AB0310|Fentanyl Alvogen|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|2144|4449|lyfalmen|V0219|4372|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||2144||2144|4449||2|0|G|1|30|dagar|0
504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|591|2311|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||591||591|2311||1|0|G|0|||0
504763|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.09.2020||R|0|1|0|0|1|GRP|0|0|0|100|XEU|11819|5933|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||3222||3222|5933||1|H|0|0|||0
504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|14475|27632|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||14475||14475|27632||1|0||0|||0
505003|S01ED5122|Fixopost|augndr|||0,2|ml|30|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|2666|5167|lyfalmen|||2|6|0|30,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||2666||2666|5167||1|0|G|0|||0
505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|2874|lyfalmen|V0335|2601|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2874||2|0|G|0|||0
505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
505803|N06BA0703|Aspendos|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|5200|8655|lyfalmen|V0657|8655|2|30|0|10,0000|LYFIS ehf|Medochemie Limited|Modafinil||5200||5200|8655||2|0|E|2|||0
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|1|PLS|0|0|0|100|DKK|3291|6028|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3291||3291|6028||1|H|S|0|||0
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|1|PLS|0|0|0|100|DKK|8228|12823|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8228||8228|12823||1|H|S|0|||0
506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|G|0|EIG|0|0|0|100|SEK|22061|31176|lyfalmen|V0664|31176|1|28|0|14,0000|Vistor hf|Eisai GmbH|Perampanel||22061||22061|31176||1|0|G|0|||0
506553|C01CA1703|Hypotron|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|7114|11290|lyfalmen|V0968|10556|2|50|0|4,1666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||7114||7114|11290||2|0|G|0|||0
506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5601|7554|lyfalmen|V0831|7554|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4400||4400|7554||2|0|G|0|||0
506938|N02AA0507|OxyContin Depot|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|15420|22722|lyfalmen|V0587|14165|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxýcódon||15420||15420|22722||2|0|G|1|30|dagar|0
507822|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4018|lyfalmen|V0812|3839|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1831||1831|4018||2|0|E|0|||0
507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|4233|7324|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||4233||4233|7324||2|0|G|0|||0
507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|2017|4274|lyfalmen|V0092|4274|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||2017||2017|4274||1|0|G|0|||0
507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|G|0|AML|0|0|1|100|SEK|927|2774|lyfalmen|||1|5|0||Amdipharm Limited|Amdipharm Limited|Fúsidínsýra||927||927|2774||2|0|G|0|||0
508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3276|3838|lyfalmen|V0687|2766|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0
508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|767|2303|lyfalmen|V0555|2113|2|2|0|1,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||585||585|2303||1|0|E|0|||0
508634|J07BM0301|Gardasil 9|stl|||0,5|ml|1|áf.spr|dreifa + 2 nálar|J07BM03|01.04.2018||R|0|0|0|0|0|MVA|0|0|0|100|DKK|21187|30071|lyfalmen|||1|0,5|0||Vistor hf|MSD VACCINS|Papillomavírus (mannagerð 6, 11, 16, 18, 31, 33, 45, 52, 58)||21187||21187|30071||1|0||0|||0
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5282|10192|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5282|10192||2|0||0|||0
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4759|9199|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4759||4759|9199||2|0||0|||0
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|14099|26919|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||14099||14099|26919||2|0||0|||0
508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|0|1|SGB|0|1|0|100|XEU|670297|840173|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||670297||670297|840173||1|H|L|0|||0
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|G|0|LBK|0|0|0|100|DKK|9253|14234|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9253||9253|14234||1|0|G|0|||0
509050|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.06.2020||R|0|1|1|G|0|ATE|0|0|0|100|XEU|7114|5984|lyfalmen|V0187|5984|2|50|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mýcófenólsýra||3259||3259|5984||1|0|G|0|||0
509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||5425||5425|10463||2|0||0|||0
509259|J07BB0209|VaxigripTetra|stl|15|mcg|0,5|ml|1|áfspr|dreifa í áf. sprautu|J07BB02|01.06.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|1502|3565|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Inflúensa, hreinsaðir  mótefnavakar||1502||1502|3565||2|0||0|||0
509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2|0||0|||0
509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|BAB|0|0|0|100|DKK|2274|4143|lyfalm11|V0134|3491|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||2274||2274|4143||2|0||0|||0
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|1|0|1|VIC|0|0|0|100|DKK|46745|62397|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín og lamívúdín||46745||46745|62397||1|0|S|0|||0
509776|A02BC0513|Esomeprazole Jubilant|sþ-tfl|40|mg|56|stk|1|þpakki||A02BC05|01.09.2019||R|1|0|0|0|0|JUB|0|0|1|100|IKR|3164|4113|lyfalmen|V0012|3228|2|56|0|74,6700|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól||1900||1900|4113||2|0|E|0|||0
509806|L01XC2401|Darzalex|stl|1800|mg|15|ml|1|hgl|120mg/ml|L01XC24|01.10.2020||R|0|1|0|0|1|JCI|0|1|0|100|SEK|867080|1084916|lyfsjukr|||1|15|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||867080||867080|1084916||1|H|L|0|||0
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002|30.11.2020|R|0|0|1|0|1|RRG|0|0|0|100|DKK|24257|33954|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche Registration GmbH|Epóetín||24257||24257|33954||2|0|S|0|||0
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|1|0|1|RRG|0|0|0|100|DKK|65276|85835|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche Registration GmbH|Epóetín||65276||65276|85835||2|0|S|0|||0
510462|J01DH0205|Meropenem WH|sts/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|1|WEH|0|0|1|100|XEU|25784|26515|lyfsjukr|||2|10|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Meropenem||18176||18176|26515||2|0|S|0|||0
510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|TPA|0|0|0|100|DKK|497|2182|lyfalmen|V0601|2182|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||497||497|2182||1|0|G|0|||0
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|155387|199769|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||155387|199769||1|0|S|0|||0
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4306|3985|lyfalmen|V0445|2984|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fínasteríð||1807||1807|3985||1|0|G|0|||0
510983|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|4149|4939|lyfalmen|V0687|4939|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||2500||2500|4939||2|0|E|0|||0
511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|þpakki|30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|ATE|0|0|1|100|XEU|841|2655|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||841||841|2655||1|0|E|3|||0
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2783|5328|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2783||2783|5328||1|0|G|0|||0
511418|A10BD2301|Segluromet|filmhtfl|1002,5|mg|196|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|22134|31269|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||22134||22134|31269||1|0|G|0|||0
511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|0|1|WIL|0|0|0|100|XEU|2732|5258|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2732|5258||2|H|S|0|||0
511560|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|áfpen|+ 6 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|45895|61322|lyfalmen|||1|1,08|0|3,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||45895||45895|61322||1|0|G|0|||0
511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
511900|B02BC3002|TISSEEL|vefjalím|||2|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|1|BAM|0|0|0|100|SEK|17859|26079|lyfsjukr|||1|2|0||Icepharma hf|Baxter Medical AB|Blöndur||17859||17859|26079||2|H|S|0|||0
511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|BAB|0|0|0|100|DKK|16782|22018|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||16782||16782|22018||2|0|E|0|||0
512465|J05AR0304|Emtricitabine/Tenofovir disoproxil Mylan|filmhtfl|445|mg|30|stk|1|þpakki|200+245 mg|J05AR03|01.06.2020||R|1|1|1|0|1|ASD|0|1|0|100|DKK|55000|72838|lyfsjukr|||2|30|0|30,0000|Icepharma hf|Mylan S.A.S.|Tenófóvír dísóproxíl og emtrícítabín||55000||55000|72838||2|0|L|0|||0
512477|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.01.2020||R|1|0|0|G|0|SHS|0|0|1|100|DKK|2893|2376|lyfalmen|V0006|2186|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||638||638|2376||1|0|G|0|||0
512532|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|1|FKA|0|0|0|100|DKK|6928|11034|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||6928||6928|11034||1|0|S|0|||0
512821|H02AB0912|Alkindi|kyrnhylk|0,5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|7954|12446|lyfalmen|||1|50|0|0,8333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||7954||7954|12446||2|0|G|0|||0
512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1971|3563|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1500||1500|3563||2|0|G|0|||0
513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1104|2445|lyfalmen|V0109|2424|2|100|0|66,6700|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||688||688|2445||1|0|G|0|||0
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2|0||0|||0
513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|3901|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||1985||1985|3901||2|0|0|0|||0
513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|2782|5449|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2782||2782|5449||2|0||0|||0
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|2189|3966|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||2018||2018|3966||2|0|0|0|||0
513993|N02BG0901|Penthrox|innö.guf|99,9|%|3|ml|1|glas||N02BG09|01.10.2019||R|0|0|0|0|1|MUP|0|0|0|100|DKK|5310|8807|lyfsjukr|||1|3|0||Icepharma hf|Mundipharma A/S|Methoxyflurane||5310||5310|8807||2|H|0|0|||0
514029|C03DA0407|Eplerenon Krka|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9764|6315|lyfalmen|V0111|6315|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||3500||3500|6315||2|0||0|||0
514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2000|4251|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4251||2|0|G|0|||0
514105|N05AH0415|Quetiapin Krka|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6000|7554|lyfalmen|V0910|7540|2|100|0|37,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||4400||4400|7554||2|0|G|0|||0
514280|J07BB0207|Influvac Tetra|stl|||0,5|ml|10|áf.spr|með nál|J07BB02|01.10.2019||R|0|0|0|0|0|MDK|0|0|0|100|DKK|16757|24562|lyfalmen|||1|5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir  mótefnavakar||16757||16757|24562||2|0||0|||0
514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|DAN|0|0|0|100|XEU|18877|27480|lyfalmen|V0818|12789|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||18877|27480||2|0|E|0|||0
514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|2131|2530|lyfalmen|V0692|2507|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2530||2|0|G|0|||0
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|0|PLS|0|0|0|100|DKK|4355|5551|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2945||2945|5551||1|0|G|0|||0
515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||2|0||0|||0
515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|13280|19777|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||13280||13280|19777||3|0|G|0|||0
515699|C08CA0106|Amlodipin Medical Valley|töflur|5|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|1660|2584|lyfalmen|V0056|2584|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||789||789|2584||2|0|G|0|||0
516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|1|LLS|0|1|0|100|DKK|129826|167978|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||129826|167978||2|0|L|0|||0
516694|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.08.2019||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1800|3136|lyfalmen|V0069|2884|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1190||1190|3136||2|0|G|0|||0
516803|L01XE0105|Imatinib ratiopharm|filmhtfl|100|mg|120|stk|1|þpakki||L01XE01|01.01.2019||R|1|0|1|0|1|RTH|0|1|0|100|XEU|108055|71918|lyfsjukr|||2|120|0||Alvogen|ratiopharm GmbH|Imatiníb||54273||54273|71918||2|0|L|0|||0
516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|7383|11660|lyfalmen|V0384|11660|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||7383||7383|11660||1|0|G|0|||0
517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|9000|5077|lyfalmen|V0273|5008|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||2600||2600|5077||2|0|G|0|||0
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3146|5828|lyfalmen|V0462|3661|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3146||3146|5828||1|0|G|0|||0
517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|32531|44419|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai GmbH|Rúfínamíð||32531||32531|44419||1|0|G|0|||0
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3346|6103|lyfalmen|V0471|3723|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3346||3346|6103||1|0|G|0|||0
517803|H02AB0208|Dexavit|stl|4|mg/ml|1|ml|3|lykjur||H02AB02|01.03.2019||R|0|0|0|0|0|VIT|0|0|1|100|DKK|3831|6771|lyfalmen|||2|3|0|8,0000|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||3831||3831|6771||1|0|0|0|||0
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3601|6454|lyfalmen|V0472|3498|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3601||3601|6454||1|0|G|0|||0
517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|31123|42638|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||31123||31123|42638||2|H|S|0|||0
517914|QI09AL0801|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL08|01.01.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|10636|18332|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||10636||10636|18332||2|0||0|||0
518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|12509|lyfalmen|V0711|12509|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||8000||8000|12509||2|0|G|0|||0
518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|1155|3088|lyfalmen|||1|20|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||1155||1155|3088||1|0|G|0|||0
518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|4762|8052|lyfalmen|||1|100|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||4762||4762|8052|31.10.2020|1|0|G|0|||0
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|MBV|0|0|0|100|DKK|2155|3996|lyfalm11|V0590|3095|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||2155||2155|3996||1|0||0|||0
518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1309|3300|lyfalmen|V0004|2839|2|28|0|18,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||1309||1309|3300||1|0|E|0|||0
518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|16900|24759|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||16900||16900|24759||1|0|G|0|||0
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|1038|2927|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||1038||1038|2927||2|0|E|0|||0
519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|2728|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8739||2|0|G|0|||0
519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|792|2113|lyfalmen|V0564|2113|2|100|0|50,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||447||447|2113||2|0|G|0|||0
519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|Sulfadiazinum og trimethoprimum||||2463|4841||2|0||0|||0
519172|L01XE0303|Erlotinib WH|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.06.2020||R|0|1|1|0|1|WEH|0|1|0|100|XEU|280981|310979|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlótiníb||244804||244804|310979||2|0|L|0|||0
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|AEP|0|0|1|100|DKK|1130|3053|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1130||1130|3053||2|0|E|0|||0
519722|N07BC0102|Buvidal|stl|64|mg|0,18|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|1|CMS|0|1|0|100|DKK|62206|81952|lyfsjukr|||1|0,18|0|8,0000|Vistor hf|Camurus AB|Búprenorfín||62206||62206|81952||1|H|L|1|30|dagar|0
519755|L01XE3901|Rydapt|hylki|25|mg|56|stk|1|þpakki|2x28|L01XE39|01.03.2020||R|0|0|1|0|1|NEL|0|1|0|100|DKK|1029320|1286697|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||1029320||1029320|1286697||1|0|L|0|||0
520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|3250|5971|lyfalmen|V0515|5198|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3250||3250|5971||1|0|G|0|||0
520082|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|112|stk|1|þpakki||C09CA01|01.07.2020||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1629|3740|lyfalmen|V0213|3740|2|112|0|28,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1629||1629|3740||2|0|G|0|||0
520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|24779|34614|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||24779||24779|34614||1|0|G|0|||0
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|18519|26987|lyfalmen|V0143|3594|1|12|0|12,0000|Icepharma hf|Upjohn EESV|Síldenafíl||18519||18519|26987||1|0|E|0|||0
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|6026|9792|lyfalmen|V0144|1386|1|4|0|8,0000|Icepharma hf|Upjohn EESV|Síldenafíl||6026||6026|9792||1|0|E|0|||0
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|16673|24447|lyfalmen|V0144|4157|1|12|0|24,0000|Icepharma hf|Upjohn EESV|Síldenafíl||16673||16673|24447||1|0|E|0|||0
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1516|2793|lyfalmen|V0056|2307|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||941||941|2793||1|0|G|0|||0
520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|0|1|IND|0|0|0|100|DKK|12629|18880|lyfsjukr|||1|28|0|28,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||12629||12629|18880||1|0|ES|1|30|dagar|0
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2451|2793|lyfalmen|V0057|2307|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||941||941|2793||1|0|G|0|||0
520633|N06AB0607|Sertralin Krka|filmhtfl|100|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|9292|8380|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Sertralín||5000||5000|8380||2|0|G|0|||0
520659|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|12602|9730|lyfalmen|V0440|9648|2|90|0|90,0000|Icepharma hf|Mylan AB|Sólífenacín||5981||5981|9730||2|0|G|0|||0
520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|691|2449|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||691||691|2449||2|0|G|0|||0
520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
521273|B01AA0303|Warfarin Teva|töflur|3|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1724|3871|lyfalmen|||2|100|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1724||1724|3871||1|0|G|0|||0
521428|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
522158|L01XC0302|Kanjinti|st/irþ|420|mg|1|hgl|1|pakki||L01XC03|01.07.2020||R|0|0|0|0|1|AEB|0|1|0|100|DKK|218117|277788|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||218117||218117|277788||1|H|L|0|||0
522175|N02BE0124|Paracaff|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE01|01.04.2019||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,7666|Acare ehf|Acare ehf|Paracetamól|||||||2|0|0|0|||0
522290|C01BD0702|Dronedarone STADA|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2020||R|1|1|1|0|0|ASR|0|0|0|100|IKR|12900|19253|lyfalmen|||2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Dronedarón||12900||12900|19253|30.11.2020|2|0|E|0|||0
522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|1|0|1|BNB|0|0|0|100|XEU|93242|121206|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||93242||93242|121206||2|0|S|0|||0
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|0|1|NEL|0|0|0|100|DKK|158351|203456|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||158351||158351|203456||1|H|S|0|||0
522985|D01AE1603|Amorolfin Apofri|lakk|5|%|3|ml|1|glas||D01AE16|01.05.2018||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||2|3|0||LYFIS ehf|Apofri AB|Amorolfín|||||||2|0||0|||0
523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5205|3682|lyfalmen|V0285|3287|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||1587||1587|3682||1|0|G|0|||0
523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1916||1|0|G|0|||0
523346|L01XC0304|Ontruzant|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.05.2020||R|0|0|0|0|1|SUN|0|1|0|100|DKK|87901|114451|lyfsjukr|||1|150|0||Vistor hf|Samsung Bioepis NL B.V.|Trastuzumab||87901||87901|114451||1|H|L|0|||0
523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|1|0|1|NAS|0|0|0|100|DKK|182704|233744|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||182704||182704|233744||1|H|S|0|||0
523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1764|2698|lyfalmen|V0144|1386|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||872||872|2698||1|0|E|0|||0
523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|1|0|1|NEL|0|1|0|100|DKK|373637|471211|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||373637||373637|471211||1|0|L|0|||0
523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2|0||0|||0
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1024|2907|lyfalmen|V0903|2625|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1024||1024|2907||1|0|G|0|||0
523937|C10AX0903|Ezetimib Krka|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10278|7004|lyfalmen|V0954|6627|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||4000||4000|7004||2|0|E|0|||0
523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1636|3750|lyfalmen|V0584|3750|2|28|0|7,4700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||1636||1636|3750||1|0|G|1|30|dagar|0
524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|G|0|TOG|0|0|0|100|SEK|367|2003|lyfalmen|||1|28|0|21,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||367||367|2003||1|0|G|0|||0
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E|0|||0
524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|3042|lyfalmen|||2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1122||1122|3042||2|0|G|0|||0
524630|N03AX1610|Pregabalin Medical Valley|hylki|300|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2900|3824|lyfalmen|||2|70|0|70,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1690||1690|3824|31.10.2020|2|0|E|0|||0
524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|GAL|0|0|0|100|XEU|7388|11667|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||7388||7388|11667||2|0|E|0|||0
525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|1383|3401|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||1383||1383|3401||2|0|G|0|||0
525122|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GLZ|0|0|0|100|DKK|4256|6458|lyfalmen|V0437|6458|2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||3604||3604|6458||2|0|G|0|||0
525418|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||500|ml|20|pokar|lausn|B05BB01|01.07.2018||R|0|0|0|0|1|BAM|0|0|1|100|SEK|4897|8238|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4897||4897|8238||2|0|S|0|||0
525689|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfpen||N02CD03|01.07.2020||R|0|0|1|0|0|TGH|0|0|0|100|XEU|82883|100887|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||77177||77177|100887||1|0|E|0|||0
525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|33302|45394|lyfalmen|V0977|45394|1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||33302|45394||2|0|G|0|||0
525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|1|RAU|0|0|0|100|XEU|6033|9802|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||6033||6033|9802||2|H|S|0|||0
525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|1|RAU|0|0|0|100|XEU|5516|9090|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||5516||5516|9090||2|H|S|0|||0
525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|1|VIN|0|0|1|100|DKK|2666|5167|lyfsjukr|||2|1000|0|2,5000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2666|5167||2|0|ES|0|||0
525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4863||2|0||0|||0
526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4925||2|0||0|||0
526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|8040|12564|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||8040||8040|12564||1|0|G|0|||0
526396|N03AX1408|Levetiracetam STADA|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|9168|14117|lyfalmen|V0516|7108|2|100|0|66,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||9168||9168|14117||2|0|G|0|||0
526496|H02AB0207|Dexamethasone Krka|töflur|4|mg|100|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|15000|13060|lyfalmen|V0423|13060|2|100|0|266,6666|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||8400||8400|13060||2|0|G|0|||0
526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|15826|6975|lyfalmen|V0111|6315|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||3979||3979|6975||2|0|E|0|||0
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|4480|7664|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4480||4480|7664||1|0|G|0|||0
527132|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|18|stk|1|þpakki||N02CC04|01.06.2019||R|0|0|0|G|0|MSD|0|0|0|100|DKK|6890|10981|lyfalmen|V0621|10723|1|18|0|18,0000|Vistor hf|M.S.D.|Rizatriptan||6890||6890|10981||1|0|G|0|||0
527412|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.11.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|4195|6880|lyfalmen|V0054|4939|2|100|0|133,3333|Artasan ehf|Hexal A/S|Metóprólól||3910||3910|6880||1|0|G|0|||0
527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|11433|7108|lyfalmen|V0516|7108|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4076||4076|7108||1|0|G|0|||0
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1649|3768|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1649||1649|3768||1|0|G|0|||0
527632|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|áfpen|FlexTouch|A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5589|9191|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5589||5589|9191||1|0|G|0|||0
527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2273|3150|lyfalmen|V0825|2811|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1200||1200|3150||2|0|G|0|||0
527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|272223|345080|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||272223||272223|345080||1|0|G|0|||0
527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|RPG|0|0|0|100|XEU|1884|3703|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|Prednisolonum og sýkingalyf||1884||1884|3703||2|0||0|||0
528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1036|2505|lyfalmen|V0046|2505|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||732||732|2505||1|0|G|0|||0
528076|D11AX1002|Finasterid STADA|filmhtfl|1|mg|30|stk|1|þpakki||D11AX10|01.07.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3884|6844|lyfalmen|||2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||3884||3884|6844||2|0||0|||0
528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13632|lyfalmen|||2|100|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13632||2|0|G|0|||0
528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Skópólamín|||||3261||1|0||0|||0
528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|10095|6653|lyfalmen|V0011|4960|1|100|0|66,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||3745||3745|6653||1|0|G|0|||0
528303|N02AA0507|OxyContin Depot|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|2743|5273|lyfalmen|V0584|3750|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||2743||2743|5273||2|0|G|1|30|dagar|0
528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|668|2349|lyfalmen|V0562|2349|2|100|0|33,3300|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||618||618|2349||2|0|G|0|||0
528418|D07AC1302|Ovixan|krem|1|mg/g|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|2117|4412|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||2117||2117|4412||1|0|G|0|||0
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|6240|10087|lyfalmen|V0971|10087|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||6240||6240|10087||3|0|G|0|||0
528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|G|0|FEL|0|0|0|100|DKK|6821|10886|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6821||6821|10886||1|0|G|0|||0
528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6702|10723|lyfalmen|V0621|10723|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||6702||6702|10723||2|0|G|0|||0
528948|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|17401|25449|lyfalmen|V0718|25449|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||17401||17401|25449||1|0|G|0|||0
529142|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|100|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|5730|9108|lyfalmen|V1003|9108|2|100|0|6,6667|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5529||5529|9108||2|0|E|1|30|dagar|0
529352|N05AX1304|Paliperidon Krka|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|0|KNM|0|0|0|100|IKR|9787|14969|lyfalmen|V0963|14969|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||9787||9787|14969||2|0|E|0|||0
529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|1|PLS|0|0|0|100|DKK|67103|88145|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||67103||67103|88145||1|H|S|0|||0
529955|J05AE0803|Atazanavir Krka|hylki|300|mg|30|stk|1|glas||J05AE08|01.06.2020||R|0|0|1|0|1|KAN|0|0|0|100|IKR|39565|53315|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Atazanavír||39565||39565|53315||2|0|S|0|||0
530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||7594||1|0|E|0|||0
530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2488|3081|lyfalmen|V0824|3081|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|3081||2|0|G|0|||0
530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|1684|3310|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||1684||1684|3310||2|0||0|||0
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2949|5557|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2949||2949|5557||1|0|G|0|||0
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|1|FKA|0|0|0|100|DKK|6567|10537|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6567||6567|10537||1|0|S|0|||0
531360|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|7255|6917|lyfalmen|V0622|6677|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3937||3937|6917||1|0|E|1|30|dagar|0
531382|A10BK0401|Steglatro|filmhtfl|15|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|21499|30466|lyfalmen|||1|98|0|147,0000|Vistor hf|M.S.D.|Ertugliflozin||21499||21499|30466||1|0|G|0|||0
531501|N05CH0105|Slenyto|forðatfl|1|mg|60|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|7232|6295|lyfalmen|||2|60|0|30,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||3485||3485|6295||2|0|0|0|||0
532257|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2020||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2590|5063|lyfalmen|V0117|5063|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2590||2590|5063||2|0|E|0|||0
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|JAS|0|0|0|100|SEK|879|2708|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||879||879|2708||1|0||0|||0
532526|L04AA4201|Mayzent|filmhtfl|0,25|mg|12|stk|1|þpakki|Skammtastillingarpakkning|L04AA42|01.11.2020||R|1|1|1|0|1|NEP|0|0|0|100|DKK|26439|36714|lyfsjukr|||1|12|0||Vistor hf|Novartis Europharm Limited|Siponimod||26439||26439|36714||1|0|0|0|||0
532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|G|0|WEH|0|0|0|100|XEU|47861|12954|lyfalmen|V0711|11169|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||8323||8323|12954||2|0|G|0|||0
532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|0|1|WEH|0|1|0|100|XEU|121624|157777|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||121624||121624|157777||2|H|L|0|||0
532869|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|27473|47352|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||27473||27473|47352||2|0||0|||0
532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|2049|4318|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2049||2049|4318||2|0|S|0|||0
532984|N02AJ0601|Parkodin|filmhtfl|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1397|3421|lyfalmen|||2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1397||1397|3421||1|0|E|3|||0
533001|A10BA0205|Metformin EQL|filmhtfl|500|mg|105|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|500|2186|lyfalmen|V0500|2186|2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Metformín||500||500|2186||2|0|G|0|||0
533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|1|CSB|0|1|0|100|SEK|261391|331608|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||261391||261391|331608||2|0|L|0|||0
533363|L04AA3601|Ocrevus|irþ|300|mg|10|ml|1|hgl|lausn|L04AA36|01.04.2018||R|0|0|0|0|1|RRG|0|1|0|100|DKK|835949|1046198|lyfsjukr|||1|10|0|91,1854|Icepharma hf|Roche Registration GmbH|Ocrelizumab||||835949|1046198||2|H|L|0|||0
534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|23365|32826|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||23365||23365|32826||1|0|G|0|||0
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|1|G|0|PEU|0|0|0|100|DKK|60630|79958|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||60630||60630|79958||1|0|G|0|||0
534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|CES|0|0|0|100|XEU|3101|6054|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Amoxicillinum||3101||3101|6054||2|0||0|||0
534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|5481|5283|lyfalmen|V0117|5166|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2750||2750|5283||2|0|E|0|||0
534712|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|2533|4984|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2533||2533|4984||2|0|G|1|30|dagar|0
534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|5492|9057|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5492||5492|9057||2|H|S|0|||0
534942|R01AD5801|Dymista|nefúði|187|mcg/sk|120|skammtar|1|glas|137+50mcg|R01AD58|01.10.2019||R|0|0|0|G|0|MEA|0|0|1|100|DKK|3256|5979|lyfalmen|||1|120|0|30,0000|Icepharma hf|Meda AB|Fluticasone í samsetningum||3256||3256|5979||2|0|G|0|||0
535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|TPA|0|0|0|100|DKK|2320|4691|lyfalmen|V0092|4274|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2320||2320|4691||1|0|G|0|||0
535453|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|19 mg/4 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2591|4466|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2591||2591|4466||1|0||0|||0
535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2378|2984|lyfalmen|V0826|2870|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1080||1080|2984||2|0|G|0|||0
535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2|0||0|||0
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|387|2031|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||387||387|2031||1|0|G|0|||0
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|402|2051|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||402||402|2051||1|0|G|0|||0
536179|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|10|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|1|AEE|0|0|0|100|XEU|6446|10370|lyfsjukr|||2|100|0|33,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||6446||6446|10370||1|H|S|2|450|mg|0
536385|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0112|2750|2|98|0|49,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
536429|A02BA0208|Asýran|filmhtfl|150|mg|30|stk|1|þpakki||A02BA02|01.07.2019|30.09.2020|L|1|0|0|0|0|TEE|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín|||||||1|0|||||
536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|92137|119808|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||92137||92137|119808||1|0|E|0|||0
536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|POF|0|0|1|100|IKR|14133|10995|lyfalmen|V0419|10582|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||6900||6900|10995||2|0|E|0|||0
536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|2746|5278|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2746||2746|5278||2|H|S|0|||0
536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9914|15144|lyfalmen|V0611|15144|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||9914||9914|15144||1|0|G|0|||0
536958|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|2|stk|1|þpakki||N02CC04|01.08.2020||L|0|0|0|0|0|POF|0|0|0|100|XEU|||lyflausa|||2|2|0|2,0000|Alvogen|Alvogen|Rizatriptan|||||||2|0|0|0|||0
537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|1|0|1|GSE|0|0|0|100|DKK|66846|87820|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||66846||66846|87820||2|0|S|0|||0
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|1|FKA|0|0|1|100|DKK|5696|9338|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5696||5696|9338||1|0|S|0|||0
537580|R03DC0306|Montelukast ratiopharm|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.07.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|11670|17561|lyfalmen|V0492|17561|2|98|0|39,2000|Alvogen|Teva Sweden AB|Montelúkast||11670||11670|17561||2|0|G|0|||0
537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1500|3563|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3563||2|0|G|0|||0
537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|14000|13473|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13473||2|0|G|0|||0
537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2492||1|0|G|0|||0
537873|N05CM0901|Sefitude|húðuðtfl|445|mg|60|stk|1|þpakki||N05CM09|01.06.2018||L|1|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||1|60|0||Florealis ehf|Florealis ehf|Valerianae radix|||||||2|0||0|||0
538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7909|12384|lyfalmen|V0609|12384|2|56|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||7909||7909|12384||1|0|E|0|||0
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538272|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|1173|3112|lyfalmen|||3|12|0|0,5000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||1173||1173|3112||3|0|G|0|||0
538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3080|5737|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3080||3080|5737||2|0|G|0|||0
538713|R03BB0702|Incruse Ellipta|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|G|0|RGP|0|0|0|100|DKK|4798|8102|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Umeclidiniumbrómið||4798||4798|8102||1|0|G|0|||0
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|1|G|0|SNP|0|0|0|100|XEU|8852|13682|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||8852||8852|13682||1|0|G|0|||0
539310|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|rörlyk|Penfill|A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5298|8790|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5298||5298|8790||1|0|G|0|||0
539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|1|BMS|0|1|0|100|DKK|70398|92313|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||70398||70398|92313||1|H|L|0|||0
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|810|2613|lyfalmen|||2|25|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||810||810|2613||1|0||2|130|töflur|0
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|0|100|DKK|906|2745|lyfalmen|||2|100|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||906||906|2745||1|0||2|130|töflur|0
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1|0||0|||0
539793|L01XE4201|Kisqali|filmhtfl|200|mg|63|stk|1|þpakki||L01XE42|01.11.2018||R|0|0|1|0|1|NEL|0|1|0|100|DKK|533087|669522|lyfsjukr|||1|63|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||533087||533087|669522||1|0|L|0|||0
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1855|4051|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1855||1855|4051||1|0|G|0|||0
539990|C10AX0905|Ezetimibe ratiopharm|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.12.2018||R|1|0|0|0|0|RTH|0|0|0|100|DKK|10121|7041|lyfalmen|V0954|6494|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Ezetimíb||4027||4027|7041||2|0||0|||0
540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|1|FKA|0|0|0|100|DKK|19885|28868|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||19885||19885|28868||1|0|S|0|||0
540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|45158|14292|lyfalmen|V0721|8450|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||9295||9295|14292||2|0||0|||0
540141|N03AX1213|Gabapentin Teva|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.10.2019||R|1|0|0|G|0|TVA|0|0|0|100|DKK|14021|18952|lyfalmen|V0256|18952|2|100|0|44,4400|Alvogen|Teva B.V.|Gabapentín||12681||12681|18952||2|0|G|0|||0
540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|0|1|TEA|0|0|0|100|SEK|23454|32938|lyfsjukr|||1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||23454||23454|32938||1|H|S|0|||0
540503|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|60|pokar|lausn|B05BB01|01.03.2020||R|0|0|0|0|1|BAM|0|0|1|100|DKK|7995|12502|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7995||7995|12502||2|0|S|0|||0
540752|H01CB0203|Octreoanne|sts|30|mg|30|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|1|TVI|0|0|0|100|NOK|173656|164989|lyfsjukr|||2|30|0|42,8600|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||127422||127422|164989||1|0|S|0|||0
540854|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2075|3631|lyfalmen|V0686|3631|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1550||1550|3631||2|0|E|0|||0
540857|L01XC3201|Tecentriq|irþ|840|mg|14|ml|1|hgl|lausn|L01XC32|01.02.2020||R|0|1|0|0|1|RRG|0|1|0|100|DKK|522771|656692|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||522771||522771|656692||2|H|L|0|||0
540859|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4018|lyfalmen|V0813|3839|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1831||1831|4018||2|0|E|0|||0
540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|1|0|1|CPV|0|1|0|100|XEU|694800|870648|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe B.V.|Lenalídómíd||||694800|870648||2|0|L|0|||0
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
541493|N03AX1602|Lyrica (Lyfjaver)|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|2463|4888|lyfalmen|V0685|2190|3|56|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||2463||2463|4888||3|0|E|0|||0
541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|203723|259886|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||203723||203723|259886||1|0|L|0|||0
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|1|LEM|0|0|1|100|XEU|5595|9199|lyfsjukr|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||5595||5595|9199||2|0|ES|0|||0
542291|L01BC0603|Ecansya|filmhtfl|150|mg|60|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|1|KAN|0|0|0|100|IKR|4301|7418|lyfsjukr|||2|60|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||4301||4301|7418||2|0|S|0|||0
542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|G|0|WEH|0|0|0|100|XEU|5722|3228|lyfalmen|V0682|3060|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1257||1257|3228||2|0|G|0|||0
542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|mælipumpa|G03CA03|01.07.2019||R|0|0|0|G|0|BES|0|0|0|100|DKK|1171|3110|lyfalmen|||2|64|0||Vistor hf|Besins Healthcare Ireland Limited|Estradíól||1171||1171|3110||1|0|G|0|||0
542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|4247|7343|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||4247||4247|7343||2|0|S|0|||0
542893|H05BX0106|Cinacalcet ratiopharm|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|XEU|19014|8006|lyfalmen|V0720|8006|2|28|0|14,0000|Alvogen|ratiopharm GmbH|Cinacalcet||4728||4728|8006||2|0||0|||0
543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|18670|27195|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||18670||18670|27195||1|0|G|0|||0
543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|G|0|BFP|0|0|0|100|IKR|3122|4030|lyfalmen|V0203|4026|2|12|0|84,0000|Vistor hf|Bluefish Pharmaceuticals AB|Alendrónsýra||1840||1840|4030||1|0|G|0|||0
543374|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|G|0|POF|0|0|0|100|XEU|1668|3794|lyfalmen|||2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1668||1668|3794||2|0|G|0|||0
543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|1|BAM|0|0|0|100|SEK|96306|125081|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||96306||96306|125081||2|H|S|0|||0
543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
544374|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|1|0|1|GSE|0|0|0|100|DKK|586863|736404|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||586863||586863|736404||2|0|S|0|||0
544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|1|CSB|0|1|0|100|SEK|400707|504879|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||400707||400707|504879||2|H|L|0|||0
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|12524|18736|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12524||12524|18736||1|0|G|0|||0
544571|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|SHS|0|0|0|100|DKK|9024|11013|lyfalmen|V0145|4210|2|8|0|16,0000|Artasan ehf|Sandoz A/S|Tadalafíl||6913||6913|11013||1|0|E|0|||0
545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37583|lyfalmen|||2|100|0|120,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37583||2|0|G|0|||0
545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|0|1|RRG|0|1|0|100|DKK|286504|362842|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||286504||286504|362842||2|H|L|0|||0
545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|RTH|0|0|0|100|XEU|1745|3491|lyfalm11|V0134|3491|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1745||1745|3491||2|0||0|||0
545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
545639|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3533|3865|lyfalmen|V0438|3836|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||1720||1720|3865||2|0|G|0|||0
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|952|2808|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||952||952|2808||1|0||0|||0
545705|N02AB0310|Fentanyl Alvogen|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5929|9492|lyfalmen|V0223|8797|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||5808||5808|9492||2|0|G|1|30|dagar|0
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|904|2742|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||904||904|2742||1|0|G|0|||0
545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|1|0|G|0|ATE|0|0|1|100|XEU|1279|2625|lyfalmen|V0903|2625|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prómetazín||819||819|2625||1|0|G|0|||0
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|2078|4358|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2078||2078|4358||1|0|G|0|||0
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|73634|96406|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||73634||73634|96406||1|0|G|0|||0
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|54991|72826|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||54991||54991|72826||1|0|G|0|||0
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|64212|84489|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||64212||64212|84489||1|0|G|0|||0
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|53184|70541|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||53184||53184|70541||1|0|G|0|||0
546319|A02BA0208|Asýran|filmhtfl|150|mg|10|stk|1|þpakki||A02BA02|01.07.2019|30.09.2020|L|1|0|0|0|0|TEE|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín|||||||1|0|||||
546660|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|582|2299|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||582||582|2299||2|0|G|1|30|dagar|0
546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|4476|4354|lyfalmen|V0010|3916|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||2075||2075|4354||1|0|G|0|||0
547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|G|0|FER|0|0|0|100|DKK|16469|24166|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16469||16469|24166||1|0|G|0|||0
547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|1|RAU|0|0|1|100|XEU|3277|6008|lyfsjukr|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||3277||3277|6008||2|0|S|0|||0
547200|C09DA0312|Valsartan/Hydroklortiazid Jubilant|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|4100|6302|lyfalmen|V0581|6302|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan og þvagræsilyf||3490||3490|6302||2|0|G|0|||0
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|ORC|0|0|1|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5334||1|0||0|||0
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|0|1|RGP|0|0|0|100|DKK|9982|15237|lyfsjukr|||1|100|0|0,3800|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||9982||9982|15237||1|H|S|0|||0
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|0|1|RGP|0|0|0|100|DKK|3209|5915|lyfsjukr|||1|10|0|0,1000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||3209||3209|5915||1|H|S|0|||0
547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|1|BAM|0|0|0|100|SEK|6950|11064|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6950|11064||2|0|S|0|||0
548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|1|0|1|FIN|0|0|0|100|DKK|110264|143649|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||110264||110264|143649||2|0|S|0|||0
548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|2308|4675|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2308||2308|4675||2|0|G|0|||0
548162|M04AA0304|Aburic|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.03.2020||R|1|0|0|0|0|WEH|0|0|0|100|XEU|9539|14627|lyfalmen|V1011|14627|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|febuxostat||9539||9539|14627||2|0|E|0|||0
548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|481|2160|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||481||481|2160||1|0|G|0|||0
548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2219||1|0|G|0|||0
548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|157368|202233|lyfsjukr|||1|20|0||Icepharma hf|Baxter Medical AB|Blöndur||157368||157368|202233||2|H|S|0|||0
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|G|0|JAS|0|0|0|100|SEK|7284|11524|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||7284||7284|11524||1|0|G|0|||0
549442|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|4950|5283|lyfalmen|V0117|5166|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2750||2750|5283||2|0|E|0|||0
549476|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|V0997|10169|2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0
549545|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.2020||R|0|0|0|0|0|CES|1|0|0|100|DKK|4589|8877|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4589||4589|8877||2|0||0|||0
549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|32846|44817|lyfalmen|V0976|44486|1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||32846|44817||2|0|G|0|||0
550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|G|0|SAO|0|0|1|100|XEU|975|2840|lyfalmen|||2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||975||975|2840||2|0|G|0|||0
550147|QN01BB0201|Lidor vet.|stl|20|mg/ml|50|ml|1|hgl|lausn|QN01BB02|01.05.2019||R|0|0|0|0|0|RPG|1|0|0|100|XEU|1380|2712|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Lidocaine||1380||1380|2712||2|0||0|||0
550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1609|2165|lyfalmen|V0551|2007|2|7|0|1,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||485||485|2165||1|0|E|0|||0
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.05.2019||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2518|4964|lyfalmen|V0471|4964|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4964||2|0|G|0|||0
551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|G|0|GLW|0|0|0|100|DKK|1779|3947|lyfalmen|||1|100|0|25,0000|Vistor hf|Glenwood GmbH P. Erzeugnisse|Dípýrídamól||1779||1779|3947|31.10.2020|1|0|G|0|||0
551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1|0||0|||0
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|1|BAM|0|0|0|100|SEK|8059|12590|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||8059||8059|12590||2|H|S|0|||0
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|G|0|MEA|0|0|1|100|DKK|5213|8673|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||5213||5213|8673||2|0|G|0|||0
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1812|2276|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2691|3966|lyfalmen|V0467|2772|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1160|1527|lyfalmen|V0003|1119|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1527||1|0|E|0|||0
551904|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|1|HSS|0|1|0|100|DKK|57055|75437|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||57055||57055|75437||1|H|L|0|||0
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2821|2276|lyfalmen|V0003|2238|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|5587|3966|lyfalmen|V0010|2193|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0
552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|1728|3876|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1728||1728|3876||2|0|S|0|||0
552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
552481|R06AE0501|Postafen|töflur|25|mg|20|stk|1|þpakki||R06AE05|01.05.2018||L|1|0|0|0|0|GOP|0|0|1|100|DKK|||lyflausa|||1|20|0|10,0000|Sofus Regulatory Affairs AB|Gen. Orph|Meklózín|||||||1|0|0|0|||0
552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|GBP|16761|27019|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||16761||16761|27019||1|0||0|||0
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|3324|6073|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3324||3324|6073||1|0|G|0|||0
552913|QJ01GB0301|Genta-Equine|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01GB03|01.01.2019||R|0|0|0|0|0|FRA|1|0|0|100|IKR|3657|7109|vetalmen|||0|100|0||Dýraheilsa ehf|Franklin Pharmaceuticals Ltd.|Gentamicin||3657||3657|7109||2|0||0|||0
553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|172749|221363|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||172749||172749|221363||2|H|S|0|||0
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|G|0|PLS|0|0|0|100|DKK|6639|10636|lyfalmen|V0237|10636|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||6639|10636||1|0|G|0|||0
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2507|4949|lyfalmen|V0237|3545|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||2507||2507|4949||1|0|G|0|||0
553382|R06AD0102|Alimemazin Evolan|hylki|20|mg|100|stk|1|glas|hart|R06AD01|01.09.2018||R|1|0|0|G|0|EVO|0|0|1|100|IKR|5684|9321|lyfalmen|||2|100|0|66,6666|LYFIS ehf|Evolan Pharma AB|Alímemazín||5684||5684|9321||2|0|G|0|||0
553387|J01CR0205|Spectracillin|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.12.2018||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1430|2530|lyfalmen|V0169|2530|2|14|0|8,1667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill||750||750|2530||2|0||0|||0
553580|QN01BB0202|BelOcain vet.|stl|20|mg/ml|100|ml|12|hgl|lausn|QN01BB02|01.06.2019||R|0|0|0|0|0|Bel|1|0|0|100|IKR|15300|24075|vetalmen|||0|1200|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Lidocaine||12600||12600|24075||2|0||0|||0
553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|1|0|1|NEL|0|1|0|100|DKK|472603|594297|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||472603||472603|594297||1|0|L|0|||0
554131|L01XC0303|Trazimera|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|1|PEU|0|1|0|100|DKK|91074|118464|lyfsjukr|||1|150|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||91074||91074|118464||1|H|L|0|||0
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|BID|1|0|0|100|DKK|9966|19078|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||9966||9966|19078||1|0||0|||0
554441|N02AA0508|Oxycodone Alvogen|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|20999|26325|lyfalmen|V0588|26325|2|98|0|104,5300|Alvogen|Alvogen ehf|Oxýcódon||18038||18038|26325||2|0|G|1|30|dagar|0
554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6860|6134|lyfalmen|V0029|6134|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klópídógrel||3368||3368|6134||1|0|G|0|||0
554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|1|CPV|0|1|0|100|XEU|1338996|1671847|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1338996||1338996|1671847||2|0|L|0|||0
555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|1|0|1|NEL|0|1|0|100|DKK|178056|227963|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||178056||178056|227963||1|0|L|0|||0
555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1723|3869|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1723||1723|3869||1|0|G|0|||0
555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|2397|4797|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2397||2397|4797||1|0|G|0|||0
555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1225|3184|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1225||1225|3184||1|0|G|0|||0
556146|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|21|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|2011|3563|lyfalmen|V0461|3563|2|21|0|5,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||1500||1500|3563||2|0|E|0|||0
556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2|0||0|||0
556578|N02BE5106|Panodil Extra|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE51|01.12.2019||L|1|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||1|0|0|0|||0
556694|C10AX1401|Praluent|stl|150|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|75807|99154|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||75807||75807|99154||1|0|E|0|||0
556903|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.07.2018||R|0|0|0|0|0|VAL|0|0|0|100|DKK|12230|7006|lyfalmen|V0954|6627|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||4002||4002|7006||2|0|E|0|||0
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|1|MEC|0|1|0|100|SEK|20236|28868|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||20236||20236|28868||2|0|L|0|||0
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|5037|8431|lyfalmen|V0972|7390|1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||5037||5037|8431||1|0|G|0|||0
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|10536|16000|lyfalmen|V0973|12977|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||10536||10536|16000||1|0|G|0|||0
557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|11029|4018|lyfalmen|V0814|3839|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||1831||1831|4018||2|0|E|0|||0
557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|1479|3534|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1479||1479|3534||2|0|G|0|||0
558386|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.07.2020||L|0|0|0|0|0|MAR|0|0|1|100|DKK|||lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur|||||9480||2|0||0|||0
558417|L01XE1401|Bosulif|filmhtfl|400|mg|28|stk|1|þpakki||L01XE14|01.03.2019||R|1|0|1|0|1|PEU|0|1|0|100|DKK|535974|673113|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bósútíníb||535974||535974|673113||1|0|L|0|||0
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|1|NEL|0|1|0|100|DKK|239001|303762|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||239001|303762||1|0|L|0|||0
558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
559165|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.06.2020||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0
559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|4824|8138|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4824||4824|8138||1|0|G|0|||0
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1958||1|0|G|0|||0
560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|0|1|CBV|0|1|0|100|XEU|42830|57445|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe B.V.|Paklítaxel||42830||42830|57445||2|H|L|0|||0
560293|L01XX4601|Lynparza|filmhtfl|100|mg|56|stk|1|þpakki||L01XX46|01.03.2020||R|0|0|1|0|1|AZA|0|1|0|100|SEK|392860|495119|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||392860||392860|495119||1|0|L|0|||0
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Acíklóvír|||||||1|0||0|||0
560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|0|1|COR|0|0|0|100|DKK|114042|148348|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||114042||114042|148348||1|H|S|0|||0
560682|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|1|0|1|ACC|0|1|0|100|XEU|177309|126573|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatiníb||97485||97485|126573||1|0|L|0|||0
561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
561239|L01XE2701|IMBRUVICA|filmhtfl|420|mg|28|stk|1|þpakki||L01XE27|01.04.2020||R|1|0|1|0|1|JCI|0|1|0|100|SEK|765588|958688|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||765588||765588|958688||1|0|L|0|||0
561745|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|innöndunartæki og 1 áfylling|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|6650|10651|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6650||6650|10651||1|0|G|0|||0
561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|1|BRE|0|1|0|100|DKK|203723|259886|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||203723||203723|259886||1|0|L|0|||0
562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1717|3148|lyfalmen|V0098|2675|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1199||1199|3148||1|0|G|0|||0
562176|B02BD0401|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD04|01.02.2013||R|0|0|1|0|1|PEU|0|0|0|100|DKK|51445|68341|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||51445||51445|68341||1|0|S|0|||0
562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|4419|7580|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4419||4419|7580||1|0|G|0|||0
562419|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|1|FEC|0|0|0|100|XEU|984937|1231497|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||984937||984937|1231497||2|H|S|0|||0
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|1|RGP|0|1|0|100|DKK|87663|114150|lyfsjukr|||1|1|0|16,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||87663||87663|114150||1|H|L|0|||0
562774|H01CB0203|Octreoanne|sts|20|mg|20|mg|1|hgl|+ leysir|H01CB02|01.05.2020||R|0|0|0|0|1|TVI|0|0|0|100|NOK|136170|129594|lyfsjukr|||2|20|0|28,5700|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||99874||99874|129594||1|0|S|0|||0
563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015|31.10.2020|R|0|0|0|G|0|BOE|0|0|0|100|DKK|6547|10509|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||6547||6547|10509||1|0|G|0|||0
563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|34550|46972|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||34550||34550|46972||2|H|S|0|||0
563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1427|3462|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1427||1427|3462||1|0|G|1|30|dagar|0
563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|24675|9913|lyfalmen|V0720|8006|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||6114||6114|9913||2|0||0|||0
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3865|6818|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||||3865|6818||2|0|G|0|||0
563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1398|2748|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1398|2748||2|0||0|||0
563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|RRD|0|0|0|100|DKK|475129|597439|lyfalmen|||1|60|0|15,0000|Vistor hf|Recordati Rare Diseases|PAsireótið disapartate||475129||475129|597439||1|0|E|0|||0
563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||10463||10463|18034||2|0||0|||0
563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||2|0||0|||0
564048|J07BA0103|TicoVac|stl|2,4|mcg/sk|0,5|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3827|6765|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3827||3827|6765||1|0||0|||0
564124|N06DA0405|Galantamin STADA|forðahlk|8|mg|30|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3200|5902|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||3200||3200|5902||2|0|G|0|||0
564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|1|TMA|0|1|0|100|DKK|20809|29593|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||20809||20809|29593||3|0|L|0|||0
564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|G|0|MBV|0|0|1|100|DKK|918|2761|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme B.V.|Deslóratadín||918||918|2761||1|0|G|0|||0
564448|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1523|2704|lyfalmen|V0056|2307|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||876||876|2704||1|0|G|0|||0
564607|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|V0959|4870|2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870||2|0|E|1|30|dagar|0
564827|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|9 mg/2 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2471|4259|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2471||2471|4259||1|0||0|||0
564892|H05BX0106|Cinacalcet ratiopharm|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.04.2019||R|1|0|0|0|0|RTH|0|0|0|100|XEU|43123|8450|lyfalmen|V0721|8450|2|28|0|28,0000|Alvogen|ratiopharm GmbH|Cinacalcet||5051||5051|8450||2|0|0|0|||0
565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|1|FKA|0|0|1|100|DKK|2738|5267|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2738||2738|5267||1|0|S|0|||0
565251|A10BJ0602|Rybelsus|töflur|14|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|22998|32361|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||22998||22998|32361||1|0||0|||0
565303|C01CA0303|Noradrenalina Normon|irþ|1|mg/ml|10|ml|100|lykjur|lausn|C01CA03|01.04.2019||R|0|0|0|0|1|LNA|0|0|0|100|XEU|287748|346268|lyfsjukr|||2|1000|0||Williams & Halls efh|Laboratorios Normon, S.A.|Noradrenalín||273178||273178|346268||2|H|0|0|||0
565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|8782|6109|lyfalmen|V0286|5627|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3350||3350|6109||2|0|G|0|||0
565423|A02BA0208|Asýran|filmhtfl|150|mg|60|stk|1|þpakki||A02BA02|01.07.2019|30.09.2020|R|1|0|0|G|0|TEE|0|0|1|100|XEU|920|2764|lyfalmen|||2|60|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Ranitidín||920||920|2764||1|0|G||||
565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|8943|17137|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|maropitant||||8943|17137||2|0||0|||0
565921|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|glas|95 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|2357|4398|lyfalmen|V0049|2943|2|100|0|66,6667|Artasan ehf|Hexal A/S|Metóprólól||2107||2107|4398||1|0|G|0|||0
565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|1|FEL|0|0|0|100|DKK|24714|34532|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||24714||24714|34532||1|H|S|0|||0
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1582|3675|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1582||1582|3675||1|0|G|0|||0
566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|15299|22555|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||15299||15299|22555||1|0|G|0|||0
567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|1|0|1|NEL|0|0|0|100|DKK|193993|247784|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||193993||193993|247784||1|0|S|0|||0
567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3587|2806|lyfalmen|V0114|2806|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|G|0|APE|0|0|0|100|XEU|16580|24319|lyfalmen|V0651|24316|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16580||16580|24319||1|0|G|0|||0
567371|M05BA0306|Pamidronatdinatrium Pfizer|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|1|PLS|0|0|0|100|DKK|6394|10299|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||6394||6394|10299||1|H|S|0|||0
567372|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC05|01.09.2019||R|1|0|0|0|0|JUB|0|0|1|100|IKR|2000|4113|lyfalmen|V0011|2778|2|56|0|37,3300|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól||1900||1900|4113||2|0|E|0|||0
567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||3412||2|0|G|0|||0
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5996|9751|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5996|9751||1|0|G|0|||0
567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|2141|4445|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2141||2141|4445||1|0|G|0|||0
567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2771|5312|lyfalmen|V0291|2048|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2771||2771|5312||1|0|G|0|||0
567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|3668|6547|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||3668||3668|6547||2|0|G|0|||0
567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0
567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|366415|462229|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||366415|462229||2|0|E|0|||0
567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
567837|G04BE0808|Tadalafil Sandoz|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.01.2018|30.09.2020|R|1|0|0|0|0|SHS|0|0|0|100|DKK|10004|15267|lyfalmen|||2|28|0|14,0000|Artasan ehf|Sandoz A/S|Tadalafíl||10004||10004|15267||1|0|E||||
567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
568054|N02CD0101|Aimovig|stl|70|mg|1|ml|1|áfpen||N02CD01|01.12.2018||R|0|0|1|0|0|NEL|0|0|0|100|DKK|71568|93793|lyfalmen|||1|1|0|28,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||71568||71568|93793||1|0|E|0|||0
568324|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6690|11531|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6690||6690|11531||2|0|0|0|||0
568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ALO|0|0|1|100|IKR|2446|2870|lyfalmen|V0826|2870|2|28|0|42,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||997||997|2870||2|0|G|0|||0
568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2874|lyfalmen|V0334|2601|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1000||1000|2874||2|0|G|0|||0
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1064|2962|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||1064||1064|2962||1|0||0|||0
568745|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.02.2020||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|28|0|18,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0|0|0|||0
568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2664|2815|lyfalmen|V0058|2815|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||957||957|2815||1|0|G|0|||0
568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4041|3491|lyfalmen|V0059|3273|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||1448||1448|3491||1|0|G|0|||0
569171|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|25|stk|1|þpakki||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|759|2543|lyfalmen|||2|25|0|12,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||759||759|2543||2|0|G|0|||0
569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2159|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||500||500|2186||2|0|G|0|||0
569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|0|1|0|1|VIC|0|0|0|100|DKK|134948|174349|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare BV|Abacavír, dolutegravír og lamivudín||134948||134948|174349||1|0|S|0|||0
569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|1|BAM|0|0|0|100|SEK|11018|16663|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||11018||11018|16663||2|H|S|0|||0
569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|4800|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2874||2|0|G|0|||0
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|1|HES|0|0|0|100|DKK|13949|20697|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||13949||13949|20697||1|0|S|0|||0
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|1|HES|0|0|0|100|DKK|16041|23577|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||16041||16041|23577||1|0|S|0|||0
569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|5971|lyfalmen|V0811|5695|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3250||3250|5971||2|0|G|0|||0
570106|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|100|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|10891|14733|lyfalmen|V1005|14733|2|100|0|13,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||9616||9616|14733||2|0|E|1|30|dagar|0
570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3957|2701|lyfalmen|V0110|2701|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||874||874|2701||2|0|G|0|||0
570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2634|5123|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2634||2634|5123||2|0|G|0|||0
570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|G|0|MSD|0|0|0|100|DKK|2147|4453|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2147||2147|4453||1|0|G|0|||0
570775|M01AH0108|Celecoxib Medical|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|3584|6431|lyfalmen|V0196|6431|2|100|0|100,0000|LYFIS ehf|Medical ehf|Celekoxíb||3584||3584|6431||2|0|G|0|||0
571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|EST|0|0|0|100|DKK|3503|6816|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3503||3503|6816||1|0||0|||0
571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|650|2048|lyfalmen|V0908|2048|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||400||400|2048||2|0|G|0|||0
571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BFP|0|0|1|100|XEU|3658|6533|lyfalmen|V0384|5830|2|15|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||3658||3658|6533||2|0|G|0|||0
571181|R07AA0201|Curosurf|innönddr|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|1|CHI|0|0|0|100|XEU|75077|98231|lyfsjukr|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||75077||75077|98231||1|H|S|0|||0
571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|0|1|RRG|0|1|0|100|DKK|563838|707768|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Obinutuzumab||563838||563838|707768||2|H|L|0|||0
571667|N03AX1602|Lyrica (Lyfjaver)|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|17117|25058|lyfalmen|V0687|4939|3|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||17117||17117|25058||3|0|E|0|||0
571872|J01CR0206|Amoxicillin/Clavulanic Acid Normon|sts/irs|1200|mg|100|hgl|1|pakki|1000+200 mg|J01CR02|01.09.2019||R|0|0|0|0|1|LNA|0|0|1|100|XEU|59096|78018|lyfsjukr|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Amoxicillín og beta-laktamasa hemill||59096||59096|78018||2|0|0|0|||0
571902|N05AH0416|Quetiapin Medical Valley|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|5400|7540|lyfalmen|V0910|7540|2|100|0|37,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||4390||4390|7540||2|0|0|0|||0
572062|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|1|CLU|0|1|0|100|XEU|39720|53511|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||39720||39720|53511||1|0|L|0|||0
572119|J01DD0206|Ceftazidima Normon|sts|1|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|1|LNA|0|0|1|100|XEU|92694|120513|lyfsjukr|||2|50|0|12,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||92694||92694|120513||2|0|0|0|||0
572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|76444|99960|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||76444||76444|99960||1|0|G|0|||0
572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2695||2|0|G|0|||0
572777|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|7237|3060|lyfalmen|V0684|3060|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1135||1135|3060||2|0|G|0|||0
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|3294|6032|lyfalmen|V0994|2448|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||3294||3294|6032||1|0|G|0|||0
573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|1|0|1|GSE|0|0|0|100|DKK|2218259|2765404|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir og ledipasvir||||2218259|2765404||2|0|S|0|||0
573477|L01XC0301|Herceptin|st/irþ|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|0|1|RRG|0|1|0|100|DKK|91719|119280|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||91719||91719|119280||2|H|L|0|||0
573579|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6670|3060|lyfalmen|V0683|3060|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1135||1135|3060||2|0|G|0|||0
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|1|PLS|0|0|1|100|DKK|15332|18473|lyfsjukr|||1|10|0|1,6667|Icepharma hf|Pfizer ApS|Meropenem||12333||12333|18473||1|0|ES|0|||0
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|1|PLS|0|0|1|100|DKK|24961|28896|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Pfizer ApS|Meropenem||20258||20258|28896||1|0|ES|0|||0
573863|V03AB3403|FOMEPIZOLE SERB|irþ|5|mg/ml|20|ml|5|lykjur||V03AB34|01.06.2020||R|0|0|0|0|1|SER|0|0|0|100|XEU|99829|129537|lyfsjukr|||1|100|0||SERB SA|SERB SA|Fómepízól||99829||99829|129537||3|H|S|0|||0
574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2|0||0|||0
574395|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.06.2020||R|0|0|0|0|1|AEE|0|0|0|100|XEU|1519|3589|lyfsjukr|||2|10|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1519||1519|3589||1|H|S|2|450|mg|0
574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|0|1|RRG|0|1|0|100|DKK|439245|552809|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Pertuzumab||439245||439245|552809||2|H|L|0|||0
574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|9461|14520|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||9461||9461|14520||1|0|G|0|||0
574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|G|0|PLS|0|0|0|100|DKK|7961|7686|lyfalmen|V0322|2858|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4496||4496|7686||1|0|G|0|||0
575356|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|15015|4340|lyfalmen|V0817|3968|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||2065||2065|4340||2|0|E|0|||0
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|G|0|PLS|0|0|0|100|DKK|13575|7686|lyfalmen|V0323|4166|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4496||4496|7686||1|0|G|0|||0
575458|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 50 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|25814|35923|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og  lixisenatide||25814||25814|35923||1|0|E|0|||0
575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|1|WIL|0|1|0|100|XEU|41269|55471|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||41269||41269|55471||2|H|L|0|||0
575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|1|0|1|NAS|0|0|0|100|DKK|799129|1000404|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||799129||799129|1000404||1|H|S|0|||0
575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1408|2387|lyfalmen|V0159|2387|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||646||646|2387||2|0|E|0|||0
575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1726|3209|lyfalmen|V0160|2945|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1243||1243|3209||2|0|E|0|||0
575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1570|2858|lyfalmen|V0158|2858|2|20|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||988||988|2858||2|0|E|0|||0
575715|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|áfpen|+ 9 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|91790|119370|lyfalmen|||1|2,16|0|6,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||91790||91790|119370||1|0|G|0|||0
575959|N06BA0409|Methylphenidate STADA|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|5600|7898|lyfalmen|V0996|7898|2|30|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||4650||4650|7898||2|0|E|1|30|dagar|0
576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|1|CPV|0|1|0|100|XEU|1298220|1621133|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1298220||1298220|1621133||2|0|L|0|||0
576253|B01AC2202|Prasugrel Krka|filmhtfl|10|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|V0806|10445|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445||2|0|G|0|||0
576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Dexmedetomidinum||5680||5680|10947||2|0||0|||0
576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|G|0|AEP|0|0|0|100|DKK|9136|14073|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||9136||9136|14073||2|0|G|0|||0
576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|13500|16638|lyfalmen|V0680|16638|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||11000||11000|16638||2|0||0|||0
577021|N02AJ0601|Parkodin|filmhtfl|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|492|2175|lyfalmen|||2|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||492||492|2175||1|0|E|3|||0
577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|21964|31054|lyfalmen|V0727|28872|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||21964||21964|31054||1|0|E|0|||0
577505|L04AC0701|RoActemra|stl|162|mg|4|áf-penni|1|pakki||L04AC07|01.03.2019||R|0|1|1|0|1|RRG|0|1|0|100|DKK|151437|194856|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||151437||151437|194856||2|0|L|0|||0
577616|N06BA0905|Atomoxetin STADA|hylki|60|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|4251|lyfalmen|V0816|4251|2|30|0|22,5000|LYFIS ehf|LYFIS ehf|Atomoxetín||2000||2000|4251||2|0|E|0|||0
577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|11866|17830|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11866||11866|17830||2|H|S|0|||0
578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4775|8070|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4775||4775|8070||1|0||0|||0
578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|1|GEH|0|0|0|100|NOK|345498|436214|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||345498||345498|436214||2|H|S|0|||0
578537|J05AR2501|DOVATO|filmhtfl|350|mg|30|stk|1|glas|50 mg/300 mg|J05AR25|01.09.2020||R|1|0|1|0|1|VIC|0|0|0|100|DKK|109674|142915|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravir og lamivudin||109674||109674|142915||1|0|0|0|||0
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|7238|12475|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||7238||7238|12475||2|0||0|||0
578794|A06AB0202|Toilax|sþ-tfl|5|mg|100|stk|1|glas||A06AB02|01.12.2016||R|1|0|0|0|0|ERC|0|0|0|100|DKK|1125|3046|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||1125||1125|3046||1|0|E|0|||0
579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|14658|14436|lyfalmen|V0423|13060|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||9400||9400|14436||2|0|G|0|||0
579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016|30.11.2020|R|1|0|0|G|0|MDK|0|0|0|100|DKK|2629|5116|lyfalmen|||1|98|0|98,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||2629||2629|5116||2|0|G|0|||0
579184|L01CD0205|Docetaxel Accord|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.06.2020||R|0|0|0|0|1|CLU|0|0|0|100|XEU|36655|49635|lyfsjukr|||2|8|0||Artasan ehf|Accord Healthcare S.L.U.|Docetaxel||36655||36655|49635||1|H|S|0|||0
579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|1|BMS|0|1|0|100|DKK|175909|225293|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||175909||175909|225293||1|H|L|0|||0
579322|L01BC0503|Gemcitabine W&H|irs|1000|mg|1000|mg|1|hgl|innrennslistofn|L01BC05|01.02.2019||R|0|0|0|0|1|WEH|0|0|0|100|XEU|9730|14890|lyfsjukr|||2|1000|0||Williams & Halls efh|Williams & Halls ehf|Gemcitabín||9730||9730|14890||2|H|S|0|||0
579491|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Innöndunartæki og 3 áfyllingar|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|21449|28405|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||19549||19549|28405||1|0|G|0|||0
579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|þpakki|30+500 mg|N02AJ06|01.02.2018||R|1|0|0|0|0|ATE|0|0|1|100|IKR|1810|3989|lyfalmen|||2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1810||1810|3989||1|0|E|1|||0
579910|L04AA3701|OLUMIANT|filmhtfl|4|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|1|NED|0|1|0|100|XEU|129504|167578|lyfsjukr|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||129504||129504|167578||2|0|L|0|||0
579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|10631|16130|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||10631||10631|16130||1|0|G|0|||0
579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|3302|2544|lyfalmen|V0107|2530|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||760||760|2544||2|0|E|0|||0
579972|C03DA0403|Eplerenon  Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BFP|0|0|0|100|XEU|15238|10584|lyfalmen|V0111|6315|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||6601||6601|10584||2|0|E|0|||0
580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8850|13679|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8850||8850|13679||1|0||0|||0
580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|0|1|FKD|0|0|0|100|DKK|10977|16607|lyfsjukr|||1|8|0||Vistor hf|Fresenius Kabi Deutschland GmbH|Docetaxel||10977||10977|16607||1|H|S|0|||0
580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|4163|7228|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4163||4163|7228||1|0|G|0|||0
580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|1|BAM|0|0|1|100|SEK|1635|3748|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1635||1635|3748||2|0|S|0|||0
581379|C08CA0106|Amlodipin Medical Valley|töflur|10|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2927|2584|lyfalmen|V0057|2584|2|112|0|224,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||789||789|2584||2|0|G|0|||0
581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3361|6124|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3361||3361|6124||2|0|G|0|||0
581474|N02BA5105|Treo Hindbær|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.06.2020||L|0|0|0|0|0|MDK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
581661|N02CC0406|Rizatriptan Alvogen|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|XEU|3684|6569|lyfalmen|||2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||3684||3684|6569||2|0|G|0|||0
581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|24209|lyfalmen|||2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||16500||16500|24209||2|0|G|0|||0
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|ANI|1|0|0|100|XEU|14861|28365|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14861||14861|28365||2|0||2|||0
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2494|4931|lyfalmen|V0669|4165|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||2494||2494|4931||1|0|G|0|||0
582004|L01XE2901|Lenvima|hylki|4|mg|30|stk|1|þpakki||L01XE29|01.12.2018||R|0|0|1|0|1|SIE|0|0|0|100|SEK|251826|319712|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||251826||251826|319712||1|0|S|0|||0
582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||||4185|8110||2|0||0|||0
582096|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|4401|7390|lyfalmen|V0972|7390|2|100|0|30,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||4281||4281|7390||2|0|G|0|||0
582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|18075|26376|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||18075||18075|26376||3|0|G|0|||0
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|1|GEH|0|0|0|100|NOK|22893|32229|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Iohexol||22893||22893|32229||2|H|S|0|||0
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|18645|27161|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Iohexol||18645||18645|27161||2|H|S|0|||0
582611|A10BJ0601|Ozempic|stl|1|mg|3|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|20312|28964|lyfalmen|||1|3|0|27,2727|Vistor hf|Novo-Nordisk|Semaglutide||20312||20312|28964||1|0||0|||0
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|55935|74020|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Iohexol||55935||55935|74020||2|H|S|0|||0
582671|H02AB0912|Alkindi|kyrnhylk|5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|79546|103883|lyfalmen|||1|50|0|8,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||79546||79546|103883||2|0|G|0|||0
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|23279|32717|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||23279||23279|32717||2|H|S|0|||0
582981|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.06.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3897|5636|lyfalm11|V0983|5636|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3486||3486|5636||2|0||0|||0
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|1|MEC|0|1|0|100|SEK|34355|46726|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||34355||34355|46726||2|0|L|0|||0
583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|G|0|PLS|0|0|0|100|DKK|2109|4401|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2109||2109|4401||1|0|G|0|||0
583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|47556|63422|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||47556||47556|63422||2|H|S|0|||0
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1248|3216|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||1248||1248|3216||2|0|G|0|||0
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|80312|104852|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||80312||80312|104852||2|H|S|0|||0
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|25444|35455|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||25444||25444|35455||2|H|S|0|||0
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|40710|54764|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||40710||40710|54764||2|H|S|0|||0
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|1|GEH|0|0|0|100|NOK|76331|99817|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||76331||76331|99817||2|H|S|0|||0
583888|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|4061|7087|lyfalmen|V0985|7087|2|30|0|60,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||4061||4061|7087||2|0|G|0|||0
583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|1|RAU|0|0|1|100|XEU|2139|4442|lyfsjukr|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||2139||2139|4442||2|0|S|0|||0
584577|A04AD1202|Aprepitant Medical Valley|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.07.2019||R|1|0|0|0|1|VAL|0|0|1|100|XEU|8555|10200|lyfsjukr|||2|3|0|1,7273|Acare ehf|Medical Valley Invest AB|Aprepitant||6322||6322|10200||2|0|S|0|||0
584738|N03AX1212|Gabapenstad|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|1|0|G|0|ASR|0|0|0|100|IKR|1800|3975|lyfalmen|V0250|3268|2|120|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1800||1800|3975||2|0|G|0|||0
584834|N06AX2701|Spravato|nefúði|28|mg|28|mg|1|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|0|0|100|SEK|34588|47021|lyfalmen|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||34588||34588|47021||1|H||0|||0
584851|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.09.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|640|2379|lyfalmen|V0448|2379|2|100|0|50,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||640||640|2379||1|0|G|0|||0
585283|S01ED5122|Fixopost|augndr|||0,2|ml|90|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|7862|12319|lyfalmen|||2|18|0|90,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||7862||7862|12319||1|0|G|0|||0
585287|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|65893|86615|lyfalmen|V0727|86615|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||65893||65893|86615||1|0|E|0|||0
585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|0|1|MBV|0|1|0|100|DKK|549074|689406|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||549074||549074|689406||1|H|L|0|||0
585458|M02AA1502|Voltaren|hlaup|11,6|mg/g|75|g|1|túpa||M02AA15|01.11.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|75|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|19297|28058|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||19297||19297|28058||1|0|G|0|||0
585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|LEP|0|0|1|100|DKK|6360|10252|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||6360||6360|10252||1|0||0|||0
585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2500|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||500||500|2186||2|0|G|0|||0
585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|G|0|AEP|0|0|0|100|DKK|12768|19072|lyfalmen|||1|4|0|20,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||12768||12768|19072||2|0|G|0|||0
585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|GPH|0|0|0|100|DKK|4309|7429|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4309||4309|7429||1|0||0|||0
585905|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|11089|10720|lyfalmen|V0440|10720|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||6700||6700|10720||2|0|G|0|||0
585914|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|1|HSS|0|1|0|100|DKK|142821|184141|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||142821||142821|184141||1|H|L|0|||0
586005|N03AX1212|Gabapenstad|hylki|400|mg|100|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|1|0|G|0|ASR|0|0|0|100|IKR|1833|3150|lyfalmen|V0251|3150|2|100|0|22,2200|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1200||1200|3150||2|0|G|0|||0
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|28924|39857|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||28924||28924|39857||1|0|G|0|||0
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|1|LEM|0|0|1|100|XEU|13461|20026|lyfsjukr|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||13461||13461|20026||2|0|ES|0|||0
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|0|1|MYE|0|1|1|100|DKK|337020|425670|lyfsjukr|||1|224|0|56,0000|Icepharma hf|Mylan Ireland Limited|Tobramýcín||337020||337020|425670||2|0|L|0|||0
586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|72209|94604|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||72209||72209|94604||1|0|E|0|||0
586579|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|2861|lyfalmen|V0335|2861|2|110|0|165,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||990||990|2861||2|0|G|0|||0
586627|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|30|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2358|4743|lyfalmen|||2|30|0|90,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||2358||2358|4743||2|0|0|0|||0
586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7148|4018|lyfalmen|V0815|3839|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1831||1831|4018||1|0|E|0|||0
586939|N05AH0415|Quetiapin Krka|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.07.2019||R|0|0|0|G|0|KRK|0|0|0|100|IKR|12500|11408|lyfalmen|V0261|11408|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||7200||7200|11408||2|0|0|0|||0
586959|L01BC0207|Flúoróúracil Accord|stl/irl|50|mg/ml|100|ml|1|hgl||L01BC02|01.12.2019||R|0|0|0|0|1|AEE|0|0|0|100|XEU|4768|8061|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare B.V.|Flúóróúracíl||4768||4768|8061||1|H|0|0|||0
586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|30431|41763|lyfalmen|V0652|41761|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||30431|41763||1|0|G|0|||0
587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4615|6460|lyfalmen|V0196|6431|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||3605||3605|6460||1|0|G|0|||0
587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|1|0|1|JAN|0|1|0|100|DKK|166721|213865|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||166721||166721|213865||1|0|L|0|||0
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|6682|10695|lyfalmen|V0095|10695|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||6682||6682|10695||1|0|E|0|||0
587658|M05BA0606|Ibandronic acid WH|stl|3|mg|3|ml|1|áfspr||M05BA06|01.05.2018||R|0|1|0|0|0|WEH|0|0|0|100|IKR|11132|16820|lyfalmen|V0957|16820|2|3|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||11132||11132|16820||2|0|E|0|||0
587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4451|6812|lyfalmen|V0081|6812|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3861||3861|6812||2|0|G|0|||0
588134|L04AC1201|Kyntheum|stl|210|mg|1,5|ml|2|áf.spr||L04AC12|01.10.2018||R|0|0|1|0|1|OEL|0|1|0|100|DKK|175837|225203|lyfsjukr|||1|3|0|28,0000|Vistor hf|LEO Pharma A/S|Brodalumab||175837||175837|225203||1|0|L|0|||0
588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|1|0|G|0|WEH|0|0|0|100|XEU|6782|3228|lyfalmen|V0683|3060|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1257||1257|3228||2|0|G|0|||0
588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|1|PEU|0|0|0|100|DKK|718628|900283|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||718628||718628|900283||1|0|ES|0|||0
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|PLS|0|0|1|100|DKK|2005|4258|lyfalmen|V0461|3393|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2005||2005|4258||1|0|E|0|||0
588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|18492|13462|lyfalmen|V0282|13079|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||8692||8692|13462||1|0|G|0|||0
589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|1|0|1|NEL|0|1|0|100|DKK|674384|845256|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||674384||674384|845256||1|0|L|0|||0
589302|N02AX0213|Tramadol Krka|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|3500|5352|lyfalmen|V0228|5352|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2800||2800|5352||2|0|G|1|30|dagar|0
589312|N03AX2201|Fycompa|mixtúra|0,5|mg/ml|340|ml|1|glas||N03AX22|01.10.2019||R|0|0|0|G|0|SIE|0|0|0|100|SEK|27074|37517|lyfalmen|||1|340|0|21,2500|Eisai AB|Eisai GmbH|Perampanel||27074||27074|37517||1|0|G|0|||0
589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|1|ABC|0|0|0|100|SEK|11209|16926|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||11209||11209|16926||2|H|S|0|||0
589893|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4580|6185|lyfalmen|V0691|6051|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3405||3405|6185||1|0|E|1|30|dagar|0
590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|1|0|1|CLU|0|0|0|100|XEU|42999|57659|lyfsjukr|||2|90|0|36,0000|Artasan ehf|Accord Healthcare S.L.U.|Síldenafíl||42999||42999|57659||1|0|ES|0|||0
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3161|5105|lyfalmen|V0041|3931|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísósorbíð mónónítrat||2621||2621|5105||1|0|G|0|||0
590825|L01XX5001|Ninlaro|hylki|2,3|mg|1|stk|3|þpakki|hvert hylki sérpakkað í þynnu|L01XX50|01.01.2019||R|0|0|1|0|1|TPA|0|0|0|100|DKK|873742|1093202|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||873742||873742|1093202||1|0|S|0|||0
590845|N06AB0406|Citalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.01.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1600|3700|lyfalmen|V0317|3675|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||1600||1600|3700||2|0|G|0|||0
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|1|BOI|0|0|0|100|DKK|152765|196508|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||152765||152765|196508||1|H|S|0|||0
590947|H05BX0105|Cinacalcet Accord|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2018|30.11.2020|R|1|0|0|0|0|AEE|0|0|0|100|XEU|37213|9169|lyfalmen|||2|28|0|28,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||5573||5573|9169||1|0||0|||0
591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|9789|14971|lyfalmen|V0347|14971|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||9789||9789|14971||3|0|G|0|||0
591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|1|0|1|PEU|0|1|0|100|DKK|125847|163030|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||125847||125847|163030||1|0|L|0|||0
591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2135|4437|lyfalmen|V0561|3747|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||2135||2135|4437||2|0||0|||0
591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1200|3150|lyfalmen|V0168|2917|1|21|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1200||1200|3150||1|0|E|0|||0
591812|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|1|HSS|0|1|0|100|DKK|142821|184141|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||142821||142821|184141||1|H|L|0|||0
592068|J01DD0402|Ceftriaxona Normon|sts|1000|mg|1|stk|1|hgl|+ 1 lykja með leysi.|J01DD04|01.06.2018||R|0|0|0|0|1|LNA|0|0|1|100|XEU|2510|4953|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2510||2510|4953||2|0|ES|0|||0
592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|V0825|3012|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0
592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3921|7609|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3921||3921|7609||1|0||0|||0
592961|H05BX0107|Cinacalcet STADA|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|41798|15262|lyfalmen|V0722|15262|2|28|0|42,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||10000||10000|15262||2|0||0|||0
592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|1|0|1|GEB|0|0|0|100|XEU|747101|932946|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||744890||744890|932946||1|0|S|0|||0
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|983|2851|lyfalmen|||1|150|0|9,3750|Icepharma hf|Roche A.S.|Klónazepam||983||983|2851||2|0|G|2|450|töflur|0
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1259|3231|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche A.S.|Klónazepam||1259||1259|3231||2|0|G|2|100|töflur|0
593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|G|0|WEH|0|0|0|100|XEU|7974|4432|lyfalmen|V0694|4135|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2132||2132|4432||2|0|G|0|||0
593555|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|70|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1556|3474|lyfalmen|V0686|2542|2|70|0|17,5000|Acare ehf|Medical Valley Invest AB|Pregabalín||1436||1436|3474||2|0|E|0|||0
594343|N02AE0104|Buprenorphine ratiopharm|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018||R|0|0|0|G|0|RTH|0|0|0|100|IKR|3504|6321|lyfalmen|V0945|6321|2|4|0|11,2000|Alvogen|ratiopharm GmbH|Búprenorfín||3504||3504|6321||2|0|G|1|30|dagar|0
594709|C01CA1702|Midodrin Evolan|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|G|0|EVO|0|0|0|100|IKR|10293|13734|lyfalmen|V0969|12927|2|50|0|8,3333|LYFIS ehf|Evolan Pharma AB|midodrine||8890||8890|13734||2|0|G|0|||0
595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|16953|24832|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16953||16953|24832||1|0|G|0|||0
595364|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|V0959|4870|2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870||2|0|E|1|30|dagar|0
595455|A10BA0205|Metformin EQL|filmhtfl|500|mg|330|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|2000|4251|lyfalmen|||2|330|0|82,5000|LYFIS ehf|EQL Pharma AB|Metformín||2000||2000|4251||2|0|G|0|||0
595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|1|PEU|0|1|0|100|DKK|21147|30020|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||21147||21147|30020||1|0|L|0|||0
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|1|RAG|0|0|0|100|DKK|53569|71028|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||53569|71028||1|0|S|0|||0
596223|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|40|skammtar|1|glas||N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|40|0|1,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1367|2356|vetorma|||0|2|0||Icepharma hf|Vetoquinol S.A.|Febantel, Pyrantelembonat,Prazikvantel||1367||1367|2356||2|0||0|||0
597167|J01DD0206|Ceftazidima Normon|sts|2|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|1|LNA|0|0|1|100|XEU|100614|112937|lyfsjukr|||2|50|0|25,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||86704||86704|112937||2|0|0|0|||0
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1823|4007|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1823||1823|4007||1|0|E|0|||0
597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|1|BMS|0|1|0|100|DKK|586283|735683|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||586283||586283|735683||1|H|L|0|||0
597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|1|0|1|BNB|0|0|0|100|XEU|107228|139873|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||107228||107228|139873||2|0|S|0|||0
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|G|0|ADI|0|0|0|100|SEK|2483|4916|lyfalmen|||1|100|0|33,3333|Abcur AB|Amdipharm Limited|Acetazólamíð||2483||2483|4916||2|0|G|0|||0
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|SNP|0|0|1|100|XEU|385|2028|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||385||385|2028||1|0||0|||0
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0
598843|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|tfílát||A07EC03|01.04.2018||R|1|0|0|G|0|ATN|0|0|0|100|DKK|4390|7540|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4390||4390|7540|30.11.2020|2|0|G|0|||0
598859|M05BA0306|Pamidronatdinatrium Pfizer|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|1|PLS|0|0|0|100|DKK|5658|9286|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5658||5658|9286||1|H|S|0|||0
598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|EKI|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Íbúprófen|||||2289||1|0||0|||0
599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|1|0|1|PEU|0|1|0|100|DKK|547094|686943|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||547094||547094|686943||1|0|L|0|||0
599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|0|1|ATE|0|0|0|100|XEU|8207|12794|lyfsjukr|||2|20|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxalíplatín||8207||8207|12794||1|H|S|0|||0
599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3732|7251|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||3732||3732|7251||1|0||0|||0
599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|4665|9021|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4665||4665|9021||2|0||0|||0
599460|S01XA2024|Oculac án rotvarnar|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2611||1|0|G|0|||0
599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|30144|41400|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||30144|41400||1|0|G|0|||0
599531|H05BX0105|Cinacalcet Accord|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2018|30.11.2020|R|1|0|0|0|0|AEE|0|0|0|100|XEU|20130|7357|lyfalmen|||2|28|0|14,0000|Artasan ehf|Accord Healthcare B.V.|Cinacalcet||4257||4257|7357||1|0||0|||0
599632|B01AA0303|Warfarin Teva|töflur|1|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1365|3377|lyfalmen|||2|100|0|13,3333|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1365||1365|3377||1|0|G|0|||0
599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|3776|3863|lyfalmen|V0334|2601|2|100|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1718||1718|3863||1|0|G|0|||0
954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|0|1|EAG|0|0|0|100|NOK|114805|149297|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare B.V.|Lofendýlat||114805||114805|149297||2|H|S|0|||0
957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22309|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22309||2|0||0|||0
957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3296|6035|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||3296||3296|6035||2|0||0|||0
968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|1918|4138|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1918||1918|4138||2|0||0|||0
968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27471|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27471||2|0||0|||0
968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|1|0|0|PAR|0|0|0|100|IKR|7280|11518|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7280||7280|11518||2|0||0|||0
968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5529|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5529||2|0||0|||0
968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6522|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6522||2|0||0|||0
970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|PAR|0|0|1|100|IKR|4187|7261|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||4187||4187|7261||2|0||0|||0
970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23513|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23513||2|0||0|||0
970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2095|4381|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||2095||2095|4381||2|0|E|0|||0
974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6143|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6143||2|0||0|||0
974792|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|2,5|mg/ml|100|ml|1|fl||C09AA01|01.07.2018||R|0|0|0|0|0|PAR|0|0|0|100|IKR|23568|33082|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||23568||23568|33082||2|0||0|||0
974809|A01AC0002|Fluticasone propionate - forskriftarlyf|munnskol|0,1|mg/ml|300|ml|1|fl||A01AC|01.12.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3962|6951|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3962|6951||2|0||0|||0
974825|D07XA0103|HTH krem - forskriftarlyf|krem|||30|g|1|túpa|4%/0,025%/1%|D07XA01|01.06.2019||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3475|6281|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Hydrocortisone||3475||3475|6281||2|0|0|0|||0
974841|D10AD0104|Tretinoin - forskriftarlyf|krem|0,05|%|30|g|1|túpa||D10AD01|01.01.2020||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2979|5598|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||2979||2979|5598||2|0|0|0|||0
980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|5245|8717|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||5245||5245|8717||2|0||0|||0
980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|PAR|0|0|1|100|IKR|16998|24894|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24894||2|0||0|||0